<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d7" for="edge" attr.name="order" attr.type="long" />
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="clusters" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="&quot;METABOLIC SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by a cluster of metabolic abnormalities including high blood pressure, insulin resistance, and dyslipidemia."&lt;SEP&gt;"The composition of the gut microbiota can be associated with metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;SERUM TOTAL CHOLESTEROL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Represents the total cholesterol in serum which includes LDL and HDL cholesterol and other lipoproteins."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;LDL CONCENTRATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Low-density lipoprotein (LDL) concentrations represent a type of blood lipid that can contribute to cardiovascular disease when present in high amounts."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM TRIGLYCERIDE CONCENTRATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Concentration of triglycerides in serum, representing stored fat in the body which can affect health if elevated."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;HDL CONCENTRATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High-density lipoprotein (HDL) concentrations represent a type of blood lipid that helps remove cholesterol from arteries and is typically considered beneficial."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;LIPID PROFILES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A set of measurements related to the levels of various types of fats in the bloodstream, including cholesterol and triglycerides."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;HS-CRP CONCENTRATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High-sensitivity C-reactive protein concentrations are a marker for inflammation which can be elevated in obesity."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;BLOOD PRESSURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measure of the force exerted by circulating blood against the walls of blood vessels, with high levels associated with cardiovascular diseases."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;EGFR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Estimated glomerular filtration rate is a measure used to check kidney function."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM ALANINE AMINOTRANSFERASE (ALT) AND ASPARTATE AMINOTRANSFERASE (AST)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Liver enzymes, their higher concentrations in serum indicate liver damage or dysfunction."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;DAILY ENERGY INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Total amount of energy consumed through food intake over a day."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;PROTEIN INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Amount of protein contained in the diet which is essential for body functions and structure."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;CARBOHYDRATE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of carbohydrates is a dietary factor investigated for interaction with genetic variants impacting Type 2 Diabetes risk."&lt;SEP&gt;"Total amount of carbohydrates consumed through food intake over a day."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FAT INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fats including saturated, monounsaturated, polyunsaturated fatty acids, and cholesterol found in dietary patterns."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;DIET INFLAMMATORY INDEX (DII)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A score indicating the degree of inflammation-promoting diet based on food intake data."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by the consumption of fried foods, which interacts with PRS to influence BMI and obesity risk."&lt;SEP&gt;"The amount of fried foods consumed which can be a factor in obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;SUGAR-CONTAINING FOODS INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of sugar-containing foods like desserts, drinks etc., which contribute to the overall dietary pattern."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;KOREAN BALANCED DIET AND WESTERN-STYLE DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The proportion of these diets consumed in relation to obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;PLANT-BASED DIET AND RICE-BASED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake patterns related to plant-based and rice-based diet, linked with body composition and health status."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;ALCOHOL INTAKE&quot;">
      <data key="d0">"FOOD/BEVERAGE"</data>
      <data key="d1">"Drinking alcohol in moderate to high amounts increasing the risk of type 2 diabetes, especially among those at genetic predisposition."&lt;SEP&gt;"The amount of alcohol consumed which may be a risk factor for obesity."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;CURRENT SMOKERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Individuals who are current smokers, indicating smoking as a lifestyle characteristic."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;REGULAR EXERCISE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engagement in regular physical activity which can influence body composition and health outcomes."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SEC16B (RS543874)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in SEC16 Homolog B involved in obesity risk by modulating transcription factors related to energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;DNAJC27 (RS713586)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in DnaJ heat shock protein family member C27, contributing to obesity risk through modulation of transcription factors and influencing energy regulation."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;CDKAL1 (RS9356744)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variation in CDK5 regulatory subunit-associated protein 1-like 1 associated with the risk of obesity by modulating transcriptional processes."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TFAP2B (RS2206277)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Transcription factor AP-2 Beta, a gene involved in energy intake regulation and associated with obesity risk through genetic variation."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;BDNF (RS6265)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in Brain-Derived Neurotrophic Factor involved in obesity risk by influencing the transcriptional regulatory network related to metabolic processes."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MYL2 (RS3782889)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variation in myosin light chain-2, contributing to obesity risk through effects on energy expenditure and regulation of muscle function."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;OLFM4 (RS9568856)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Olfactomedin-4 gene, involved in the regulation of energy intake or expenditure and associated with obesity through genetic variation."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;FTO (RS1421085)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in FTO influencing obesity risk by modulating transcription factors related to energy regulation."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MC4R (RS6567160)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Melanocortin 4 receptor gene, a hub gene affecting the risk of obesity through genetic variation and modulation of metabolic processes."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;GIPR (RS1444988703)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in G protein-coupled receptor for gastric inhibitory polypeptide, impacting obesity risk via regulation of energy balance."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of body fat based on height and weight that is used to assess the risk for disease. In this study, BMI was significantly higher in asthmatic patients compared to healthy controls."&lt;SEP&gt;"A measure of body fat based on height and weight, influencing various physiological processes including bile acid metabolism."&lt;SEP&gt;"A measure of body fat based on height and weight, used to assess obesity-related health risks."&lt;SEP&gt;"A measure used to assess whether an individual is underweight, normal weight, overweight, or obese."&lt;SEP&gt;"Body Mass Index is a physiological process used to quantify and assess the impact of genetic variations on body weight status and obesity risk."&lt;SEP&gt;"BMI is a physiological process that reflects the relationship between an individual's height and body mass. It serves as a measure for obesity risk."&lt;SEP&gt;"An indicator of body fat based on height and weight; used in this study to adjust for potential confounding factors related to metabolic health."&lt;SEP&gt;"BMI is a measure used to assess body fat based on height and weight. It influences metabolic health and dietary adherence."&lt;SEP&gt;"BMI was observed to be lower in carriers of any minor alleles compared to those without, adjusting for age and other factors."&lt;SEP&gt;"A physiological process indicating the weight status of an individual, influencing snoring severity and prevalence."&lt;SEP&gt;"Cases had slightly higher BMI compared to controls, indicating a possible link between obesity and colorectal cancer risk."&lt;SEP&gt;"Body Mass Index is a measure used to assess obesity or underweight based on an individual's height and weight, relevant in this context for its potential impact on T2D risk."&lt;SEP&gt;"A measure used to determine whether a person is at a healthy weight for their height."&lt;SEP&gt;"BMI is a measure of body fat based on height and weight, which differs significantly according to the rs671 polymorphism in men."&lt;SEP&gt;"BMI is a measure of body fat based on an individual's height and weight, influencing various physiological processes including bile acid metabolism."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-a34b927ed42ff0917960122b4d203f83&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;PRS SCORE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Polygenic Risk Scores representing the cumulative effect of multiple genetic variants on metabolic pathways influencing obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TMEM18 (RS6543156)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant near Transmembrane protein 18 influencing obesity risk by modulating transcriptional processes related to metabolic regulation."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;PRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polygenic risk score for obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;EARLY MENARCHE AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The age of initial menstruation in women, which interacts with PRS to influence BMI and obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LATE MENARCHE AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The later age of initial menstruation in women, which has a lower impact of PRS on BMI compared to early menarche age."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;BMI&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Body Mass Index (BMI) is a measure of body fat based on an individual's weight in relation to their height. It was one of several T2D related quantitative traits assessed in the study for association with genomic variants."&lt;SEP&gt;"Body Mass Index (BMI) is a measure that shows positive correlation with the prevalence of snoring in both males and females."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to assess obesity and is related to metabolic pathways and physiological processes such as insulin resistance in conditions like T2D and IFG/IGT."&lt;SEP&gt;"Body Mass Index (BMI) was tested for its influence but did not show a significant interaction with genetic risk factors (P = 0.47)."&lt;SEP&gt;"Body Mass Index is a measure used to assess obesity risk and was higher in participants with early menarche age and high PRS."&lt;SEP&gt;"Body mass index (BMI) is a cardiovascular risk factor that increases hyperuricaemia risk and serum uric acid levels in T allele carriers of the ABCG2 rs2231142 variant."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by the consumption of plant-based foods, which interacts with PRS to influence obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;HIGH PLANT-BASED DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of a high amount of plant-based diet that can protect against obesity in individuals with a high PRS."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;OBESITY RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Increased obesity risk can be influenced by genetic variants and educational background."&lt;SEP&gt;"Increased obesity risk is influenced by the presence of certain genetic variants like the FTO SNP and educational level."&lt;SEP&gt;"The risk of developing obesity, influenced by interactions between genetic factors (PRS) and dietary patterns such as plant-based diets and fried-food intake."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;NUTRIENT INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The intake of various nutrients that can interact with PRS to influence obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;DIETARY PATTERNS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Different dietary patterns such as plant-based and fried-food diets, which interact differently with PRS in terms of BMI and obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;GENDER DIFFERENCES&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"Women have higher serum total cholesterol and LDL levels than men in this study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OBESITY STATUS&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"Estimated glomerular filtration rate is lower in the obese group than nonobese participants, indicating potential kidney function issues associated with obesity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM ALT AND AST CONCENTRATIONS&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"Higher liver enzymes (ALT and AST) are observed in obese groups compared to nonobese individuals across genders, highlighting the impact of obesity on liver health.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;SEX DIFFERENCES&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"Intake of fats like saturated fatty acids shows sex-specific associations, being higher among men and contrasting patterns among women.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DII&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"Men have a higher DII score compared to women, indicating a more inflammatory diet for males.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENERGY REGULATION&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"The CDKAL1 genomic variant affects energy regulation by modulating transcriptional mechanisms involved in metabolic pathways."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR AP-2 BETA&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"Genetic variation in TFAP2B impacts the function of Transcription factor AP-2 Beta, influencing energy intake and obesity risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METABOLIC PROCESSES&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"A BDNF genetic variant influences metabolic processes through modulation of transcriptional regulatory networks related to energy balance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUSCLE FUNCTION&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"Genetic variation in MYL2 impacts muscle function and contributes to obesity risk through effects on energy expenditure."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTORS&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"A FTO genetic variant modulates transcription factors related to energy regulation, affecting the risk of obesity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"Campylobacter's metabolic pathways are affected by genomic variants linked to antibiotic resistance."&lt;SEP&gt;"The MC4R gene affects metabolic pathways and is a hub gene influencing obesity risk through genetic variation."</data>
      <data key="d0">"METABOLIC PATHWAY"</data>
    </node>
    <node id="&quot;ENERGY BALANCE&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"Genetic variation in GIPR impacts energy balance by modulating the effects of gastric inhibitory polypeptide."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO RS1558902&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the FTO gene that affects body weight and composition."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by a high intake of protein, which interacts with the FTO rs1558902 genotype to influence weight loss and body composition changes."&lt;SEP&gt;"A dietary pattern characterized by higher protein intake compared to standard or low-protein diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by a low intake of protein, showing no significant interaction effects on weight loss and body composition when paired with the FTO rs1558902 genotype."&lt;SEP&gt;"A dietary pattern characterized by lower protein intake compared to standard or high-protein diets."&lt;SEP&gt;"A dietary pattern prescribed to patients with HI/HA syndrome due to a GLUD1 genetic defect, consisting of 1.5 g/kg/day of natural protein intake."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of losing weight, which is influenced by both genetic factors (such as the FTO gene) and dietary patterns."&lt;SEP&gt;"Weight loss refers to the physiological process of reducing body mass, which can be influenced by genetic factors such as SNP rs4771122."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;BODY COMPOSITION CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in body composition, including fat mass and muscle mass, that are influenced by genetic variants such as the FTO rs1558902 genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in how fat is distributed within the body, which can be affected by both genetics (like the FTO variant) and diet."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TOTAL FAT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The reduction in total body fat, which is influenced by both genetic factors (e.g., FTO rs1558902) and dietary patterns."&lt;SEP&gt;"The reduction of total fat mass in the body, influenced by genetic factors such as the presence or absence of the risk allele in the FTO rs1558902 genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;LEAN MASS CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in lean muscle mass due to interactions between the FTO rs1558902 genotype and protein intake."&lt;SEP&gt;"Changes in lean muscle mass, which are affected by interactions between the FTO rs1558902 genotype and dietary protein intake."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant of the FTO gene that influences body weight changes based on dietary protein intake."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WC (WAIST CIRCUMFERENCE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measurement of the waist that helps determine the amount of abdominal fat and assess health risks."&lt;SEP&gt;"Waist circumference is a measurement that helps in assessing abdominal obesity, impacting cardiovascular risk factors."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;FAT-FREE MASS (FFM)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The part of body weight that is not fat, which can be influenced by genetic variants like FTO rs1558902 in response to dietary changes."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;VISCERAL ADIPOSE TISSUE (VAT)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A type of fat tissue located within the abdominal cavity and around organs, which can be affected by genetic factors like FTO rs1558902 and dietary protein intake."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;SUBCUTANEOUS ADIPOSE TISSUE (SAT)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Fat tissue under the skin that is influenced by diet and genetics, such as the FTO rs1558902 variant."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TRUNK FAT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The reduction of fat accumulation in the trunk area, impacted by genetic factors like FTO rs1558902 genotype and dietary protein intake."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;AA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The AA genotype is a specific variant associated with differential responses to dietary interventions, particularly high-protein diets."&lt;SEP&gt;"The AA genotype of rs1695 polymorphism was found in controls with a frequency of 50.00% but not significantly associated with breast cancer risk."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fat distribution refers to the amount and location of fat in the body, which can change in response to diet and genotype."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TAT AND SAT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"TAT (thoracic adipose tissue) and SAT (subcutaneous abdominal adipose tissue) loss are physiological processes indicating a reduction in specific types of fat deposits."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LOW-FAT DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by lower fat intake compared to standard or high-fat diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TOTAL FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total fat refers to the overall amount of body fat, which can change in response to diet and genotype."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FM% (FAT MASS PERCENTAGE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FM% represents the percentage of total body mass that is fat mass, influenced by dietary patterns and genetic factors."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The distribution of fat in the trunk area, which can change in response to dietary interventions based on genotype."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE CHANGES&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The genetic variant affects the change in waist circumference, particularly in response to dietary protein intake."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FM%&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"Participants with the AA genotype showed differential responses to low-fat diet interventions, specifically affecting their fat mass percentage compared to other genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO rs9939609 polymorphism is associated with anthropometric variables such as weight, BMI and waist circumference."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by excessive accumulation of fat tissue; studied due to its association with genetic variants and dietary patterns."&lt;SEP&gt;"Obesity is a condition characterized by excessive accumulation of body fat, associated with various health risks including cardiovascular disease and diabetes."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;EDUCATION LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Educational level is a lifestyle factor that can influence the prevalence of obesity and the relationship between genetic factors like FTO polymorphism and obesity risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 27}]</data>
    </node>
    <node id="&quot;FTO GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene where the effect on CRP diminishes considerably after adjustment for multiple factors, suggesting mediation by physiological processes such as BMI."&lt;SEP&gt;"FTO gene contains a SNP (rs1558902) located in the first intron, which showed significant association with CRP after multiple testing correction."&lt;SEP&gt;"The FTO gene contains a polymorphism (rs9939609) that is associated with anthropometric variables such as weight, BMI, and waist circumference."&lt;SEP&gt;"FTO is a gene previously linked to multiple health traits including smoking, alcohol consumption, and musculoskeletal conditions."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;ANTHROPOMETRIC VARIABLES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Anthropometric variables include measurements like weight, BMI, and waist circumference which are physiological processes used to assess body composition."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Age as a physiological process and risk factor is considered in studies on HIV disease progression."&lt;SEP&gt;"Age is a physiological factor affecting disease risk and genetic studies."&lt;SEP&gt;"Age is an environmental factor that influences the relationship between FTO SNP and anthropometric variables. Different age groups may exhibit varying effects of genetic polymorphisms on these variables."&lt;SEP&gt;"Age was tested for interaction with genetic variants but no significant evidence was found (P = 0.20)."&lt;SEP&gt;"Age is an environmental factor that shows a positive correlation with snoring prevalence."&lt;SEP&gt;"The age of an individual influences the composition of their gut microbiota, with changes observed over different life stages."&lt;SEP&gt;"Age is an important demographic factor influencing physiological and psychological development including behavioral traits like social disinhibition."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;SEX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sex is a lifestyle factor that can influence the relationship between FTO SNP and anthropometric measurements, as seen in statistical adjustments for sex differences."&lt;SEP&gt;"Sex was considered as an environmental factor without showing a significant interaction effect on the analysis results (P = 0.59)."&lt;SEP&gt;"Sex is a physiological process that can influence genetic associations."&lt;SEP&gt;"Sex, particularly being male, significantly influences the risk of snoring due to inherent physiological differences between sexes."&lt;SEP&gt;"Sex, as a physiological characteristic, is analyzed for its impact on HIV disease progression."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;SMOKING STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An indicator of smoking behavior, which can affect physiological processes including blood cortisol level."&lt;SEP&gt;"Smoking status is an environmental factor used to adjust models assessing the impact of FTO SNP on BMI and obesity risk."&lt;SEP&gt;"Smoking status refers to an individual's smoking behavior, categorized as smoker or non-smoker."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A metabolic disorder characterized by high blood glucose levels due to defects in insulin production or function."&lt;SEP&gt;"Diabetes is a disease condition that can influence anthropometric measurements such as BMI, and it’s considered in statistical adjustments for its potential confounding effect."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engagement in physical activity showing interaction with genetic variants to influence the protective effect against type 2 diabetes incidence."&lt;SEP&gt;"PA, or physical activity level, can influence the statistical significance of FTO SNP's effect on obesity risk."&lt;SEP&gt;"Physical activity levels are lifestyle factors that may modify the relationship between FTO SNP and obesity risk. Different levels of PA can affect metabolic processes and body composition."&lt;SEP&gt;"Physical activity is a lifestyle factor studied in relation to gene-environment interactions and its impact on health outcomes such as diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d3">[{"level": 0, "cluster": 15}]</data>
    </node>
    <node id="&quot;PRIMARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Having primary studies education level is a specific category within educational attainment, which influences the interaction with the FTO SNP in terms of BMI and obesity risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;SECONDARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Secondary studies education level is another category under educational attainment that interacts with genetic polymorphisms like the FTO rs9939609 to affect BMI and obesity risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;UNIVERSITY-LEVEL EDUCATION&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Having a university-level education is associated with lower obesity risk compared to individuals without higher education, affecting interactions between lifestyle factors and genetic susceptibility to obesity."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;FTO SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO SNP is a genomic variant associated with obesity risk, particularly in individuals without university studies."&lt;SEP&gt;"The FTO SNP is a genomic variant associated with obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;UNIVERSITY STUDIES&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Having university studies is associated with lower significance in the FTO SNP's impact on obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISM (GP)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The GP refers to genetic factors that influence dietary patterns and nutrition-related health outcomes."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;HEALTH CARE RECORDS (HCR)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"HCR data includes records related to healthcare access, which can affect disease risk assessment."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 15}]</data>
    </node>
    <node id="&quot;OBESITY RISK ASSESSMENT (OHP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The OHP is a physiological process that assesses obesity risk through various health markers and genetic factors."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;EDUCATION&quot;">
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d1">"There is a significant interaction between educational level and the FTO SNP in determining obesity risk."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;TCF7L2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene is associated with Type 2 Diabetes and End Stage Renal Disease (T2D-ESRD)."&lt;SEP&gt;"The TCF7L2 gene is associated with risk variants such as rs7903146."&lt;SEP&gt;"The TCF7L2 gene is frequently investigated for its interaction with dietary factors in the context of type 2 diabetes risk."&lt;SEP&gt;"The TCF7L2 gene is involved in Wnt signaling and has genetic variants like rs7903146 that are associated with type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;GENETIC VARIANT (G × D)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Investigations have focused on genetic variants interacting with dietary patterns and specific nutrients, particularly fiber and whole grains."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fiber intake is a key dietary factor studied for its interaction with genetic variants in relation to type 2 diabetes risk."&lt;SEP&gt;"Intake of dietary fiber shows interactions with certain genetic variants such as rs7903146 in the TCF7L2 gene, impacting Type 2 Diabetes incidence."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;WHOLE GRAINS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"High intake of whole grains potentially reducing type 2 diabetes incidence through interaction with genetic variants."&lt;SEP&gt;"Whole grain consumption has been examined for interactions with specific genetic variants associated with the development of type 2 diabetes."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Various dietary patterns, including adherence to specific diets like the Mediterranean diet or low-fat diets, have been examined for their interaction with genetic variants."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 15}]</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES (T2D)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A metabolic disorder characterized by high blood sugar levels due to insulin resistance or lack of insulin production."&lt;SEP&gt;"The risk of developing type 2 diabetes is influenced by gene-diet and gene-environment interactions as well as lifestyle factors like physical activity and dietary patterns."&lt;SEP&gt;"A metabolic disorder characterized by high blood sugar levels over a prolonged period due to insulin resistance or insufficient insulin production."&lt;SEP&gt;"T2D is characterized by insulin resistance or insufficient insulin production, often preceded by IFG or IGT. It's associated with significant increases in KB levels."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-180ca3d6d27d84b30ebf5d20f135de18&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;GLYCEMIC LOAD (GL)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Glycemic load, a measure related to carbohydrate intake, has been studied for its interaction with genetic variants in the context of type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;VITAMIN A INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Vitamin A intake is among dietary factors considered in gene-diet interactions affecting the risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;MAGNESIUM INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of magnesium showing no significant interaction with genetic variants for type 2 diabetes risk."&lt;SEP&gt;"Intake of magnesium, a key nutrient, has been investigated for its interaction with genetic variants related to type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;NURSES' HEALTH STUDY (NHS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Nurses' Health Study is a cohort study that investigates various health outcomes, including diet-related interactions with genetic factors."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;HEALTH PROFESSIONALS FOLLOW-UP STUDY (HPFS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Health Professionals Follow-Up Study examines dietary patterns and their interaction with genetic variants in relation to disease risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;MALMÖ DIET AND CANCER STUDY (MDCS)&quot;">
      <data key="d0">"COHORT STUDY"</data>
      <data key="d1">"A cohort study focusing on diet, lifestyle factors, and genetic interactions related to cancer and other diseases."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER (EPIC)‐INTERACT &quot;">
      <data key="d0">"COHORT STUDY"</data>
      <data key="d1">"A large-scale European cohort study examining the interaction of environmental, dietary, and genetic factors with disease outcomes."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;SHANGHAI DIABETES GWAS STUDY &quot;">
      <data key="d0">"COHORT STUDY"</data>
      <data key="d1">"A genome-wide association study focusing on genetic variants associated with diabetes in a Chinese population."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;EPIC‐POTSDAM &quot;">
      <data key="d0">"COHORT STUDY"</data>
      <data key="d1">"An observational cohort study investigating the interaction of environmental and lifestyle factors, including diet, with disease risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;EPIDEMIOLOGICAL STUDY ON THE INSULIN RESISTANCE SYNDROME (DESIR)&quot;">
      <data key="d0">"COHORT STUDY"</data>
      <data key="d1">"A cohort study focused on understanding insulin resistance syndrome and its genetic and environmental determinants."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;KOREAN GENOME AND EPIDEMIOLOGY STUDY (KOGES)&quot;">
      <data key="d0">"COHORT STUDY"</data>
      <data key="d1">"A population-based study in Korea investigating the interaction of genetic factors, diet, and lifestyle with health outcomes."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;FINISH DIABETES PREVENTION STUDY (DPS)&quot;">
      <data key="d0">"RCT"</data>
      <data key="d1">"Randomized controlled trial aimed at preventing type 2 diabetes through lifestyle interventions such as diet and physical activity."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;AMERICAN DIABETES PREVENTION PROJECT (DPP)&quot;">
      <data key="d0">"RCT"</data>
      <data key="d1">"A major randomized clinical trial evaluating the effectiveness of lifestyle interventions in reducing risk factors for type 2 diabetes."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;PREVENCIÓN CON DIETA MEDITERRÁNEA (PREDIMED)&quot;">
      <data key="d0">"RCT"</data>
      <data key="d1">"An RCT focusing on dietary patterns, specifically the Mediterranean diet, and its effects on cardiovascular health and type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;STUDY IN ITALIANS FROM ASTI &quot;">
      <data key="d0">"RCT"</data>
      <data key="d1">"A randomized controlled trial conducted among Italian participants to assess lifestyle interventions for metabolic abnormalities and their impact on diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;RS7903146 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs7903146 is a variant of the TCF7L2 gene known to be strongly associated with Type 2 Diabetes (T2D) risk and modifies incretin effects on insulin secretion."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS4506565 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs4506565 is another variant of the TCF7L2 gene that has shown interaction with fiber and whole grain intake in relation to T2D incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS12255372 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs12255372 is a genetic variant within the TCF7L2 gene which shows interaction effects with fiber and glycemic load intake, impacting T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;NOTCH2 GENE (RS10923931)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NOTCH2 gene harbors the rs10923931 variant that showed interactions with dietary fiber in relation to T2D incidence, though replication was not observed."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;ZBED3 GENE (RS4457053)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ZBED3 gene has a variant rs4457053 involved in Wnt signaling and showed interaction with dietary fiber on T2D risk, lacking replication evidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;IRS1 GENE (RS2943641)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IRS1 gene harbors the rs2943641 variant known to enhance insulin sensitivity but lacks validation in other studies regarding interaction with carbohydrate intake on T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;GIPR GENE (RS10423928)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GIPR gene has the rs10423928 variant known to decrease insulin secretion and showed no consistent interactions with total fat or carbohydrate intake on T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARΓ GENE (RS1801282)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PPARγ gene has the rs1801282 variant involved in fatty acid storage, showing a trend towards interaction with fat intake and Type 2 Diabetes risk but lacking consistent evidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE GENE (RS1799945)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HFE gene has the rs1799945 variant that shows modification of heme iron association on T2D incidence, particularly among women with high dietary heme iron intake."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FFAR4 GENE (RS116454156)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FFAR4 gene harbors the rs116454156 variant involved in Gαq signaling, showing a trend for interaction with fat intake and Type 2 Diabetes risk among specific genotype carriers."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;ADH1C GENE (*1/*2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ADH1C gene has variants *1/*2 that modify the association of alcohol consumption on T2D incidence, particularly in US women carrying allele *2."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FAT INTAKE (TOTAL AND SATURATED)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary fat intake, including total fat and saturated fatty acids, is under investigation for its modifying effects on T2D risk in relation to specific genetic variants."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;WHOLE GRAIN CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of whole grains is a dietary pattern that interacts with specific genetic variations like those in the TCF7L2 gene to affect T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;T2D (TYPE 2 DIABETES)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 diabetes is a metabolic disorder whose incidence can be modified by interactions between genetic variants and dietary factors such as fiber or whole grain consumption."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE VARIANTS RS1799945 (H63D)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with haemochromatosis, linked to increased risk of type 2 diabetes among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HFE VARIANTS RS1800562 (C282Y)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant associated with haemochromatosis, also linked to increased risk of type 2 diabetes among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC40A1 RS744653 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the SLC40A1 gene showing interaction with heme iron intake in men and borderline significance with TMPRSS6 variant in total sample."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;TMPRSS6 VARIANT RS855791&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with increased risk of type 2 diabetes when interacting with dietary factors, particularly for the total sample in EPIC-InterAct study."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC30A8 VARIANTS (ZINC TRANSPORTER)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in SLC30A8 gene showing interaction with zinc intake but without a clear trend of association with type 2 diabetes incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;VITAMIN A&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of vitamin A displaying nonsignificant interactions with genetic factors influencing type 2 diabetes incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;RED MEAT&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"High intake of red meat increasing the risk of developing type 2 diabetes among men with a high T2D-GRS, but not among those with low GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d3">[{"level": 0, "cluster": 15}]</data>
    </node>
    <node id="&quot;PROCESSED MEAT&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Similar to red meat, processed meat intake also increases T2D risk among men with high genetic risk score (T2D-GRS)."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;OLIVE OIL&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Interaction of olive oil consumption with GIPR variant rs10423928 in EPIC-InterAct, showing a marginally significant association."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Intake of dairy products potentially modifying T2D incidence through interaction with lactase persistence LCT gene variant rs4988235."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;COFFEE INTAKE&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Interaction between coffee consumption and genetic variants (e.g., TCF7L2, IGF2BP2) influencing type 2 diabetes risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;T2D-GRS&quot;">
      <data key="d0">"GENETIC RISK SCORE"</data>
      <data key="d1">"A genetic risk score indicating the combined effect of multiple genetic variants associated with type 2 diabetes risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d3">[{"level": 0, "cluster": 15}]</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by high intake of olive oil, nuts, fruits, vegetables, legumes, fish, and moderate wine consumption."&lt;SEP&gt;"Consumption of a Mediterranean diet pattern showing interaction with genetic factors like CLOCK variant rs4580704 to lower T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;WESTERN DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern reflecting Western diet associated with higher type 2 diabetes risk among individuals with high T2D-GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;LTPA (LEISURE-TIME PHYSICAL ACTIVITY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increase or reduction of leisure-time physical activity interacting with specific genetic variants to modify T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;T2D INCIDENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE"</data>
      <data key="d1">"The incidence of type 2 diabetes influenced by interactions between dietary and genetic factors, as well as lifestyle choices like physical activity."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;IGF2BP2 VARIANT RS11075984&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant linked to higher susceptibility for developing type 2 diabetes."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d3">[{"level": 0, "cluster": 15}]</data>
    </node>
    <node id="&quot;CLOCK VARIANT RS4580704&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the CLOCK gene, interacting with Mediterranean diet consumption to reduce T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;FRUITS AND VEGETABLES&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Consumption of fruits and vegetables showing interactions with genetic factors to influence T2D risk reduction."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC2A2 VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SLC2A2 gene has multiple variants including rs5393, rs5394, rs5400, and rs5404."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LTPA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LTPA stands for Long-Term Physical Activity and is a physiological process of interest in genetic studies."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372 RISK TT-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TCF7L2 rs12255372 risk allele (TT genotype) modifies the risk to develop Type 2 Diabetes (T2D)."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 RS7903146 RISK T-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TCF7L2 rs7903146 risk allele (T) modifies the risk to develop Type 2 Diabetes (T2D)."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ENPP1 RS1044498 DIABETOGENIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ENPP1 rs1044498 is a genetic variant associated with increased diabetes risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;MC4R RS17066829 GENETIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The MC4R rs17066829 variant has been investigated for interaction with weight loss interventions in Type 2 Diabetes (T2D) incidence."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;PPARΓ RS1152003 CC-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The PPARγ rs1152003 CC genotype is associated with reduced T2D risk following weight loss intervention."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TNFΑ RS1800629 GG-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TNFα rs1800629 GG genotype shows lower incidence of Type 2 Diabetes (T2D) in response to weight loss interventions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ADRA2B GLU9-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ADRA2B Glu9 allele is associated with a reduced risk of developing T2D following intervention."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LIPC RS2070895 A-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"LIPC rs2070895 A allele shows lower incidence of Type 2 Diabetes (T2D) in response to weight loss interventions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;G × L INTERACTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The interaction between genetic factors (G) and lifestyle/behavioral factors (L), such as physical activity or diet, influences disease risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;WEIGHT LOSS INTERVENTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern aimed at reducing weight to lower the risk of developing Type 2 Diabetes (T2D)."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;INCIDENT T2D&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of developing Type 2 Diabetes for the first time."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 GENE (RS7903146)&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs7903146 variant in the TCF7L2 gene shows interaction with dietary fiber intake, modifying its association with Type 2 Diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;HEME IRON INTAKE&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs1799945 variant in the HFE gene modifies the association of heme iron with T2D incidence, particularly among women."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"High levels of alcohol consumption during pregnancy can lead to fetal growth restriction and developmental issues in children."&lt;SEP&gt;"The *1/*2 variants in the ADH1C gene modify the association between alcohol consumption and T2D risk, specifically in US women carrying allele *2."</data>
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
    </node>
    <node id="&quot;GLYCEMIC LOAD INTAKE&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs12255372 variant in the TCF7L2 gene interacts with glycemic load intake, affecting T2D risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCF7L2 GENE (RS12255372)&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs12255372 variant in the TCF7L2 gene interacts with glycemic load intake, affecting T2D risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLUT2 GENE (RS545389)&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs545389 variant in GLUT2 shows interaction with carbohydrate intake on T2D risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT INTAKE (SATURATED)&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs13266634 variant in SLC30A8 shows interaction with saturated fat intake on T2D risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLC30A8 GENE (RS13266634)&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs13266634 variant in SLC30A8 shows interaction with saturated fat intake on T2D risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT INTAKE (TOTAL)&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs2237892 variant in KCNQ1 interacts with total fat intake, affecting insulin resistance and T2D risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KCNQ1 GENE (RS2237892)&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs2237892 variant in KCNQ1 interacts with total fat intake, affecting insulin resistance and T2D risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ZINC INTAKE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Intake of zinc interacts with SLC30A8 variants but without clear trend for type 2 diabetes association."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES RISK&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Change in LTPA modifies the risk of type 2 diabetes incidence based on specific genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES INCIDENCE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Consumption of fruits and vegetables showing a significant interaction with genetic factors to lower the incidence rate of type 2 diabetes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC RISK SCORE (T2D-GRES)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Moderate to high alcohol intake increasing T2D risk among individuals with high genetic predisposition."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;RS7903146 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in the TCF7L2 gene, rs7903146, is associated with an increased risk of Type 2 Diabetes and End Stage Renal Disease."&lt;SEP&gt;"A specific variant of the TCF7L2 gene, rs7903146, is linked to disease risk and influences association results in analyses."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;WFS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The WFS1 gene has a genomic variant (rs10010131) that is associated with the risk of developing T2D-ESRD, but this association was not as strong in European-derived populations."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;CDKAL1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CDKAL1 gene harbors a variant (rs10946398) that is associated with an increased risk of developing T2D-ESRD, similar to findings in European samples."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;JAZF1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in the JAZF1 gene (rs864745) has been found to be associated with a higher risk for Type 2 Diabetes and End Stage Renal Disease, consistent with previous findings in European populations."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;ADAMTS9 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ADAMTS9 gene includes a variant (rs4607103) which is inversely associated with T2D-ESRD risk compared to the direction observed in European samples."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by the progression of type 2 diabetes mellitus into a stage where kidney function is severely impaired."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;CUMULATIVE RISK SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS, METABOLIC PATHWAY"</data>
      <data key="d1">"A measure that evaluates the cumulative effect of genetic risk variants on the likelihood of developing a disease such as T2D-ESRD."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;END STAGE RENAL DISEASE (ESRD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The final stage of chronic kidney disease where dialysis or transplantation is required for survival."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;AFRICAN ANCESTRY PROPORTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The proportion of genetic ancestry from Africa that individuals carry, which was found to be similar across case and control groups in the study."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;TCF7L2 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of TCF7L2 gene is influenced by genomic variants such as rs7903146 associated with Type 2 Diabetes and End Stage Renal Disease."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;WFS1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of WFS1 gene, harboring the rs10010131 variant, is linked to an increased risk for T2D-ESRD."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CDKAL1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of CDKAL1 gene includes a variant (rs10946398) that increases the likelihood of developing T2D-ESRD, consistent with previous findings in European populations."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;JAZF1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A genomic variant (rs864745) found within the JAZF1 transcript is associated with an increased risk for Type 2 Diabetes and End Stage Renal Disease, similar to results observed in European samples."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;ADAMTS9 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The ADAMTS9 transcript includes a variant (rs4607103) that is inversely associated with T2D-ESRD risk compared to the direction observed in European populations."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;AFRICAN ANCESTRY DEGREE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The degree of African ancestry is an environmental factor considered in the analysis, showing no significant interaction effect (P = 0.74)."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 24}]</data>
    </node>
    <node id="&quot;RISK ALLELE COUNT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The count of risk alleles is considered as a physiological process in genetic analyses."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS (SUPPLEMENTARY TABLE 3 AND FIG. 2A, B)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Analysis results from the association of TCF7L2 risk variant rs7903146 are detailed in Supplementary Table 3 and Figures 2A and B."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;UNWEIGHTED OR (ODDS RATIO)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The unweighted odds ratio (OR) is a measure used to assess the interaction between risk alleles and disease susceptibility."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;WEIGHTED OR (ODDS RATIO)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The weighted odds ratio (OR) measures the interaction considering the genetic background, providing adjusted results for TCF7L2 variant analysis."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;RS10010131 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"A specific variant (rs10010131) in the WFS1 gene is associated with an increased risk of developing T2D-ESRD, although this association was weaker compared to European populations."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;RS10946398 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The rs10946398 variant in the CDKAL1 gene is associated with an increased risk of developing T2D-ESRD, consistent with previous findings in European samples."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;RS864745 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The rs864745 variant in the JAZF1 gene is associated with an increased risk of developing T2D-ESRD, similar to results observed in European populations."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;RS4607103 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"A variant (rs4607103) in the ADAMTS9 gene is associated with T2D-ESRD risk, but this association differs directionally from that found in European populations."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The count of risk alleles is associated with the TCF7L2 risk variant rs7903146 in association analyses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 Diabetes (T2D) is a chronic condition characterized by high blood sugar levels over a prolonged period."&lt;SEP&gt;"Type 2 diabetes (T2D), a chronic metabolic disorder characterized by high blood sugar levels, was the primary disease of interest in this study."&lt;SEP&gt;"Type 2 Diabetes is a disease for which methylation levels in HIST1H4D and DVL1 genes are predictive of increased incidence."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;IFG/IGT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Impaired Fasting Glucose and Impaired Glucose Tolerance (IFG/IGT) are intermediate states between normal glucose tolerance and type 2 diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FPG measures glucose level in the blood after an overnight fast and is used to assess pre-diabetic conditions like IFG as well as diabetes."&lt;SEP&gt;"FPG measures the concentration of glucose in the blood after an overnight fast, used to diagnose pre-diabetes or diabetes."&lt;SEP&gt;"Fasting plasma glucose (FPG) is a physiological process indicating the level of blood sugar before eating, which interacts with genetic factors like LEPR rs1011527 to affect BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;TWO-HOUR PLASMA GLUCOSE (2HPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"2hPG is a measure taken two hours after consuming a glucose drink as part of an oral glucose tolerance test for diagnosing diabetes or pre-diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;NGT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Normal Glucose Tolerance (NGT) is a state where an individual’s blood sugar levels remain within a normal range."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;EAST ASIAN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Refers to individuals with ancestry from East Asia, showing significant ethnic differences in the prevalence of IFG/IGT and T2D."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;AFRICAN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with African ancestry have specific patterns of IFG/IGT and T2D distribution compared to other ethnic groups."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;EUROPEAN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with European heritage exhibit certain rates of IFG/IGT and T2D in comparison to other ethnicities."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;NATIVE NORTH AMERICAN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Refers to individuals from Native North America, displaying distinct distribution patterns of IFG/IGT and T2D compared to others."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;LATINO AMERICAN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with Latino American background show specific rates of IFG/IGT and T2D relative to other groups."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;SOUTH ASIAN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Refers to individuals from South Asia, showing particular prevalence patterns for IFG/IGT and T2D compared to others."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;FEMALES&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"A group of participants in the study characterized by higher percentages across all glycemic statuses."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;MALES&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Another participant group with a higher likelihood of being IFG/IGT or T2D compared to NGT counterparts."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;PG LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"PG levels are a physiological process that is associated with baseline body mass index (BMI) and changes in BMI."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMI BASELINE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline body mass index (BMI) is a physiological measurement used to assess obesity risk, showing significant associations with PG levels and genetic variants linked to obesity."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMI CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in body mass index (BMI) over time represent a physiological process that reflects the impact of genetic factors on weight management."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms (SNPs) are genomic variants associated with predispositions to obesity, showing significant associations with baseline BMI and genotype risk score (GRS)."&lt;SEP&gt;"Single nucleotide polymorphisms (SNPs) common to both studies were tested for association with 'age at first tooth' and 'number of teeth at one year'."&lt;SEP&gt;"Single nucleotide polymorphisms tested in the study did not show any statistically significant associations after multiple testing adjustments."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8&lt;SEP&gt;chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;FTO RS9939609&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs9939609 in the FTO gene is a single nucleotide polymorphism associated with an increased risk of obesity at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;TAL1 RS2984618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2984618 in TAL1 is a genomic variant that has been significantly linked to an elevated BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;TCF7L2 RS7903146&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs7903146 in the TCF7L2 gene represents a genetic variant contributing to increased body mass index (BMI) at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Genetic Risk Score (GRS) is derived from genotyping results of six polymorphisms and predicts neurotoxicity-related cognitive impairment in patients."&lt;SEP&gt;"The genotype risk score (GRS) is a physiological measurement derived from multiple obesity-associated SNPs that correlates with an elevated BMI at baseline."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;LEPR RS1011527&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1011527 in the LEPR gene shows significant interaction effects on baseline BMI when combined with fasting plasma glucose (FPG) levels, but no main effect alone."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMI LEVEL CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in body mass index (BMI) over time reflect alterations in physiological processes related to weight management and obesity risk factors."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GLYCEMIC STATUS TRAITS&quot;">
      <data key="d0">"DISEASE, PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Traits related to glycemic status are indicators of metabolic health and can influence the main effects and interactions with genetic variants on body mass index (BMI)."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;2HPG&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Both fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG) are measures of blood sugar regulation, where high values in both correlate positively with baseline BMI but negatively predict changes in BMI over time."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FPG&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Both fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG) are measures of blood sugar regulation, where high values in both correlate positively with baseline BMI but negatively predict changes in BMI over time."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FPG LEVELS&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The interaction between fasting plasma glucose (FPG) levels and the LEPR gene variant, rs1011527, is significant for predicting changes in body mass index (BMI).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR 1298A&gt;C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in the MTHFR gene associated with increased risk of neurocognitive impairment."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MS 2756A&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in the MS gene related to performance on attention and processing speed tests."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTHFR 677C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in the MTHFR gene not significantly associated with neurocognitive impairment or test performance."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;SHMT 1520C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in SHMT gene not related to general neurocognitive impairment on the DIVERGT battery."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTRR 66A&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in MTRR gene associated with lower PEGNDH and CFL scores compared to other genotypes."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TSER POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism related to performance on TMTA and TMTB tests, particularly the 2R/3R genotype."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PEGDH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Assessment of fine motor skills in neurocognitive testing."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PEGNDH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Measures the effect of nerve damage on fine motor skills."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;DIG (DIGIT SPAN TEST)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Assesses working memory in neurocognitive testing."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;CFL (COLOR FIGURE MEMORY TEST)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Tests executive function and cognitive flexibility."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TMTA (TRAIL MAKING TEST A)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Measures focused attention and processing speed in neurocognitive assessment."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TMTB (TRAIL MAKING TEST B)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Evaluates shifting attention and cognitive flexibility."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;DIVERGT BATTERY&quot;">
      <data key="d0">"ASSESSMENT METHOD"</data>
      <data key="d1">"A comprehensive battery used to assess neurocognitive impairment in patients with ALL."&lt;SEP&gt;"Comprehensive battery for assessing neurocognitive function, particularly memory and attention in cancer survivors."&lt;SEP&gt;"The DIVERGT battery is a cognitive test used to assess various aspects of cognition but did not show an association with GRS or MTX-related neurotoxicity."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;EARLY MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Neurological damage caused by early administration of methotrexate (MTX)."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;GENETIC RISK SCORE (GRS)&quot;">
      <data key="d0">"METRIC/SCORE"</data>
      <data key="d1">"Summation score indicating genetic risk for neurocognitive impairment based on polymorphisms."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;ALL (ACUTE LYMPHOBLASTIC LEUKEMIA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of cancer that affects blood-forming cells in bone marrow."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PEDIATRIC ONCOLOGY GROUP PROTOCOLS&quot;">
      <data key="d0">"THERAPY/MEDICAL PROTOCOL"</data>
      <data key="d1">"Treatment protocols for childhood cancers used primarily by the Pediatric Oncology Group (POG)."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTX (METHOTREXATE)&quot;">
      <data key="d0">"DRUG/CHEMOTHERAPY AGENT"</data>
      <data key="d1">"A chemotherapy drug commonly used in the treatment of ALL."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Early MTX-related neurotoxicity does not predict impairment on specific cognitive tests but correlates with lower performance on TMTA and TMTB based on GRS value."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;TMTA, PEGDH, PEGNDH, DIG, CFL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These are cognitive assessments used to evaluate neurotoxicity-related impairment in patients treated with MTX."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;INTRATHECAL MTX EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Intrathecal methotrexate exposure is an environmental factor that influences the association between GRS and TMTB performance but does not significantly impact other cognitive tests."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;CUMULATIVE IV MTX EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cumulative intravenous methotrexate exposure is an environmental factor considered in the analysis of the relationship between GRS and neurotoxicity-related impairment."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism is a genetic variation that contributes to the calculation of Genetic Risk Score (GRS)."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;SURVIVORS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Survivors are patients who have undergone treatment and survived, with their cognitive performance assessed based on GRS."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;COGNITIVE IMPAIRMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cognitive impairment refers to a decline in cognitive functions such as memory and attention due to MTX-related neurotoxicity."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;TMTB (TRAIL MAKING TEST PART B)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A specific cognitive test used to assess executive function and processing speed, with significant association observed between lower scores and higher GRS values."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;DIAGNOSIS AGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Age at diagnosis is an environmental factor that affects the association between GRS and neurotoxicity-related impairment."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;CFL&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MTRR 66AA genotype perform worse on CFL test compared to those with the MTRR 66AG/GG genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMTB&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Individuals with TSER 2R/3R and 3R/3R genotypes score lower on TMTB than those with the 2R/2R genotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Higher genetic risk scores correlate with worse performance on certain cognitive tests and a higher likelihood of neurocognitive impairment."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;">
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"A genomic variant associated with quinolone resistance affects Campylobacter jejuni's response to fluoroquinolones."&lt;SEP&gt;"A genomic variant in the FADS1/2 gene cluster influences colon arachidonic acid (AA) concentrations after a dietary intervention."&lt;SEP&gt;"A polymorphism contributes to the calculation of GRS, which in turn predicts neurotoxicity-related cognitive impairment."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
    </node>
    <node id="&quot;SLC30A8 RS13266634&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SLC30A8 rs13266634 variant is associated with higher fasting proinsulin levels and a risk allele."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting proinsulin levels are influenced by the presence of the SLC30A8 risk allele and can be decreased by lifestyle or pharmacological interventions."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DPP COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The DPP cohort is a group subjected to dietary and physical activity intervention studies."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;LIFESTYLE INTERVENTION&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A lifestyle intervention that includes diet and exercise can significantly reduce fasting proinsulin levels compared to placebo or pharmacological interventions."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;METFORMIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Metformin is a drug used in the DPP study for lowering fasting proinsulin levels, but it was less effective than lifestyle intervention."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TROGLITAZONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Troglitazone is another drug studied alongside metformin and lifestyle interventions for reducing proinsulin levels."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;GENOTYPE × TREATMENT INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The interaction between genotype (SLC30A8 risk allele) and treatment (lifestyle or pharmacological intervention) did not significantly modify the effectiveness of the treatments."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING INSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting insulin levels are adjusted for when analyzing the relationship between SLC30A8 risk alleles and proinsulin levels."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;AGE, SEX, ETHNICITY&quot;">
      <data key="d0">"DEMOGRAPHIC FACTOR"</data>
      <data key="d1">"These demographic factors were controlled in the analysis of proinsulin levels after intervention."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;PLACEBO GROUP&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"The placebo group served as a control for comparing the effects of lifestyle and drug interventions on proinsulin levels."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;PROINSULIN LEVELS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Adjusting for fasting insulin helps isolate the effect of SLC30A8 risk alleles on proinsulin levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNPLA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PNPLA3 is a gene that regulates the expression in liver tissues and its mRNA level correlates with lipogenic conditions."&lt;SEP&gt;"The PNPLA3 gene is involved in lipid metabolism and does not respond to insulin or glucagon stimulation in HepG2 cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SREBP1c is a key transcriptional factor involved in lipid metabolism regulation."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;ACC-1 (ACETYL-COA CARBOXYLASE 1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ACC-1 catalyzes the formation of malonyl-CoA, an essential step in fatty acid synthesis."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HIGH CARBOHYDRATE DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by high carbohydrate intake."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;LIPID EMULSION (LE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An emulsion containing lipids, used to provide fat as an energy source."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HIGH FAT DIET (HF)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by high fat intake."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY (EXERCISE)&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Voluntary exercise as a lifestyle factor that influences health and gene expression."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;FATTY LIVER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease condition where excessive lipid accumulation occurs in liver tissue."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HEPG2 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A cell line derived from human hepatocellular carcinoma, used for studying liver biology and diseases."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;CHREBP (CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ChREBP is a transcription factor that responds to glucose levels and regulates gene expression."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;2-DEOXY-D-GLUCOSE (2DG)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A non-metabolizable analog of glucose used in experiments to inhibit glycolysis."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;TG (TRIGLYCERIDES)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A metabolic pathway involving triglyceride synthesis and accumulation in liver tissues."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;DEPLETION-REFEEDING CONDITIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process where cells are exposed to conditions of glucose depletion followed by refeeding, used for studying gene expression regulation."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;NON-METABOLIZABLE GLUCOSE ANALOG (2DG)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An analog of glucose that does not undergo metabolism, used in experiments to inhibit glycolysis and study its effects on gene expression."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;FAS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Fatty Acid Synthase (FAS) protein, a known target of insulin action, was shown to be upregulated by insulin treatment in contrast to PNPLA3's lack of response."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ACC-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Acetyl-CoA Carboxylase 1 (ACC-1), similar to FAS and PNPLA3, showed a similar expression pattern under high glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;CITRATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Citrate, a Krebs cycle intermediate downstream of glucose metabolism, increased the levels of PNPLA3 in HepG2 cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ISOCITRATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Isocitrate did not affect PNPLA3 levels, indicating specificity of citrate's effect on PNPLA3."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;INSULIN RECEPTOR PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HepG2 cells express the insulin receptor protein but do not upregulate PNPLA3 mRNA in response to insulin treatment."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;GLUCAGON&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Treatment with glucagon did not affect PNPLA3 mRNA expression, unlike its effect on pyruvate carboxylase (PC)."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LINOLEIC ACID (LA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"LA treatment suppressed PNPLA3 gene expression in HepG2 cells under both high and low glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;OLEIC ACID (OA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"OA treatment also led to suppression of PNPLA3 mRNA levels similarly to LA, showing a similar effect on PNPLA3 regulation."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;Α-LINOLENIC ACID (ALA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"ALA had no effect on the expression of PNPLA3 under both high and low glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;EICOSAPENTAENOIC ACID (EPA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Treatment with EPA suppressed PNPLA3 gene expression in HepG2 cells, similar to OA and LA effects."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Like EPA, DHA treatment also reduced PNPLA3 mRNA levels under both high and low glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;SREBP1C GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The expression of SREBP1c gene was significantly suppressed by a combination of OA, LA, and ALA in HepG2 cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;HIGH GLUCOSE CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Incubation with high glucose resulted in an increase of lipid accumulation but did not affect PNPLA3 mRNA levels as expected from insulin or glucagon treatment response."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LOW GLUCOSE CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In contrast to the effects under high glucose, low glucose conditions were used for comparative studies and showed no specific effect on PNPLA3 expression patterns in HepG2 cells except for unsaturated fatty acid treatments."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;SCRAMBLED SIRNA&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Used as a non-targeting control to compare effects of PNPLA3-specific siRNA transfection in HepG2 cells, showing no effect on lipid accumulation but an increase in FAS mRNA levels."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;2-DEOXY-D-GLUCOSE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Treatment with 2-deoxy-D-glucose altered PNPLA3 expression, indicating its role in glucose metabolism."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;HIGH GLUCOSE DIET (HC-DIET)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Induced PNPLA3 gene expression in mouse liver but was reversed by Intralipid® treatment in HepG2 cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;INTRALIPID®&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Suppressed PNPLA3 gene expression and affected SREBP1c and FAS expression in HepG2 cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;KNOCKDOWN OF FAS (FASN)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Did not affect the level of PNPLA3 expression in contrast to PNPLA3 knockdown, showing specificity."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;OIL RED O STAINING&quot;">
      <data key="d0">"ASSAY METHOD"</data>
      <data key="d1">"Used to measure lipid accumulation and showed no difference between cells with knocked down PNPLA3 and controls under glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;FAS PROTEIN&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"FAS protein is upregulated by insulin treatment, contrasting with no change observed for the PNPLA3 gene expression under similar conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INSULIN TREATMENT&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"FAS protein is upregulated by insulin treatment, contrasting with no change observed for the PNPLA3 gene expression under similar conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNPLA3 GENE&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Under high glucose condition, although lipid accumulation increased, there was no significant effect on PNPLA3 mRNA levels as opposed to expected upregulation of FAS or ACC-1."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOUSE LIVER&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Induced PNPLA3 gene expression which was reversed by Intralipid® treatment, demonstrating dietary effects on hepatic lipid metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FATTY ACIDS (OA, LA, ALA)&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"When combined with OA and LA but not ALA, significantly suppressed PNPLA3 mRNA levels in HepG2 cells under both glucose conditions, indicating a complex interaction."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEPG2 CELLS WITH KNOCKED DOWN PNPLA3&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"No difference was observed in lipid accumulation between knocked down PNPLA3 cells and controls, indicating that knockdown did not affect lipid storage capacity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"PNS refers to psychological stress that leads to an increase in FoxO1 expression within the hippocampus of animals exposed to such stress."&lt;SEP&gt;"Prenatal stress exposure is an environmental factor that causes transcriptomic changes in the hippocampus of adult male rats."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HIPPOCAMPUS TRANSCRIPTOME&quot;">
      <data key="d0">"TRANSCRIPTOME"</data>
      <data key="d1">"The hippocampus transcriptome analysis revealed significant modulation of 916 genes after PNS in comparison to control animals."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;AXONAL GUIDANCE SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A biological process involved in neurodevelopment that was altered by PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;PROTEIN KINASE A SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process involved in neurodevelopment and altered by PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;GLUTAMATE RECEPTOR SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A biological process involved in neurodevelopment that was altered by PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;WNT/Β-CATENIN SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A signaling pathway involved in neurodevelopment and altered by PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;CREB SIGNALING IN NEURONS PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A biological process involving CREB signaling in neurons that was affected by PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;SYNAPTIC LONG TERM DEPRESSION PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process involved in synaptic plasticity and altered due to PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;IL-8 SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An inflammatory signaling pathway that was identified as being altered by PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;STAT3 PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A biological process involved in inflammation and affected by PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;CDK5 SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A signaling pathway implicated in neuronal development and altered due to PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;IL-1 SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An inflammatory signaling pathway affected by PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;IL-6 SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A biological process involved in inflammation and altered due to PNS exposure according to pathway analysis."&lt;SEP&gt;"The biological mechanism by which IL-6 mediates its effects on cell function and inflammation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;BMP SIGNALING PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Bone morphogenetic protein (BMP) signaling is a metabolic pathway that was affected by PNS exposure, as identified through pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;TGF-Β SIGNALING PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Transforming Growth Factor beta (TGF-β) signaling pathway plays a significant role in cellular processes such as development, differentiation, and immune responses."&lt;SEP&gt;"Transforming growth factor-beta (TGF-β) signaling is a metabolic pathway altered due to PNS exposure according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;MIRNOME CHANGES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Changes in miRNA levels and their interactions with mRNA transcripts identified from the transcriptomics analysis post-PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;EARLY LIFE TRAUMA EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to early life trauma is an environmental factor linked to differential gene expression and pathway modulation observed in blood mRNA analyses of adult humans."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;ENOS SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An endothelial nitric oxide synthase signaling pathway involved in inflammation that was affected by exposure to early life trauma according to pathway analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;916 DIFFERENTIALLY REGULATED GENES LIST&quot;">
      <data key="d0">"GENE LIST"</data>
      <data key="d1">"A list of 916 genes that were differentially regulated in the hippocampus of male adult rats exposed to PNS compared to controls."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;42 PATHWAYS INVOLVED IN NEURODEVELOPMENT AND INFLAMMATION&quot;">
      <data key="d0">"PATHWAY LIST"</data>
      <data key="d1">"List of pathways involved in neurodevelopment (Wnt/Ca+ pathway, cAMP signaling, CREB signaling) and inflammation (eNOS signaling, chemokine signaling, B cell activation), identified through transcriptomics analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;528 SIGNIFICANT GENES PANEL&quot;">
      <data key="d0">"GENE LIST"</data>
      <data key="d1">"A panel of 528 significant genes involved in neurodevelopment and inflammation pathways that were both modulated by PNS exposure and targeted by miRNAs also modulated due to PNS, as identified from combined mRNA-miRNA analysis."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;BLOOD TRANSCRIPTOMICS OF EARLY LIFE TRAUMA&quot;">
      <data key="d0">"TRANSCRIPTOME ANALYSIS"</data>
      <data key="d1">"Analysis revealing 250 genes differentially modulated in individuals exposed to early life trauma compared to those without exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;INTEGRATED DATA SET FROM ANIMAL AND HUMAN STUDIES&quot;">
      <data key="d0">"DATA INTEGRATION"</data>
      <data key="d1">"Combination of data from PNS-exposed rats and humans with a history of early-life trauma, identifying 22 common genes that were modulated in the same or opposite direction in both groups."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;REAL-TIME PCR VALIDATION&quot;">
      <data key="d0">"VALIDATION METHOD"</data>
      <data key="d1">"Method used to validate gene expression levels of the 22 common genes identified from integrated data sets, confirming the microarray results."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;ISOC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Isochorismatase domain containing 1 (ISOC1) is a gene that shows modulated expression in both animals and humans under certain conditions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LDLRAP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Low density lipoprotein receptor adapter protein 1 (LDLRAP1) is a gene whose expression changes are observed in both animal models and human studies."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LRRN3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Leucine-rich repeat neuronal protein 3 (LRRN3) shows differential regulation between rats and humans under specific conditions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;MYO1D&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Myosin ID (MYO1D) is a gene that exhibits similar modulation patterns in both animals and humans."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PIK3C2B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta (PIK3C2B) shows differential expression regulation across species under stress conditions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PPAP2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phosphatidic acid phosphatase type 2A (PPAP2A) is a gene that displays similar modulation patterns in both animals and humans."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SAMD12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Sterile alpha motif domain containing 12 (SAMD12) is a gene that displays changes in expression levels across different conditions and species."&lt;SEP&gt;"Sterile alpha motif domain containing 12 (SAMD12) shows regulation changes under specific environmental conditions in animals and humans."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SERINC5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Serine incorporator 5 (SERINC5) exhibits differential regulation patterns between species under stress-related studies."&lt;SEP&gt;"Serine incorporator 5 (SERINC5) is a gene that exhibits differential expression patterns between species in stress-related studies."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TGF-Β1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Transforming growth factor, beta 1 (TGF-β1) plays a role as a signaling molecule and modulates cellular processes under various conditions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;A2M&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Alpha-2-macroglobulin (A2M) is a gene involved in immune response and protein homeostasis, showing interaction with other genes in depression studies."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARID5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ARID5B plays a role in cellular processes under conditions of stress or trauma exposure."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARRDC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Adaptor related protein complex 1 delta subunit (ARRDC4) is involved in intracellular transport and shows interaction with other genes in depression research."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;EPHA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Ephrin type-A receptor 4 (EPHA4) plays a role in neuronal development and signaling, interacting with other genes studied for GxE interactions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FBXO32&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"F-box protein 32 (FBXO32), also known as Atrogin-1, is involved in muscle atrophy under conditions of stress or trauma exposure."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FOXO1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Forkhead box O1 (FoxO1) mediates the negative effect of stress on neurogenesis and plays a significant role in GxE interactions for depression."&lt;SEP&gt;"FoxO1 is a gene activated in hippocampal progenitor stem cells following cortisol exposure and mediates the negative effect of stress on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;HSF2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Heat shock transcription factor 2 (HSF2) is involved in cellular responses to environmental stresses or trauma exposure."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SNP RS17592371&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific single nucleotide polymorphism located within the FoxO1 gene that shows a significant interaction with emotional stress during childhood, predicting depressive symptoms in adulthood."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"B-Cell CLL/Lymphoma 2 (BCL2) is a gene involved in apoptosis regulation and exhibits differential expression patterns between rats and humans."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"B-Cell CLL/Lymphoma 9 (BCL9) is a gene that shows down-regulation in rats and up-regulation in humans under certain conditions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LEF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Lymphoid Enhancer-Binding Factor 1 (LEF1) is a gene displaying differential expression patterns between species in the context of stress-related studies."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LIN54&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Lin-54 DREAM MuvB Core Complex Subunit (LIN54) shows up-regulation in humans and down-regulation in rats under specific conditions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"This pathway is involved in mediating the effects of stress hormones on gene expression and cellular processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;CORTISOL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cortisol is an environmental factor, specifically a human stress hormone that affects FoxO1 expression and neuronal proliferation when applied to hippocampal progenitor cell lines in vitro."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HIPPOCAMPUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The hippocampus is a region of the brain where FoxO1 upregulation occurs following exposure to PNS (Psychological stress) or childhood trauma, and it plays a role in neurogenesis under stress conditions."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CHILDHOOD TRAUMA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Childhood trauma is an environmental factor linked to increased levels of FoxO1 expression in blood samples from individuals who have experienced it."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;AS1842856&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"AS1842856 is a cell-permeable inhibitor used to study the functional relevance of FoxO1 by counteracting its effects on neuronal proliferation when cortisol is present."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SGK-1 (SERUM GLUCOCORTICOID KINASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SGK-1 is a gene that mediates some of the glucocorticoid's effect on brain function, including reducing neurogenesis, and its mRNA levels are upregulated following cortisol treatment."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neuronal proliferation is a physiological process affected by FoxO1 activation under stress conditions in vitro when treated with cortisol."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;FOXO1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The FoxO1 protein is activated following cortisol exposure in hippocampal progenitor stem cells."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HIPPOCAMPAL PROGENITOR STEM CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These are the stem cells found in the hippocampus that can differentiate into neurons and glial cells, affected by FoxO1 activation under stress conditions."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEUROGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of generating new neurons from neural stem cells or progenitor cells, which is negatively impacted by FoxO1 under stress conditions."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;BASELINE CONDITIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Under baseline conditions, without any environmental stressors like cortisol, FoxO1 does not exhibit significant effects on neuronal proliferation."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;PRENATAL STRESS MODEL&quot;">
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d1">"Panel of significant genes from the PNS model's combined mRNA-miRNA analysis that were also modulated in individuals exposed to early-life trauma.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL EXPOSURE&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"FoxO1 activation occurs in hippocampal progenitor stem cells following cortisol exposure, indicating its role as a mediator between stress and neurogenesis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GXE INTERACTION STUDIES&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Transforming growth factor beta 1 (TGF-β1) is involved in GxE interaction studies, showing significant associations with emotional stress and depressive symptoms in adulthood."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOXO1 SNPS&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Single nucleotide polymorphisms within the FoxO1 gene interact significantly with childhood trauma to predict higher levels of depressive symptoms in adulthood."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYTOKINES SIGNALING PATHWAY&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"The TGF-β1 signaling pathway is involved in cytokine signaling, indicating interconnected pathways that play a role in cellular communication and stress responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TGF-Β1 SIGNALING PATHWAY&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"The TGF-β1 signaling pathway is involved in cytokine signaling, indicating interconnected pathways that play a role in cellular communication and stress responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4771122&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs4771122 is a genomic variant that has been associated with long-term weight loss after bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;BARIATRIC SURGERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bariatric surgery is a procedure that leads to significant weight loss and metabolic changes, often associated with long-term health outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;LONG-TERM WEIGHT LOSS AFTER BARIATRIC SURGERY&quot;">
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d1">"The minor (G) allele of SNP rs4771122 is associated with larger percentage weight lost after bariatric surgery, adjusted for several variables including pre-surgical BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;PRE-SURGICAL WEIGHT&quot;">
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d1">"Additional copies of the minor (G) allele in SNP rs4771122 were significantly associated with increased pre-surgical weight, indicating a relationship between genotypic variation and baseline characteristics.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;GCK VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the GCK gene have been identified through Sanger sequencing or MODY gene panel."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PROBAND&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"A proband is a person with suspected or confirmed GCK-MODY who tests positive for a GCK variant."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No variants were found in the GCK gene in this study."&lt;SEP&gt;"The GCK gene is associated with glucose metabolism and has variants linked to GCK-MODY (Maturity-Onset Diabetes of the Young)."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SANGER SEQUENCING&quot;">
      <data key="d0">"MEDICAL PROCEDURE"</data>
      <data key="d1">"A method used for sequencing DNA fragments by selectively amplifying specific regions."&lt;SEP&gt;"A technique used for sequencing DNA, particularly for identifying genetic variations in genes such as GCK."&lt;SEP&gt;"Sanger sequencing is used for verification and validation of genotypes identified by HRMA, ensuring accuracy in genotype assignment."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5&lt;SEP&gt;chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MODY GENE PANEL&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"A gene panel used to detect variants in multiple MODY-related genes including the GCK gene."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;UNIVERSITY OF CHICAGO&quot;">
      <data key="d0">"INSTITUTION"</data>
      <data key="d1">"The University of Chicago has conducted research and clinical testing for GCK-MODY through Sanger sequencing or MODY gene panels."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;RESEARCH BASIS&quot;">
      <data key="d0">"BASIS"</data>
      <data key="d1">"A basis for identifying novel GCK variants through genetic analysis and interpretation."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CLINICAL BASIS&quot;">
      <data key="d0">"BASIS"</data>
      <data key="d1">"The use of clinical data to identify, classify, and understand the implications of GCK gene variants."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;ACMG GUIDELINES&quot;">
      <data key="d0">"GUIDELINES"</data>
      <data key="d1">"American College of Medical Genetics and Genomics (ACMG) guidelines for variant interpretation."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PATHOGENIC VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants classified as pathogenic according to ACMG guidelines, indicating a strong association with disease."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;LIKELY PATHOGENIC VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants likely to be pathogenic based on interpretation of clinical and genetic data."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;VARIANT OF UNCERTAIN SIGNIFICANCE (VUS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genetic variants that do not meet criteria for pathogenicity but cannot be ruled out as benign."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;DE NOVO MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic mutation that occurs in a germ cell and is present for the first time in one family member."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;IN-SILICO TOOLS&quot;">
      <data key="d0">"TOOL"</data>
      <data key="d1">"Computational tools used to predict the impact of genetic variants on protein function."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;STABLE FASTING HYPERGLYCEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition where fasting blood glucose levels remain stable but elevated in individuals with GCK gene mutations."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK-MODY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A form of maturity-onset diabetes of the young (MODY) caused by mutations in the GCK gene."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;FASTING HYPERGLYCEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Elevated blood glucose levels before meals, often observed in individuals with genetic predispositions like GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;HBA1C LEVEL&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASUREMENT"</data>
      <data key="d1">"A measure of average blood sugar control over the past 2-3 months, used to assess diabetes management."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;NONSENSE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A type of mutation that introduces a premature stop codon in the sequence and can lead to loss-of-function protein."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MISSENSE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant that results in a single amino acid change, which may or may not affect protein function."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SPLICE SITE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A mutation located within the intron-exon boundaries affecting mRNA splicing and protein synthesis."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;IN-FRAME DELETION/DUPLICATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Alterations in the DNA sequence that do not disrupt the reading frame of the genetic code, potentially altering protein structure but retaining function.""</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;INSERTION/DELETION (INDEL)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A mutation involving the insertion or deletion of nucleotides leading to changes in amino acid sequence and potential protein dysfunction."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PATHOGENICITY CLASSIFICATION&quot;">
      <data key="d0">"PROCESS"</data>
      <data key="d1">"The process of determining whether a genetic variant is pathogenic, likely pathogenic, VUS, or benign based on clinical and genetic data."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CLINICAL INFORMATION&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Clinical information for a subset of probands with GCK variants was available and analyzed."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VUS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Variants not meeting criteria for pathogenicity or benign but classified as VUS based on limited evidence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN FUNCTION&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Nonsense variants can lead to truncated proteins, impacting their function and contributing to disease."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AMINO ACID CHANGE&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Missense variants result in single amino acid changes that may alter protein structure or function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN SYNTHESIS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Splice site variants can affect mRNA splicing and subsequently impact the efficiency of protein synthesis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;READING FRAME&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"These genomic changes maintain the reading frame but may alter amino acid sequence, potentially affecting protein function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AMINO ACID SEQUENCE&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Indels can introduce frameshift mutations or simply alter amino acid sequences without disrupting the coding frame."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET (MD)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Mediterranean diet is a dietary pattern associated with improved metabolic health, characterized by high intake of fruits, vegetables, whole grains, and olive oil."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;TAG (TRIGLYCERIDES)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Triglyceride levels are part of the lipid profile that can be influenced by dietary patterns such as adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;HDL-C (HIGH-DENSITY LIPOPROTEIN CHOLESTEROL)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"HDL cholesterol is a component of the lipid profile and its concentration is positively associated with adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The apoB:apoA-1 ratio is a physiological process related to cardiovascular risk assessment, influenced by dietary patterns such as the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;HBA1C (GLYCATED HEMOGLOBIN)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"HbA1c reflects average blood glucose levels over several months and its concentration is inversely associated with adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;GENETIC VARIANT (RS780094 SNP IN GCKR GENE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant located on the glucokinase regulatory protein (GCKR) gene that influences triglyceride levels among other metabolic markers."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Physical activity level is a lifestyle factor influencing adherence to dietary patterns such as the Mediterranean diet and associated metabolic outcomes."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;LDL-C (LOW-DENSITY LIPOPROTEIN CHOLESTEROL)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"LDL cholesterol is another component of the lipid profile influenced by dietary patterns and genetic variants like GCKR rs780094 SNP."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;TC (TOTAL CHOLESTEROL)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Total cholesterol includes both LDL and HDL cholesterol, reflecting overall cardiovascular risk factors."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hypertriacylglycerolaemia refers to high levels of triglycerides in the blood, a condition influenced by dietary patterns and genetic predispositions."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 10}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A gene-diet interaction involves the combined effect of genetic variation and dietary intake on a biological trait or disease risk."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genotype refers to an individual's genetic makeup, which can influence traits such as TAG levels (triglyceride levels)."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;TAG LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"TAG levels refer to the concentration of triglycerides in blood, a physiological process influenced by both genetics and diet."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;DIETARY FACTOR Y&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A specific dietary factor or nutrient that interacts with a genetic variant to influence TAG levels."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;MEDITERRADIAN DIET (MD)&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"Individuals adhering more closely to the MD tend to have smaller waist circumferences."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE X&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"Smoking status may modify the effect of Gene X on health outcomes through gene-diet interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;ABCC8 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ABCC8 gene is involved in the regulation of insulin secretion through its role in potassium channel function."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;KCNJ11 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"KCNJ11 encodes a component of the ATP-sensitive potassium (KATP) channels but no mutations were identified in this study."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GLUD1 gene is associated with hyperinsulinism and hypoglycemia, contributing to CHI pathology."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;ABCC8 MUTATION C.3224-3226DELACC INS CAGCCAGGAACTG (P.THR1042GLNFSX75)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This specific mutation in ABCC8 is a deletion/insertion mutation found in five unrelated patients, representing a common variant."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 MUTATION P.ARG322 HIS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous mutation found in three different patients with hypoglycaemia and hyperinsulinism."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment for CHI patients, effective in some but not all cases."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA (HI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition marked by abnormally low blood glucose levels often linked to hyperinsulinism."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;MACROSOMIC PATIENTS&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"Patients with unusually high birth weight, indicating a potential genetic or environmental factor influencing growth."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;18F-DOPA PET/CT SCAN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An imaging technique used to detect focal lesions in the pancreas of CHI patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"Pancreatic disease affecting multiple areas of the organ, often linked with diazoxide-unresponsive cases."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;NOVEL MUTATIONS P.PHE5SERFSX72, P.GLN273ARGFSX85, P.LEU724DEL, P.ASP1447GLY AND IVS 25-1G&gt;T IN ABCC8 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A set of novel mutations identified in the study that contribute to CHI pathology."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIC BRAIN INJURY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain damage caused by prolonged periods of hypoglycemia, leading to developmental delays."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CHI (CONGENITAL HYPERINSULINISM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by excessive insulin secretion leading to hypoglycemia."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;NEONATAL PERIOD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The initial phase after birth when infants may exhibit symptoms of CHI."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;INFANCY PERIOD (1-12 MONTHS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The period from one month to twelve months post-birth, during which CHI symptoms can manifest."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CHILDHOOD (&gt;12 MONTHS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The phase after the first year of life when CHI symptoms may continue or become apparent."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;FREQUENT FEEDING THERAPY (SOLIDS AND COW'S MILK)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A dietary management approach used to maintain blood glucose levels in CHI patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;UNCOOKED CORNSTARCH THERAPY (1.6 G/KG)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"An intervention that helps stabilize blood sugar levels, especially at night or during prolonged periods without food.""</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;PANCREATIC Β-CELL NUCLEI ENLARGEMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abnormal growth of pancreatic cells, often seen in CHI patients with genetic mutations."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GLUD1 gene is associated with hypoglycaemia, hyperinsulinism (HI), and mild hyperammonaemia (HA) in patients."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG322HIS MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous mutation at position p.Arg322His of the GLUD1 gene identified in three patients, specifically 54, 55 and 56, who are sisters inherited from their father as an autosomal dominant trait."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous mutation at position p.Ser498Leu of the GLUD1 gene identified in a single patient (patient 52)."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous mutation at position p.Asn463Asp of the GLUD1 gene found in another single patient (patient 53)."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPOGLYCAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by abnormally low blood sugar levels and is associated with mutations in the GLUD1 gene."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPERINSULINISM (HI)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Abnormally high levels of insulin production leading to hypoglycaemia, often linked to genetic defects like those in the GLUD1 gene."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;MILD HYPERAMMONAEMIA (HA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by mild elevations in blood ammonia concentration due to metabolic issues associated with mutations in the GLUD1 gene."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used for managing hyperinsulinism, particularly when caused by genetic defects like those found in the GLUD1 gene."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;OCTREOTIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Used as a second-line treatment for patients who do not respond well to diazoxide therapy."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Surgical procedure involving removal of part or all of the pancreas in cases where medical treatments are ineffective, used as a last resort for managing persistent hypoglycaemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;GLUD1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the GLUD1 gene is associated with hypoglycaemia in patients due to mutations."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;ENDOCRINE CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abnormal active endocrine cells found in the pancreas contribute to hyperinsulinism and hypoglycemia conditions."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SERUM AMMONIA CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Elevated serum ammonia levels are observed in patients with mutations in the GLUD1 gene, indicating a metabolic disturbance."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE THERAPY SIDE EFFECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gastrointestinal disturbances and hypertrichosis were reported as side effects of diazoxide treatment for managing hypoglycaemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;OCTREOTIDE TREATMENT FAILURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Some patients did not respond to octreotide, indicating a lack of effectiveness compared to diazoxide in certain cases."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A severe side effect observed in one patient treated with diazoxide leading to discontinuation of the therapy."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIABETES MELLITUS POST-SURGERY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Development of diabetes mellitus after surgical intervention for managing hypoglycaemia due to GLUD1 gene mutations."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;MALABSORPTION SYMPTOMS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Some patients experienced malabsorption symptoms post-surgery, impacting their overall health and management of hypoglycemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;ABCC8 GENE MUTATIONS&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Patients with high birth weight are more likely to have mutations affecting the ABCC8 gene."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL PERIOD SYMPTOMS&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Symptoms of CHI can begin to appear during the neonatal period, characterized by episodes of hypoglycemia."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"This therapy is used to manage hypoglycemic episodes by maintaining consistent blood glucose levels through regular feeding."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LONG-TERM BLOOD GLUCOSE CONTROL&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Used in combination with frequent feedings, this therapy helps maintain stable blood sugar levels over extended periods, preventing hypoglycemic episodes at night or during fasting."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC MUTATIONS&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"The enlargement of pancreatic cells' nuclei is often a result of specific genetic mutations found in CHI patients, particularly those with compound heterozygous ABCC8 mutations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACETOACETATE (ACAC)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A ketone body produced during fat metabolism when acetyl-CoA is converted to acetoacetyl-CoA, then AcAc, which can be further metabolized or utilized as an energy source."&lt;SEP&gt;"Acetoacetate is a ketone body that increases in concentration with hyperglycemia and type 2 diabetes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;BETA-HYDROXYBUTYRATE (BHB)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Another ketone body produced during fatty acid metabolism; it's often used as a measure of metabolic state and ketosis."&lt;SEP&gt;"Beta-hydroxybutyrate is another ketone body that rises significantly in individuals diagnosed with newly developed type 2 diabetes compared to healthy subjects, correlating with both fasting and 2-hour post-glucose levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;2-HOUR POST-PRANDIAL GLUCOSE (2HPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"2hPG measures blood glucose levels two hours after consuming a meal rich in carbohydrates, used for diagnosing impaired glucose tolerance (IGT) and type 2 diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLYCAEMIA (IFG)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IFG is a pre-diabetic state characterized by elevated fasting blood sugar levels but not high enough to be classified as diabetes, leading to higher AcAc and BHB compared to the reference group."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An intermediate state between normal glucose tolerance and impaired glucose tolerance, characterized by reduced ability to handle ingested glucose, potentially progressing towards type 2 diabetes."&lt;SEP&gt;"IGT is a pre-diabetic condition where blood sugar rises above normal but not high enough to be classified as diabetes, often leading to the development of T2D over time."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;KETONE BODIES (KBS)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"KBs are produced by the liver from fatty acids during periods of fasting or carbohydrate restriction; their levels correlate with glucose metabolism and hyperglycemia risk."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY (IS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"IS measures how effectively cells respond to insulin, inversely correlated with AcAc and BHB in high-IS individuals compared to low-IS subjects."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SECRETION (ISEC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"ISec refers to the production of insulin by pancreatic beta-cells; it's inversely associated with KB levels when adjusted for IS, weakening or abolishing associations between KBs and hyperglycemia."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These single nucleotide polymorphisms are associated with an increased risk of developing type 2 diabetes and hyperglycemia, influencing the levels of AcAc and BHB."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;GLUCOSE TOLERANCE TEST (GTT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A test that measures how quickly a person's blood glucose returns to normal after drinking a sugary beverage. It helps diagnose IFG, IGT, and diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Condition where cells fail to respond properly to insulin, resulting in higher levels of AcAc and BHB and increased risk for T2D development."&lt;SEP&gt;"The reduced ability of tissues to respond to insulin; observed both in the liver and in adipose tissue under HFD conditions, particularly severe in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;GLUCOSE AREA UNDER THE CURVE (AUC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measures glucose levels over time during GTT; an elevated AUC is associated with a higher risk of developing diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;HYPERGLYCEMIA&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"A condition characterized by high blood glucose levels, observed earlier and more severely in SENP1-aP2KO mice under HFD conditions compared to controls."&lt;SEP&gt;"A condition characterized by high blood sugar levels, often preceding the diagnosis of pre-diabetes or type 2 diabetes."&lt;SEP&gt;"The presence of abnormally high blood glucose levels, often associated with diabetes or other metabolic disorders."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;GCKR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GCKR is a gene involved in glucose metabolism and regulation."&lt;SEP&gt;"One of the 12 genes near which cardiometabolic SNPs are located, involved in glucose metabolism."&lt;SEP&gt;"The GCKR gene is one of twelve genes identified where cardiometabolic SNPs are located."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;RS780094 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant of the GCKR gene, known as rs780094, is associated with elevated levels of BHB and AcAc."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FADS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FADS1 is a gene involved in fatty acid metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ANK1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ANK1 is a gene linked to cell adhesion and cytoskeletal dynamics, but here it's associated with levels of AcAc or BHB."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GIPR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GIP receptor (GIPR) gene has been identified in studies as being related to glucose metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGA2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGA2 is a gene that encodes high mobility group A2, which plays a role in chromatin structure and transcription regulation."&lt;SEP&gt;"The HMGA2 gene is associated with height and influences dental development traits."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;SLC2A2 GENE (GLUT2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC2A2 gene codes for the GLUT2 transporter involved in glucose transport across membranes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FFA OXIDATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fatty acid oxidation is a metabolic process that breaks down fatty acids to generate energy."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KETOGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The production of ketone bodies from acetyl-CoA in the liver during fasting or low carbohydrate intake."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CPT1A GENE (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CPT1A is a gene encoding an enzyme involved in fatty acid transport into mitochondria for oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS1 GENE (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1, SOLUBLE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGCS1 encodes an enzyme that catalyzes a rate-limiting step in ketogenesis."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS2 GENE (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGCS2 is involved in ketone body synthesis within mitochondria."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACAT1 GENE (ACETYL-COA ACETYLTRANSFERASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ACAT1 is a gene encoding an enzyme that catalyzes the final step of ketolysis, converting acetoacetyl-CoA to two molecules of acetyl-CoA."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BDH1 GENE (BHB DEHYDROGENASE, TYPE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BDH1 encodes an enzyme involved in beta-hydroxybutyrate metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;OXCT1 GENE (3-OXOACID COA TRANSFERASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"OXCT1 is a gene encoding an enzyme that catalyzes reactions important for ketolysis and fatty acid oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACSS2 GENE (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ACSS2 encodes an enzyme involved in the activation of short chain fatty acids to acyl-CoAs, which can then enter metabolic pathways."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CARNITINE PALMITOYLTRANSFERASE 1A PROTEIN (CPT1A)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein product of CPT1A gene involved in the transport of long-chain fatty acids into mitochondria for oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACETYL-COA ACETYLTRANSFERASE 1 PROTEIN (ACAT1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An enzyme that catalyzes the final step of ketolysis, converting acetoacetyl-CoA to two molecules of acetyl-CoA."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BHB DEHYDROGENASE TYPE 1 PROTEIN (BDH1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This protein is involved in beta-hydroxybutyrate metabolism as part of the ketolysis process."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-OXOACID COA TRANSFERASE 1 PROTEIN (OXCT1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An enzyme that catalyzes important reactions for ketolysis and fatty acid oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GLUCOSE AUC PARAMETER&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measure of the area under the curve for glucose levels over time, reflecting glucose metabolism in response to an oral glucose challenge."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;MATSUDA ISI PARAMETER&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A measure used to quantify insulin sensitivity based on plasma glucose and insulin concentrations during a hyperglycemic clamp test."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;INSULIN SECRETION PARAMETER&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measure reflecting the ability of beta cells to secrete insulin in response to an increase in blood glucose levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FATTY ACIDS (FFAS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lipids that serve as a major energy source and are broken down through fatty acid oxidation pathways."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic disease characterized by high blood sugar levels over a prolonged period."&lt;SEP&gt;"A condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;BHB LEVELS&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"The C allele of the GCKR gene variant rs780094 shows a significant increase in BHB levels, suggesting its role in regulating ketone body metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAC LEVELS&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"Variants in FADS1 have been associated with the level of AcAc, indicating their involvement in fatty acid and lipid metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY PARAMETER (MATSUDA ISI)&quot;">
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d1">"Expression of ACAT1 is positively correlated with insulin sensitivity, indicating its role in maintaining metabolic health."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRP GWAS SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"283 cardiometabolic SNPs were associated with serum CRP levels, out of which 19 had p-values smaller than the multiple testing correction threshold."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;APOC1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The APOC1 gene harbors a SNP (rs4420638) that increases serum CRP levels but decreases cholesterol and triglycerides levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HNF1A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HNF1A gene contains a SNP (rs1183910) associated with increased CRP but decreased cholesterol and LDL-cholesterol levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL6R GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL6R gene locus showed lower linkage disequilibrium (r² = 0.52) between CRP GWAS and CAD GWAS compared to other loci."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PPP1R3B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene among the 12 where cardiometabolic SNPs are located, involved in metabolic processes."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HNF4A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One of the twelve genes with associated SNPs near it that affect cardiometabolic traits and CRP levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TMEM18 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with pleiotropic effects mediated through BMI, indicating potential mediation in the relationship between genetic loci and metabolic phenotypes."&lt;SEP&gt;"Near TMEM18 on chromosome 2 is a SNP (rs2867125), not identified in CRP GWAS but associated with it here, having a p-value of 5.0×10-6."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;PLTP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A SNP near PLTP gene on chromosome 20 shows association with CRP (p-value = 6.7×10^-6) and is linked to metabolic phenotypes."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;MC4R GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MC4R locus has an associated SNP upstream, which showed a significant p-value of 3.8×10-5 for CRP association."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;LDL-CHOLESTEROL AND TOTAL CHOLESTEROL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of LDL cholesterol and total cholesterol are influenced by genetic variants like those in the APOC1 locus, which affect both these processes and CRP levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC PHENOTYPES GWAS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"GWAS studies investigating cardiometabolic phenotypes revealed significant associations with SNPs that also influence CRP levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CRP LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"C-reactive protein (CRP) levels are influenced by genetic variants and are linked to metabolic diseases such as diabetes and cardiovascular disease."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CAD GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular Disease Genome-Wide Association Study (GWAS), where the lead SNP from CRP GWAS showed lower linkage disequilibrium with it compared to other loci."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A novel gene identified in the analysis with associations close to or within it, which was not previously reported in GWAS for specific phenotypes."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PABPC GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One of twelve genes where cardiometabolic SNPs are located and affect CRP levels and other metabolic traits."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;BCL7B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene among the 12 with associated SNPs near it, influencing both cardiometabolic phenotypes and CRP levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;BMI AND SBP GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The body mass index (BMI) and systolic blood pressure (SBP) GWAS did not show significant deviations in QQ-plots compared to the null hypothesis for CRP SNPs."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC TRAITS GWAS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"GWAS studies focusing on cardiometabolic traits reveal genetic variants influencing these pathways, including those also affecting CRP levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TOTAL CHOLESTEROL AND TRIGLYCERIDES LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of total cholesterol and triglycerides are influenced by SNPs such as rs4420638 in the APOC1 locus."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;FASTING GLUCOSE AND INSULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genetic variants influencing CRP levels also impact fasting glucose and insulin levels, reflecting pleiotropy."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GCKR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with CRP levels and cardiometabolic phenotypes."&lt;SEP&gt;"GCKR codes for a gene whose missense variant p.Pro446Leu impacts de novo triglyceride and cholesterol synthesis and plasma glucose concentrations."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;IL1F10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An interleukin 1 family gene, not identified in previous analysis for association between SNPs and CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PPP1R3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with cardiometabolic phenotypes and CRP levels."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A hepatocyte nuclear factor 4 alpha, involved in regulating the expression of genes in liver cells."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;BCL7B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with cardiometabolic phenotypes where effect size diminished after adjustment for CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A hepatocyte nuclear factor 1 alpha, involved in the pleiotropic effects observed on CRP levels and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PABPC4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with cardiometabolic phenotypes where effect size diminished after adjustment for CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CHOLESTEROL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of cholesterol in blood can mediate pleiotropic effects observed from genetic loci."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HBA1C&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An indicator of average blood glucose control over a period of 2 to 3 months."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;TRIGLYCERIDES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of triglyceride in the bloodstream, which can mediate pleiotropic effects observed from genetic loci."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HDL-CHOLESTEROL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High-density lipoprotein cholesterol levels that can mediate certain genetic associations with metabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;BMI ADJUSTMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adjusting for body mass index in statistical analyses to account for its influence on cardiometabolic outcomes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CRP ADJUSTMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adjusting for C-reactive protein levels in analyses to account for inflammation's role in metabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC PHENOTYPE&quot;">
      <data key="d0">"DISEASE OR CONDITION"</data>
      <data key="d1">"A condition related to heart health and metabolism, influenced by genetic factors and environmental mediators."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CRP SNPS&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"The association of 18 CRP SNPs with cardiometabolic traits is significant across multiple phenotypes, suggesting shared genetic underpinnings."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS STUDY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"The IL1F10 gene was not identified in a previous GWAS for association between SNPs and CRP, but has been found to be significant with cholesterol levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRP PROTEIN&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Effects on CRP levels from BCL7B decrease significantly when adjusted for CRP, indicating potential mediation through lipids.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAD DISEASE&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"The HNF1A gene's variant rs1183910 is linked to increased serum CRP and lower risk of CAD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D DISEASE&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs4420638 near APOC1 increases CRP levels but reduces the risk of type 2 diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FXR/RXR PATHWAY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"The FXR/RXR pathway is enriched in the analysis of GCKR and other pleiotropic genes involved in metabolic pathways.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"The effects observed from TMEM18 are mainly mediated by BMI, suggesting its role in metabolic phenotypes through body mass index.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;GENETIC LOCI MEDIATION&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Lipids, particularly cholesterol levels, mediate pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOC1 GENE AND T2D DISEASE RELATIONSHIP&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjustment for HbA1c leads to significant reduction in the association between APOC1 and type 2 diabetes, indicating mediation through glycemic control.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HBA1C PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjustment for HbA1c leads to significant reduction in the association between APOC1 and type 2 diabetes, indicating mediation through glycemic control.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PABPC4 GENE AND METABOLIC PHENOTYPE RELATIONSHIP&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjustment for triglyceride levels leads to significant reduction in the association between PABPC4 gene and metabolic phenotypes, indicating mediation through this physiological process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRIGLYCERIDES PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjustment for triglyceride levels leads to significant reduction in the association between PABPC4 gene and metabolic phenotypes, indicating mediation through this physiological process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BCL7B GENE AND METABOLIC PHENOTYPE RELATIONSHIP&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjustment for HDL-cholesterol levels leads to significant reduction in the association between BCL7B gene and metabolic phenotypes, indicating mediation through this physiological process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HDL-CHOLESTEROL PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjustment for HDL-cholesterol levels leads to significant reduction in the association between BCL7B gene and metabolic phenotypes, indicating mediation through this physiological process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI ADJUSTMENT PHYSIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjusting for BMI significantly affects the pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLEIOTROPIC EFFECTS OF GENETIC LOCI&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Adjusting for BMI significantly affects the pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in miR-34b/c region, associated with decreased risk of IA."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d3">[{"level": 0, "cluster": 13}]</data>
    </node>
    <node id="&quot;TP53 ARG72PRO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An Arginine to Proline substitution variant in the TP53 gene, not associated with IA risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d3">[{"level": 0, "cluster": 14}]</data>
    </node>
    <node id="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by a bulge or balloon-like dilation of an artery within the skull, which is studied for its association with genotypic variations."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d3">[{"level": 0, "cluster": 13}]</data>
    </node>
    <node id="&quot;NUMBER OF ANEURYSMS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The number of aneurysms refers to the count of IA in patients, which can be a measure of severity or recurrence."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d3">[{"level": 0, "cluster": 17}]</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 CC&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The combined genotype of miR-34b/c rs4938723 CC and TP53 Arg72Pro CG/CC/GG is associated with a decreased risk of IA compared to the combined genotypes CT/TT + CG/CC/GG."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TP53 ARG72PRO CG/CC/GG&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The combined genotype of miR-34b/c rs4938723 CC and TP53 Arg72Pro CG/CC/GG is associated with a decreased risk of IA compared to the combined genotypes CT/TT + CG/CC/GG."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INADL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The INADL gene is associated with weight, BMI, FFM, FM, trunk FM, and hip circumference."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RS1056513 (G1178S) SNP IN INADL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A nonsynonymous SNP (rs1056513; G1178S (NP_005790.2)) in INADL on chromosome 1 attained near genome-wide significance for weight and BMI."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;COL4A1 GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in COL4A1 on chromosome 13 was associated with weight z-score change."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TSEN34 GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant in the 5′UTR region of TSEN34 on chromosome 19 is linked to linear growth (height change)."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MTNR1B GENE INTRONIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in MTNR1B on chromosome 11 was strongly associated with fasting glucose."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;APOA5-ZNF259 REGION VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Intronic and 3′UTR variants in the APOA5-ZNF259 region on chromosome 11 were associated with triglycerides."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;PCSK2 GENE INTRONIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in PCSK2 on chromosome 20 was linked to total antioxidants levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RNASE1 FLANKING 3′UTR REGION VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the flanking 3′UTR regions of RNASE1 on chromosome 14 were associated with 24-h urinary nitrogen excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ASS1P11 FLANKING 3′UTR REGION VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the flanking 3′UTR regions of ASS1P11 on chromosome 7 were linked to creatinine excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GCH1 GENE INTRONIC SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic SNP in GCH1 on chromosome 14 was associated with the 24-h urinary dopamine: creatinine ratio."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;KLKB1 GENE NONSYNONYMOUS SNP (RS3733402; S143T)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A nonsynonymous SNP (rs3733402; S143T (NP_000883.2)) in KLKB1 on chromosome 4 was identified for serum free IGF-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MPRIP GENE INTRONIC SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic SNP in MPRIP on chromosome 17 was linked to serum IGFBP-3 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;XPA/FOXE1 FLANKING 5′UTR REGION SNPS BLOCK &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A block of twenty-three SNPs in the flanking 5′UTR region of XPA/FOXE1 on chromosome 9 were highly associated with serum TSH."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DARC GENE NONSYNONYMOUS SNP (RS12075; G42D)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A nonsynonymous SNP (rs12075; G42D) in DARC on chromosome 1 was identified for MCP-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GREB1 GENE CODING VARIANT &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Coding variants in GREB1 on chromosome 2 were associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DFNB31 GENE CODING VARIANT &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Coding variants in DFNB31 on chromosome 9 were identified for MCP-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CCR3 FLANKING 3′UTR REGION VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the 3′UTR region of CCR3 were highly associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RASGEF1A GENE INTRONIC SNP &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic SNP in RASGEF1A was strongly associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ABO GENE INTRONIC VARIANT &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant in the intronic region of ABO gene is strongly linked to IL-6 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TMEM229B GENE VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in TMEM229B on chromosome 14 was associated with energy intake at dinner."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A GENE INTRONIC SNP &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in ARHGAP11A on chromosome 15 is linked to sleep duration."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;C21ORF34 GENE INTRONIC SNP &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;FASTING GLUCOSE LEVELS &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"An intronic variant in MTNR1B on chromosome 11 was strongly associated with fasting glucose levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TRIGLYCERIDES LEVEL &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"Intronic and 3′UTR variants in the APOA5-ZNF259 region on chromosome 11 were linked to triglyceride levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TOTAL ANTIOXIDANTS LEVELS &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"An intronic variant in PCSK2 on chromosome 20 was associated with total antioxidants levels."&lt;SEP&gt;"Genetic variations influence total antioxidants in the body, possibly impacting oxidative stress and health."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;URINARY NITROGEN EXCRETION &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"Variants in the flanking 3′UTR regions of RNASE1 were linked to urinary nitrogen excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CREATININE EXCRETION &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"Flanking 3′UTR variants in ASS1P11 were associated with creatinine excretion levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;24-HOUR URINARY DOPAMINE: CREATININE RATIO &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"An intronic SNP in GCH1 was linked to urinary dopamine: creatinine ratio."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SERUM FREE IGF-1 LEVELS &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"A nonsynonymous SNP (rs3733402; S143T) in KLKB1 on chromosome 4 was associated with serum free IGF-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SERUM IGFBP-3 LEVELS &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"An intronic SNP in MPRIP on chromosome 17 was linked to serum IGFBP-3 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SERUM TSH LEVELS &quot;">
      <data key="d0">"ENDOMETABOLIC TRAIT"</data>
      <data key="d1">"A block of SNPs in the flanking 5′UTR region of XPA/FOXE1 were highly associated with serum TSH."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;IL-6 LEVELS &quot;">
      <data key="d0">"SUBSTRATE UTILIZATION TRAITS"</data>
      <data key="d1">"A variant in the intronic region of ABO was strongly associated with IL-6 levels."&lt;SEP&gt;"Genetic variations affecting IL-6 levels also impact metabolic health."&lt;SEP&gt;"Genetic variations affecting IL-6 levels highlight the influence on systemic inflammation."&lt;SEP&gt;"Genetic variations affecting IL-6 levels impact dietary behaviors and energy expenditure during physical activities."&lt;SEP&gt;"Genetic variations affecting IL-6 levels impact dietary behaviors and energy expenditure."&lt;SEP&gt;"Genetic variations affecting IL-6 levels impact physical activity patterns."&lt;SEP&gt;"Genetic variations affecting IL-6 levels impact substrate utilization during physical activities."&lt;SEP&gt;"Genetic variations affecting IL-6 levels impact substrate utilization."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SLEEP DURATION &quot;">
      <data key="d0">"INFLAMMATION MARKERS"</data>
      <data key="d1">"A variant in ARHGAP11A on chromosome 15 is linked to sleep duration."&lt;SEP&gt;"Variants associated with sleep duration can impact inflammatory markers."&lt;SEP&gt;"Variants associated with sleep duration can impact inflammatory responses."&lt;SEP&gt;"Variants associated with sleep duration can impact overall energy expenditure."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT (RQ) DURING SLEEP &quot;">
      <data key="d0">"DIET AND PHYSICAL ACTIVITY TRAIT"</data>
      <data key="d1">"An SNP in C21orf34 was detected for respiratory quotient during sleep."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;LIGHT ACTIVITY &quot;">
      <data key="d0">"PHYSICAL ACTIVITY TRAIT"</data>
      <data key="d1">"A variant in the 5′UTR region of RPL was identified for accelerometer-measured light activity."&lt;SEP&gt;"Variants affecting light activity can also impact inflammatory markers."&lt;SEP&gt;"Variants affecting light activity highlight the genetic basis of physical activity patterns."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SUBSTRATE UTILIZATION &quot;">
      <data key="d0">"DIET AND PHYSICAL ACTIVITY TRAIT"</data>
      <data key="d1">"Variants associated with substrate utilization impacting diet metabolism."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MCP-1 (CCL2) LEVELS &quot;">
      <data key="d0">"ENDOMETABOLIC TRAITS"</data>
      <data key="d1">"Highly significant genetic associations highlight the importance of MCP-1 in metabolic regulation and inflammation."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;AD LIBITUM ENERGY INTAKE AT DINNER &quot;">
      <data key="d0">"INFLAMMATION MARKERS"</data>
      <data key="d1">"An intronic variant in TMEM229B affects inflammatory markers through dinner energy intake."&lt;SEP&gt;"An intronic variant in TMEM229B affects metabolic outcomes through dinner energy intake."&lt;SEP&gt;"An intronic variant in TMEM229B affects physical activity patterns through dinner energy intake."&lt;SEP&gt;"An intronic variant in TMEM229B affects substrate utilization through dinner energy intake."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;BMI TRAITS &quot;">
      <data key="d0">"SUBSTRATE UTILIZATION TRAITS"</data>
      <data key="d1">"Genetic factors influencing BMI are also linked to metabolic traits such as total antioxidants levels."&lt;SEP&gt;"Genetic factors influencing BMI are also linked to physical activity patterns."&lt;SEP&gt;"Genetic factors influencing BMI traits are linked to inflammatory responses during physical activities."&lt;SEP&gt;"Genetic factors influencing BMI traits are linked to inflammatory responses."&lt;SEP&gt;"Genetic factors influencing BMI traits are linked to metabolic outcomes such as total antioxidants levels."&lt;SEP&gt;"Genetic factors influencing BMI traits are linked to substrate utilization patterns."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in ARHGAP11A, located on chromosome 15, was associated with sleep duration."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;C21ORF34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RPL7P3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant identified in the 5′UTR region of RPL7P3 on chromosome 9 was associated with accelerometer-measured light activity."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CTCFL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in the 3′UTR region of CTCFL on chromosome 20 was linked to sedentary-light activity."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;MATK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Highly significant variants for total energy expenditure were identified for MATK on chromosome 19, after adjusting for body weight."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CHRNA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants for sleeping energy expenditure were found in CHRNA3 on chromosome 15, after controlling for body weight."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;INTRONIC VARIANT OF ARHGAP11A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in the gene ARHGAP11A on chromosome 15 is associated with sleep duration."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SNP IN C21ORF34 INTRONIC REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;VARIANT IN 5′UTR OF RPL7P3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant identified in the 5′UTR region of RPL7P3 on chromosome 9 is associated with accelerometer-measured light activity."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;VARIANT IN 3′UTR OF CTCFL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant was found in the 3′UTR region of CTCFL on chromosome 20 and linked to sedentary-light activity."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE VARIANTS FOR MATK&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Highly significant variants for total energy expenditure were identified for MATK, a gene located on chromosome 19 after adjusting for body weight."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE VARIANTS FOR CHRNA3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants for sleeping energy expenditure were found in CHRNA3, a gene located on chromosome 15 after controlling for body weight."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A SNP in C21orf34's intronic region was detected for respiratory quotient during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A variant in RPL7P3’s 5′UTR region is associated with accelerometer-measured light activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Variants in CTCFL's 3′UTR region were linked to sedentary-light activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Significant variants for MATK on chromosome 19 are associated with total energy expenditure after adjusting for body weight."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Variants in CHRNA3 on chromosome 15 are linked to sleeping energy expenditure, after controlling for body weight."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEP DURATION&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"An intronic variant in the gene ARHGAP11A on chromosome 15 is associated with sleep duration."&lt;SEP&gt;"The amount of sleep duration correlates with the prevalence of snoring (Supplementary Table 1)."</data>
      <data key="d0">"LIFESTYLE FACTOR"</data>
    </node>
    <node id="&quot;BODY WEIGHT&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"After adjusting for body weight, variants in MATK are associated with total energy expenditure, indicating a complex genetic and environmental interaction affecting metabolic rate."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOBR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"APOBR is a gene that codes for apolipoprotein B receptor (BDL), which plays a role in lipid metabolism."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;RS74949322, RS151233, RS149271, RS3833080, RS368546180, RS180743, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genomic variants identified in the coding region of APOBR that include both synonymous and non-synonymous mutations."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS3833080: P.GLY369_ASP370DEL9, RS180743: P.PRO428ALA, AND RS368546180: P.THR321_GLY329DEL9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"These are protein variants resulting from the genomic variants in APOBR that affect amino acid sequence."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;FATTY ACIDS (LIPIDS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A nutrient essential for energy storage and transport, relevant to lipid metabolism affected by APOBR gene function."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern associated with obesity in children and adolescents studied in the research."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;LIPID METABOLISM REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of lipid metabolism regulation influenced by APOBR gene variants."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;SULT1A1 (SULFOTRANSFERASE 1A1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SULT1A1 is a gene involved in metabolic processes including sulfate conjugation, which may impact the body's handling of certain hormones and xenobiotics."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, PROVEAN&quot;">
      <data key="d0">"TOOL"</data>
      <data key="d1">"Bioinformatics tools used for predicting the effects of genetic mutations on protein function."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;FAMILY-BASED ASSOCIATION STUDIES (FBAT)&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"A method for studying genetic associations in families, particularly useful for identifying genetic factors contributing to complex traits like obesity."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;CASE-CONTROL ASSOCIATION ANALYSIS&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"An approach used to identify genetic variations that are more common in people with a specific disease compared to those without the disease."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS142786317: C.*118_*119DELCA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant affects splicing enhancer and silencer binding sites as well as transcription factor binding sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SULT1A1 gene is part of the SULT1 family genes that are involved in obesity studies, but no significant variants were confirmed independently for this gene."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;MET1VAL VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant was not explained by other members of the SULT1A family and could not be replicated with independent genotyping methods."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;P.PRO200 = (RS3176926)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The synonymous variant in SULT1A1 predicted to change splicing enhancer and silencer, or directly affect splice sites and transcription factor binding sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene was studied for non-synonymous SNPs with potential functional effects on protein activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4149403: P.ILE7THR, RS10797300: P.PRO19LEU, ETC.&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Several non-synonymous SNPs in SULT1A2 predicted to have functional changes, particularly affecting binding sites and splicing regulators."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS1690407: P.SER8 =, RS139896537: P.ALA164 =&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Synonymous SNPs in SULT1A2 predicted to alter transcription factor binding or splicing regulator sites."&lt;SEP&gt;"These synonymous SNPs were predicted to alter transcription factor binding or splicing regulator sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;TUFM GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene had a previously unknown variant in the 3’ untranslated region and intronic variants affecting transcription factor binding sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;C.3536C&gt;G VARIANT IN TUFM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A non-coding variant found in the 3' UTR of TUFM predicted to impact splicing regulator or transcription factor binding sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;NON-SYNONYMOUS VARIANTS (SULT1A1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Seven non-synonymous variants initially detected in SULT1A1 in 95 extremely obese children and adolescents, but could not be confirmed with an independent method."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;UNSPECIFIC AMPLIFICATION ARTIFACTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"High sequence similarity between SULT1A gene family led to unspecific amplification artifacts during mutation screening."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A2 GENE FAMILY MEMBERS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Amplified alongside SULT1A1 due to high sequence similarity, leading to confusion in variant attribution."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS3176926: P.PRO200=&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Predicted to change splicing enhancer and silencers, or directly affect splice sites and transcription factor binding sites (particularly AML-1)."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;POLYPHEN2 SOFTWARE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Software used for in silico prediction of functional effects of genetic variants."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;PANTHER SOFTWARE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Used to predict the impact of non-synonymous SNPs on protein function and stability."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SNAP (SEQUENCE NAME ANNOTATION PREDICTION)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Predicts the effect of genetic variations on molecular properties, including splicing regulation."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SIFT (SORTING INTOLERANT FROM TOLERANT)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analyzes protein sequences to predict the impact of amino acid substitutions on biological function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;NON-CODING VARIANTS (SULT1A2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Five non-coding variants identified with potential impacts on regulatory regions, affecting splicing and transcription factors binding."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS7187776: C.-55T&gt;C, RS4788099: C.500−19T/C, ETC.&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Intronic variants in TUFM predicted to alter splicing regulator or transcription factor binding sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS61737565: C.922+29C&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in TUFM located at position c.922+29, changing from C to G, disrupting transcription factor binding sites."&lt;SEP&gt;"Non-coding intronic variant affecting regulatory regions of the TUFM gene."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;TUFM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TUFM is a gene with five variants that are predicted to alter splicing regulator or transcription factor binding sites."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;RS8061877&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant that disrupts a transcription factor binding site for SRY, HFH 2, and HMG-IY factors."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;G.28854194C/G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An unknown variant in TUFM located at position g.28854194 changing from C to G, altering splice enhancer binding sites and splicing silencer sites."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICE ENHANCER BINDING SITES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Splice enhancer binding sites are regulatory sequences that influence the efficiency of alternative splicing in RNA processing."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICING SILENCER SITES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Splicing silencer sites are regions within pre-mRNA molecules that inhibit the activity of spliceosomes during mRNA splicing."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SRY, HFH 2, HMG-IY TRANSCRIPTION FACTORS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Transcription factors SRY, HFH 2, and HMG-IY are proteins involved in DNA binding and regulation of gene expression."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;3’ UTR OF TUFM&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The non-coding 3' UTR region of the TUFM transcript, where the variant g.28854194C/G is located, affects RNA processing and stability."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;RS3833080 AND RS180743&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"These studies confirm associations between genetic variants and obesity in families."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS180743: P.PRO428ALA AND RS3833080: P.GLY369_ASP370DEL9&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"This analysis showed nominal associations between these genetic variants and obesity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C.3536C&gt;G VARIANT&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"The variant in TUFM predicted to alter splicing regulator or transcription factor binding sites, indicating a role in regulatory function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALOX15 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the ALOX15 gene is associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;ALOX5 SNP RS1864414&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in arachidonate 5-lipoxygenase (ALOX5) is associated with decreased risk of ovarian cancer, showing an odds ratio of 0.77 at p=0.004."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3 SNP RS743507&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in nitric oxide synthase 3 (NOS3) is associated with decreased ovarian cancer risk, showing an odds ratio of 0.79 at p=0.003."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL18 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in interleukin 18 (IL18) gene is associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CRP SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the CRP gene, which codes for C-reactive protein, is associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CCL2 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in chemokine (C-C motif) ligand 2 (CCL2) is associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1A SNP RS17561&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This missense variant in the interleukin 1, alpha gene (IL1A) shows a strong association with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1A SNP RS4848300&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP near the 3' end of the IL1A gene showing similar results to rs17561 in terms of ovarian cancer risk reduction."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;ALOX5 SNP RS745986&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is correlated with ALOX5 rs1864414 and also associated with decreased ovarian cancer risk, but its effect appears less significant."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B SNP RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in interleukin 1 beta (IL1B) shows an association with increased ovarian cancer risk."&lt;SEP&gt;"A genomic variant in interleukin 1 beta (IL1B) shows an association with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS1 SNP RS2282169&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in prostaglandin-endoperoxide synthase 1 (PTGS1) is associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;OVARIAN CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by the growth of malignant tumors in the ovaries, influenced by genetic factors including variants in inflammation-related genes."&lt;SEP&gt;"Ovarian cancer is a type of disease that affects women and is often associated with genetic predisposition and environmental factors."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;IL1A SNPS RS3783516 AND RS2856838&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Additional SNPs in IL1A, specifically rs3783516 (OR 1.10) and rs2856838 (r2=0.993), show associations with increased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 1 beta gene (IL1B) is associated with ovarian cancer risk through genetic variants."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS1 &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Prostaglandin-endoperoxide synthase 1 (PTGS1) gene shows associations with ovarian cancer risk through genetic variations."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1A &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 1 alpha gene (IL1A), particularly through its SNPs, is linked to a reduced risk of developing ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3 &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Nitric oxide synthase 3 gene (NOS3) has genetic variants associated with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B (INTERLEUKIN 1, BETA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 1 beta is a pro-inflammatory cytokine involved in immune response and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant of the IL1B gene associated with ovarian cancer risk."&lt;SEP&gt;"A specific variant of the IL1B gene suggested to be associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An enzyme involved in prostaglandin biosynthesis."&lt;SEP&gt;"Prostaglandin-endoperoxide synthase 1, also known as cyclooxygenase-1, is involved in the biosynthesis of prostaglandins."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;RS2282169&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant of the PTGS1 gene associated with ovarian cancer risk."&lt;SEP&gt;"A specific variant of the PTGS1 gene suggested to be associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;ALOX15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An enzyme involved in lipid metabolism and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;CCL2 (CHEMOKINE LIGAND 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A chemokine that plays a role in immune cell recruitment and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;CRP (C-REACTIVE PROTEIN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An acute-phase protein involved in the body's inflammatory response."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL18 (INTERLEUKIN 18)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A cytokine that plays a role in immune responses and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL6 (INTERLEUKIN 6)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An inflammatory cytokine involved in immune response and acute-phase reactions."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"Risk factor for developing ovarian cancer, as influenced by genetic variants such as FokI."&lt;SEP&gt;"This SNP in nitric oxide synthase 3 is associated with a decreased risk of ovarian cancer, showing an odds ratio of 0.79 at p=0.003."</data>
      <data key="d0">"DISEASE"</data>
    </node>
    <node id="&quot;CRP SNP &quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"A genetic variant in the CRP gene, which codes for C-reactive protein, shows an association with ovarian cancer risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL1B SNP RS7596684 &quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"This variant in IL1B is associated with increased ovarian cancer risk, showing a significant result (p=0.02)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATION&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"The ALOX15 gene plays a role in inflammation and lipid metabolism, influencing the body's inflammatory response."&lt;SEP&gt;"The process in which the body's immune system responds to harmful stimuli such as pathogens, damaged cells, or irritants."</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;IMMUNE RESPONSE&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"CCL2 is involved in immune cell recruitment during inflammation and infection responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFD2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTHFD2 is a gene involved in folate metabolism, and SNPs within this gene were analyzed for association with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BHMT2 is a gene involved in the remethylation of homocysteine to methionine, part of the folate metabolic pathway; SNPs within BHMT2 were also analyzed for their association with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 GENE (RS3918186)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the NOS3 gene was identified as having a Bayes Factor of 7.38, suggesting an increased risk of developing childhood ALL for each copy of the minor allele."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 GENE (RS1051266)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in SLC19A1 gene was found to have a Bayes Factor, though less convincing than NOS3 rs3918186, suggesting an increased risk of developing childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Childhood ALL is the disease under study in this research, with SNPs associated with it being investigated for potential genetic risk factors."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC GENES&quot;">
      <data key="d0">"GENE GROUP"</data>
      <data key="d1">"This group includes genes involved in folate metabolism that were analyzed for their SNPs potentially linked to childhood ALL, such as MTHFD2, BHMT2, NOS3, and SLC19A1."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BAYESIAN ANALYSIS MODEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Bayesian analysis model was used to evaluate the association between genetic variants (SNPs) and the risk of childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC GENES SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT GROUP"</data>
      <data key="d1">"This group includes tagging SNPs of 16 folate metabolic genes analyzed for associations with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 RS3918186&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the NOS3 gene with a Bayes Factor of 7.38, indicating an increased risk of developing childhood ALL per copy of the minor allele."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 RS1051266&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in SLC19A1 gene with a Bayes Factor less than NOS3, but still indicating an increased risk of developing childhood ALL per copy of the minor allele."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD ALL RISK FACTORS&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"Risk factors include genetic variations such as SNPs in genes like MTHFD2 and BHMT2 which may increase susceptibility to childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"The SNP rs3918186 in NOS3 gene, involved in the nitric oxide synthesis pathway, was found to significantly increase the risk of childhood ALL."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FADS1/2 HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FADS1/2 haplotype is defined by four SNPs chosen for genotyping with minor allele frequencies ranging from 25.0% to 32.9%."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"This dietary pattern was assigned to half of the participants in a study on diet and genotype effects."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Participants in this group followed a Mediterranean diet characterized by increased intake of long chain n-3 PUFA, MUFA, and decreased SFA and n-6 PUFA."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;AA (ARACHIDONIC ACID)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An omega-6 polyunsaturated fatty acid whose baseline concentration in serum was significantly predicted by the number of minor alleles in FADS1/2 haplotype SNPs."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;EPA (EICOSAPENTAENOIC ACID)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A long-chain n-3 PUFA nutrient which did not show significant differences between diet groups or associations with genotype at baseline."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The sum of EPA and DHA, whose concentrations were significantly predicted by dietary intake rather than the number of minor alleles in FADS1/2 haplotype SNPs."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;POLYUNSATURATED FAT:SATURATED FAT RATIO&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The ratio between polyunsaturated fat intake and saturated fat intake is a measure used to assess dietary healthfulness."&lt;SEP&gt;"The ratio increased in the Healthy Eating group but not significantly so in the Mediterranean diet group over 6 months."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;FADS1/2 GENE CLUSTER&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FADS1/2 gene cluster is involved in fatty acid metabolism and has been shown to interact with dietary interventions."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;COLON AA CONCENTRATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The concentration of arachidonic acid (AA) in the colon is influenced by both genotype and diet interventions."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern emphasizing the inclusion of a wide variety of foods that are nutrient-dense and low in added sugars and unhealthy fats."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;18:2 N-6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Linoleic acid (LA), represented as 18:2 n-6, is an essential fatty acid that plays a role in the formation of arachidonic acid (AA)."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MUFA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Monounsaturated fatty acids (MUFA) are important for maintaining cardiovascular health."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;N-3 PUFA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Omega-3 polyunsaturated fatty acids (PUFAs) play a role in reducing inflammation and improving heart health."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 PUFA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The increase of long chain omega-3 PUFAs in the colon can impact inflammatory processes and cardiovascular health."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;AA CONCENTRATION IN COLON&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The concentration of arachidonic acid (AA) in the colon is a measure affected by genotype and diet interventions."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;EPA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Eicosapentaenoic acid (EPA), an omega-3 fatty acid, is involved in reducing inflammation and cardiovascular risk."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MUFA AND N-3 PUFA&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Decreased 18:2 n-6 levels are associated with increased MUFA and n-3 PUFAs in the Mediterranean diet intervention."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE BY DIET INTERACTION&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Statistical analysis reveals significant interactions between genotype (FADS1/2 gene cluster) and diet interventions affecting fatty acid concentrations in the colon."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LINEAR MIXED MODEL RESULTS&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Statistical analysis reveals significant interactions between genotype (FADS1/2 gene cluster) and diet interventions affecting fatty acid concentrations in the colon."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNORING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Snoring is a condition characterized by loud, harsh or hoarse breathing during sleep, prevalent in about 37% of individuals according to the UK Biobank data."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;SOCIOECONOMIC STATUS (SES)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"SES, as measured by Townsend deprivation index and average household income, is an environmental factor that increases snoring risk in males only."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SMOKING FREQUENCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Frequency of smoking correlates positively with the prevalence of snoring in females and to a lesser extent in males."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION FREQUENCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Frequency of alcohol consumption correlates positively with snoring in males and to a lesser extent in females."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;WHOLE-BODY FAT MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Whole-body fat mass is correlated with snoring, indicating its role as an influential physiological process."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;GENOMIC RISK LOCI &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genomic risk loci are specific locations in the genome associated with increased susceptibility to develop a condition like habitual snoring."&lt;SEP&gt;"Specific genomic regions identified through GWAS that contain genetic variants associated with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;SELF-REPORTED SLEEP APNOEA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Self-reported sleep apnoea is a disease that shows high genetic correlation with habitual snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;GENETIC CORRELATION &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genetic correlation refers to the degree of similarity in genetic risk factors between two traits or diseases, such as habitual snoring and other health conditions."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;BMI, WHOLE-BODY FAT MASS, SODIUM IN URINE, MOOD SWINGS, CORONARY ARTERY DISEASE, ALCOHOL INTAKE FREQUENCY, PULSE RATE, CURRENT TOBACCO SMOKING, HEART DISEASE, LUNG CANCER &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A range of diseases and physiological traits such as BMI, coronary artery disease, mood swings, heart disease, lung cancer etc. show significant genetic correlations with habitual snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;PULSE RATE, WHOLE-BODY FAT MASS, AND BMI &quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"These measures are phenotypically associated with the condition of habitual snoring (see above and Supplementary Table 1)."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SCHIZOPHRENIA, FVC, FEV1, FLUID INTELLIGENCE SCORE, EDUCATIONAL ATTAINMENT, AGE AT MENARCHE, MEAN ACCUMBENS VOLUME &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"These traits show negative genetic correlation with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;GWAS STUDY &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genome-wide association study (GWAS) was conducted to uncover genetic associations with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;ODDS RATIO (OR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Odds Ratio is a statistical measure indicating the strength of association or non-independence between an exposure and a health outcome."&lt;SEP&gt;"The odds ratio is used as a measure of effect size, indicating the increased likelihood of an event occurring due to an exposure or risk factor."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;SNP HERITABILITY (H2SNP)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The proportion of phenotypic variance in a trait due to additive genetic effects, indicating the heritable component of snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;GENETIC CORRELATION (RG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A statistical measure representing the degree of similarity between two traits or diseases at the genetic level."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;OXYHEMOGLOBIN SATURATION &quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Measures related to blood oxygen levels during sleep, including average SpO2, minimum SpO2 and percent of sleep with oxyhemoglobin saturation under 90% (Perc90)."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;FORCED EXPIRATORY VOLUME IN 1 SECOND (FEV1)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A measure reflecting lung function, genetically correlated negatively with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;ANOREXIA NERVOSA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition showing a negative genetic correlation with habitual snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;DLEU7 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"DLEU7 is a gene located on chromosome 13 that has been identified as one of the nearest genes to top signals in genome-wide significant variants for snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MSRB3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MSRB3 is a gene located on chromosome 12, also among the closest genes to the top signals for snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNP (GENOMIC VARIANT)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs are genomic variants that have been mapped in relation to their impact on snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;EQTL MAPPING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Expression quantitative trait loci mapping is used to identify genetic variations impacting gene expression levels, particularly for snoring-related genes."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;BMI (ENVIRONMENTAL FACTOR)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"BMI is an environmental factor that was adjusted for in studies of snoring genetics and its associations with other traits."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNORING (PHYSIOLOGICAL PROCESS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Snoring is a physiological process influenced by genetic factors, as well as environmental and lifestyle factors such as BMI."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;PULSE RATE (PHYSIOLOGICAL PROCESS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Pulse rate is another physiological measure that shows genetic correlation with snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;BLOOD VESSEL TISSUE EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Gene expression data from blood vessel and tibial artery tissues are associated with snoring after adjusting for BMI."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANT SNP (GENOMIC VARIANT)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific set of genome-wide significant SNPs were mapped to genes significantly associated with the predisposition to snore."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Snoring-related genetic associations converge in cardiometabolic pathways and are linked to diseases such as coronary heart disease and heart attack."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;COGNITIVE/NEUROLOGICAL DISEASE (DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genetic predispositions for snoring also overlap with cognitive/neurological disorders, indicating shared genetic factors between snoring and these conditions."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;RESPIRATORY TRAITS/DISEASES (DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Snoring is genetically related to respiratory traits such as sleep apnea, which can affect breathing during sleep."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;PSYCHIATRIC DISORDERS (DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genetic predispositions for snoring are also associated with certain psychiatric disorders like schizophrenia and narcolepsy."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;RS199797821&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genome-wide significant SNP identified for snoring in males."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RS200391180&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genome-wide significant SNP identified for snoring in females."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;PGS (POLYGENIC SCORE)&quot;">
      <data key="d0">"DISEASE RISK PREDICTION MODEL"</data>
      <data key="d1">"Derived from GWAS summary statistics to predict recent snoring in an independent sample."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RECENT SNORING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process characterized by loud, harsh breathing during sleep."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;PROBABLE OSA (OBSTRUCTIVE SLEEP APNEA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by repeated episodes of breathing cessation and choking or struggling for breath during sleep."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SEX STRATIFIED GWAS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Genome-wide association studies stratified by sex to identify genetic variants associated with snoring."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A method to find genetic associations with snoring across the entire genome."&lt;SEP&gt;"A research method used to find genetic variations associated with a particular disease or trait."&lt;SEP&gt;"A study method used to identify genetic variants associated with diseases across the entire genome."&lt;SEP&gt;"A study design used to identify genetic variations associated with a particular trait or disease within the human genome."&lt;SEP&gt;"A study aiming to associate genetic variations with diseases or traits across the entire genome."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-a34b927ed42ff0917960122b4d203f83&lt;SEP&gt;chunk-7efd4f037425eeac77e329347b16beb2&lt;SEP&gt;chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;H2SNP (SNP HERITABILITY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measures the proportion of phenotypic variance in a trait due to additive effects of all SNP genotypes, as found in GWAS analyses."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;TOP HITS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Genetic variants with the strongest association signals identified from GWAS studies."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;AGDS (AUSTRALIAN GENETICS OF DEPRESSION STUDY)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An independent target sample used for deriving and validating PGS for recent snoring."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SES&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Lower SES is associated with higher risk of habitual snoring, especially among males."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;BMI AND HEART DISEASE &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Traits like BMI and heart disease are genetically correlated to habitual snoring, suggesting common underlying genetic risk factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNORING &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"The GWAS study uncovered 127 independent genome-wide significant associations across 41 genomic risk loci for snoring."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FEV1 AND FVC &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) show negative genetic correlations with snoring, highlighting their importance in lung function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROBABLE OSA&quot;">
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d1">"Severe cases of recent snoring may indicate probable obstructive sleep apnea, characterized by breathing cessation and choking during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDBP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"VDBP is a gene associated with vitamin D binding protein that plays a role in the regulation of vitamin D levels."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"VDBP single nucleotide polymorphisms are variations in the DNA sequence at specific sites within the VDBP gene, which can affect vitamin D binding and regulation."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;TOTAL 25(OH)D&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Total 25-hydroxyvitamin D (total 25(OH)D) is a metabolite of vitamin D that serves as the main circulating form in blood, reflecting overall vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT, PRE-PREGNANCY BMI, TERMINAL BMI, UVB, WEEKS OF GESTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These physiological processes and environmental factors are covariates used to adjust for potential confounders in the analysis of vitamin D status between mothers and neonates."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VITAMIN D EQUILIBRIUM STATE&quot;">
      <data key="d0">"DISEASE OR PHYSIOLOGICAL CONDITION"</data>
      <data key="d1">"Different states of maternal and neonatal vitamin D equilibrium refer to varying levels of vitamin D sufficiency, deficiency, and toxicity in both mother and newborn."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VDBP POLYMORPHISMS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Maternal variations in the VDBP gene can influence maternal vitamin D status during pregnancy."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VDBP POLYMORPHISMS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variations in neonates' VDBP gene may affect their vitamin D binding and levels at birth."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VITAMIN D STATUS&quot;">
      <data key="d0">"DISEASE OR PHYSIOLOGICAL CONDITION"</data>
      <data key="d1">"Vitamin D status refers to the overall level of vitamin D in an individual, which can be categorized as sufficient, deficient, or toxic."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D CUT-OFFS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cut-off levels used for categorizing maternal vitamin D sufficiency or deficiency during pregnancy."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D CUT-OFFS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Threshold values used to classify neonatal vitamin D status at birth."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;PCOS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Polycystic ovary syndrome (PCOS) is a condition characterized by hormonal imbalances, insulin resistance, and other clinical features."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGFA GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The VEGFA gene encodes the vascular endothelial growth factor A, which plays a role in angiogenesis and blood vessel formation."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS3025020 (-583T&gt;C)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) located at position -583 of the VEGFA gene, with a higher minor allele frequency in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS2010963 (-634C&gt;G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) located at position -634 of the VEGFA gene, showing different genotype distributions between PCOS cases and controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGF PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein product of the VEGFA gene, involved in angiogenesis and vascular permeability."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE INDEX (HOMA-IR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An index used to estimate insulin resistance based on fasting plasma glucose and serum insulin levels."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;SERUM VEGF LEVELS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The concentration of vascular endothelial growth factor A in the blood, which is correlated with certain genotypes of PCOS patients."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE TESTOSTERONE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of testosterone that is not bound to sex hormone-binding globulin (SHBG), which can be elevated in women with polycystic ovary syndrome."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;BIOACTIVE TESTOSTERONE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Testosterone available for cellular functions, often measured as a ratio or index involving SHBG and total testosterone levels."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;SHBG (SEX HORMONE-BINDING GLOBULIN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein that binds sex hormones like testosterone and estradiol in the blood, affecting their bioavailability."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TOTAL TESTOSTERONE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The total amount of testosterone circulating in the bloodstream."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;LH (LUTEINIZING HORMONE)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A hormone produced by the anterior pituitary gland that plays a role in ovulation and steroidogenesis."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FSH (FOLLICLE-STIMULATING HORMONE)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A hormone produced by the anterior pituitary gland that stimulates ovarian follicular growth and maturation."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE ANDROGEN INDEX (FAI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An index used to estimate free testosterone levels in women, often correlated with clinical features of PCOS."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TSH (THYROID-STIMULATING HORMONE)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A hormone produced by the anterior pituitary gland that stimulates the thyroid gland to produce T3 and T4 hormones."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VAL CARRIER GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Val carrier genotype is a genetic variant associated with differential response bias in behavioral studies."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;ISO HOMOZYGOTE GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Iso homozygote genotype is another genetic variant often compared to the val carrier genotype for studying genetic influences on behavior."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;RESPONSE BIAS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Response bias refers to a behavioral process where participants alter their responses based on reinforcement contingencies."&lt;SEP&gt;"The tendency to respond more to frequently rewarded stimuli as measured in experimental tasks under conditions of stress or no-stress."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b&lt;SEP&gt;chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;SHOCK INTENSITY SELECTION BEHAVIOR&quot;">
      <data key="d0">"BEHAVIORAL PATTERN"</data>
      <data key="d1">"The selection of shock intensity is a behavioral pattern that can be influenced by genetic factors such as genotype."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;STAI SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"STAI scores represent the level of state anxiety reported by participants, which can vary based on condition and time."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;PANAS NA SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"PANAS negative affect (NA) scores measure emotional distress or negative emotions experienced during a task."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;NON-SPECIFIC SC RESPONSES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Skin conductance (SC) responses are non-specific physiological measures of arousal that increase in stressful situations."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;TIME MAIN EFFECT ON STAI SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A time main effect on STAI scores shows an increase in reported anxiety over the duration of the experiment."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;CONDITION × TIME INTERACTION ON STAI SCORES&quot;">
      <data key="d0">"BEHAVIORAL PATTERN"</data>
      <data key="d1">"An interaction between condition and time indicates that the difference in anxiety levels is greater at later times within the stress condition compared to no-stress conditions."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;PRE-STRESS ASSESSMENT DIFFERENCES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Pre-stress assessment differences refer to the minor changes or lack thereof before a stressor is introduced, which may be indicative of baseline states."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;MAIN EFFECT ON PANAS POSITIVE AFFECT (PA)&quot;">
      <data key="d0">"BEHAVIORAL PATTERN"</data>
      <data key="d1">"No significant main effect on positive affect suggests no change in reported happiness or pleasure across conditions and time."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;VAL CARRIER&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Individuals carrying the val variant of a gene, typically the COMT gene, show altered response bias in stress conditions compared to iso homozygotes."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;ISO HOMOZYGOTE&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Individuals with two copies of the isoleucine allele (iso) show less alteration in response bias under stress conditions compared to val carriers."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CONDITION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition that involves different levels of stress manipulation affecting physiological and psychological responses, particularly in the context of reward processing."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;DISCRIMINABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The ability to distinguish between different reward contingencies, which was shown to vary across blocks but not due to genotype differences."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SHOCK INTENSITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A measure of the intensity or degree of stress applied during experimental tasks, affecting participant responses and physiological measures like skin conductance."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Electrodermal activity used as an index of sympathetic nervous system arousal in response to stress conditions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CRHR1 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific single nucleotide polymorphisms within the CRHR1 gene that are associated with alterations in reward learning and responses to stress."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;COMT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding catechol-O-methyltransferase (COMT), where a valine (val) to methionine (met) substitution at position 158 affects enzyme activity and influences stress response."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition where individuals under stress show altered reward learning, particularly associated with genetic variations like the COMT gene val158met polymorphism."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CRHR1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CRHR1 gene encodes the corticotropin-releasing hormone receptor 1, which plays a role in stress response pathways and is linked to variations affecting reward learning."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;BMP4 RS17563&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs17563 is a SNP located in the BMP4 gene, which reached genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CACNB2 RS10740993&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs10740993 is a SNP located in or near the CACNB2 gene, reaching genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CDON RS4937076&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs4937076 is a SNP located in or near the CDON gene, reaching genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CALU/OPN1SW RS1799922&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1799922 is associated with 'age at first tooth' and located within CALU or OPN1SW genes."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;AJUBA/C14ORF93 RS997154&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs997154 is a SNP located in the AJUBA gene region, reaching genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;ADK RS7924176&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs7924176 is associated with 'age at first tooth' and 'number of teeth'."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;TEX14/RAD51C RS412000&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs412000 is a SNP located in or near the TEX14/RAD51C gene region, reaching genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;DLEU7 RS9316505&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs9316505 is a SNP located within the DLEU7 gene, reaching genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;HMGA2 RS17101923&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs17101923 is associated with 'number of teeth' in the HMGA2 region, reaching genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;KCNJ2 RS17105278 AND RS9788982&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Two SNPs (rs17105278 for 'age at first tooth' and rs9788982 for 'number of teeth') in the KCNJ2 gene are mentioned as having secondary signals."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;MSRB3 RS1458991&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs1458991 is associated with 'age at first tooth' and located near MSRB3, showing evidence of a secondary signal."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;IGF2BP1 RS10932688 AND RS9894411&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Two SNPs in the IGF2BP1 gene (rs10932688 for 'age at first tooth' and rs9894411 for 'number of teeth') are significant, with secondary signals."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;EDA RS2520397 AND RS2804391&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Two SNPs near the EDA gene (rs2520397 for 'age at first tooth' and rs2804391 for 'number of teeth') are significant, with secondary signals."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;RAD51L1 RS17105278 AND RS1956529&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Two SNPs in the RAD51L1 gene (rs17105278 for 'age at first tooth' and rs1956529 for 'number of teeth') show suggestive evidence, with secondary signals."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;TMEM9 REGION SNP(S)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs in the TMEM9 region are reported as having a suggestive level of association."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;NID2 RS9870336&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs9870336 is a SNP located near the NID2 gene, reaching genome-wide significance."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;KCNJ160&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"KCNJ160 is a gene identified as having associated genomic variants with 'age at first tooth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FAM155E–EDA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2804391 and rs2520397 are genomic variants located in the FAM155E-EDA region, associated with 'number of teeth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BMP4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BMP4 gene is linked to both 'age at first tooth' and 'number of teeth', suggesting a role in craniofacial development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HMGA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGA2 is associated with early tooth eruption, number of teeth, and specific craniofacial measures such as face width."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;IGF2BP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IGF2BP1 gene has genomic variants (rs8069452) linked to 'age at first tooth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ADK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genomic variant rs7924176 in ADK is associated with the width of the nose and measures related to tooth eruption timing."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;AJUBA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The AJUBA gene's genomic variant (rs997154) affects mid-brow height and prominence."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;MSRB3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genomic variants in MSRB3 are linked to 'number of teeth' at genome-wide significance levels."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HEIGHT-ASSOCIATED SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs associated with height, such as rs1351394 (HMGA2) and rs12534093 (IGF2BP3), also show associations with tooth eruption age and number of teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS2520397&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the FAM155E-EDA region associated with 'age at first tooth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1951867&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs1951867) located near BMP4, linked to 'number of teeth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1472259&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is found in HMGA2 and associated with both tooth eruption timing and craniofacial measures."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS8069452&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs8069452) located near IGF2BP1, linked to 'age at first tooth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS9788982&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is in KCNJ2 and associated with 'number of teeth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS2804391&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs2804391) located near FAM155E-EDA, linked to 'number of teeth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS7924176&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located in ADK and associated with measures indexing the width of the nose."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS997154&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Found near AJUBA, this variant is linked to an increase in height and prominence of the mid-brow."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;CRANIOFACIAL DEVELOPMENT&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Refers to the developmental process involving the skull and face structures, related to dental development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;TOOTH ERUPTION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which teeth emerge through the gums into the mouth; associated with genetic factors like HMGA2 and ADK variants."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;PERMANENT TEETH&quot;">
      <data key="d0">"ANATOMICAL STRUCTURE"</data>
      <data key="d1">"Teeth that are not deciduous, developing after primary teeth and influenced by genes such as BMP4 and MSRB3."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BMP4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BMP4 gene, involved in bone and tooth formation, shows association with height and dental development traits."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANT SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Significant SNPs identified for 'Age at first tooth' and 'Number of teeth', showing associations with height but weakened after removing HMGA2 and BMP4 variants."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;PMETA SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A PMETA score is a meta-analysis measure indicating the evidence of association between genetic markers and traits; in this context, it measures the association between SNP scores and height."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH GWAS PATHWAYS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathways identified through GWAS analysis for 'age at first tooth' that show over-representation of genes with significant associations."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;ALLIGATOR SOFTWARE ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis using ALLIGATOR software to identify pathways enriched in SNPs associated with dental development traits, particularly 'Age at First Tooth'."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genome-wide association study focusing on the age when an individual gets their first tooth."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;NUMBER OF TEETH GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genome-wide association study examining genetic factors influencing the number of teeth in individuals."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;ALLIGATOR SOFTWARE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Software used to conduct pathway analysis on GWAS data, identifying significant pathways associated with traits like 'Age at First Tooth'."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Small variations at individual positions within a DNA sequence that can influence disease susceptibility or treatment response."&lt;SEP&gt;"Specific genetic variations at single nucleotide positions that are investigated for their association with dental development and height."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs10740993 is significantly associated with the age of eruption of primary teeth.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUMBER OF TEETH&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"rs4937076 is linked to 'number of teeth' and may influence tooth development or number.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUMBER OF TEETH AND AGE AT FIRST TOOTH&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"This SNP affects both the number of teeth and the timing of their emergence, suggesting a role in overall dentition development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH AND NUMBER OF TEETH&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"These SNPs near KCNJ2 are significant for both timing and number, indicating a complex role in dentition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAM155E-EDA&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Genomic variants in FAM155E-EDA are linked to 'number of teeth', reflecting its role in craniofacial traits related to tooth count."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FACE WIDTH&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"The ADK gene's variant affects the width of the nose, indicating a genetic influence on craniofacial morphology related to tooth eruption timing."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MID-BROW HEIGHT&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Genomic variants in AJUBA are linked to increased mid-brow height and prominence, suggesting a role in craniofacial development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUMBER OF PRIMARY TEETH&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"The MSRB3 gene's variant is associated with 'number of primary teeth', highlighting its involvement in early dental development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH AND NUMBER OF PERMANENT TEETH&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Genomic variant rs1472259 in HMGA2 shows associations with both early tooth eruption and permanent teeth count, suggesting a broad genetic influence on dental health."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FACE WIDTH AND TOOTH ERUPTION TIMING&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Genomic variant rs7924176 in ADK affects both face width and measures related to tooth eruption timing, indicating its role in craniofacial morphology."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MID-BROW HEIGHT AND CRANIOFACIAL DEVELOPMENT&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Genomic variant rs997154 near AJUBA influences mid-brow height and prominence, highlighting its role in craniofacial development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEIGHT-ASSOCIATED SNPS IN DENTAL PHENOTYPES&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"The HMGA2 gene's variants show strong associations with both height and tooth eruption timing, suggesting overlapping genetic influences between these traits."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEIGHT&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"The HMGA2 gene is significantly associated with height and impacts dental development through this association.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BONE AND TOOTH FORMATION&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"The BMP4 gene plays a role in bone and tooth formation, influencing the 'Number of Teeth' trait.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10RΑ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin-10 receptor alpha subunit (IL-10Rα) is a protein component of the IL-10 receptor that plays a crucial role in immune regulation."&lt;SEP&gt;"The IL-10 receptor alpha gene plays a role in signaling pathways associated with immune responses and inflammation regulation."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;T CELL TRANSFER-COLITIS MODEL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A model of colitis induced by transferring T cells from donor mice into immunocompromised recipient mice to study the development of inflammatory bowel disease."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;COLONIC INFLAMMATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of inflammation in the colon, which is a key aspect of evaluating the impact of IL-10 signaling on colitis severity."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10 SIGNALING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A molecular interaction involving the binding and activation of the IL-10 receptor, leading to downstream anti-inflammatory effects."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MACROPHAGE (MΦ)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of immune cell involved in phagocytosis and regulation of inflammatory responses; plays a crucial role in the context of colitis development."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;DSS COLITIS MODEL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A toxin-induced model of acute colitis, distinct from T cell transfer-mediated colitis, used to assess macrophage response to IL-10."&lt;SEP&gt;"An acute colitis model induced by administration of dextran sodium sulfate (DSS), a toxin that causes inflammation and ulceration in the colon."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CX3CR1-CRE DRIVER LINE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic driver line that expresses Cre recombinase specifically in a subset of immune cells (including LPMϕs), used for conditional deletion of IL-10Rα gene."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑTDEL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant where IL-10Rα is selectively deleted in T cells."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NAIVE CD4+CD25−CD45RBHI T CELLS&quot;">
      <data key="d0">"CELL TYPE (TRANSCRIPT)"</data>
      <data key="d1">"Naïve T cells, specifically CD4+ T cells with high levels of CD45RB and low levels of CD25 used in the transfer model to induce colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑDCDEL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant where IL-10Rα is selectively deleted in dendritic cells (DCs)."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDEL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant where IL-10Rα is selectively deleted in macrophages."&lt;SEP&gt;"The IL-10RαMdel gene is associated with the development of differential colitis severity when expressed in Rag1−/− mice."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CX3CR1-DRIVEN CRE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic driver line expressing Cre recombinase driven by CX3CR1, leading to conditional deletion of IL-10Rα primarily in LPMϕs (lymphoid tissue-resident macrophages)."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-10 is a gene encoding for Interleukin 10, a protein with anti-inflammatory properties that modulates immune system activity."&lt;SEP&gt;"Interleukin 10 acts as an anti-inflammatory cytokine, inhibiting the production of pro-IL-1β and maturing IL-1β from macrophages."&lt;SEP&gt;"Interleukin 10, an anti-inflammatory cytokine that plays a role in immune regulation and tolerance maintenance."&lt;SEP&gt;"Interleukin-10 (IL-10) is a cytokine involved in reducing inflammation by inhibiting the production of pro-inflammatory molecules and promoting anti-inflammatory effects."&lt;SEP&gt;"Interleukin-10 (IL-10) is a cytokine that plays a role in immune regulation, inhibiting pro-inflammatory responses."&lt;SEP&gt;"Interleukin-10 is a cytokine that plays a role in anti-inflammatory processes by inhibiting pro-inflammatory cytokines and enhancing the production of anti-inflammatory mediators."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RΑ−/−RAG1−/−&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant where IL-10Rα is germline deleted in mice also lacking Rag1, used to assess the impact of global IL-10Rα deletion on colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;LPMΦS (LYMPHOID TISSUE RESIDENT MACROPHAGES)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A subset of macrophages found in lymphoid tissues that play a role in immune regulation and inflammation."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/−&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A genomic variant that modifies the Rag1 gene and impacts colitis susceptibility."&lt;SEP&gt;"The IL-10RαMdelRag1−/− is a genetic variant associated with heightened inflammatory responses in mice."&lt;SEP&gt;**Note: This should likely be a Genomic Variant or Disease entity based on context rather than Dietary Pattern. Let's correct to "Genomic Variant".**</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;LPMΦS (LAMINA PROPRIA MACROPHAGES)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Lamina propria macrophages are a type of immune cells that play a role in the immune response within the gut, particularly in colitis models."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;FOXP3+ ITREG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Foxp3+ iTreg refers to induced regulatory T cells expressing Foxp3, which are involved in modulating immune responses and preventing excessive inflammation."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;TREGS (REGULATORY T CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulatory T cells are a subset of T lymphocytes that play critical roles in suppressing immune responses to prevent autoimmunity."&lt;SEP&gt;"STAT5B plays a role in the maintenance of regulatory T cells, which are crucial for immune self-tolerance and prevention of autoimmunity. A deficiency can result in reduced function and number of these cells over time."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by chronic inflammation in the colon."&lt;SEP&gt;"An inflammatory bowel disease characterized by chronic inflammation of the colon and rectum."&lt;SEP&gt;"Colitis refers to inflammation of the colon, often characterized by symptoms such as abdominal pain, diarrhea, and bloody stools, and can be caused by various factors including immune dysregulation."&lt;SEP&gt;"An inflammatory condition of the colon characterized by abdominal pain, diarrhea, and intestinal inflammation."&lt;SEP&gt;"Colitis is an inflammatory condition of the colon that can be influenced by genetic factors such as CARD9 deficiency."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;NEUTROPHILS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Neutrophils are a type of granulocyte that plays an important role in the innate immune system, particularly in phagocytosing pathogens and dead cells."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD11B&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD11b is a cell surface protein that functions as an integrin involved in leukocyte adhesion and migration, often used to identify specific immune cells such as neutrophils and macrophages."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD64&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD64 is a cell surface protein that acts as the high-affinity receptor for human IgG, primarily expressed on activated monocytes and macrophages."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD103&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD103 is a cell surface protein that acts as an adhesion molecule, often expressed on epithelial tissue-resident T cells."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;LY6G&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Ly6G is a mouse-specific cell surface protein that serves as an important marker for identifying neutrophils and other granulocytes."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;SIGLECF&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SiglecF is a cell surface receptor expressed on eosinophils, playing a role in modulating their activity and interactions with other cells."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD80&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD80 is a cell surface protein that acts as an activating ligand for the T cell receptor co-stimulatory molecule CD28, enhancing T cell proliferation and cytokine production."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD86&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD86 is a cell surface protein that acts as an activating ligand for the T cell receptor co-stimulatory molecule CD28, enhancing T cell proliferation and cytokine production."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RΒ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin-10 Receptor Beta (IL-10Rβ) is a subunit of the IL-10 receptor complex, essential for signaling downstream effects mediated by IL-10."&lt;SEP&gt;"The IL-10Rβ gene encodes for Interleukin 10 receptor subunit beta, which together with IL-10Rα forms the IL-10 receptor complex essential for signaling and immune regulation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;RAG2−/−&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Recombination Activating Gene 2 (RAG2) is crucial for the generation of a diverse T and B cell receptor repertoire; its absence results in severe immunodeficiency."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of white blood cell (leukocyte) crucial for immune responses and can be classified into different subsets such as CD4+ T helper cells and CD8+ cytotoxic T cells."&lt;SEP&gt;"T cells are a type of white blood cell that plays a central role in adaptive immunity."&lt;SEP&gt;"T cells are immune cells that play a role in regulating immune responses, including the production of cytokines like IL-10 which can influence disease progression."&lt;SEP&gt;"A type of white blood cell crucial for adaptive immunity; includes CD4+ T helper cells and CD8+ cytotoxic T lymphocytes."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;RAG1−/− MICE&quot;">
      <data key="d0">"ANIMAL MODEL (DISEASE)"</data>
      <data key="d1">"Mice deficient in Rag1 gene, which is essential for the development of functional immune cells."&lt;SEP&gt;"Rag1−/− mice are knockout mice lacking Rag genes essential for T and B cell development, often used in studies of autoimmune diseases like colitis."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;COLONIC INFILTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which immune cells accumulate within the colon, contributing to inflammation and disease severity."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TH17 CELLS&quot;">
      <data key="d0">"CELL TYPE (PROTEIN)"</data>
      <data key="d1">"T helper 17 cells, a subset of T cells involved in autoimmune inflammation and responses to certain pathogens."&lt;SEP&gt;"Th17 cells are a subset of CD4+ T helper cells that produce IL-17, playing critical roles in autoimmunity and inflammatory diseases."&lt;SEP&gt;"Th17 cells are involved in the pathologic response contributing to colonic inflammation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-6&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin 6 gene encoding the pro-inflammatory cytokine IL-6 which is involved in immune responses and inflammation."&lt;SEP&gt;"Interleukin 6 is a cytokine that plays a critical role in mediating inflammatory responses."&lt;SEP&gt;"Interleukin 6, a cytokine involved in systemic inflammation and acute-phase reactions."&lt;SEP&gt;"Interleukin-6 (IL-6) is an inflammatory cytokine involved in the regulation of immune responses and hematopoiesis."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TNF-Α (TUMOR NECROSIS FACTOR ALPHA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TNF-α gene encodes a pro-inflammatory cytokine contributing to cell death, inflammation, and cellular changes during disease progression."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-1Β (INTERLEUKIN 1 BETA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A cytokine involved in immune response activation and inflammatory responses."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN-1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A chemokine that recruits monocytes, memory T cells, and dendritic cells to sites of inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-17&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin-17 (IL-17) is another cytokine involved in immune responses but was observed to have no production differences when compared with IL-22 in intraepithelial γδ T cells."&lt;SEP&gt;"The gene encoding interleukin 17 which is a pro-inflammatory cytokine involved in immune responses."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IFN-Γ (INTERFERON GAMMA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene for Interferon Gamma, which plays an important role in the regulation of immune responses and inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;RORΓT-GFP REPORTER T CELLS&quot;">
      <data key="d0">"ANIMAL MODEL (CELL TYPE)"</data>
      <data key="d1">"Reporter T cells used to track RORγt expression in Th17 cells within colonic tissues."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;CD4+IL-17A+ T CELLS&quot;">
      <data key="d0">"CELL TYPE (PROTEIN)"</data>
      <data key="d1">"T helper 17 cells that produce IL-17, important for inflammatory responses."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;LPMΦS (LY6C+ PERITONEAL MACROPHAGES)&quot;">
      <data key="d0">"CELL TYPE (PROTEIN)"</data>
      <data key="d1">"Macrophage population within the peritoneum of mice, characterized by high expression of Ly6C and low CD11c, associated with inflammatory responses."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-23P19&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 23 subunit alpha gene encoding IL-23p19 which is a pro-inflammatory cytokine involved in immune response regulation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;ARGINASE&quot;">
      <data key="d0">"PROTEIN (ENZYME)"</data>
      <data key="d1">"An enzyme that breaks down the amino acid arginine, often used as an indicator of alternative macrophage activation during inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;INOS (INDUCIBLE NITRIC OXIDE SYNTHASE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in nitric oxide synthesis which is upregulated under inflammatory conditions and promotes the production of reactive nitrogen species."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;CD163&quot;">
      <data key="d0">"PROTEIN (RECEPTOR)"</data>
      <data key="d1">"Marker expressed on macrophages indicating their anti-inflammatory phenotype and scavenger function."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;NF-ΚB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A protein complex that plays a key role in regulating inflammation by activating genes involved in immune responses and cellular stress."&lt;SEP&gt;"NF-κB is a transcription factor complex involved in regulating immune responses, inflammation, and cell survival. Its activation can lead to increased expression of proinflammatory cytokines."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;STAT3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The STAT3 gene encodes for Signal Transducer and Activator of Transcription 3, which is crucial for the regulation of inflammatory responses through cytokine signaling."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;FOXP3+ TREGS (REGULATORY T CELLS)&quot;">
      <data key="d0">"CELL TYPE (PROTEIN)"</data>
      <data key="d1">"A subset of CD4+ T cells that express Foxp3 and play a critical role in immune tolerance and suppression of excessive inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-27&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin 27 is a cytokine with anti-inflammatory properties, known to regulate the differentiation of Th1 and Th17 cells."&lt;SEP&gt;"Interleukin-27, a cytokine produced by innate immune cells, forms a heterodimer with EBI3 to interact with its receptor IL27RA and activate the STAT1/STAT3 pathway in T cells."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IDO (INDOLEAMINE 2,3-DIOXYGENASE)&quot;">
      <data key="d0">"PROTEIN (ENZYME)"</data>
      <data key="d1">"An enzyme that catalyzes the first step in tryptophan catabolism, which can lead to immunosuppressive effects during inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-10RΑMDEL MICE&quot;">
      <data key="d0">"ANIMAL MODEL (DISEASE)"</data>
      <data key="d1">"Genetically modified mice lacking functional IL-10 receptor alpha protein, used as a model for studying inflammatory bowel disease and immune responses."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TH1 CELLS&quot;">
      <data key="d0">"CELL TYPE (PROTEIN)"</data>
      <data key="d1">"CD4+ T helper cells that produce IFN-gamma and are involved in cell-mediated immunity and inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-22&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin 22 is a cytokine with pro-inflammatory properties, particularly important for epithelial protection and immune regulation."&lt;SEP&gt;"Interleukin-22 (IL-22) is a cytokine involved in regulating mucosal immunity, particularly in the gastrointestinal tract."&lt;SEP&gt;"Interleukin-22 (IL-22) protein is required for the production of AHR ligands and is involved in normalizing AHR ligand production in Card9 knockout mice."&lt;SEP&gt;"Interleukin-22 plays a protective role in the gut and mediates recovery from inflammation via its target genes Reg3g and Reg3b."&lt;SEP&gt;"Interleukin 22, a pro-inflammatory cytokine produced by T helper cells that plays a role in epithelial tissue repair and defense against pathogens."&lt;SEP&gt;"Interleukin-22 is a cytokine that plays a role in immune responses."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CCR6&quot;">
      <data key="d0">"PROTEIN (RECEPTOR)"</data>
      <data key="d1">"A chemokine receptor expressed on Th17 cells and involved in their migration to sites of inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;CYTOKINES&quot;">
      <data key="d0">"GENE/PROTEIN FAMILY"</data>
      <data key="d1">"A family of small proteins that play a role in cell signaling, particularly important for immune responses and regulation of inflammation."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IMMUNE CHECKPOINTS&quot;">
      <data key="d0">"MECHANISM"</data>
      <data key="d1">"Mechanisms by which the immune system regulates its response to prevent excessive damage to healthy tissues."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-6RΑ−/−&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant affecting the IL-6 receptor alpha subunit gene, leading to impaired signaling for Th17 cell development."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;RAG1−/−&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant affecting the Rag1 gene, impacting immune system development and function."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-1Β&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin 1 beta is a pro-inflammatory cytokine generated from an inactive cytosolic precursor (pro-IL-1β) by caspase-1 cleavage and plays a role in colonic inflammation."&lt;SEP&gt;"Interleukin 1 beta, a pro-inflammatory cytokine that plays a role in innate immunity."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;FOXP3+ CD4+ T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulatory T cells expressing FoxP3 transcription factor, playing critical roles in immune regulation and tolerance maintenance."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;T CELL EXPANSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process by which T cells proliferate and differentiate into effector or memory T cells."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;RORΓT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Retinoid-related orphan receptor gamma t (RORγt), a transcription factor specifically expressed by Th17 cells."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;MΦ (MACROPHAGES)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of white blood cell involved in the immune system, particularly in phagocytosis and antigen presentation."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6RΑ−/− T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Transfers of IL-6Rα−/− T cells showed no detectable alteration in disease severity."&lt;SEP&gt;**Note: This should be corrected as it refers to a cell type with genomic variant condition rather than protein. Let's correct to "Genomic Variant".**</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;WT NAIVE T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Wild-type naive T cells, which are immature T lymphocytes that have not been exposed to antigen."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-1R−/− T CELLS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Transfers of IL-1R−/− T cells led to diminished clinical and histologic measures of colitis compared with control WT T cell transfers."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MICE&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"Mice with a genomic variant involving the IL-10 receptor alpha subunit in a Rag1 knockout background, affecting immune responses."&lt;SEP&gt;"This model represents mice lacking a specific gene (IL-10Rα) and having Rag1 deficiency, used to study immune responses in colitis conditions."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LPMΦS (LY6G−/LOSIGLECF− MΦ)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Colon-resident macrophages that are key in producing IL-1β, contributing to colonic inflammation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;CASPASE-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An enzyme that cleaves pro-IL-1β into its active form and is activated by inflammasome stimulation."&lt;SEP&gt;"An enzyme that processes pro-IL-1β to its active form, IL-1β, crucial for inflammatory response regulation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;INFLAMMASOME&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A molecular complex involved in the activation of caspase-1 and subsequent processing of pro-inflammatory cytokines like IL-1β."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;PRO-IL-1Β PRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process through which pro-IL-1β is produced, primarily by LPMϕs under conditions of colonic inflammation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-1R−/− MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice lacking IL-1 receptor genes show diminished clinical measures of colitis."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;WT T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Wild-type (normal) T cells used as a control in comparison with genetically altered T cells."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;TH17 RESPONSE MEDIATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process through which Th17 cells contribute to the pathogenesis of autoinflammatory diseases like colitis."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-10 SIGNALING PATHWAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A biological pathway involving IL-10 that regulates immune responses, particularly inhibiting inflammation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;LPMΦ (LY6G−/LOSIGLECF− MΦ)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD11b+ macrophages resident in the colon which produce IL-1β and contribute to colitis development."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;MFI (MEAN FLUORESCENCE INTENSITY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of protein expression levels used in flow cytometry analysis."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;PRO-IL-Β&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The precursor form of interleukin-1 beta (IL-1β), which requires processing by caspase-1 to become active."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;RAG1−/− CULTURES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Cultures derived from Rag1 knockout mice, lacking mature T and B cells due to the absence of RAG1 gene function."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/−-DERIVED MΦS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Macrophages (Mϕs) derived from Rag1 knockout mice with a mutated IL-10 receptor alpha subunit, showing altered cytokine signaling."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-1Β LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of mature interleukin-1 beta (IL-1β), a pro-inflammatory cytokine involved in immune responses and inflammation."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LPS AND ATP STIMULATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Stimulation of macrophages with lipopolysaccharide (LPS) and adenosine triphosphate (ATP), inducing pro-inflammatory responses."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TH17 CELL MATURATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The development of Th17 cells, a subset of T helper cells that play a role in immune defense against extracellular pathogens."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LPMΦS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Leucocyte Populated Migratory Phagocytes, cells that play a role in tissue repair and inflammation."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TGFΒ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Transforming growth factor beta (TGFβ), a cytokine involved in cell differentiation and regulation of immune responses."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-6R−/− T CELL TRANSFER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Transfer of IL-6 receptor knockout T cells, used to study the role of IL-6 signaling in immune processes."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ANTI-IL-10R ANTIBODY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An antibody that targets and blocks the function of IL-10 receptors, inhibiting their signaling pathway."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-1Β MATURATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which pro-interleukin-1 beta is converted into mature interleukin-1 beta through caspase-1 activation."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;CASPASE-1 CLEAVAGE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The enzymatic activity of caspase-1 that leads to the processing and activation of pro-inflammatory cytokines like IL-1β."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-6RΑ BLOCKING ANTIBODY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An antibody that blocks the interaction between IL-6 and its receptor, reducing the signaling pathway mediated by IL-6."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TH17 CELL MATURATION IN VIVO&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The development of Th17 cells in living organisms, which is influenced by cytokine environments such as those affected by IL-10R mutations."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;CX3CR1-DRIVEN CRE DRIVER LINE&quot;">
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d1">"This genetic driver line is used specifically in LPMϕs to assess the role of IL-10Rα deletion on colitis development and inflammation regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MACROPHAGES&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">"CD64 expression on macrophages indicates their activation status and potential role in inflammation or immune response regulation."&lt;SEP&gt;"Immune cells that play a role in the stimulation of IL-22-producing cells via interactions with dendritic cells and cytokine production."</data>
      <data key="d0">"CELL TYPE"</data>
    </node>
    <node id="&quot;EPITHELIAL T CELLS&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Expression of CD103 marks epithelial tissue-resident T cells, which play a role in immune surveillance and regulation within the gut."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EOSINOPHILS&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Expression of SiglecF on eosinophils modulates their functional capabilities, impacting immune responses and inflammation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BRDU (BROMODEOXYURIDINE)&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Incorporation of BrdU into DNA is used to measure and quantify cell proliferation, particularly in immune cells like macrophages."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL PROLIFERATION&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Incorporation of BrdU into DNA is used to measure and quantify cell proliferation, particularly in immune cells like macrophages."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNODEFICIENCY&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"The absence of recombination activating gene 2 results in a significant impairment of adaptive immune responses, leading to severe immunodeficiency."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 PRODUCTION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The production of IL-10 by T cells does not affect disease severity, suggesting that other cell types or mechanisms are more critical for controlling inflammatory processes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE RECRUITMENT&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"MCP-1 facilitates the recruitment of monocytes and other immune cells to sites of inflammation, contributing to the amplification of inflammatory responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Increased IL-17 levels are indicative of heightened Th17 cell activity, which is critical for exacerbating inflammatory processes and disease progression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE REGULATION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"IFN-γ plays a regulatory role in immune responses but its levels are not increased during Th17-dependent colitis, suggesting other cytokines are more influential."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLITIS SEVERITY&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The absence of IL-10Rα in these mice leads to severe colitis, highlighting the importance of IL-10 signaling in controlling inflammation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATION REGULATION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Tregs play a critical role in suppressing excessive immune responses and limiting tissue damage during inflammatory conditions like colitis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE RESPONSE REGULATION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"NF-κB activation is crucial for the transcription of pro-inflammatory genes, contributing to inflammation and disease progression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17 DIFFERENTIATION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"IL-27 can inhibit Th17 cell differentiation and promote alternative T cell lineages, thus modulating inflammatory processes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNOSUPPRESSION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"IDO activity leads to tryptophan depletion in the microenvironment, inducing immunosuppressive effects and limiting inflammation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLITIS PATHOGENESIS&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Increased IL-1β levels and Th17 cell activity are associated with the pathogenesis of colonic inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BACTEROIDES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Bacteroides is a genus of bacteria that constitutes the most abundant genus in gut microbiota across multiple cohorts."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;FAECALIBACTERIUM&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Faecalibacterium is a genus of bacteria present in significant abundance, contributing to the core microbiota identified in the study."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;BLAUTIA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Blautia is a genus of bacteria that was found in several cohorts as part of the gut microbial community."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ALISTIPES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Alistipes is a genus of bacteria identified within gut microbiota, though present at lower levels compared to others like Bacteroides and Faecalibacterium."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;RUMINOCLOSTRIDIUM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genus Ruminiclostridium was found in European cohorts as part of the core microbiota, producing short-chain fatty acids which are crucial for gut health."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;FUSICATENIBACTER&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Fusicatenibacter is a bacterial genus identified within the core microbiota of certain homogeneous clusters (e.g., European cohorts), known to contribute beneficial metabolic processes in the gut."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;BUTYRICICOCCUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The genus Butyricicoccus was part of the core microbiota found in specific clusters, contributing to the diversity and function of the gut microbial ecosystem."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;EUBACTERIUM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Eubacterium is a bacterial genus identified within the core microbiota of certain homogeneous groups, such as European cohorts, playing roles in producing beneficial compounds like short-chain fatty acids."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;16S RRNA GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The 16S rRNA gene is targeted for sequencing to profile microbial composition across different variable regions (V4, V3-V4, and V1-V2), providing insights into the diversity and structure of gut microbiota."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;DNA EXTRACTION METHOD&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"The DNA extraction method significantly influences heterogeneity in microbiome studies, contributing to 29% of variance in microbial composition across cohorts."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;HETEROGENEITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Microbiome heterogeneity refers to the variation observed among different populations or samples within a study, which is influenced by factors such as ethnicity and DNA extraction methods."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;GENETIC FACTORS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genetic background of individuals influences their microbiome composition, contributing significantly to inter-individual differences in gut microbial communities."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Environmental factors such as dietary habits and geographic location contribute to the variation observed in microbiome composition across different cohorts."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ALPHA DIVERSITY METRICS (SHANNON, SIMPSON, INVERSE SIMPSON)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"These metrics measure diversity within microbial communities. The study did not find evidence of heritability for these metrics but noted significant differences across cohorts regarding richness and Shannon diversity."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;HERITABILITY ESTIMATION (H2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process involves estimating the proportion of variation in gut microbiome composition due to genetic factors using twin studies and SNP-based heritability estimates."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;19 BACTERIAL TAXA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Out of 159 bacterial taxa, nineteen showed evidence for heritability in the TwinsUK cohort, with some concordance found in replication through NTR MZ twins."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;VEILLONELLA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Veillonella is a bacterial genus found in the human gut, known for its role in carbohydrate fermentation and short-chain fatty acid production."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ROSEBURIA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Roseburia is a bacterial genus that contributes to butyrate production within the gut microbiota, important for colon health."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;COPROCOCCUS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Coprococcus is a bacterial genus present in the human gut microbiota and involved in metabolizing complex carbohydrates."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;DIETARY FIBER&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Consumption of dietary fiber can influence the composition of gut microbiota, promoting diversity and abundance of beneficial bacteria."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ANTIBIOTICS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to antibiotics can alter gut microbiota composition by reducing microbial diversity and affecting core taxa presence."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;GENDER&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Gender can influence gut microbiota composition, with differences often observed between males and females."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MICROBIOME STABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The stability of the gut microbiome refers to its ability to maintain a consistent community structure despite external perturbations."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;GUT HEALTH&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A healthy gut microbiota is crucial for maintaining overall health, influencing metabolic processes and immune responses."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;RUMINICLOSTRIDIUM 9&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A bacterial taxon identified through LD score regression showing significant correlation with genetic variations."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;PEPTOSTREPTOCOCCAEAE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another bacterial taxon identified through LD score regression as significantly correlated with genetic factors."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;LCT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in mbBTL associations with gut microbiota abundance."&lt;SEP&gt;"The LCT gene, associated with the abundance of Bifidobacterium and showing age and ethnic heterogeneity."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;FUT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A functionally relevant variant suggested by earlier studies in relation to gut microbiota variation."&lt;SEP&gt;"FUT2 gene encodes alpha-1,2-fucosyltransferase responsible for the secretion of fucosylated mucus glycans in the gastrointestinal mucosa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The abundance of Bifidobacterium influenced by genetic and dietary factors, especially milk products intake."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MILK PRODUCTS INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern that positively correlates with the abundance of Bifidobacterium in individuals carrying specific genotypes."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;RS182549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP associated with high levels of Bifidobacterium abundance, particularly significant among adults with a CC genotype."&lt;SEP&gt;"A genomic variant associated with higher abundance of Bifidobacterium in adults but not younger individuals."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;NC_000002.11:G.136616754CC (RS182549)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant associated with higher Bifidobacterium abundance in adults but not in younger individuals."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;AGE AND ETHNICITY INTERACTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The interaction between age and ethnicity modulates the effect of genetic variants on gut microbiota composition."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;SIMPSON DIVERSITY INDEX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of diversity in microbiota abundance levels."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;INVERSE SIMPSON DIVERSITY INDEX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Another measure assessing microbial diversity, complementing Simpson's index."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;SHANNON DIVERSITY INDEX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An additional metric to assess the diversity of bacterial taxa in gut microbiota."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MBQTL MAPPING ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis identifying genetic variants associated with microbial abundance levels."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MBBTL MAPPING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Method used to identify loci affecting the presence/absence of bacterial taxa in gut microbiota."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;TWIN-BASED HERITABILITY CORRELATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Analysis showing correlation between SNP-based heritability and twin-based heritability for bacterial taxa."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;LCT LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic locus strongly associated with the abundance of Bifidobacterium in multiple cohorts."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located at rs4988235 associated with lactase persistence and milk drinking patterns."&lt;SEP&gt;"Functional variant within the LCT gene, highly correlated with rs182549."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;COPSAC2010 COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A cohort of children aged 4-6 years used to investigate genetic and environmental impacts on gut microbiota."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GEM COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Multi-ethnic cohort comprising individuals across different age ranges for investigating gene-diet interactions."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MULTI-ETHNICITY &quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Factor affecting the genetic association with microbial taxa abundance, highlighting ethnic heterogeneity in mbQTL effects."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;FUT2-FUT1 LOCUS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The FUT2-FUT1 locus is associated with the abundance of Ruminococcus torques and Ruminococcus gnavus genera groups, indicating a molecular interaction between genetic variation and gut microbiota."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS TORQUES GROUP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A genus from the Lachnospiraceae family that is involved in the degradation of complex carbohydrates, indicating its role in metabolism."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2 SNP (RS601338)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A functional variant in FUT2 that introduces a stop-codon affecting ABO antigen expression on intestinal mucosa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS GNAVUS GROUP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Another genus involved in the breakdown of complex carbohydrates, similar to R. torques."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;MUCUS GLYCANS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Mucin glycans secreted by FUT2 affect the abundance and composition of gut microbiota."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FRUIT INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern that correlates with the Ruminococcus torques group, influenced by genetic variation in FUT2."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;ALLISONELLA ABUNDANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The abundance of Allisonella is linked to genetic variants affecting riboflavin and mucin biosynthesis pathways."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;9Q21 LOCUS (PCSK5, RFK, GCNT1)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genetic locus involved in host-microbiome crosstalk through enzymes and glycosyltransferase activities related to riboflavin metabolism and mucin biosynthesis."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COBALAMIN ABSORPTION AND METABOLISM PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A metabolic pathway involving vitamin B12 absorption, regulation by the CUBN gene, and its role in host-microbial interactions."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PEPTOSTREPTOCOCCACEAE FAMILY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Heritable family of bacteria affected by genetic variants related to cobalamin metabolism and host immune defense."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE FAMILY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A taxon negatively associated with stool levels of gut inflammation markers such as chromogranin A and calprotectin."&lt;SEP&gt;"The Peptococcaceae family is a taxon negatively associated with stool levels of chromogranin A and calprotectin, indicating an inverse relationship with gut inflammation."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;B12-DEFICIENT ANEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Anemia resulting from insufficient vitamin B12 absorption, linked to genetic variants in the CUBN gene."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS SP.&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Specialized bacteria involved in degrading complex carbohydrates."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;9Q21 LOCUS (PCSK5, RFK)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genetic locus involving genes related to riboflavin metabolism and glycosylation processes."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;CUBN GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CUBN gene encodes a receptor for cobalamin complexes involved in vitamin B12 absorption and is linked to heritable microbiota abundance changes."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RIBOFLAVIN METABOLISM PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway involving riboflavin phosphorylation regulated by RFK enzyme, impacting host-microbiome interactions."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;MUCIN BIOSYNTHESIS PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Glycosylation pathway regulated by GCNT1 glycosyltransferase affecting intestinal microbiota composition."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COBALAMIN (VITAMIN B12)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A vitamin crucial for host-microbial interactions, involved in metabolic pathways and immune defense regulation."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GASTRIC INTRINSIC FACTOR COMPLEXES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Complexes of cobalamin with gastric intrinsic factor required for B12 absorption, regulated by CUBN gene expression."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;KIDNEY AND INTESTINAL EPITHELIUM EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Expression sites of the CUBN receptor in the body involved in vitamin B12 and albumin metabolism."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS7574352&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs7574352) is associated with stool levels of gut inflammation markers and ulcerative colitis."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CHROMOGRANIN A LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Chromogranin A levels are markers of gut inflammation that decrease in association with the Peptococcaceae family (taxon)."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CALPROTECTIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Calprotectin levels, another marker of gut inflammation, also show a negative association with the presence of the Peptococcaceae family."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inflammatory bowel disease that affects only the colon and rectum, causing long-lasting inflammation and ulcers in the innermost lining of the large intestine."&lt;SEP&gt;"Ulcerative colitis is an inflammatory bowel disease (IBD) for which certain gut microbial taxa may have protective effects."&lt;SEP&gt;"Ulcerative colitis is associated negatively with the presence of the Peptococcaceae family in stool samples."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;INTERFERON REGULATORY FACTOR 1 (IRF1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IRF1, located near a block of SNPs associated with gut inflammation and ulcerative colitis, is involved in insulin resistance and susceptibility to type 2 diabetes."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;ACTINOBACTERIA CLASS&quot;">
      <data key="d0">"GENOMIC VARIANT OR GENE (IMPLIED BY ASSOCIATION STUDY)"</data>
      <data key="d1">"The class Actinobacteria has been associated with a protective effect against ulcerative colitis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM GENUS&quot;">
      <data key="d0">"GENOMIC VARIANT OR GENE (IMPLIED BY ASSOCIATION STUDY)"</data>
      <data key="d1">"The genus Bifidobacterium, part of the class Actinobacteria, is linked to a reduced risk of developing ulcerative colitis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;OXALOBACTERACEAE FAMILY&quot;">
      <data key="d0">"GENOMIC VARIANT OR GENE (IMPLIED BY ASSOCIATION STUDY)"</data>
      <data key="d1">"The family Oxalobacteraceae has been linked to a reduced risk of rheumatoid arthritis, another autoimmune disease."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;RHEUMATOID ARTHRITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Rheumatoid arthritis is an autoimmune condition for which certain gut microbial taxa may have protective effects."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific location in a genome where variation occurs, often used to study genetic associations with traits or diseases."&lt;SEP&gt;"A variation in a single nucleotide that occurs at a specific position in the genome."&lt;SEP&gt;"SNPs are genetic variants that were used to perform MR analysis for identifying causal links between gut microbial taxa and phenotypes."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2&lt;SEP&gt;chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GUT MICROBIAL TAXA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Gut microbial taxa refer to the diverse communities of microorganisms in the gastrointestinal tract, which can be associated with various health outcomes."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;DIETARY PREFERENCES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Dietary preferences are patterns of food intake that were not found to have a causal relationship with gut microbial composition based on MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISEASES&quot;">
      <data key="d0">"DISEASE (CATEGORY)"</data>
      <data key="d1">"Autoimmune diseases include conditions like rheumatoid arthritis and ulcerative colitis, where the immune system attacks healthy tissue in the body."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASES&quot;">
      <data key="d0">"DISEASE (CATEGORY)"</data>
      <data key="d1">"Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, some of which may be influenced by gut microbial composition."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;METABOLIC DISEASES&quot;">
      <data key="d0">"DISEASE (CATEGORY)"</data>
      <data key="d1">"Metabolic diseases involve disorders in metabolic processes; these could potentially be linked to alterations in gut microbiome."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;PSYCHIATRIC DISORDERS&quot;">
      <data key="d0">"DISEASE (CATEGORY)"</data>
      <data key="d1">"Psychiatric disorders include mental health conditions that might be influenced by the composition of the gut microbiota."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;HOST GENETICS&quot;">
      <data key="d0">"GENOMIC VARIANT OR GENE"</data>
      <data key="d1">"Host genetics refers to the genetic makeup of an individual, which can influence their microbiome and, consequently, various phenotypes including diseases and dietary patterns."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;PROTEIN METABOLISM&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The abundance and distribution of Bacteroides within the gut microbiota can influence protein metabolism processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIOME HETEROGENEITY&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The presence of Blautia reflects broader patterns of heterogeneity observed in microbiome studies across different cohorts and populations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHORT-CHAIN FATTY ACIDS PRODUCTION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The presence of Fusicatenibacter within core microbiota supports the production of short-chain fatty acids, beneficial for gut health and metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIOME CORE TAXA&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Butyricicoccus is part of the core taxa found in homogeneous clusters, indicating its role in maintaining stable microbial communities under various conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;16S RRNA GENE SEQUENCING&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Sequencing the 16S rRNA gene helps in profiling microbial diversity, identifying core microbiota across different populations and cohorts.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIOME PROFILING&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Sequencing the 16S rRNA gene helps in profiling microbial diversity, identifying core microbiota across different populations and cohorts.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HETEROGENEITY IN MICROBIOME STUDIES&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The DNA extraction method significantly contributes to heterogeneity in microbiome studies by affecting microbial composition variance across studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY FIBER METABOLISM&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Prevotella's abundance is often linked to high-fiber diets due to its ability to ferment complex carbohydrates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREVOTELLA&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Prevotella's abundance is often linked to high-fiber diets due to its ability to ferment complex carbohydrates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARBOHYDRATE FERMENTATION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Veillonella plays a key role in carbohydrate fermentation, producing short-chain fatty acids that support gut health.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BUTYRATE PRODUCTION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Roseburia is particularly noted for its ability to produce butyrate, which supports colonic epithelial cell integrity and function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIOME DIVERSITY&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The presence of Coprococcus within the gut microbiota indicates a more diverse microbial community capable of metabolizing complex carbohydrates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT MICROBIOTA COMPOSITION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Consumption of dietary fiber influences the diversity and abundance of bacteria in the gut, promoting health benefits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIAL DIVERSITY REDUCTION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Antibiotic use can reduce microbial diversity within the gut microbiome, affecting core taxa presence and stability.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT MICROBIOTA DYNAMICS&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The composition of the gut microbiota changes with age, impacting its role in health and disease."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 25}]</data>
    </node>
    <node id="&quot;MICROBIAL ABUNDANCE VARIATIONS&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Gender differences influence microbial abundance within the gut microbiome, reflecting sex-specific factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL INFLUENCES&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Stability of the gut microbiome is influenced by various environmental factors including diet and antibiotic exposure."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIAL COMPOSITION IMPACT&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"Maintaining a healthy gut microbial composition supports overall health, affecting metabolic processes and immune responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIOTA DYSBIOSIS&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"An imbalance in the gut microbiota is associated with an increased risk of developing metabolic syndrome, indicating a link between microbiome composition and systemic diseases."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUCUS GLYCANS PRODUCTION&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"Genetic variation in rs601338 affects the secretion of mucus glycans, impacting gut microbiota composition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPLEX CARBOHYDRATES DEGRADATION&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"These bacteria are specialized in breaking down complex carbohydrates, supporting their role in metabolic pathways within the gut."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HOST-MICROBIOME CROSSTALK&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"The genetic locus involved in regulating riboflavin metabolism and mucin biosynthesis contributes to host-microbiota interactions within the intestine."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALBUMINURIA REGULATION&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"Genetic variation affecting cobalamin absorption via CUBN gene is linked to albuminuria, indicating a role in metabolic regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COBALAMIN ABSORPTION PATHWAY&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"Genetic variation affecting cobalamin absorption via CUBN gene is linked to albuminuria, indicating a role in metabolic regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTESTINAL MICROBIOTA COMPOSITION&quot;">
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d1">"The glycosylation pathway regulated by GCNT1 impacts the composition of intestinal microbiota through mucin production."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IRF1 GENE&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"Genetic variation near IRF1 influences susceptibility to T2DM, indicating potential pathways linking gene function with metabolic diseases."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS (T2DM)&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"Genetic variation near IRF1 influences susceptibility to T2DM, indicating potential pathways linking gene function with metabolic diseases."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HOST GENETICS AND GUT MICROBIAL TAXA&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"There is a complex relationship between cardiovascular health, host genetics, and the composition of the gut microbiome.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT MICROBIAL TAXA AND HOST GENETICS&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"There is emerging evidence suggesting a link between gut microbiota, genetic predisposition, and the development of psychiatric disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 T/T GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs4988235 T/T genotype is a genetic variant associated with lactase persistence and higher milk intake."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;LP (LACTASE PERSISTENCE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LP refers to the gene responsible for lactase persistence, which affects the ability to digest milk sugar lactose into adulthood."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MILK INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Milk intake varies between countries and is a dietary pattern that can be influenced by genetic factors such as LP genotype."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;C15:0&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"C15:0 is a fatty acid involved in metabolic pathways related to diet and health outcomes, specifically associated with higher plasma levels due to LP genotypes."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"HDL cholesterol is a physiological process indicator of cardiovascular health that was shown to be modestly lower in individuals carrying the LP allele."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of dairy products is influenced by genetic factors, such as the rs4988235 T/T genotype, and can affect health outcomes."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIABETES RISK FACTORS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Certain dietary patterns and genotypes influence diabetes risk factors like HDL cholesterol and other biomarkers."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;BASELINE HBA1C LEVELS&quot;">
      <data key="d0">"DISEASE BIOMARKER"</data>
      <data key="d1">"HbA1c levels are a biomarker for assessing long-term blood sugar control, which was not significantly affected by the LP genotype in this study."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIABETES RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The risk of developing diabetes did not differ based on lactase persistence genotypes as indicated by this study's results."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;ENERGY INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Energy intake refers to the total amount of energy derived from food consumption, which was not found to be affected by LP genotypes in this study."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;POULTRY CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake of poultry is a dietary pattern that showed a slight decrease associated with the LP genotype in this study."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;NON-ALCOHOLIC BEVERAGES INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Consumption of non-alcoholic beverages was found to be lower among individuals carrying the rs4988235 T allele compared to those without."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;C15:0 LEVELS&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"Intake of dairy products is associated with higher plasma C15:0 levels, reflecting metabolic pathways influenced by dietary habits."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Choline is a nutrient essential for various physiological processes, including methylation reactions and phospholipid biosynthesis."&lt;SEP&gt;"Choline is a nutrient that plays an important role in fetal development and cognitive function."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;FETAL ALCOHOL SPECTRUM DISORDER (FASD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fetal Alcohol Spectrum Disorders (FASD) are a range of conditions that can occur in a child whose mother drank alcohol during pregnancy, affecting physical growth and mental abilities."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;EYEBLINK CONDITIONING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Eyeblink conditioning is a measure used to assess learning and memory functions in infants."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;VISUAL RECOGNITION MEMORY FUNCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Visual recognition memory function refers to the ability of an infant to recognize previously seen objects, which can be assessed using tests like FTII."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FETAL ALCOHOL GROWTH RESTRICTION (FAGR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fetal alcohol growth restriction is a condition where fetal development is impaired due to maternal alcohol consumption during pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NOVELTY PREFERENCE SCORE&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"A novelty preference score is used in the Fagan Test of Infant Intelligence (FTII) to assess visual recognition memory function in infants."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SOCIAL CLASS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"The social class of participants did not differ between the treatment and placebo groups."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL EDUCATION&quot;">
      <data key="d0">"BACKGROUND INFORMATION"</data>
      <data key="d1">"Educational background was similar for mothers in both the choline treatment and placebo arms."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;VERBAL INTELLECTUAL COMPETENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Assessment of verbal intellectual competence did not differ significantly between groups."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NONVERBAL INTELLECTUAL COMPETENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Nonverbal intellectual competence was also similar for both treatment and placebo groups."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PERCEIVED STRESS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Levels of perceived stress were comparable in the choline treatment group compared to the placebo group."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DEPRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Rates of depression did not differ between mothers receiving choline supplementation and those on placebo."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NUTRITIONAL STATUS&quot;">
      <data key="d0">"BACKGROUND INFORMATION"</data>
      <data key="d1">"Both groups had similar nutritional statuses at baseline, though many were poorly nourished based on dietary caloric intake."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DIETARY CHOLINE INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Only a minority of participants met the AI for dietary choline intake during pregnancy."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;HEAVY ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Women in both groups consumed alcohol heavily before and during early stages of pregnancy but reduced frequency later on."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SMOKING&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"A lifestyle factor where the frequency or level of smoking may affect disease risk, including RCC."&lt;SEP&gt;"Both treatment arms had similar smoking habits, with an average of a quarter pack per day."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ILLICIT DRUG USE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Use of illicit drugs other than marijuana was rare among the participants; methamphetamine use occurred in a few cases."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE&quot;">
      <data key="d0">"SUBSTANCE"</data>
      <data key="d1">"A small number of women used methamphetamine during pregnancy, affecting some infants’ development."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;GESTATIONAL AGE (GA)&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"The majority of pregnancies were full-term and there was no difference in GA between the groups."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;BIRTH WEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Low birth weight (&lt;2500 g) was common, but incidence did not differ significantly between treatment arms."&lt;SEP&gt;"The body weight at birth of a newborn influenced by both maternal and fetal nutrient levels, such as B12 and folate."&lt;SEP&gt;"The body weight of a newborn, influenced by maternal and fetal nutrient levels such as B12 and folate."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CATCH-UP GROWTH&quot;">
      <data key="d0">"DISEASE PROGRESSION"</data>
      <data key="d1">"Infants in the choline arm showed catch-up growth in weight and head circumference compared to placebo group."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FAGAN TEST OF INFANT INTELLIGENCE (FTII)&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"The FTII test was used to assess visual recognition memory function at 12 months."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CHROMOSOME ABNORMALITIES (PFAS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Some infants had partial fetal alcohol syndrome, indicating chromosomal abnormalities related to prenatal alcohol exposure."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FASD DIAGNOSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Diagnosis related to Fetal Alcohol Spectrum Disorders, including FAS and PFAS."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;MATERNAL DIETARY CHOLINE STATUS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The dietary pattern of choline intake by pregnant mothers affects fetal development and outcomes."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PEMT ENZYME VARIANT (RS12325817)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the PEMT gene that influences endogenous choline synthesis."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;FAS (FETAL ALCOHOL SYNDROME)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition within Fetal Alcohol Spectrum Disorders characterized by specific facial abnormalities, growth deficiencies, and central nervous system impairments."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PFAS (PARTIAL FETAL ALCOHOL SYNDROME)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A less severe form of FAS that includes some but not all criteria for FAS, such as partial facial abnormalities or neurobehavioral deficits."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PLACEBO ARM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The group of infants whose mothers did not receive choline supplementation during pregnancy; instead, they received a placebo."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE-TREATED GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Infants born to mothers who received choline supplementation during pregnancy."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;ENDOGENOUS CHOLINE SYNTHESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which the body synthesizes choline internally through enzymes like PEMT, independent of dietary intake."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;MATERNAL ALCOHOL CONSUMPTION&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"High levels of alcohol consumption during pregnancy are linked to the development of FASD in children."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FETAL DEVELOPMENT&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Maternal smoking can contribute to developmental delays and other adverse outcomes in children exposed to prenatal nicotine."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEVELOPMENTAL OUTCOMES&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Use of illicit drugs during pregnancy may lead to poor developmental outcomes, including lower cognitive abilities in infants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE SUPPLEMENTATION&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d1">"Infants receiving choline supplementation showed improved growth patterns compared to those without supplementation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GRK5 (CA)N POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GRK5 (CA)n polymorphism is a genomic variant where the number of CA repeat sequences varies within the population."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;IFG (IMPAIRED FASTING GLUCOSE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IFG, or Impaired Fasting Glucose, indicates an abnormal increase in blood glucose levels during fasting and is linked to prediabetes conditions."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;IGT (IMPAIRED GLUCOSE TOLERANCE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IGT, or Impaired Glucose Tolerance, represents a condition where blood glucose levels are higher than normal but not high enough for a diabetes diagnosis."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;T2DM (TYPE 2 DIABETES MELLITUS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T2DM is a chronic disease characterized by high blood sugar levels due to insulin resistance or insufficient insulin production."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE, BMI, SBP, DBP, FPG, AND 2 H PG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These clinical parameters indicate metabolic and physiological processes affected in individuals with abnormal glucose metabolism."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;CA REPEAT SEQUENCES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CA repeat sequences are short tandem repeats found within the human genome that can influence gene expression through splicing enhancers or repressors."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;GRK5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GRK5 gene plays a role in physiological processes, particularly related to glucose metabolism."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;PIC VALUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Polymorphism Information Content (PIC) values are used to assess genetic diversity within populations by measuring allele frequencies."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A statistical method analyzing the association between genotypes and disease risk."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;T2DM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 Diabetes Mellitus, characterized by insulin resistance and relative lack of insulin due to inadequate pancreatic beta cell function; T2DM phenotypes are also exacerbated by HFD in SENP1-aP2KO mice."&lt;SEP&gt;"Type 2 diabetes mellitus (T2DM) is a disease characterized by high blood sugar levels over a prolonged period."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)16 ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The (CA)16 allele is a specific genomic variant that serves as a reference in genetic studies of T2DM and abnormal blood glucose conditions."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IFG&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Impaired Fasting Glucose (IFG), a condition characterized by higher than normal fasting blood sugar levels but not high enough to be classified as diabetes, is associated with an increased risk of developing Type 2 Diabetes Mellitus."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;IGT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Impaired Glucose Tolerance (IGT) is a prediabetic state characterized by higher than normal blood sugar levels after consuming glucose, which can progress to Type 2 Diabetes Mellitus if not addressed."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These alleles represent multiple genomic variants that are studied in relation to T2DM risk and blood glucose regulation."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;NFG GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The NFG group is used as a control group in studies comparing different dietary patterns or genetic factors related to blood glucose levels."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;IFG, IGT, T2DM&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The presence of GRK5 (CA)16 allele polymorphisms is significantly associated with increased risk for prediabetes and type 2 diabetes mellitus."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL PARAMETERS&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"Abnormal glucose metabolism as seen in IFG, IGT, and T2DM leads to an increase in clinical parameters such as waist circumference, BMI, SBP, DBP, FPG, and 2 h PG."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GRK5 GENE&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The genetic variation within the GRK5 gene is assessed using PIC values to determine polymorphism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="(&quot;CA)16, (CA)17 ALLELES&quot;)">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The PIC values indicate significant differences in the frequency distribution of specific alleles like (CA)16 and (CA)17 across different groups."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABNORMAL BLOOD GLUCOSE&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"There are no significant associations between the (CA)16 allele and abnormal blood glucose conditions, indicating that this allele does not significantly influence these conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GPX4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GPX4 gene has a SNP (rs8178974) that was statistically significantly associated with colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SNP IN GPX4 GENE (RS8178974)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant (rs8178974) in the GPX4 gene is linked to an increased risk of colorectal cancer."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SELENIUM SUPPLEMENTS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium supplements were not associated with a different risk of colorectal cancer compared to controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;COLORECTAL CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colorectal cancer is the disease under study, particularly its association with selenium and genetic factors."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;SERUM SELENIUM CONCENTRATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Serum selenium concentration was studied for its potential role in colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;CALCIUM INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intakes of calcium were lower in cases (colorectal cancer patients) than controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;DIETARY FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intakes of dietary fiber were also lower among colorectal cancer cases compared to healthy controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLON CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study indicates that serum selenium may be marginally significantly associated with the risk of colon cancer, a type of colorectal cancer."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANTS IN SELENOENZYMES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genetic variants within selenoenzyme genes did not modify the association between serum selenium and colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;NSAIDS (NONSTEROIDAL ANTI-INFLAMMATORY DRUGS)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Use of NSAIDs was similar between cases with colorectal cancer and controls, indicating no significant impact on disease risk from this medication use."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;POSTMENOPAUSAL HORMONE USE&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Cases used postmenopausal hormone less frequently than controls, suggesting a potential influence on colorectal cancer incidence."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Cases were less physically active than controls, suggesting reduced activity levels may be associated with increased disease risk."&lt;SEP&gt;"The amount of physical activity individuals engage in is a lifestyle factor that influences overall health and hormone levels."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;CARD9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CARD9 is a gene that contributes to the susceptibility of mice to colitis by altering IL-22 signaling pathway via impaired tryptophan metabolism."&lt;SEP&gt;"CARD9 is a gene that plays a role in mediating recovery from DSS-induced colitis."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3G AND REG3B&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Reg3g (encoding REGIII-γ) and Reg3b (encoding REGIII-β) are transcripts induced by IL-22, contributing to antimicrobial defense in the gut during colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 1beta gene is upregulated in Card9−/− mice compared to wild-type mice under DSS-induced colitis conditions."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3G, REG3B, AND IL22&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Colonic expression of these transcripts is reduced on day 12 in Card9−/− mice relative to wild-type mice during recovery from DSS-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-17A&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Interleukin 17A, a pro-inflammatory cytokine produced by T helper cells (Th17), contributing to inflammation and tissue damage."&lt;SEP&gt;"This cytokine has a protective role alongside IL-22 during colitis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;DSS-INDUCED COLITIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A model for studying inflammatory bowel disease induced by dextran sodium sulfate (DSS) that is influenced by factors such as IL-22 signaling."&lt;SEP&gt;"An experimental model of colonic inflammation induced by dextran sulfate sodium, used to study the mechanisms of inflammatory bowel disease."&lt;SEP&gt;"Colonic inflammation induced by dextran sodium sulfate (DSS), a model for studying inflammatory bowel disease."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IMMUNE-RELATED PATHWAYS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathways activated in response to DSS-induced colitis are enriched for immune processes in Card9−/− mice compared to wild-type controls."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;INTESTINAL EPITHELIAL CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells lining the gut that express antimicrobial proteins such as REGIII-γ and REGIII-β when stimulated by IL-22."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;GUT MICROBIOTA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The collective microbial community in the gastrointestinal tract, which includes bacteria, fungi, and other microorganisms."&lt;SEP&gt;"The gut microbiota influences the susceptibility of mice to colitis by altering IL-22 signaling pathway via impaired tryptophan metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;DSS (DEXTRAN SULFATE SODIUM)&quot;">
      <data key="d0">"CHEMICAL COMPOUND"</data>
      <data key="d1">"A chemical compound used experimentally to induce colitis in mice."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;WT MICE (WILD-TYPE MICE)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Genetically normal mice used as controls in experiments."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CARD9−/− MICE&quot;">
      <data key="d0">"ANIMAL MODEL"</data>
      <data key="d1">"Mice lacking the CARD9 gene, making them more susceptible to colitis and having impaired recovery."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;KI67 (PROLIFERATION MARKER)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein present in all phases of the active cell cycle but absent in resting cells. It serves as an indicator for cellular proliferation status."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CLEAVED CASPASE 3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A marker used to identify apoptosis, or programmed cell death, in tissues."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-22+ CELLS (INTERLEUKIN-22 POSITIVE CELLS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Immune cells that produce interleukin-22 and contribute to the regulation of epithelial barrier functions and antimicrobial defense during inflammation."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CD3−CD4−NKP46− SUBSET&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A subset of IL-22+ cells characterized by the absence of CD3, CD4, and NKp46 markers. These are innate lymphoid cells (ILCs)."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;MICROBIAL COMPOSITION (FUNGAL AND BACTERIAL)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The microbial composition in feces or colonic samples reflects changes due to genetic modifications like CARD9 deficiency."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CARD9 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CARD9 gene plays a role in shaping bacterial and fungal gut microbiota, specifically controlling fungal expansion during colitis."&lt;SEP&gt;"The Card9 gene plays a critical role in immune responses and contributes to susceptibility to DSS-induced colitis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;GERM-FREE (GF) MICE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Germ-free mice are used to isolate the effect of gut microbiota in disease models, particularly when investigating the role of specific genes like Card9."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DEXTRAN SODIUM SULFATE (DSS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DSS is an environmental factor used to induce colitis in experimental mouse models."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL-22 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-22 gene encodes a cytokine that plays a critical role in intestinal homeostasis and innate antimicrobial resistance, as observed in the context of CARD9 deficiency."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;CYTOKINES (CXCL1, CXCL5)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CXCL1 and CXCL5 are chemokine proteins that play roles in inflammation. In Card9−/− mice, their expression is altered during colitis, suggesting involvement in the disease process."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR (FOS)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FOS gene encodes a transcription factor involved in cellular responses to growth factors and cytokines, with reduced expression observed in Card9−/− mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;REG3G AND REG3B GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"REG3G and REG3B encode proteins that are part of the innate immune system's response against fungi. Their decreased expression in Card9−/−→GF mice suggests a compromised fungal resistance mechanism."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTERLEUKIN-17 (IL-17)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-17 is a cytokine produced by various immune cells and involved in inflammation. The study did not find changes in IL-17 expression or production, indicating that the defect seen in Card9−/−→GF mice might be specific to other pathways."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INNATE LYMPHOID CELLS (ILCS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"ILCs are immune cells known for their role in producing cytokines like IL-22 and IL-17. Their function was altered in Card9−/−→GF mice, particularly in the production of IL-22."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;TH22 CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"TH22 cells are a subset of T helper cells that produce IL-22 and play an important role in mucosal immune responses. Their function was decreased in Card9−/−→GF mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL-23 SIGNALING PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The IL-23 pathway is crucial for the induction of IL-17 and IL-22 production by specific T cells and innate lymphoid cells. This pathway appears to be intact in Card9−/−→GF mice, as dendritic cells and macrophages involved in this process did not show differences."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;ADLERCREUTZIA (GENUS)&quot;">
      <data key="d0">"MICROBIAL SPECIES"</data>
      <data key="d1">"Adlercreutzia is a genus of bacteria that was observed to decrease in Card9−/− mouse microbiota, indicating its potential role in maintaining gut homeostasis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;ACTINOBACTERIA (PHYLUM)&quot;">
      <data key="d0">"MICROBIAL PHYLUM"</data>
      <data key="d1">"Actinobacteria is a phylum of bacteria. Its reduction in the Card9−/− mouse microbiota suggests it plays an important role in gut health and may be influenced by CARD9 deficiency."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;LACTOBACILLUS REUTERI (SPECIES)&quot;">
      <data key="d0">"MICROBIAL SPECIES"</data>
      <data key="d1">"Lactobacillus reuteri is a species of bacteria that was found to decrease in the Card9−/− mouse microbiota, possibly indicating its importance in gut health under CARD9 influence."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTERLEUKIN-1Β (IL-1Β)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-1β is a pro-inflammatory cytokine that works with TNF-α and others to initiate inflammatory responses in the body."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;NOD2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with inflammatory bowel disease, but not linked to reduced AHR activation by fecal samples in the study."&lt;SEP&gt;"The NOD2 gene encodes a protein involved in innate immune recognition of bacterial products, similar to CARD9's role in fungal sensing."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM LONGUM (SPECIES)&quot;">
      <data key="d0">"MICROBIAL SPECIES"</data>
      <data key="d1">"Bifidobacterium longum is a species of bacteria commonly found in the gut microbiota that influences host health and immune responses."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;FIBROBLAST GROWTH FACTOR 15 (FGF15)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FGF15 is involved in regulating intestinal inflammation and metabolism, with its expression affected by genetic factors like CARD9 deficiency."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The metabolism of tryptophan by gut microbiota influences the activation of Aryl Hydrocarbon Receptor (AHR)."&lt;SEP&gt;"The process by which tryptophan is metabolized into indole derivatives or kynurenine via different pathways involving gut bacteria and host cells."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR ACTIVATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Activation of the Aryl Hydrocarbon Receptor (AHR) through ligand binding, which promotes local IL-22 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An enzyme that converts tryptophan into kynurenine as part of the immune response and regulation of T cell activation."&lt;SEP&gt;"IDO1 is a protein involved in the catabolism of tryptophan to produce Kynurenine (Kyn) which plays a role in immune regulation and AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INDOLE-3-ACETIC ACID (IAA)&quot;">
      <data key="d0">"METABOLIC PATHWAY PRODUCT"</data>
      <data key="d1">"A metabolite derived from tryptophan metabolism by gut bacteria, which activates AHR and promotes local IL-22 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;KYNURENINE (KYN)&quot;">
      <data key="d0">"METABOLIC PATHWAY PRODUCT"</data>
      <data key="d1">"A metabolite of tryptophan that can influence immune responses through AHR activation."&lt;SEP&gt;"A product of tryptophan metabolism via the enzyme IDO1, involved in immune regulation."&lt;SEP&gt;"Kyn is a metabolite of tryptophan involved in immune regulation through AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;LACTOBACILLUS STRAINS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Specific strains of Lactobacillus that were isolated from WT mice due to their ability to activate AHR and contribute to the regulation of colitis susceptibility."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INTRAEPITHELIAL ΓΔ T CELLS&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"T cells that reside within the epithelial layer and can produce cytokines like IL-22 or IL-17."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INTESTINAL DENDRITIC CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Immune cells located in the intestine involved in antigen presentation and activation of T cells via cytokine production, such as IL-23."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IL-23 PRODUCTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process by which intestinal dendritic cells produce interleukin-23 to stimulate IL-22-producing cells."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;MICROBIOTA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The community of microorganisms living within the gut, which affects immune responses and colonic health."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IDO1−/− MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice deficient in the Ido1 gene, which results in altered tryptophan metabolism and subsequent effects on AHR activation and IL-22 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;L. REUTERI AND ALLOBACULUM SP.&quot;">
      <data key="d0">"MICROBIOTA STRAINS"</data>
      <data key="d1">"Specific bacterial strains identified for their ability to activate the Aryl Hydrocarbon Receptor (AHR) and are decreased in abundance in Card9−/− mice microbiota."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IL22−/− MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice deficient in IL-22, which show alterations in their gut microbiota affecting AHR activity and IAA levels."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;ARYL HYDROCARBON RECEPTOR (AHR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Aryl Hydrocarbon Receptor is activated by ligands produced through tryptophan metabolism, playing an important role in the gut microbiota's interaction with host immune cells."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CROHN’S DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IBD-ASSOCIATED SINGLE-NUCLEOTIDE POLYMORPHISM (RS10781499)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant within CARD9 that is associated with increased risk for inflammatory bowel disease (IBD)."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;TRYPTOPHAN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An essential amino acid involved in the production of neurotransmitters and important for immune regulation via its metabolism to Kynurenine."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IDO1 ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The enzymatic activity of IDO1 leading to the production of Kyn from tryptophan, which is reduced in subjects with IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AHR LIGAND PRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Production of AHR ligands is influenced by the gut microbiota and is crucial for normalizing AHR ligand production in Card9−/− mice."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;INFLAMMATORY BOWEL DISEASE (IBD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic inflammatory condition affecting the gastrointestinal tract, including Crohn’s disease and ulcerative colitis."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;FECAL SAMPLES ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Analysis of fecal samples to assess the ability of gut microbiota to activate Aryl Hydrocarbon Receptor (AHR)."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;SUPPLEMENTARY FIG. 13C–H AND SUPPLEMENTARY FIG. 14&quot;">
      <data key="d0">"FIGURE REFERENCE"</data>
      <data key="d1">"Figures showing the effects of exogenous IL-22 on AHR ligand production in Card9−/− mice and its relation to gut microbiota."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AUTOPHAGY-RELATED 16-LIKE 1 (ATG16L1) GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene associated with IBD, showing no correlation with decreased AHR activation through microbiota-derived metabolites."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;LEUCINE-RICH REPEAT KINASE 2 (LRRK2) GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene related to IBD that did not show an association with reduced AHR activation in the study."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;DSS-INDUCED COLITIS RECOVERY&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"Decreased proliferation (Ki-67) and increased apoptosis (cleaved caspase 3) indicate impaired intestinal healing in Card9−/− mice."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KI67 AND CLEAVED CASPASE 3&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"Decreased proliferation (Ki-67) and increased apoptosis (cleaved caspase 3) indicate impaired intestinal healing in Card9−/− mice."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-22+ CELLS&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"The CD3−CD4−NKp46− subset is a subpopulation of IL-22+ cells that plays a crucial role in the immune response to colitis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 GENE &quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"The unaltered levels of IL-17 production indicate that the defect seen in Card9−/−→GF mice might be specific to pathways other than those regulated by IL-17."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-22 GENE &quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"ILC function is compromised in the production of IL-22, indicating a critical role for these cells in maintaining gut homeostasis through this cytokine."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REG3G AND REG3B GENES &quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"TH22 cell dysfunction leads to decreased production of REG3G and REG3B, highlighting the importance of IL-22 for maintaining anti-fungal defense mechanisms in the gut."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-23 SIGNALING PATHWAY &quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"While the IL-23 pathway is intact in Card9−/−→GF mice, the inability of ILCs to produce sufficient IL-22 indicates a specific defect downstream of this pathway."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNF-Α GENE &quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"Together, IL-1β and TNF-α form a cytokine network critical for initiating inflammation in the body. Their roles are intertwined with those of CARD9 during colitis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-22 PRODUCTION&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">"The production of Kyn through IDO1 activity modulates IL-22 levels, impacting the susceptibility to DSS-induced colitis in Card9−/− mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDO1 PROTEIN&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"IDO1 is responsible for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KYNURENINE PRODUCTION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"IDO1 is responsible for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 GENE EXPRESSION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"A specific genetic variant within CARD9 affects the ability of gut microbiota to produce AHR ligands, influencing disease susceptibility in IBD patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBD-ASSOCIATED SNP (RS10781499)&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"A specific genetic variant within CARD9 affects the ability of gut microbiota to produce AHR ligands, influencing disease susceptibility in IBD patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT MICROBIOTA FUNCTION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Impaired tryptophan metabolism by the gut microbiota leads to defective AHR activation and increased susceptibility to IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR ACTIVATION &quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Fecal samples from patients with IBD show reduced ability to activate Aryl Hydrocarbon Receptor (AHR), indicating impaired tryptophan metabolism and microbiota function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBD-DERIVED FECAL SAMPLES&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Fecal samples from patients with IBD show reduced ability to activate Aryl Hydrocarbon Receptor (AHR), indicating impaired tryptophan metabolism and microbiota function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9 GENE VARIANT (RS10781499)&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"An SNP within CARD9 associated with increased susceptibility to IBD, affecting AHR activation by gut microbiota-derived metabolites.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBD SUSCEPTIBILITY &quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"An SNP within CARD9 associated with increased susceptibility to IBD, affecting AHR activation by gut microbiota-derived metabolites.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDO1 ENZYMATIC ACTIVITY&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The enzymatic activity of IDO1 is crucial for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM &quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The enzymatic activity of IDO1 is crucial for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE RESPONSE REGULATION &quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Activation of Aryl Hydrocarbon Receptor (AHR) regulates immune responses through metabolites produced by tryptophan metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Β2M GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"β2M, also known as Beta-2-Microglobulin, is a gene that encodes the beta-2-microglobulin protein."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;RS3184504 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs3184504 polymorphism is associated with plasma β2M levels and SH2B3 expression."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3 EXPRESSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Expression of the SH2B3 gene, which may be influenced by genomic variants like rs3184504."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by persistently elevated blood pressure."&lt;SEP&gt;"A disease characterized by persistently high blood pressure levels that can lead to cardiovascular complications."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;SH2B3 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SH2B3 protein, whose expression is associated with β2M levels and hypertension risk."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ANGIOTENSIN II-INDUCED HYPERTENSION MODEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A model that uses angiotensin II to induce hypertension in mice for research purposes."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;CIRCULATING BETA-2-MICROGLOBULIN LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The pathway through which β2M levels are regulated and influence disease risk, such as hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;RENAL/VASCULAR DYSFUNCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Dysfunctions in the kidney and blood vessels that occur during hypertension or other cardiovascular conditions."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3−/− MOUSE MODEL&quot;">
      <data key="d0">"ANIMAL MODEL"</data>
      <data key="d1">"A model involving mice with a deficiency of SH2B3 protein used to study the effects on β2M expression and hypertensive responses."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;Β2M PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The β2M protein is encoded by the β2M gene and has been linked to hypertension risk."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;SH2B3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SH2B3, also known as SH2-containing B adaptor-like protein 3, plays a role in regulating β2M expression and hypertension risk through its expression level."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ALBUMINURIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition where albumin is present in the urine, often indicating kidney dysfunction associated with hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;LOW EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A measure of kidney function that can indicate early-stage chronic kidney disease and influence risk factors for hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;STATIN USE&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Medication used to lower cholesterol levels, which is often considered in the context of cardiovascular health along with β2M levels."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d3">[{"level": 0, "cluster": 6}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;ANGIOTENSIN II&quot;">
      <data key="d0">"NUTRIENT/MOLECULAR INTERACTION"</data>
      <data key="d1">"A hormone that plays a role in regulating blood pressure and can be used as an inducer of hypertension in experimental models."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;MTHFD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTHFD1 is a gene associated with increased risk of neural tube defects in infants who carry specific variants and have low dietary folate intake."&lt;SEP&gt;"Methylenetetrahydrofolate dehydrogenase 1 gene (MTHFD1) encodes an enzyme with three activities: 5,10-methylene-THF dehydrogenase, cyclohydrolase, and synthetase. It is crucial for methionine, thymidylate, and purine synthesis."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223&lt;SEP&gt;chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS2236224&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2236224 is a genomic variant within the MTHFD1 gene that shows an association with increased risk of neural tube defects in infants when there is low maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS2236225&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2236225 is a genomic variant within the MTHFD1 gene that shows an association with increased risk of neural tube defects in infants when there is low maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS11627387&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs11627387 is a genomic variant within the MTHFD1 gene that appears to be associated with an increased risk of neural tube defects in infants when there is low maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTHFR is a gene whose variants have shown reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake."&lt;SEP&gt;"The MTHFR gene codes for the methylenetetrahydrofolate reductase enzyme, which plays a critical role in homocysteine metabolism and methylation pathways."&lt;SEP&gt;"The Methylene-Tetrahydrofolate Reductase gene, which plays a role in folate metabolism and has variants associated with LV (Leiomyoma of the uterus)."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb&lt;SEP&gt;chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS1476413&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1476413 is a genomic variant within the MTHFR gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS1801131&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1801131 is a genomic variant within the MTHFR gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS1801133&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1801133 is a genomic variant within the MTHFR gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SHMT1 is a gene whose variants appear to be associated with reduced risk of neural tube defects in mothers but increased risk in infants, depending on maternal folate intake levels."&lt;SEP&gt;"Serine Hydroxymethyltransferase 1 gene (SHMT1) is involved in the conversion of serine to glycine and transferring methyl groups to tetrahydrofolate, contributing to pyrimidine synthesis during cellular proliferation."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223&lt;SEP&gt;chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS669340 CG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs669340 CG is a genomic variant within the SHMT1 gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS12939757 AG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs12939757 AG is a genomic variant within the SHMT1 gene associated with increased risk of neural tube defects in infants with low maternal dietary folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TYMS is a gene whose variants interact with dietary folate to reduce the risk of neural tube defects, especially when mothers have low dietary folate and are heterozygous for specific variants."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS502396&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs502396 is a genomic variant within the TYMS gene associated with reduced risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS699517&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs699517 is a genomic variant within the TYMS gene associated with reduced risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SNP RS2847153 AG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2847153 AG is a genomic variant within the TYMS gene associated with reduced risk of neural tube defects in infants when there is low maternal dietary folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folate is a critical nutrient involved in DNA synthesis and repair, methylation reactions, and amino acid metabolism."&lt;SEP&gt;"Folate is a nutrient essential for one-carbon metabolism, impacting DNA synthesis and repair; its periconceptional use through supplements or diet can influence the risk of neural tube defects based on genetic variations in mothers and infants."&lt;SEP&gt;"Folate is a vitamin B essential for DNA synthesis and repair."&lt;SEP&gt;"Folate is a crucial nutrient involved in various physiological processes and metabolic pathways related to cardiovascular health and cell metabolism."&lt;SEP&gt;"Folate is a vitamin B9 that plays an essential role in various bodily functions including DNA synthesis, repair, and cell division."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704&lt;SEP&gt;chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-dd3c1834035af8b4436c8058609b6fd8&lt;SEP&gt;chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;NEURAL TUBE DEFECTS (NTDS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Neural tube defects are birth anomalies that occur due to improper closure of the embryonic neural tube, influenced by folate intake and specific gene variants during pregnancy."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;RS10399931&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the CHI3L1 gene, rs10399931, was examined for its association with T2D and related quantitative traits."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;RS4950928&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant of CHI3L1, rs4950928, was also assessed for an association with type 2 diabetes (T2D) and various quantitative traits."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;CHI3LI TG SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Several tag single nucleotide polymorphisms (tgSNPs) of the CHI3L1 gene were studied for their potential associations with T2D, IFG, IGT, and related quantitative traits."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLUCOSE (IFG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process indicating an early stage in the development towards type 2 diabetes where fasting glucose levels are higher than normal but not yet diabetic."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;C-PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein that serves as a marker for insulin production; its serum concentration after two hours was found to be significantly associated with the genomic variant rs10399931."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;INTER99 COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Inter99 cohort is a group of individuals whose clinical characteristics were evaluated for associations with type 2 diabetes (T2D) and related quantitative traits."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;STENO DIABETES CENTER INDIVIDUALS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Individuals recruited at Steno Diabetes Center are part of the study population used to examine the association between genomic variants and T2D-related factors."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;AGE AND SEX ADJUSTMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adjustment factors such as age and sex were considered during the analysis of genomic variants' association with T2D and related quantitative traits."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;GLUCOSE TOLERANCE TEST (NGT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A test used to determine normal glucose tolerance, which was one of the characteristics evaluated in the study for individuals not diagnosed with T2D."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;CFH Y402H RISK ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Y402H risk allele of the CFH gene is associated with an increased odds of AMD, especially when combined with low HLS."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;A69S RISK ALLELE (ARMS2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The A69S risk allele in ARMS2 increases the odds for AMD, particularly when combined with poor lifestyle scores and dietary patterns."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;RS641153 G ALLELE (CFB/C2)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homozygosity for the G allele of rs641153 is associated with increased odds of AMD in women."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The HLS score reflects an individual's dietary patterns and lifestyle habits, impacting AMD risk differently based on genetic background."&lt;SEP&gt;"The Healthy Lifestyle Score represents an individual's adherence to healthy lifestyle patterns which can influence their risk of diseases such as AMD."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"AMD is a disease associated with age-related deterioration of the macula that affects central vision."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;OMEGA-3 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A nutrient found in dietary patterns, omega-3 fatty acids were explored for their impact on AMD risk but did not significantly alter the relationship between HLS and AMD."&lt;SEP&gt;"Polyunsaturated fatty acids found in fish oil that are used as part of a drug therapy regimen for reducing TG levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;LUTEIN AND ZEAXANTHIN (LZ)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary intake of LZ was investigated as a potential mediator of the interaction between genetic risk and lifestyle score regarding AMD risk."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;CFH GENE (COMPLEMENT FACTOR H)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CFH gene is associated with AMD risk through specific alleles such as Y402H."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;ARMS2 GENE (AGE-RELATED MACULOPATHY SUSCEPTIBILITY 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ARMS2 gene, particularly the A69S allele, influences AMD risk in combination with lifestyle factors."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;C3 GENE (COMPLEMENT COMPONENT C3)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The C3 gene's polymorphisms like rs2230199 influence genetic predisposition to AMD, but effects may vary with lifestyle scores."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;CFI GENE (COMPLEMENT FACTOR I)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the CFI gene do not seem to have a main effect on AMD risk within the study sample."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Risk phenotypes for AMD involve genetic predispositions and lifestyle factors, which interact differently based on dietary stability."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;DIETARY STABILITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Stable diets limit variation in nutritional intake, potentially clarifying relationships between genetic risk factors and disease status."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;MAIN EFFECTS OF AMD GENOTYPES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The main effects refer to the direct influence of specific gene variants on the odds of developing AMD without considering interaction with lifestyle factors."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;INTERACTION BETWEEN CFH GENOTYPE AND HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This interaction highlights how genetic predisposition combined with lifestyle affects AMD risk more than either factor alone."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;INTERACTION BETWEEN ARMS2 GENOTYPE AND HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The interaction between ARMS2 genotype and HLS shows varying degrees of synergistic or sub-additive effects on AMD risk."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 20}]</data>
    </node>
    <node id="&quot;AMD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Age-related Macular Degeneration (AMD) is a disease that affects central vision due to damage in the macula."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;ARMS2 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in the ARMS2 gene that is associated with an increased risk for age-related macular degeneration (AMD)."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;CFB/C2, C3 RS2230199 AND CFI RS10033900 GENOTYPES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the complement pathway genes (CFB/C2, C3 rs2230199, and CFI rs10033900) are examined for their interaction with lifestyle to impact AMD risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 18}]</data>
    </node>
    <node id="&quot;SYNERGY INDEX (SI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Synergy Index is a measure used in epidemiology to assess the degree of deviation from an additive model in the joint effect of two or more exposures on disease risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 19}]</data>
    </node>
    <node id="&quot;PREDIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition in which blood glucose levels are higher than normal but not yet high enough to be classified as type 2 diabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The habitual intake of coffee, including black and sugared coffee."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;HECTD4, ACAD10, MYL2, CUX2 GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These genes are associated with genetic polymorphisms related to habitual coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC RISK SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Scores calculated based on the presence and number of risk alleles for certain SNPs in an individual's genome."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;BLACK COFFEE CONSUMPTION &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The regular intake of black coffee, which has been associated with a reduced risk of prediabetes and type 2 diabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SUGARED COFFEE CONSUMPTION &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The regular intake of sugared coffee, also linked to a lower risk of developing prediabetes and type 2 diabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variations at the DNA sequence level that are associated with specific traits or conditions."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;CONTINUOUS CAFFEINE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The regular intake of caffeine, often derived from coffee and other beverages."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;MANHATTAN PLOT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A graphical method used in genetic studies to display the strength of association between genetic markers and a trait across the genome."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;REGIONAL ASSOCIATION PLOT &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A plot that shows the linkage disequilibrium among SNPs around a region on the chromosome."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;Q-Q PLOT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A graph used to assess if a set of observed data comes from a distribution with specified parameters, often used in GWAS."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENOMIC INFLATION FACTOR (Λ)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A measure used in GWAS to quantify the degree of inflation or deflation in test statistics due to population stratification or other biases."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;PAIRWISE CORRELATIONS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurements indicating the degree of similarity between two variables, often SNPs, over time."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;HIGHLY-CORRELATED GENOTYPED SNPS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs that are strongly related to each other and have been selected for genetic risk score calculations."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;NON-BLACK COFFEE CONSUMERS &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Individuals who do not consume black coffee regularly, contrasting with those who do."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;NON-SUGARED COFFEE CONSUMERS &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Individuals who do not consume sugared coffee regularly, in contrast to those who do."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;INVERSE TREND &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A trend where the risk of developing a condition decreases with increasing exposure to a factor."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS RELATED TO COFFEE CONSUMPTION &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific genetic variations associated with habitual coffee intake patterns."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE-RELATED SNPS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs identified through GWAS as being significantly linked to coffee consumption habits."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;HIGH GENETIC RISK SCORES &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Indicates individuals who have a higher number of risk alleles associated with developing type 2 diabetes or prediabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP (Single Nucleotide Polymorphism) is mentioned as having an inverse relationship with minor allele type related to a disease state."&lt;SEP&gt;"A Single Nucleotide Polymorphism (SNP) is a variation at a single base pair in the DNA sequence that occurs at a particular position within the genome."</data>
      <data key="d2">chunk-b803830d07bff8ae14550f6458048707</data>
    </node>
    <node id="&quot;MINOR ALLELE OF SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor allele of each SNP refers to the less frequent variant at a specific location in the genome, which can influence disease susceptibility or other traits."</data>
      <data key="d2">chunk-b803830d07bff8ae14550f6458048707</data>
    </node>
    <node id="&quot;INVERSE RELATIONSHIP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An inverse relationship implies an opposite effect or association, often observed between genetic variants and disease outcomes."</data>
      <data key="d2">chunk-b803830d07bff8ae14550f6458048707</data>
    </node>
    <node id="&quot;GENETIC RISK SCORES &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"The association between habitual coffee consumption and the risk of developing type 2 diabetes is modified by genetic risk scores."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HECTD4, ACAD10, MYL2, CUX2 GENES &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Certain SNPs located within these genes are associated with habitual coffee consumption and may influence the risk of developing type 2 diabetes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Regular black coffee intake is inversely associated with the risk of developing type 2 diabetes, particularly in individuals with high genetic risk scores."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREDIABETES &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Consumption of sugared coffee is associated with a reduced risk of prediabetes and type 2 diabetes combined."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Certain genetic polymorphisms are linked to an increased risk of developing type 2 diabetes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Genome-wide association studies help in identifying SNPs that contribute to the calculation of genetic risk scores."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTINUOUS CAFFEINE INTAKE &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"The regular intake of caffeine, often through black coffee, is associated with lower risks for type 2 diabetes and prediabetes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MANHATTAN PLOT &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A Manhattan plot visually represents the association between genetic polymorphisms and traits or diseases across the genome."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Q-Q PLOT &quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A Q-Q plot helps in the assessment of the inflation factor by comparing observed vs. expected test statistics distribution."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SENP1 is a gene associated with the regulation of adipogenesis and inflammation in adipose tissues."&lt;SEP&gt;"SENP1 is a gene involved in regulating the activation of NF-κB and cytokine production in adipocytes."&lt;SEP&gt;"SENP1 is a gene whose expression in adipocytes of non-obese diabetic (NOD) mice and human T1DM patients correlates with disease progression."&lt;SEP&gt;"The SENP1 gene is involved in regulating various biological processes including inflammation and diabetes."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPONECTIN GENE PROMOTER (ADIPOQ-CRE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant using the Adiponectin promoter to drive Cre recombinase expression specifically in adipocytes."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PDGFRΑ GENE PROMOTER (PDGFRΑ-CRE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant using the PdgfRα gene promoter to drive Cre recombinase expression predominantly in bipotent progenitor cells, including white and beige adipocytes."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;AP2/FABP4 GENE PROMOTER (AP2-CRE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant using the aP2/Fabp4 gene promoter to drive Cre recombinase expression in adipocytes with variable degrees of target gene recombination in macrophages or capillary endothelium."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1 (SENP1-ADIPOQKO, SENP1-PDGFRKO, AND SENP1-AP2KO)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A transcript that describes adipocyte-specific deletion of the SENP1 gene in mice models using different Cre recombinase promoters."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by the SENP1 gene, which is expressed in adipocytes and involved in regulating inflammation and diabetes development."&lt;SEP&gt;"The protein encoded by the SENP1 gene, which is expressed in adipocytes and involved in the regulation of inflammation and diabetes."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;DIABETES MELLITUS TYPE 1 (T1DM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by autoimmune-mediated destruction of pancreatic beta cells leading to deficient insulin production and high blood glucose levels."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GLUCOSE METABOLISM REGULATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A metabolic pathway responsible for regulating glucose metabolism affected by SENP1 deficiency leading to diabetes and high blood sugar levels."&lt;SEP&gt;"A metabolic pathway responsible for regulating glucose metabolism, which is affected by SENP1 deficiency leading to diabetes and high blood sugar levels."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1 IN SMOOTH MUSCLE CELLS/PERICYTES (SENP1-SMKO)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant where the SENP1 gene is specifically deleted in smooth muscle cells or pericytes, not leading to a high-glucose phenotype."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1 IN VASCULAR ENDOTHELIAL CELLS (SENP1-ECKO)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant where the SENP1 gene is specifically deleted in vascular endothelial cells, also not leading to a high-glucose phenotype."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which insulin is released from pancreatic beta cells into the bloodstream. Insufficient insulin secretion contributes to diabetes development in SENP1-deficient mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GLUCOSE-STIMULATED INSULIN ASSAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An assay used to assess the ability of isolated islets to secrete insulin in response to glucose stimulation, revealing reduced insulin secretion in SENP1-deficient islets."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INTERSCAPULAR BROWN ADIPOSE TISSUE (BAT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process involving brown adipose tissue that plays a significant role in thermogenesis and glucose homeostasis, influenced by SENP1 expression."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PERIGONADAL WHITE ADIPOSE TISSUE (WAT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"White adipose tissue involved in lipid storage and energy metabolism affected by the deletion of SENP1 gene."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PERIPHERAL PANCREATIC ADIPOSE TISSUE (PAT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adipose tissue surrounding the pancreas, influenced by changes in SENP1 expression affecting glucose homeostasis."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;MACROPHAGES CD11B+F4/80+ CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of immune cell involved in inflammation and tissue repair, showing intact SENP1 expression despite adipocyte-specific deletion."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PANCREATIC ISLETS (Β CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The endocrine component of the pancreas that produces insulin; affected by SENP1 deficiency leading to reduced insulin secretion."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SENP1 gene is involved in the development of type-1-like diabetic phenotypes when deficient specifically in adipocytes."&lt;SEP&gt;"The SENP1 gene plays a critical role in the development and progression of Type 1 Diabetes (T1DM) in mice."&lt;SEP&gt;"The SENP1 gene regulates adipocyte differentiation and inflammation in peri-pancreatic adipose tissue (PATs)."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 1)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by T-cell-mediated destruction of insulin-producing pancreatic β cells, leading to hyperglycaemia and islet damage."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;T-CELL MEDIATED DESTRUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process where immune system T-cells attack and destroy insulin-producing β cells in the pancreas."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;PANCREATIC ISLETS STRUCTURE DISRUPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The disruption of pancreatic islet structures with increased apoptosis of β cells after onset of diabetes, indicative of insulitis."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;APOPTOSIS OF Β CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cell death mechanism of β-cells in SENP1-deficient mice as indicated by TUNEL staining."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;IMMUNE CELL INFILTRATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process where immune cells, such as CD8+ and CD4+ T cells, invade pancreatic tissues causing inflammation and islet damage."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;INSULIN AUTOANTIBODY (IAA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Autoantibodies directed against β-cells that appear in the pre-diabetic phase of Type 1 Diabetes Mellitus."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;C-REACTIVE PROTEIN (CRP)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An inflammatory marker used for diagnosing and monitoring diabetes, showing elevated levels in individuals with higher risk of developing T1DM."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;Β-HYDROXYBUTYRATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A ketone body produced when the body loses its ability to absorb glucose properly, often elevated in diabetic patients."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;IMMUNE SYSTEM REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The regulation of immune responses through T-cell subsets such as Th1 and Th17 cells with reduction of regulatory T-cells (Tregs) observed in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mice that are deficient in the SENP1 gene specifically in adipocytes, leading to type-1-like diabetic phenotypes."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;TUNEL POSITIVE APOPTOSIS OF Β CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Apoptosis process marked by TdT-mediated dUTP nick end labelling (TUNEL) positivity indicating cell death."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CD31+ VASCULAR AREA LOSS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Reduction in CD31-positive vascular area within pancreatic islets, indicative of disrupted vasculature and reduced β-cell function."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;AUTOIMMUNE MEDIATED DAMAGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process where autoimmune responses lead to damages in tissues and organs, particularly in the context of diabetes development."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;Β-CELL MASS REDUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Decrease in β-cell mass due to apoptosis and immune cell infiltration leading to reduced insulin production capability."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CD8+ T CELLS INFILTRATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Invasion of CD8+ T cells into pancreatic islets, a hallmark of type 1 diabetes development."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CD4+ T CELLS INFILTRATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Presence of CD4+ T cells infiltrating the pancreas as part of autoimmune response in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;SKIN-REJECTION RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Immune rejection response observed upon skin transplantation, indicating normal immune system function despite diabetes development."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;MHCII+CD11B+CD11C− MACROPHAGES INCREASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased population of MHCII+CD11b+CD11c− macrophages in the pancreas of SENP1-aP2KO mice, contributing to inflammation."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;TH1 AND TH17 EFFECTOR T-CELL SUBSETS EXPANSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Expansion of Th1 (IFN-γ+CD4+) and Th17 (IL-17+CD4+) effector T-cell subsets in pancreatic lymph nodes."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;REGULATORY T-CELLS REDUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Decrease in regulatory T-cells (Tregs) which play a role in immune tolerance, contributing to autoimmune responses."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;ACTIVATED DENDRITIC CELLS INCREASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increase in activated dendritic cells in the lymph nodes of pancreases supporting autoimmune processes."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;NRP-V7 POSITIVE CD8+ T-CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Detection of autoantigen NRP-V7 positive CD8+ T-cells targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein, indicative of specific autoimmune response."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;NRP-V7 POSITIVE CD8+ T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These cells target a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein, detected in the pancreatic lymph nodes and spleen of SENP1-aP2KO mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This peptide is targeted by autoantigen NRP-V7 positive CD8+ T cells in the context of autoimmune diabetes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IL-6, TNF-Α AND IL-1Β&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These proinflammatory cytokines are significantly elevated in circulating serum and produced locally by peri-pancreatic adipose tissue (PATs) before the onset of T1DM in SENP1-deficient mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINE OVERPRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Overproduction of proinflammatory cytokines serves as a main reason for immunological tolerance break and immune cell expansion in diabetes, primarily in early disease phases."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An autoimmune disease characterized by the destruction of pancreatic β cells due to an auto-immune response."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PERI-PANCREATIC ADIPOSE TISSUE (PATS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This tissue produces high levels of proinflammatory cytokines, inducing local inflammatory responses and contributing significantly to the development of diabetes in SENP1-deficient mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCL5&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Chemokine (C-C motif) ligand 5, also known as RANTES, is a protein that plays a role in immune responses by attracting leukocytes to sites of inflammation."&lt;SEP&gt;"Upregulated chemokine expressed by pancreatic islets and β cells that recruits immune cells, potentially leading to further inflammation and damage of β cells."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CHEMOKINES (E.G., CCL2, CCL21, CXCL19, CXCL10)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"These chemokines are weakly upregulated in pancreatic islets, participating in the recruitment of immune cells to inflammation sites."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SENP1-AP2KO MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These mice have a specific genetic variant that leads to deficiencies in SENP1, resulting in increased proinflammatory cytokines and autoimmune responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IL-6 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of IL-6 is highly expressed in peri-pancreatic adipose tissue (PATs) from SENP1-aP2KO mice at 7 weeks, contributing to inflammatory responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TNF-Α TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The TNF-α transcript is highly expressed in PATs from SENP1-aP2KO mice at 7 weeks, contributing to inflammatory responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IL-1Β TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The IL-1β transcript is highly expressed in PATs from SENP1-aP2KO mice at 7 weeks, contributing to inflammatory responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC LYMPH NODES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Detected site of NRP-V7 positive CD8+ T cells targeting a peptide from the glucose-6-phosphatase catalytic subunit-related protein in SENP1-aP2KO mice at 12 weeks."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SPLEEN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Detected site of NRP-V7 positive CD8+ T cells targeting a peptide from the glucose-6-phosphatase catalytic subunit-related protein in SENP1-aP2KO mice at 12 weeks."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC Β CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Immune cells target and destroy these cells, leading to insulin deficiency characteristic of T1DM."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCL5 EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High levels of local proinflammatory cytokines secreted from peri-pancreatic adipose tissue (PATs) upregulate CCL5 expression in islets, contributing to the recruitment of immune cells into the pancreas and causing damage to β-cells."&lt;SEP&gt;"High levels of local proinflammatory cytokines upregulate CCL5 expression in islets, recruiting immune cells into the pancreas and causing damage to β-cells."&lt;SEP&gt;"Upregulated in pancreatic islets before the onset of diabetes, recruiting immune cells and causing damage to β cells."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC ISLETS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Site where chemokines such as CCL5 are upregulated in response to proinflammatory cytokines from PATs, contributing to autoimmune responses."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;IMMUNE CELL RECRUITMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Recruitment of immune cells into the pancreas due to elevated levels of chemokines like CCL5, leading to β cell damage."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SENP1-AP2KO ADIPOCYTE-DERIVED CYTOKINES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Adipocyte-derived cytokines, such as IL-6, TNF, and IL-1β, from SENP1-aP2KO adipocytes induce β-cell death in pancreatic islets."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NF-ΚB DEPENDENT INFLAMMATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"NF-κB dependent inflammation is enhanced in adipose tissues of SENP1-aP2KO mice, indicated by increased phosphorylations of IKK, IκBα, and NF-κB p65/RelA."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PPARΓ SUMOYLATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SUMOylation of PPARγ is not significantly different between control and SENP1-deficient adipocytes, suggesting it does not contribute to reduced adipogenesis or enhanced cytokine production in PATs."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NF-ΚB ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"NF-κB activation is increased in adipose tissues of SENP1-aP2KO mice as indicated by chromatin immunoprecipitation (ChIP) assays showing increased p65/RelA binding to the IL-6, IL-1β, and TNF-α promoters."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES (IL-6, TNF, IL-1Β)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These proinflammatory cytokines are secreted from SENP1-aP2KO adipocytes and upregulate CCL5 expression in islets."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;Β-CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"β-Cells are crucial for insulin production and are damaged by adipocyte-derived cytokines leading to impaired function."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NF-ΚB PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The NF-κB pathway, a key regulator of inflammation and immune responses, is activated more intensely in adipose tissues from SENP1-aP2KO mice."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;ADIPOCYTE DIFFERENTIATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The differentiation of adipocytes is reduced in PATs when SENP1 is deficient, leading to enhanced proinflammatory phenotypes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IΚBΑ AND IKK PHOSPHORYLATION LEVELS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The phosphorylation of IκBα and IKK is elevated in adipose tissues from SENP1-aP2KO mice, contributing to enhanced NF-κB activation."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;ERK1/2 LEVELS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Phosphorylation and total levels of ERK1/2 proteins remain unchanged in adipose tissues from SENP1-aP2KO mice."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IKK&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IKK, also known as IκB kinase, plays a role in activating NF-κB by phosphorylating IκBα, leading to its degradation."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IΚBΑ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IκBα is a protein that inhibits the activation of NF-κB by sequestering it in the cytoplasm until activated."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NF-ΚB P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NF-κB p65/RelA, also known as RelA, is a subunit of the NF-κB complex involved in immune and inflammatory responses."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IL-6, TNF-Α, IL-1Β&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These are proinflammatory cytokines produced at high levels by PATs from SENP1-aP2KO mice under normal chow conditions and further increased under HFD conditions."&lt;SEP&gt;"These cytokines are proinflammatory mediators produced by adipocytes that contribute to chronic inflammation and metabolic disorders."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NON-OBESE DIABETIC MOUSE (NOD)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The NOD mouse is a genetic model used to study type 1 diabetes, characterized by late-onset spontaneous diabetes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;T1DM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease that destroys insulin-producing beta cells in the pancreas leading to high blood sugar levels."&lt;SEP&gt;"Type 1 Diabetes Mellitus, characterized by autoimmune destruction of pancreatic beta cells leading to absolute deficiency of insulin; T1DM phenotypes are augmented by HFD in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic modification where the SENP1 gene is deleted only in adipocytes, leading to more severe hyperglycemia and pancreatic islet disruption compared with NOD mice."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Refers to a group of proteins that play a crucial role in inflammation and immune response. Their levels increase in T1DM patients and SENP1-aP2KO mice, correlating with disease progression."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;INSULIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A hormone produced by the pancreas that regulates blood sugar levels; both insulin and proinsulin are targeted by islet-reactive T-cells in T1DM patients and NOD mice."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;NF-ΚB ACTIVATION INHIBITOR II JSH-23&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An inhibitor used to block NF-κB activity, which ameliorates diabetes progression when administered to SENP1-aP2KO mice."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HIGH-FAT DIET (HFD)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A dietary pattern characterized by high intake of fats that can exacerbate the diabetic phenotype in SENP1-deficient mice."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;IFN-Γ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interferon gamma, an important cytokine involved in innate immunity and the regulation of cell-mediated immune responses."&lt;SEP&gt;"Interferon-gamma (IFN-γ) is a protein that plays a key role in the immune system, especially in activating macrophages and initiating inflammatory responses."&lt;SEP&gt;"Interferon-gamma is a protein involved in immune responses and inflammation."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;ISLET-REACTIVE T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"T-cells that react against pancreatic beta cells and are involved in the autoimmune destruction of these cells in type 1 diabetes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;Β-CELL APOPTOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The programmed cell death of beta cells in the pancreas, which can be triggered by inflammatory processes and contribute to type 1 diabetes development."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPOGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which precursor cells differentiate into adipocytes (fat cells), observed to increase under high-fat diet conditions in SENP1-deficient mice."&lt;SEP&gt;"The process by which precursor cells differentiate into adipocytes; HFD may stimulate this process in PATs from SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HFD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"High-fat diet (HFD) is an environmental factor that increases fat weight, stimulates cytokine production, disrupts islet structures, causes hyperglycemia, induces insulin resistance, and exacerbates both T1DM and T2DM phenotypes in mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;PATS&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"PATs (peripheral adipose tissues) exhibit smaller cell sizes with higher numbers of cells in SENP1-aP2KO mice compared to control, suggesting an enhanced capacity for adipogenesis."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;CTRL MICE&quot;">
      <data key="d0">"ANIMAL MODEL"</data>
      <data key="d1">"Control mice used as a reference group to compare with SENP1-aP2KO mice in studies investigating the effects of HFD on adipose tissue inflammation and insulin resistance."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;GLUCOSE-STIMULATED INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which pancreatic beta cells release insulin in response to elevated blood glucose levels; this process is significantly reduced in SENP1-aP2KO mice compared to controls under HFD conditions."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;ITT ASSAY (INSULIN TOLERANCE TEST)&quot;">
      <data key="d0">"EXPERIMENTAL PROCEDURE"</data>
      <data key="d1">"An assay used to measure the ability of injected insulin to lower blood glucose levels, indicating sensitivity to insulin; similar responses were observed between SENP1-deficient and control mice on standard chow but diverged under HFD conditions."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;ISLET STRUCTURES&quot;">
      <data key="d0">"TISSUE STRUCTURE"</data>
      <data key="d1">"Structures within the pancreas containing beta cells responsible for insulin production; disruption of these structures was observed in SENP1-aP2KO mice under HFD conditions."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1 (SENP1-AP2KO)&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"SENP1-deficient mice exhibit increased water consumption, which is associated with their higher blood glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WATER CONSUMPTION&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"SENP1-deficient mice exhibit increased water consumption, which is associated with their higher blood glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEMO (IKKΓ)&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"The SUMOylation modification of NEMO is critical for the activation of IKK-NF-κB signaling."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUMOYLATION&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"The SUMOylation modification of NEMO is critical for the activation of IKK-NF-κB signaling."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP2&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"SENP2 deSUMOylates NEMO, which can inhibit NF-κB activation by modulating p65/RelA activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA DAMAGE AGENT ETOPOSIDE VP16&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Etoposide VP16 induces phosphorylation and activation of IKK and NF-κB p65/RelA in adipocytes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NON-OBESE DIABETIC (NOD) MOUSE&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"The NOD mouse model is relevant to human type 1 diabetes as it spontaneously develops autoimmune destruction of insulin-producing cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 TRANSCRIPT&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Gene knockdown or overexpression affects the levels of SENP1 mRNA, impacting subsequent protein production."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 DEFICIENCY&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Under HFD conditions, the phenotype of SENP1-deficient mice is exacerbated, suggesting an interaction between dietary factors and genetic predisposition in diabetes development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NF-ΚB INHIBITION&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"NF-κB inhibitors reduce CCL5 expression in islets, indicating that NF-κB activity regulates chemokine production which is important for inflammation and immune cell recruitment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 DEFICIENCY AND HFD&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"High-fat diet exacerbates adipocyte hyperplasia in SENP1-deficient mice, suggesting an interaction between genetic predisposition and environmental factors in promoting obesity and inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1-AP2KO&quot;">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">"Proinflammatory cytokines such as IL-6, TNF-α and IL-1β are produced at high levels by peripheral adipose tissues in mice deficient for SENP1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1-DEFICIENT MICE&quot;">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">"Similar insulin responses were observed between SENP1-deficient and control mice on standard chow; however, HFD induced more severe insulin resistance in SENP1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOKI (RS2228570 OR RS10735810)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located at rs2228570 or rs10735810, associated with an increased risk of ovarian cancer."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;APAI (RS7975232)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located at rs7975232, evaluated in the context of ovarian cancer risk but found to have no significant association with it."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;BSMI (RS1544410)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located at rs1544410, assessed for its role in ovarian cancer risk, showing no significant association with the disease."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;CAUCASIANS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Individuals of Caucasian descent, whose genetic data was analyzed separately to evaluate the associations between genomic variants and ovarian cancer risk."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A principle used in population genetics to describe a condition where allele and genotype frequencies remain constant from one generation to the next, assuming no evolutionary influences such as mutation, selection, or migration. In studies, it is often used to check for consistency of genetic data."&lt;SEP&gt;"An assessment method for evaluating genotype frequencies in populations under random mating assumptions, without significant selection or mutation pressures."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;HETEROGENEITY BETWEEN STUDIES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The presence of differences in results across multiple studies that may be due to various factors including population genetics, environmental exposures, and study design. Used as a measure of inconsistency among research findings."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;CDX-2 (RS11568820)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the Cdx-2 gene, specifically rs11568820, has been studied for its association with ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;TAQI (RS731236)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the TaqI gene, specifically rs731236, has been investigated for its role in ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;GG CARRIERS&quot;">
      <data key="d0">"GENE VARIANT CARRIER STATUS"</data>
      <data key="d1">"Individuals with GG genotype at a specific locus are carriers of this particular gene variant."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;A ALLELE CARRIERS&quot;">
      <data key="d0">"GENE VARIANT CARRIER STATUS"</data>
      <data key="d1">"Individuals carrying the A allele (GA or AA) show an increased risk of ovarian cancer relative to GG carriers."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;JAPANESE SUBGROUP&quot;">
      <data key="d0">"SUBPOPULATION"</data>
      <data key="d1">"The Japanese subgroup is a specific population subset used in genetic studies for assessing disease risks."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NECC SUBGROUP&quot;">
      <data key="d0">"SUBPOPULATION"</data>
      <data key="d1">"The NECC subgroup refers to a specific group within the Nurses' Health Study (NHS) and NHS II, which has been used for evaluating ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NORTHERN SWEDEN SUBGROUP&quot;">
      <data key="d0">"SUBPOPULATION"</data>
      <data key="d1">"This subgroup is from Northern Sweden and was part of a study examining genetic variants in relation to disease risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;VDR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The VDR gene includes the TaqI (rs731236) variant that is studied in relation to susceptibility to degenerative disc disease and HNP."&lt;SEP&gt;"The VDR gene is involved in susceptibility to infection by T. cruzi and the development of Chagas cardiomyopathy (CCC)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS731236, RS7975232, RS1544410&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These SNPs in the VDR gene did not show a significant association with infection by T. cruzi or susceptibility to CCC."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS2228570&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was significantly associated with both reduced risk of T. cruzi infection and increased risk of developing CCC, suggesting a protective role against the former but not the latter condition."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;T. CRUZI INFECTION SUSCEPTIBILITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Susceptibility to infection by Trypanosoma cruzi is influenced by genetic variants in the VDR gene."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;CHAGAS CARDIOMYOPATHY (CCC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The development of Chagas cardiomyopathy may be associated with certain genotypes of the VDR gene, particularly the rs2228570 SNP."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS2228570*A ALLELE FREQUENCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The frequency of the rs2228570*A allele was significantly different in seronegative and seropositive individuals, suggesting a potential protective role against T. cruzi infection."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;SERONEGATIVE INDIVIDUALS VS SEROPOSITIVE INDIVIDUALS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The comparison between seronegative (no antibodies) and seropositive (antibodies present) individuals helps to identify genetic variants associated with susceptibility to T. cruzi infection."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;ASYMPTOMATIC PATIENTS VS CCC PATIENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The comparison between asymptomatic patients and those developing Chagas cardiomyopathy aids in identifying genetic factors influencing disease progression."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;HAPLOTYPE ACC, GAT, AAC&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These haplotypes of the VDR gene SNPs were observed in the studied individuals without showing significant associations with T. cruzi infection or CCC development."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;CHAGAS CARDIOMYOPATHY (CCC) RISK ASSESSMENT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The risk assessment for developing Chagas cardiomyopathy involves analyzing genetic variants like rs2228570."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;IL-1A -889C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The IL-1A -889C&gt;T variant is a genomic variant studied in relation to the risk of Human Nerve Pain (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A 238G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TNF-A 238G&gt;A variant is another genomic variant under investigation for its potential association with HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR TAQI (RS731236)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"VDR TaqI (rs731236) is a third genomic variant examined in connection to the risk of HNP and degenerative disc disease."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;IL-1A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-1A gene harbors a polymorphism at position -889C&gt;T that is studied for its potential association with Human Nerve Pain (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TNF-A gene has a polymorphism at position 238G&gt;A under investigation for its association with HNP risk."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;HNP&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"The TT genotype of IL-1A -889C&gt;T was found to be 1.37 times more frequent in HNP patients than in controls, although overall genotypes and alleles showed no significant association with the risk of HNP."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HUMAN NERVE PAIN (HNP)&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"The IL-1A gene variant is investigated for its potential association with Human Nerve Pain (HNP)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEGENERATIVE DISC DISEASE (A CONDITION OFTEN ASSOCIATED WITH HNP)&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"Genetic variants within the VDR gene are examined for their association with degenerative disc disease and possibly HNP."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUT2 VARIANT (RS602662)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the FUT2 gene associated with maternal serum B12 levels."&lt;SEP&gt;"A genomic variant in the FUT2 gene, with significant effects on maternal serum B12 levels."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MMACHC VARIANT (RS12272669)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant in the MMACHC gene that has minimal effect on fetal birth weight at 28 weeks of gestation."&lt;SEP&gt;"A variant in the MMACHC gene that showed little effect on maternal serum B12 levels during pregnancy at 28 weeks of gestation."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MATERNAL SERUM B12 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of vitamin B12 in the serum of pregnant women, which do not significantly influence birthweight according to study results."&lt;SEP&gt;"Serum B12 levels in pregnant women, which are influenced by genetic variants and can affect offspring birth weight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FOLATE LEVELS (MATERNAL)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of folate in the maternal serum during pregnancy, impacting the birthweight positively."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FOLATE LEVELS (FETAL)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of folate in the fetus during pregnancy that have been shown to negatively impact birth weight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MTHFR SNP RS1801133&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in the MTHFR gene, which can influence maternal serum folate levels and birthweight when included in genetic analyses."&lt;SEP&gt;"A variant in the MTHFR gene that significantly influences maternal serum folate levels and birthweight when included in analyses."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MATERNAL SERUM FOLATE LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum folate levels in pregnant women, which are influenced by genetic variants and can affect offspring birth weight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FETAL FOLATE LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of folate in the fetus during pregnancy that negatively impact fetal birth weight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;B12 (COBALAMIN)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"B12, also known as cobalamin, is another vitamin B nutrient crucial for red blood cell formation and nerve function."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MR EGGER RESULT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A statistical method used to detect directional pleiotropy in Mendelian randomization studies."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;IVW ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Inverse variance weighted analysis, a technique for estimating causal effects using genetic variants as instrumental variables."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;BIRTHWEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The weight of an infant at birth, which can be influenced by maternal and fetal nutrient levels."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Birthweight of the offspring is a health outcome potentially affected by maternal B12 and folate levels."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;GESTATIONAL DURATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The length of pregnancy, which was not found to be causally influenced by maternal or fetal B12 or folate levels according to MR analysis."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms (SNPs) are used as genetic instruments in Mendelian randomization studies."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;DIRECTIONAL PLEIOTROPY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A phenomenon where a gene has effects on a trait other than through its primary biological function, affecting the validity of causal inference in MR studies."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;HETEROGENEITY BETWEEN CAUSAL ESTIMATES AT EACH SNP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The variation in causal estimates across different SNPs can indicate potential issues like pleiotropy or weak instruments in MR analysis."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL FOLATE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of folate present in the mother during pregnancy, which may influence offspring health outcomes such as birth weight."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;FETAL B12 LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of vitamin B12 in the fetus, potentially affecting developmental outcomes."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;DANISH COHORTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Specific population samples used for research purposes, here focusing on maternal and offspring health."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;SUPPLEMENTARY TABLE S7-S8&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Additional tables providing detailed data from the study regarding genetic associations with folate and B12 levels."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MTHFR C677T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant located at position 677 of the MTHFR gene, which is associated with LV (Leiomyoma of the uterus) patients."&lt;SEP&gt;"The MTHFR C677T variant is a common genomic variant associated with an increased risk of thrombosis and cardiovascular disease."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;MTHFR A1298C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant located at position 1298 of the MTHFR gene, also linked to LV patients."&lt;SEP&gt;"The MTHFR A1298C variant is another genomic variant in the methylenetetrahydrofolate reductase gene, associated with reduced enzyme activity and potential health risks."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PAI-1 -675 4G/5G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the PAI-1 (Plasminogen Activator Inhibitor 1) gene associated with LV patients."&lt;SEP&gt;"The PAI-1 -675 4G/5G variant is a polymorphism in the plasminogen activator inhibitor-1 gene, which affects fibrinolysis and thrombosis risk."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PAI-1 A844G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A rare genetic variant in the PAI-1 gene, relevant to LV patients."&lt;SEP&gt;"The PAI-1 A844G variant is a polymorphism in the plasminogen activator inhibitor-1 gene, which may influence fibrinolytic activity and cardiovascular risk."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the prothrombin gene associated with thrombotic disorders, including relevance to LV conditions."&lt;SEP&gt;"A genetic variant in the prothrombin gene associated with thrombotic disorders, including relevance to LV patients."&lt;SEP&gt;"The Prothrombin G20210A variant is a genetic polymorphism associated with an increased risk of thrombotic disorders."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;FACTOR V G1691A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variation in Factor V gene that is less common but relevant to thrombosis and possibly LV conditions."&lt;SEP&gt;"The Factor V G1691A variant is a mutation in the coagulation factor V gene, linked to hypercoagulability and an elevated risk for venous thromboembolism."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;LV (LEIOMYOMA OF THE UTERUS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A benign tumour arising from smooth muscle cells, specifically found in the uterus, associated with certain genotypes and genetic variants."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PAI-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Plasminogen Activator Inhibitor 1 gene, involved in fibrinolysis and has genetic variants relevant to thrombotic disorders including LV."&lt;SEP&gt;"The PAI-1 gene encodes a protein that regulates fibrinolysis and plays a role in the risk of thrombosis due to genetic variants."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;FACTOR V &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Coagulation factor V gene that produces a protein essential for blood coagulation; associated with Factor V Leiden mutation contributing to thrombosis risk."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;LEIOMYOMA OF THE UTERUS (LV)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A benign tumour arising from smooth muscle cells, specifically found in the uterus, associated with certain genotypes and genetic variants."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;LV&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Lipoprotein(a) (LV) is a plasma protein associated with an elevated risk of cardiovascular disease and thrombotic disorders."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;PROTHROMBIN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Prothrombin gene encodes coagulation Factor II and is associated with an increased risk of thrombosis due to genetic variations."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;FACTOR V&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Factor V gene encodes a coagulation factor that is crucial for thrombin generation and its variants can lead to an increased risk of thrombosis."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;THROMBOSIS&quot;">
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d1">"The PAI-1 -675 4G/5G polymorphism increases the risk of thrombotic events due to its influence on fibrinolysis."&lt;SEP&gt;"The PAI-1 -675 4G/5G variant is associated with an increased risk of thrombotic disorders due to its effect on fibrinolysis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPERCOAGULABILITY&quot;">
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d1">"The Factor V G1691A mutation leads to a hypercoagulable state and increases the risk for venous thromboembolism."&lt;SEP&gt;"The Factor V G1691A mutation leads to hypercoagulability and an increased risk for venous thromboembolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d1">"The MTHFR C677T variant is associated with an increased risk of cardiovascular disease due to elevated homocysteine levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VITAMIN B12 (COBALAMIN)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Vitamin B12 plays an essential role in the formation of red blood cells and maintenance of the nervous system by acting as a cofactor for enzymes involved in DNA synthesis, repair, and methylation."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;THCY (TOTAL HOMOCYSTEINE)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"tHcy is an intermediate metabolite in the folate and vitamin B12-dependent remethylation pathway that converts homocysteine back to methionine, which is crucial for cellular function."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;MTHFR GENE&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"Homocysteine metabolism is regulated by MTHFR activity, impacting tHcy levels in the body."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;B12 TRANSCOBALAMIN RECEPTOR (TCBLR) GENE&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"The availability of vitamin B12 through TCblR gene expression influences folate-dependent processes and impacts health outcomes including infertility risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DNA FRAGMENTATION&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"High levels of DNA fragmentation in sperm are strongly associated with reduced fertility, indicating a link between physiological damage to sperm cells and male infertility."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MALE INFERTILITY&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"High levels of DNA fragmentation in sperm are strongly associated with reduced fertility, indicating a link between physiological damage to sperm cells and male infertility."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BODY MASS INDEX (BMI)&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"BMI may influence uric acid levels and HUA risk but was not specifically mentioned in the provided text."&lt;SEP&gt;"Higher BMI is associated with an increased risk of male infertility due to metabolic imbalances affecting reproductive health."</data>
      <data key="d0">"NUTRIENT"</data>
    </node>
    <node id="&quot;RS1979277 G ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism rs1979277 in the SHMT1 gene resulting in Leu435Phe substitution is associated with increased risk for TMD patients compared to controls."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS638416 C ALLELE AND CC GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism rs638416 of the SHMT1 promoter region resulting in a significant increase of the C allele and CC genotype in TMD patients compared to healthy controls."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS2236225 G ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Transition from G to A (rs2236225) in the MTHFD1 gene leading to an ARG-653-GLN alteration is associated with susceptibility to neural tube defects and statistical differences were observed in TMD patients compared to healthy controls."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GSTM1-NULL POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A deletion of the GSTM1 gene resulting in a null variant, which increases cancer risk and male infertility by altering detoxification efficiency and susceptibility to environmental toxins and carcinogens."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS1801394 A ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Substitution of A to G (rs1801394) in the MTRR gene results in an enzyme with less affinity for substrate, observed statistically more frequent among TMD patients compared to controls."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;DRD4-48BPTR POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A 48-bp VNTR in exon 3 of the DRD4 gene that presents statistical differences in genotype frequencies between TMD and control groups, but not a significant increase for S-DRD4 allele."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;METHIONINE SYNTHASE REDUCTASE (MTRR)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"MTRR is responsible for regenerating Methionine Synthase using SAM as methyl donor through reductive methylation, and its genetic variant impacts disease susceptibility."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GLUTATHIONE S-TRANSFERASE MU 1 (GSTM1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Encodes an enzyme involved in detoxifying electrophilic compounds by conjugation with glutathione, associated with increased cancer risk due to the null variant of GSTM1 gene."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;TETRAHYDROFOLATE (THF)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A key nutrient important for one-carbon metabolism and nucleotide synthesis, involved in methylation reactions catalyzed by enzymes encoded by SHMT1 and MTHFD1 genes."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;TMD DISEASE&quot;">
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d1">"The GSTM1-null polymorphism, a deletion of the GSTM1 gene, was found statistically more frequent in TMD patients compared to control groups, suggesting an increased risk for disease."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FOLATE MEASUREMENT METHODS (CDC MBA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"This method measures serum folate using microbiological assay techniques."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;SERUM FOLATE MEASUREMENT METHODS (CDC HPLC-MS/MS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"A chromatographic technique for measuring serum folate levels with high precision and specificity."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;5-METHYLTHF (5-METHYLTETRAHYDROFOLATE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An active form of folate that is crucial for methylation reactions in the body."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;FOLIC ACID CALIBRATOR&quot;">
      <data key="d0">"NUTRIENT/DIETARY PATTERN"</data>
      <data key="d1">"A calibrator used in laboratory tests to measure folic acid levels, essential for accurate assessment of folate status."&lt;SEP&gt;"A standard substance used to calibrate assays measuring folic acid levels."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c&lt;SEP&gt;chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;LABORATORY PROCEDURES (MICROPLATE FORMAT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"Procedures involving 96-well microplates for sample handling and analysis."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;SPECTROPHOTOMETRY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"A method used to quantify calibrators by measuring absorbance at specific wavelengths."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;MICROORGANISM EFFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The microorganism effect refers to the variability observed in laboratory results due to differences in microbial populations used as standards for measuring nutrients like folate."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CALIBRATOR EFFECT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The calibrator effect indicates how different types of calibration reagents (IH-CAL, CDC-CAL) influence the accuracy and variability of laboratory measurements for nutrients such as folate."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CDC REAGENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Reagents provided by the CDC (Centers for Disease Control and Prevention) for standardizing measurements across laboratories."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;IH REAGENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Reagents used in laboratory tests that are not standardized with CDC reagents, leading to variability in results."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC MBA TARGET VALUE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A target value established by the CDC as a standard for measuring folate levels in laboratories, crucial for diagnosing and managing conditions related to folate deficiency."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;MICROORGANISM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Used in laboratory tests with CDC reagents for comparison purposes, ensuring consistency across different testing environments."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;S-FOL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A measure or pathway associated with serum folate levels used to assess folate status in laboratories."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;WB-FOL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A measure or pathway associated with whole-blood folate levels used to assess folate status in laboratories."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY #6 AND #9&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Specific laboratories that showed deviations from the standard agreement when using CDC reagents for measuring folate levels."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;DAY 1 AND DAY 2 ANALYSIS RESULTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Results obtained during two consecutive days of analysis in laboratories, used to assess the variability of measurements."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;RS1695 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in the gene associated with breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;BREAST CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of cancer that originates in tissues of the breast."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The homozygote genotype GG is associated with an increased risk of breast cancer according to OR and 95%CI values."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;G ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Allele G is associated with the increased risk of breast cancer according to OR and 95%CI values."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;RS1138272 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in a gene not significantly associated with breast cancer risk based on statistical analysis."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;TT GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homozygote TT genotype is not associated with an increased risk of breast cancer according to OR and 95%CI values."&lt;SEP&gt;"The TT genotype serves as a reference or control in studies comparing its effects to other genotypes, such as the CT genotype."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;CT GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CT genotype is a genetic variant of interest that influences the rewarding effects of alcohol consumption."&lt;SEP&gt;"The heterozygote CT genotype is also not associated with a significant risk of breast cancer based on the provided data."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;T ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Allele T is not significantly associated with an increased risk of breast cancer according to OR and 95%CI values."&lt;SEP&gt;"The T allele was observed to be slightly lower in CRC patients compared to the control group."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ILE105VAL SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism in the GSTP1 gene that affects protein function."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GSTP1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The GSTP1 protein, whose amyloid propensity is influenced by Ile105Val SNP according to WALTZ analysis."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;AG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The AG genotype of rs1695 polymorphism had frequencies of 44.00% for controls and 49.00% for cases, without significant association to breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GG GENOTYPE (CASES)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homozygote GG genotype in case groups is associated with increased risk of breast cancer according to OR and 95%CI values."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GG GENOTYPE (CONTROLS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homozygote GG genotype in control groups has a frequency of 06.00%, not significantly altering the risk of breast cancer alone but contributing when analyzed with cases."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;CC GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A CC genotype is associated with an increased occurrence of colorectal cancer (CRC)."&lt;SEP&gt;"The CC genotype of rs1138272 polymorphism had frequencies of 92.00% for controls and 88.00% for cases, showing no significant impact on breast cancer risk."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;CT GENOTYPE (CASES)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygote CT genotype in case groups is not associated with increased breast cancer risk according to OR and 95%CI values."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;TT GENOTYPE (CONTROLS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homozygote TT genotype was not observed in control groups, indicating rare occurrence in controls."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;TT GENOTYPE (CASES)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Homozygote TT genotype is found at a frequency of 01.00% in case groups but does not significantly increase breast cancer risk according to OR and 95%CI values."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ALLELE C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Carriers of allele C did not show significant differences or associations with increased breast cancer risk compared to carriers of other alleles."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;SNP ANALYSIS SOFTWARE (SNPEFFECTS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Software used for evaluating the effects of single nucleotide polymorphisms on protein function, including aggregation tendency and chaperone binding tendency."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;WALTZ ALGORITHM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Algorithm predicting amyloid-forming areas in proteins and estimating changes due to mutations."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;AMYLOID PROPENSITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The degree to which a protein can form amyloids, influenced by specific mutations like Ile105Val SNP."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;P.R778L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A pathogenic variant in China associated with three haplogroups A, B, C."&lt;SEP&gt;"A pathogenic variant located at residue 778 of a gene, with the genetic code being R (Arginine) replaced by L (Leucine)."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.P992L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A pathogenic variant located at residue 992 of a gene, with the genetic code being P (Proline) replaced by L (Leucine)."&lt;SEP&gt;"A pathogenic variant with a more complex haplotype spectrum compared to p.R778L, including six haplogroups."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.T935M&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A pathogenic variant located at residue 935 of a gene, with the genetic code being T (Threonine) replaced by M (Methionine)."&lt;SEP&gt;"A pathogenic variant presenting a uniform state in patients with only one kind of haplogroup on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;WD PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients diagnosed with Wilson Disease (WD), a disorder caused by a build-up of copper in the body's tissues."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;FUJIAN PROVINCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"One of five regions where WD patients were predominantly found, located in southeastern China."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;ZHEJIANG PROVINCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A region contributing a significant number of WD patients and showing varying allelic frequencies for pathogenic variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGSU PROVINCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"One of the regions with a considerable number of WD patients, particularly those with p.T935M variant."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;SHANGHAI CITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A region where WD patients were identified and showed a specific allelic frequency for pathogenic variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGXI PROVINCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"One of the regions included in the study, with notable differences in allelic frequencies for p.P992L compared to other areas."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;C.2333G &gt; T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant with a genetic change from G to T at position 2333 in the DNA sequence, corresponding to p.R778L."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;C.2975C &gt; T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant with a genetic change from C to T at position 2975 in the DNA sequence, corresponding to p.P992L."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;C.2804C &gt; T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant with a genetic change from C to T at position 2804 in the DNA sequence, corresponding to p.T935M."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;D13S314&quot;">
      <data key="d0">"MARKER"</data>
      <data key="d1">"Microsatellite marker used for analyzing linkage disequilibrium and haplotype associations of pathogenic variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;D13S301&quot;">
      <data key="d0">"MARKER"</data>
      <data key="d1">"Microsatellite marker utilized in the study to observe allele distribution and linkage disequilibrium with prevalent pathogenic variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;D13S316&quot;">
      <data key="d0">"MARKER"</data>
      <data key="d1">"Another microsatellite marker used for investigating linkage disequilibrium patterns associated with p.R778L, p.P992L, and p.T935M variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;HAPLOGROUP A&quot;">
      <data key="d0">"GENOMIC VARIANT HAPLOTYPE GROUP"</data>
      <data key="d1">"A specific haplotype group predominantly found in WD patients for the variant p.R778L."&lt;SEP&gt;"The most common haplogroup for p.R778L, found overwhelmingly on WD chromosomes compared to control ones."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;VARIANT A1 (10-7-7)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant within haplogroup A that accounts for the largest proportion among patients with p.R778L."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP B (10-7-9)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A less common haplogroup compared to haplogroup A in individuals with p.R778L."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP C (12-5-7; 12-6-7)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another less frequent haplogroup in patients carrying the p.R778L variant."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP E (10-9-5)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The most common haplogroup for p.P992L on WD chromosomes, with variant E1 being the main part of this group."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;VARIANT E1 (10-9-5)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Main variant within haplogroup E that is significantly more frequent in patients carrying p.P992L compared to controls."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP D (9-7-5), F (10-9-8), G (10-11-5), H (12-4-5; 12-5-5), I (12-5-8)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Less common haplogroups for p.P992L, appearing sporadically among WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP J (12-4-8; 12-5-8)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The sole haplogroup found for p.T935M among WD chromosomes, consisting of two variants J1 and J2."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;WD CHROMOSOMES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Specific chromosomes associated with certain diseases or genetic markers in patients."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;CONTROL ONES (CHROMOSOMES)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Chromosomes used for comparison against patient chromosomes to identify differences in genetic variants and haplogroups."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;P.R778L, P.P992L, AND P.T935M&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Microsatellite marker D13S314 exhibits significant linkage disequilibrium with the pathogenic variants p.R778L, p.P992L, and p.T935M."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.R778L, P.P992L, P.T935M&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Marker D13S301 shows significant association with alleles linked to pathogenic variants p.R778L, p.P992L, and p.T935M."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1799853&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1799853 is a single nucleotide polymorphism in CYP2C9 that reduces enzyme activity."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1057910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1057910 is a single nucleotide polymorphism in CYP2C9, contributing to variant group due to low frequency and reduced enzyme activity."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371686&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs28371686 is part of the CYP2C9 star variant group linked with lower enzyme function."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS7900194&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs7900194, a member of the CYP2C9 variant group, indicates reduced activity due to genetic variation."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371685&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism in the CYP2C9 gene linked with altered enzyme function and part of a star variant group."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*2, *3, *5, *8, AND *11 &quot;">
      <data key="d0">"GENOMIC VARIANT GROUP"</data>
      <data key="d1">"Various alleles of the CYP2C9 gene that collectively indicate reduced activity through genetic variants."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;WARFARIN DOSING ALGORITHM &quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"An algorithm designed to predict warfarin dose based on demographic, clinical, and genetic factors for personalized treatment planning."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;DVT/PE &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) is a medical condition often treated with warfarin as an anticoagulant."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;HWE &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hardy-Weinberg Equilibrium, a measure used in population genetics to assess genetic diversity and allele frequency stability over generations."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"The IWPC pharmacogenomics algorithm is used to predict therapeutic doses based on genetic information."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NOVEL AA ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"A novel algorithm designed for patients of African American (AA) ancestry that predicts therapeutic drug doses more accurately than traditional methods."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC CLINICAL ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"The IWPC clinical algorithm is used to predict therapeutic doses based on clinical criteria rather than genetic information."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;HIGH-DOSE PATIENTS GROUP&quot;">
      <data key="d0">"PATIENT GROUP"</data>
      <data key="d1">"A group of patients requiring high drug dosages, specifically ≥60 mg/week in this context."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;WAA (WHOLE AFRICAN ANCESTRY)&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"Percentage of whole African ancestry in individuals which is measured using AIMs and used to correlate with the efficacy of pharmacogenomics algorithms."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;AIMS (ANCESTRY INFORMATIVE MARKERS)&quot;">
      <data key="d0">"GENETIC MARKER"</data>
      <data key="d1">"Markers that are informative for distinguishing ancestry among populations, particularly useful for studying admixed populations like African Americans."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PREDICTED DOSE&quot;">
      <data key="d0">"VARIABLE"</data>
      <data key="d1">"The predicted dose is a variable used to evaluate the performance of pharmacogenomics algorithms."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;OBSERVED DOSE&quot;">
      <data key="d0">"VARIABLE"</data>
      <data key="d1">"The observed dose refers to the actual administered drug dosage for patients, used as a reference in evaluating algorithm precision."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;MAE (MEAN ABSOLUTE ERROR)&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"A statistical measure representing the average absolute difference between predicted and observed doses."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NNG (NUMBER NEEDED TO GENOTYPE)&quot;">
      <data key="d0">"CLINICAL MEASURE"</data>
      <data key="d1">"The number of patients that need to be genotyped to prevent one patient from receiving a dose outside the therapeutic range, indicating clinical benefit."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;THERAPEUTIC DOSE RANGE&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"A 20% therapeutic dose range within which doses are considered optimal and safe for treatment."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;LINEAR REGRESSION ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A statistical method used to analyze the relationship between percent WAA and predicted dose among high-dose patients."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;Β (BETA COEFFICIENT)&quot;">
      <data key="d0">"MEASURE"</data>
      <data key="d1">"The beta coefficient indicates the strength of an inverse correlation in linear regression analysis, revealing how changes in one variable affect another."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;CYP2C9 STAR VARIANT GROUP &quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"rs1057910 is part of the combined CYP2C9 star variant group due to its low frequency and impact on enzyme activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1057910 &quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"rs1057910 is part of the combined CYP2C9 star variant group due to its low frequency and impact on enzyme activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WAA&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"There is an inverse correlation between percent WAA and predicted dose within the 20% therapeutic range for IWPC pharmacogenomics algorithm, indicating it performs poorly with varying levels of African ancestry among patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NNG&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"The NNG is calculated based on the need to prevent a dose from falling outside of the therapeutic range, indicating clinical benefit.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1 SNP RS927650&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CYP24A1 SNP rs927650 is a genomic variant that has a significant association with colorectal adenoma recurrence and advanced adenoma recurrence."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP27B1 AND CYP24A1 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs in the genes CYP27B1 and CYP24A1 are associated with features of advanced colorectal adenoma recurrence, particularly in relation to 25(OH)D concentrations."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VITAMIN D METABOLITES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Vitamin D metabolites play a role in the interaction between genetic variants and risk for colorectal adenomas."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;ADENOMA RECURRENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The recurrence of adenomas is influenced by both genetic factors and vitamin D levels, indicating a complex physiological process."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;ADVANCED ADENOMA RECURRENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Advanced adenoma recurrence represents a more severe outcome within the spectrum of colorectal diseases."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;25(OH)D CONCENTRATIONS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Levels of 25-hydroxyvitamin D (25(OH)D) are part of the metabolic pathway associated with vitamin D's effects on health outcomes, such as colorectal adenoma recurrence."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;1,25(OH)2D CONCENTRATIONS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Levels of 1,25-dihydroxyvitamin D (1,25(OH)2D) are part of the metabolic pathway involved in regulating vitamin D's biological activities and health outcomes."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1 SNP RS35051736&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with advanced adenoma recurrence and may affect the risk for more severe colorectal lesions, though its impact varies depending on specific genotypes."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VITAMIN D DEFICIENCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Deficiency in vitamin D (25(OH)D levels &lt;12 ng/ml) is an environmental factor that influences adenoma recurrence risk, especially when combined with certain genetic variants."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP27B1 SNP RS35051736&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in CYP27B1 is associated with advanced adenoma recurrence and influences the risk of more severe colorectal lesions."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VILLOUS HISTOLOGY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The presence of villous histology indicates a higher risk for recurrent adenomas, especially when considering specific genetic variants like CYP24A1 rs2296241."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;LARGER OR VILLOUS ADENOMA RECURRENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Recurrences characterized by larger size or villous histology are more concerning as they indicate a progression towards more severe colorectal diseases."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP27B1 SNP RS2762939&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant in CYP27B1 interacts with 1,25(OH)2D levels and influences the risk of adenoma recurrence."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;INADEQUATE VITAMIN D LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with inadequate vitamin D levels (between 12 and &lt;20 ng/ml) are at higher risk for adenoma recurrence, especially if they carry certain genetic variants."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1 SNPS&quot;">
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d1">"The number of G alleles in CYP24A1 rs2296241 correlates with higher odds for recurrent adenomas with villous histology, suggesting a genetic influence on this feature."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP24A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CYP24A1 gene is involved in vitamin D metabolism and has been studied for its genotypes related to specific variants."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;C.428_430DELAAG VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant in the CYP24A1 gene involves a deletion of three nucleotides (AAG) at position 428-430, leading to changes in genotype interpretation."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;C.1186C &gt; T VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant in the CYP24A1 gene involves a substitution from cytosine (C) to thymine (T) at position 1186."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS777676129 AMPLICON&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The amplicon associated with rs777676129 variant of CYP24A1 has specific melting temperatures for wt, heterozygous and homozygous genotypes."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS114368325 AMPLICON&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The amplicon associated with rs114368325 variant of CYP24A1 also has specific melting temperatures for wt, heterozygous and homozygous genotypes."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;HRMA (HIGH RESOLUTION MELTING ANALYSIS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"HRMA is a molecular interaction analysis method that allows the identification of genetic variations through high-resolution melting curve analysis."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;IIH (IDIOPATHIC INFANTILE HYPERCALCEMIA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition suspected in some samples, where IIH is associated with specific genetic variants in the CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;WILD-TYPE (WT)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The wild-type refers to a standard genetic sequence of the CYP24A1 gene without any variants or mutations."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS SAMPLE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A sample that carries two different heterozygous variants in the same gene, typically resulting from inheriting one variant from each parent."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;MELTING CURVE ANALYSIS (TM)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Melting curve analysis is used to determine the stability of DNA sequences by measuring their melting temperature (Tm), which is indicative of genetic variations."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;P1001L MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The P1001L mutation is a genomic variant located in the ATP7A gene which causes Menkes disease when present."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;ATP7A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ATP7A is a gene that encodes a protein involved in copper transport and homeostasis, mutations in this gene can lead to Menkes disease."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MENKES DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Menkes disease is a rare X-linked recessive disorder caused by mutations in the ATP7A gene leading to abnormal copper metabolism."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;COPPER TRANSPORT AND HOMEOSTASIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of copper transport and homeostasis, which is regulated by the protein encoded by the ATP7A gene, is critical for proper cellular function and development."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MOSAICISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mosaicism refers to a genomic variant where different cells within an organism have different genetic sequences, in this case, differing levels of the P1001L mutation were found between blood and fibroblast tissues."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;DENVER DEVELOPMENTAL SCREENING TEST II&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A developmental screening tool used to assess a child’s progress in areas such as gross motor skills, fine motor skills, language, and personal-social development."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BRAIN MRI&quot;">
      <data key="d0">"DIAGNOSTIC TEST"</data>
      <data key="d1">"A diagnostic imaging test used to visualize the structure of the brain including signs of atrophy or delayed myelination."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An electrophysiological measurement indicating the strength and conduction velocity of motor nerves in the median nerve pathway."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;">
      <data key="d0">"DIAGNOSTIC TEST"</data>
      <data key="d1">"A measure assessing how fast an electrical signal travels along a nerve, used to diagnose neuromuscular disorders."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CEREBROSPINAL FLUID (CSF)&quot;">
      <data key="d0">"BODY FLUID"</data>
      <data key="d1">"Fluid surrounding the brain and spinal cord that contains important biochemical markers for diagnosing neurological conditions."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;PLASMA CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"DIAGNOSTIC TEST"</data>
      <data key="d1">"A test measuring the ratio of catecholamines in plasma, reflecting enzyme activity critical to copper metabolism."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;ATROPHY AND DELAYED MYELINATION&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"A brain MRI can detect signs of atrophy and delayed myelination in neurological conditions like Menkes disease."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NERVOUS SYSTEM FUNCTION&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"The median nerve compound motor action potentials test evaluates the function of the nervous system in conducting motor signals."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUROLOGICAL DISORDERS&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Conduction velocity measurements help diagnose neurological disorders by assessing nerve health and integrity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MENKES DISEASE DIAGNOSTIC MARKERS&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"CSF contains biochemical markers that are critical for diagnosing Menkes disease, including copper levels and catecholamine ratios."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CACO-2 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Caco-2 cells are a cell line often used to study intestinal epithelial cells and their functions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;DEIODINASE GENE (IDI)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The deiodinase gene (IDI) is responsible for the synthesis of iodothyronine deiodinases, which play key roles in thyroid hormone metabolism."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 3′UTR VARIANT (T/C)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the GPX4 3′ untranslated region (UTR) with two alleles, T and C corresponding to rs713041."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;IDI-T TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The IDI transcript associated with the T allele of the GPX4 3′ UTR variant."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;IDI-C TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The IDI transcript associated with the C allele of the GPX4 3′ UTR variant."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENIUM (SE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium is an essential micronutrient that plays a critical role in antioxidant defense systems through its incorporation into selenoproteins such as GPx and TR1."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE (T-BHP)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A chemical compound often used to induce oxidative stress conditions in cellular experiments, acting as an oxidizing agent."&lt;SEP&gt;"Tert-butylhydroperoxide is an oxidizing agent used to induce oxidative stress in cells and assess their antioxidant defenses."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX4 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Glutathione peroxidase 4 is a selenoprotein involved in antioxidant defense systems."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;THIOREDOXIN REDUCTASE 1 (TR1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A selenium-dependent enzyme that plays an important role in redox homeostasis and oxidative stress response."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;ROS LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurement of reactive oxygen species levels as a way to assess oxidative stress conditions in cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN H MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Messenger RNA encoding for selenoprotein H, an important selenoenzyme involved in redox balance and antioxidant defense."&lt;SEP&gt;"Selenoprotein H mRNA encodes a protein that is part of the antioxidant defense system, particularly important for protecting against oxidative stress."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;CELL VIABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The ability of cells to survive under different environmental conditions such as oxidative stress induced by t-BHP challenge."&lt;SEP&gt;"The measure of how well cells survive under specific conditions such as oxidative challenges."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE CHALLENGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A challenge to cells using tert-butylhydroperoxide (t-BHP) to induce oxidative stress and test cell viability."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN H PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An antioxidant protein that is dependent on selenium for its function, involved in maintaining redox balance in the cell."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;OXIDATIVE CHALLENGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A challenge to cells using an oxidizing agent (such as tert-butylhydroperoxide) to induce oxidative stress and test cellular responses."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN H MRNA LEVELS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The measurement of mRNA levels for selenoprotein H, indicating the transcriptional regulation under different conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE-DEPLETED MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cell culture medium lacking sufficient selenium, used to study the impact on cellular processes such as gene expression and protein synthesis."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE-SUPPLEMENTED MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cell culture medium with adequate levels of selenium, used for comparing effects under conditions of optimal nutritional supply."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE (SELENIUM)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium is an essential trace element involved in the regulation of selenoprotein expression and cell viability."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"GPx4, also known as glutathione peroxidase 4, is a selenoenzyme that plays a role in antioxidant defense by reducing lipid hydroperoxides to their corresponding alcohols using reduced glutathione (GSH) as an electron donor."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1, GPX1 AND GPX4 MRNAS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The mRNA transcripts of TR1, GPx1, and GPx4 are involved in the regulation of selenoprotein expression."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-C CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"IDI-C cells are a type of cell line that exhibit differential selenoprotein expression patterns compared to IDI-T cells under varying selenium conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-T CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"IDI-T cells are a type of cell line used for comparison with IDI-C cells in experiments assessing the effects of selenium on oxidative stress and viability."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;ROS (REACTIVE OXYGEN SPECIES)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Reactive oxygen species are molecules that contain oxygen and can cause cellular damage when present in excessive amounts, playing a role in various physiological processes including cell signaling and death."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX ACTIVITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Glutathione peroxidase activity is an enzymatic process involved in the detoxification of hydrogen peroxide and lipid hydroperoxides to reduce oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI TRANSCRIPT LEVELS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Levels of the IDI (inositol demethylase) transcript are measured as a proxy for transgene expression levels in cells."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;INOSITOL DEMETHYLASE (IDI)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IDI gene encodes an enzyme involved in the biosynthesis of myo-inositol, and its overexpression can affect selenoprotein expression and cell responses to oxidative stress."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GLUTATHIONE PEROXIDASES (GPX1, GPX4)&quot;">
      <data key="d0">"PROTEIN FAMILY"</data>
      <data key="d1">"The glutathione peroxidase family of proteins includes enzymes that protect cells from oxidative damage by reducing hydrogen peroxide and organic hydroperoxides."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENIUM DEPLETION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Conditions where selenium is removed or significantly reduced, leading to changes in selenoprotein expression and cell viability."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;OXIDATIVE CHALLENGE (T-BHP)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A test condition involving exposure to tert-butylhydroperoxide, a powerful oxidizing agent used to induce oxidative stress in cells for study."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;CHAT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CHAT is a gene that encodes choline acetyltransferase (ChAT), an enzyme involved in neurotransmitter synthesis."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.VAL136MET MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense mutation p.Val136Met identified in the CHAT gene, observed in three patients and associated with altered protein expression levels."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ALA557THR MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense mutation p.Ala557Thr identified in the CHAT gene, seen in five patients including a homozygous case and linked to reduced ChAT enzyme activity."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;S-TYPE TRANSCRIPT OF CHAT GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The S-type transcript of the CHAT gene produces two protein isoforms (70 kDa and 74 kDa) due to alternative start sites, with a consistent expression ratio observed in spinal cord tissues."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;CHOLINE ACETYLTRANSFERASE PROTEIN (CHAT)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ChAT is an enzyme that catalyzes the synthesis of acetylcholine from acetyl-CoA and choline. Mutations in CHAT can affect its expression, kinetic properties, and thermal stability."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;NONSENSE MUTATION ON SECOND ALLELE (P.ALA557THR)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An additional nonsense mutation affecting the second allele in patient 10 along with p.Ala557Thr, contributing to a specific phenotype observed in this individual."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;THERMAL STABILITY OF CHAT MUTANT PROTEINS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The thermal stability process measures how well mutant ChAT proteins maintain their structure and function at elevated temperatures compared to the wild-type protein."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MISSENSE MUTATIONS IN CHAT GENE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Various missense mutations (e.g., p.Trp421Ser, p.Ser498Pro) impact ChAT's kinetic parameters and thermal stability, indicating a disruption of normal molecular interactions essential for enzyme function."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;HISTIDINE-TAGGED CHAT CDNA EXPRESSION IN E. COLI &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Expression and purification of histidine-tagged CHAT cDNAs in E. coli to study the kinetic properties and thermal stability of wild-type and mutant ChAT proteins."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;BOSC 23 CELLS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Bosc 23 cells are used as a host for expressing recombinant proteins, including mutant and wild-type CHATs in this study."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;KINETIC PROPERTIES OF WILD-TYPE AND MUTANT CHAT PROTEINS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The kinetic properties include rate constants that determine the speed and efficiency of enzymatic reactions by ChAT proteins under different conditions."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;BCL2L11 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BCL2-like 11 [apoptosis facilitator] gene is associated with DNA methylation patterns in individuals with oxidative stress markers."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;NDUFS7 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NADH dehydrogenase [ubiquinone] Fe-S protein 7, a mitochondrial complex I subunit that plays a role in cellular energy metabolism and is associated with DNA methylation patterns linked to oxidative stress markers."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;EIF3J GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Eukaryotic translation initiation factor 3, subunit J (EIF3J) gene shows association with DNA methylation at CpG sites related to oxidative stress markers in individuals from the PIVUS cohort."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ZNF761 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Zinc finger protein 761 (ZNF761) is a gene whose promoter region's methylation level is associated with GSSG/GSH ratio, an indicator of oxidative stress state in individuals."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;PSMG3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Proteasome assembly chaperone 3 (PSMG3) shows significant association between its promoter methylation levels and the GSSG/GSH ratio indicating potential role in oxidative stress regulation."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ENTHD1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Ent-Homologous domain containing 1 gene is associated with DNA methylation patterns at CpGs related to homocysteine levels, a marker of oxidative stress and cardiovascular risk."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;LRIG1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) gene has methylation sites associated with the amino acid HCY, indicative of signal transduction dysregulation in the context of oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RIPK3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) gene methylation sites are associated with homocysteine levels, suggesting a role in signal transduction pathways under oxidative conditions."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RPS6KC1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Ribosomal protein S6 kinase BETA-1 (RPS6KC1) gene is linked to DNA methylation patterns associated with both homocysteine levels and lipid-related processes, indicating a broad role in cellular metabolism under oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ATP2B4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ATPase Ca++ transporting 4 (ATP2B4) gene shows association between methylation patterns at CpG sites and homocysteine levels, implicating its role in signal transduction under oxidative stress conditions."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;SEMA6A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Semaphorin-6A (SEMA6A), a protein with anti-angiogenic function, shows methylation patterns at CpG sites associated with oxidized LDL levels, an indicator of lipid peroxidation and oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;TAPBP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tapasin (TAP binding protein) gene's 3'-UTR methylation level is correlated with CD marker levels indicating potential involvement in immune response regulation under oxidative conditions."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RGL2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Ral guanine nucleotide dissociation stimulator-like 2 (RGL2) gene has promoter region methylation patterns associated with CD marker, a measure of lipid peroxidation products and oxidative stress state."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CKAP5 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cytoskeleton associated protein 5 (CKAP5) shows DNA methylation patterns at CpG sites related to BCD-LDL levels, indicating potential involvement in cellular cytoskeletal organization under oxidative conditions."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FOSL2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FOS-like antigen 2 (FOSL2) gene's methylation level is associated with BCD-LDL levels, suggesting its role in inflammatory response regulation during oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FAM20C GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Family with sequence similarity 20, member C (FAM20C), a secreted enzyme involved in mineralization, has CpG sites associated with BCD-LDL levels indicating potential role in bone and dental development under oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FRMD6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FERM domain containing 6 (FRMD6) gene is linked to DNA methylation patterns at CpG sites associated with BCD-LDL, a marker of lipid peroxidation and oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Oxidative stress is a physiological process involving the production of reactive oxygen species which can damage cellular components."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPGS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CpGs are genomic variants that play roles in DNA methylation and gene regulation, potentially influencing oxidative stress-related phenotypes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PROMOTER REGION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Promoters are regulatory regions of genes that can influence transcriptional activity."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR (TF)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Transcription factors bind to DNA and regulate gene expression, often in response to physiological signals such as oxidative stress."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PHOSPHORYLATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Phosphorylation is a post-translational modification involved in signal transduction and regulation of cellular processes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;DNA METHYLATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"DNA methylation is an epigenetic mechanism that can modify gene expression without changing the DNA sequence, often influenced by environmental factors."&lt;SEP&gt;"Increased DNA methylation inhibits CTCF binding at insulator sites, which activates tissue-specific gene expression and facilitates enhancer-promoter interactions."&lt;SEP&gt;"The differential DNA methylation in CD4+ and CD8+ T cells affects gene expression levels and contributes to the detection of eQTLs."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CHD (CORONARY HEART DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Coronary heart disease involves narrowing of coronary arteries due to atherosclerosis, leading to reduced blood flow and oxygen supply to the heart muscle."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;T2D (TYPE 2 DIABETES MELLITUS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A metabolic disorder characterized by high blood sugar levels resulting from insulin resistance or insufficient insulin production."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;BCL2L11 GENE/PROTEIN&quot;">
      <data key="d0">"GENE, PROTEIN"</data>
      <data key="d1">"The BCL2L11 gene encodes a protein that plays a role in apoptosis and has been implicated in cardiovascular diseases such as CHD."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;E2F1 TRANSCRIPTION FACTOR BINDING SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"E2F1 binding sites are regions of DNA to which the E2F1 transcription factor binds, potentially regulating genes involved in cell cycle progression and cancer development."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLAND SHORES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CpG island shores are regions of DNA adjacent to CpG islands where methylation patterns can influence gene regulation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;ATHEROSCLEROSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Atherosclerosis is a disease characterized by the buildup of plaque in arteries, leading to restricted blood flow and potential cardiovascular events."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;REGULOMEDB SCORE 1A-2C&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The RegulomeDB score indicates strong evidence that CpG sites are located within functional regulatory elements affecting gene expression."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;JASPAR DATABASE&quot;">
      <data key="d0">"DATABASE, MOLECULAR INTERACTION"</data>
      <data key="d1">"A database of transcription factor binding profiles used for identifying TF binding sites on DNA sequences."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;DAVID FUNCTIONAL ANNOTATION CLUSTERING TOOL&quot;">
      <data key="d0">"SOFTWARE, PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The DAVID tool clusters genes into functional groups based on their annotations and can identify biological processes enriched among a set of genes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;MEQTL (METHYLATION QUANTITATIVE TRAIT LOCI)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"meQTLs are genetic variants that influence DNA methylation levels at specific CpG sites, affecting gene expression patterns."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CARDIOGRAM CONSORTIUM&quot;">
      <data key="d0">"DATABASE, GWAS STUDY"</data>
      <data key="d1">"A consortium focusing on genome-wide association studies (GWAS) for coronary heart disease to identify genetic risk factors."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;DIAGRAM CONSORTIUM&quot;">
      <data key="d0">"DATABASE, GWAS STUDY"</data>
      <data key="d1">"A consortium dedicated to genome-wide association studies for type 2 diabetes mellitus to find genetic variants associated with the disease."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;RS6750142 (PROXY OF RS726430)&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"A proxy SNP (single nucleotide polymorphism) for another SNP (rs726430) showing association with CHD and T2D in GWAS studies."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;BCL2L11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL2L11 is a gene whose CpG site (cg07547695) was associated with methylation variants."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CEP55&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CEP55 is a gene associated with methylation at the cg24371383 CpG site."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;CPB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CPB1 is a gene related to methylation at the cg04072156 CpG site."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CHR. 4 INTERGENIC SITE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intergenic site on chromosome 4 (cg14532755) is associated with multiple SNPs and methylation levels."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS CPGS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CpG sites associated with oxidative stress markers are tested for disease incidence associations."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HIST1H4D 3'-UTR METHYLATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"Methylation levels in the 3' untranslated region of HIST1H4D were found to be associated with incident T2D."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;DVL1 BODY METHYLATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"Body methylation of DVL1 was associated with increased risk of T2D."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ZNF341 CPG CG11842944&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Methylation levels at the ZNF341 gene body CpG (cg11842944) were associated with heart failure risk."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CVD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular Disease, including myocardial infarction, heart failure, and ischemic stroke, was tested for CpG site associations but showed no significant association with methylation levels at phenotype-associated sites."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;MYOCARDIAL INFARCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A type of cardiovascular event associated with a specific CpG site's methylation levels in ZNF341 gene body."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HEART FAILURE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An outcome within CVD where methylation at the cg11842944 CpG was most strongly predictive."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ISCHAEMIC STROKE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A cardiovascular event type which had a weaker association with ZNF341 gene body methylation compared to heart failure."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS726430&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP associated with methylation at the BCL2L11 CpG site (cg07547695) is linked to genetic variation in relation to disease risk."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS12782691&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP associated with methylation at the CEP55 CpG site (cg24371383) is identified as a potential marker for genetic variation in disease susceptibility."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS16861015&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP linked to methylation at CPB1's CpG site (cg04072156) is considered an indicator of genetic influence on health outcomes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CHR. 4 INTERGENIC SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Multiple SNPs within the intergenic region on chromosome 4 are associated with methylation levels at CpG site (cg14532755)."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS1665364, RS2236786, RS3752749, RS732754, RS744658, RS798719, RS798726, RS798727, RS798741, RS798744, RS798751, RS798754, RS798755, RS798756, RS798766, RS811316, RS8389&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Multiple SNPs found within an intergenic region on chromosome 4 are associated with methylation levels at CpG site cg14532755."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HISTONE CLUSTER 1 H4D (HIST1H4D)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene HIST1H4D's 3'-UTR region showed epigenetic changes linked to T2D risk."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d3">[{"level": 0, "cluster": 11}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;DISHEVELLED-1 (DVL1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Body methylation of DVL1 is associated with an increased risk for developing Type 2 Diabetes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ZNF341&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Methylation levels at the body CpG site cg11842944 in ZNF341 gene are linked to heart failure and previously associated with height in GWAS studies."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HOMOCYSTEINE LEVELS&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"Methylation patterns at CpGs within ENTHD1 gene are associated with homocysteine levels, a marker of oxidative stress and cardiovascular risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNAL TRANSDUCTION DYSREGULATION&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"The LRIG1 gene's methylation sites correlate with homocysteine levels indicating its role in signal transduction dysregulation during oxidative stress conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIPID PEROXIDATION PRODUCTS&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"Methylation patterns at CKAP5 gene CpGs are correlated with BCD-LDL, a marker of lipid peroxidation products and oxidative stress state, suggesting its role in cellular cytoskeletal organization under these conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATORY RESPONSE REGULATION&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"The FOSL2 gene's methylation patterns are associated with BCD-LDL levels indicating potential involvement of AP-1 transcription factors in inflammatory response regulation during oxidative stress."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS RESPONSE&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"DNA methylation patterns at FRMD6 CpG sites show significant association with BCD-LDL, a marker of lipid peroxidation and oxidative stress, indicating its role in cellular functions under these conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHD AND T2D&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"The proxy SNP rs6750142 is nominally associated with CHD and T2D in GWAS studies, indicating potential genetic overlap between these diseases."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEQTL SNPS&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"GWAS can be used to investigate the association of genetic variants (including meQTL SNPs) with disease phenotypes, providing insights into epigenetic influences on diseases."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D, CVD&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"Multiple intergenic SNPs on chromosome 4 associated with methylation levels in disease contexts suggest a genetic basis for health outcomes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ISCHAEMIC STROKE, MYOCARDIAL INFARCTION&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"Methylation levels at ZNF341's cg11842944 site influence risks for cardiovascular events like myocardial infarction and ischaemic stroke."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MT-ATP6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MT-ATP6 gene is located in mitochondrial DNA and encodes for a subunit of ATP synthase involved in the electron transport chain."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;8993T&gt;G VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An apparent homoplasmic de novo mutation in mtDNA 8993T&gt;G (c.467T&gt;G, p.Leu156Arg) located within the MT-ATP6 gene."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;LEIGH SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurological disorder due to a defect in oxidative phosphorylation, often caused by mutations in mitochondrial DNA such as 8993T&gt;G in ATP synthase 6 gene (MT-ATP6)."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COMPLEX V (ATP SYNTHASE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The fifth complex of the electron transport chain that synthesizes ATP from ADP and Pi, which is deficient due to the mutation in MT-ATP6."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NDUFV1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with mitochondrial disease encoding a protein (NADH dehydrogenase [ubiquinone] flavoprotein 1) involved in complex I of the electron transport chain."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.736G&gt;A, P.GLU246LYS VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense variant found within NDUFV1 gene that affects a highly conserved codon and is predicted to be damaging according to in silico analysis."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.349G&gt;A, P.ALA117THR VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another missense variant identified within the same NDUFV1 gene, affecting a highly conserved codon and associated with mitochondrial disease."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;EXOME SEQUENCING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of sequencing all exons in a genome to identify variants and mutations."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COQ2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The COQ2 gene encodes a protein involved in coenzyme Q10 biosynthesis."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.437G&gt;A (SER146ASN)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant found within the COQ2 gene that changes serine to asparagine at position 146, potentially causing disease."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q10 DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inherited disorder caused by mutations in genes involved in coenzyme Q10 biosynthesis leading to neurological symptoms and muscle weakness."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;C.1159C&gt;T (ARG387X)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A stop-gain variant found within the COQ2 gene that causes a premature termination codon at position 387, potentially causing disease."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MT-ND1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The mitochondrial genome-encoded NADH dehydrogenase subunit 1 (MT-ND1) gene is involved in respiratory complex I function and can cause various disorders when mutated."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;3754C&gt;A (MT-ND1)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A novel variant within the MT-ND1 gene found at heteroplasmic levels, potentially causing mitochondrial complex I deficiency or related conditions."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;LEBER OPTIC ATROPHY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inherited optic neuropathy caused by mutations in genes encoding for proteins of the respiratory chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A group of disorders characterized by a deficiency in mitochondrial complex I, leading to energy deficits and various clinical manifestations including neurological symptoms and myopathy."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MELAS (MITOCHONDRIAL ENCEPHALOMYOPATHY WITH LACTIC ACIDOSIS AND STROKE-LIKE EPISODES)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A syndrome caused by mutations affecting the respiratory chain in mitochondria resulting in neurodegeneration, lactic acidosis, stroke-like episodes, and other symptoms."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COQ2 HOMOLOG PRENYLTRANSFERASE PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by the COQ2 gene is involved in coenzyme Q10 biosynthesis."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;ELECTRON TRANSPORT CHAIN COMPLEX I (NADH DEHYDROGENASE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A series of redox reactions within mitochondria that are essential for cellular energy production, involving electron transfer from NADH to oxygen."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q10 DEFICIENCY PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway related to the biosynthesis and deficiency of coenzyme Q10 which is crucial in oxidative phosphorylation."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NADH DEHYDROGENASE SUBUNIT 1 (ND1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein encoded by the MT-ND1 gene which is a subunit of complex I in the mitochondrial electron transport chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COMPLEX I (NADH DEHYDROGENASE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An enzymatic complex that plays a key role in oxidative phosphorylation and is composed of multiple protein subunits, including those encoded by nuclear DNA and mtDNA."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL GENOME-DNA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genetic material found within mitochondria which includes genes like MT-ND1 involved in various physiological processes such as electron transport chain function."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NEXT-GENERATION EXOME SEQUENCING&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"The next-generation exome sequencing technique detected the 8993T&gt;G variant within the MT-ATP6 gene."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OPRM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The OPRM1 gene is involved in alcohol drinking behavior and its associated variables such as AUDIT score, number of drinking days, and drinks per drinking day."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;RS671 ALDH2 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs671) in the ALDH2 gene, which is involved in alcohol metabolism, was controlled for during analyses."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;RS1229984 ADH1B VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant (rs1229984) in the ADH1B gene, also involved in alcohol metabolism, was included as a covariate in the analyses."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;NALTREXONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Naltrexone is a medication that showed significant association with drowsiness and ringing in the ears side effects during the study."&lt;SEP&gt;"Naltrexone is used as a medication in studies examining its effect on alcohol self-administration and consumption behavior."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544&lt;SEP&gt;chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;PLACEBO&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A placebo was used as a control condition to compare against naltrexone's effects on alcohol craving, sedation, and stimulation responses."&lt;SEP&gt;"The placebo treatment serves as a control condition to compare against drug treatments like naltrexone."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544&lt;SEP&gt;chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;DROWSINESS&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"Drowsiness is a side effect that occurred significantly more often in participants taking naltrexone compared to placebo."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;RINGING IN THE EARS&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"Ringing in the ears is another significant side effect associated with naltrexone use during the study."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALCOHOL CRAVING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alcohol craving is a physiological process that was analyzed for pharmacogenetic effects influenced by OPRM1 genotype and medication status."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALCOHOL-INDUCED SEDATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sedation caused by alcohol consumption, which was studied in relation to genetic variants (ADH1B) and baseline sedation levels."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALCOHOL-INDUCED STIMULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Stimulation is a physiological response induced by alcohol intake that varies based on medication and genotype interaction effects."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;OPRM1 GENE GROUP DIFFERENCES &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The OPRM1 gene group differences are physiological processes that influence drinking variables such as AUDIT score, number of drinking days, and drinks per day."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DRINKING DAYS &quot;">
      <data key="d0">"DISEASE RISK INDICATOR"</data>
      <data key="d1">"Number of drinking days is an indicator used to assess risk for alcohol use disorder."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DRINKS PER DRINKING DAY &quot;">
      <data key="d0">"DISEASE RISK INDICATOR"</data>
      <data key="d1">"Drinks consumed per drinking day is another measure utilized in assessing the risk of alcohol-related health issues."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;BASELINE SUBJECTIVE RESPONSE &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Subjective response at baseline (BrAC = 0.00 g/dl) is an important physiological process that influences subsequent subjective responses to alcohol infusion."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;FISHER'S EXACT TEST &quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A statistical test used in small sample sizes to examine the significance of associations between medication side effects and genotypes."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;SAFTTEE CHECKLIST &quot;">
      <data key="d0">"ASSESSMENT TOOL"</data>
      <data key="d1">"An assessment tool for identifying potential adverse effects from medications, specifically relevant during alcohol infusion studies."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALCOHOL-INDUCED CRAVING &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cravings induced by alcohol intake are physiological responses that vary based on genotype and medication status."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;BASELINE AUQ VALUES &quot;">
      <data key="d0">"COVARIATE"</data>
      <data key="d1">"AUQ values at baseline are significant covariates in the analysis of alcohol-induced craving across different genotypes."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;NICOTINE SMOKING STATUS &quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Smoking status was considered as an environmental factor that could influence subjective responses to alcohol but did not show significant moderation effects."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ASN40 HOMOZYGOTES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Asn40 homozygote is a genomic variant in ALDH2 that affects alcohol consumption and metabolism."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALDH2 genotype influences alcohol consumption behavior, with Asp40 carriers consuming fewer drinks compared to Asn40 homozygotes."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ASP40 CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Asp40 carrier is a genomic variant in ALDH2 that influences alcohol consumption behavior, leading to significantly fewer drinks consumed compared to Asn40 homozygotes."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NICOTINE SMOKING STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Smoking status was not a significant moderator of the effects on alcohol self-administration and had no effect on medication or genotype results."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;LATENCY TO FIRST DRINK&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The latency to first drink is influenced by ALDH2 genotype, where Asn40 homozygotes have a significantly shorter latency compared to other genotypes."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NALTREXONE MEAN DRINKS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Naltrexone mean drinks refers to the average number of drinks consumed under naltrexone treatment condition (mean = 0.93, SD = 1.35)."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;PLACEBO MEAN DRINKS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Placebo mean drinks indicates the average number of drinks consumed in the absence of medication (mean = 1.19, SD = 1.43)."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;SMOKERS MEAN DRINKS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Smokers consumed an average of 1.41 drinks with standard deviation of 1.50 during alcohol self-administration studies."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NON-SMOKERS MEAN DRINKS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Non-smokers consumed an average of 0.83 drinks with a standard deviation of 1.27 during alcohol self-administration studies."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALCOHOL DRINKING BEHAVIOR &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Controlling for the rs671 variant in ALDH2 helps refine analyses related to alcohol drinking behaviors and their genetic underpinnings.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS671 ALDH2 VARIANT &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Controlling for the rs671 variant in ALDH2 helps refine analyses related to alcohol drinking behaviors and their genetic underpinnings.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DROWSINESS &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The use of naltrexone medication resulted in significantly higher incidence of drowsiness compared to placebo, indicating a drug effect on this side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NALTREXONE &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The use of naltrexone medication resulted in significantly higher incidence of drowsiness compared to placebo, indicating a drug effect on this side effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL-INDUCED SEDATION &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"This genetic variant is associated with alcohol-induced sedation responses in the presence of rising blood alcohol concentration (BrAC).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1229984 ADH1B VARIANT &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"This genetic variant is associated with alcohol-induced sedation responses in the presence of rising blood alcohol concentration (BrAC).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUBSEQUENT ALCOHOL EFFECTS &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The baseline subjective response influenced how participants subsequently experienced sedation, stimulation, and craving during alcohol intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE-DRUG INTERACTION &quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"This test was used to determine the significance of genotype-drug interactions in causing side effects such as drowsiness and ringing in ears.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALDH2 RS671 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant of the ALDH2 gene identified by the rs671 SNP, influencing alcohol consumption and cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;DAILY ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The daily intake of alcohol is a physiological process that varies based on genotype (rs671) and impacts blood cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;BLOOD CORTISOL LEVEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measurement of the level of cortisol in the blood, which can be influenced by genetic factors and daily alcohol consumption."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;EDUCATION STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"The level of education attained, which can influence health behaviors and outcomes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GENETICALLY PREDICTED ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An estimate of daily alcohol consumption based on genetic factors influencing drinking behavior."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;EX-DRINKERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Individuals who previously consumed alcohol but no longer do, a lifestyle factor that can influence health outcomes and hormone levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;ALDH2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALDH2 gene is involved in alcohol metabolism and contains the rs671 polymorphism."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;CORTISOL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of cortisol, a stress hormone, vary according to genetic factors such as the ALDH2 rs671 genotype."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;AGE DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The distribution of age among individuals with different ALDH2 genotypes shows significant differences, particularly in relation to alcohol consumption and physiological processes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;ABCG2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ABCG2 is a gene associated with uric acid levels and hyperuricemia (HUA) risk."&lt;SEP&gt;"The ABCG2 gene's variant (rs2231147) significantly influences the use of CSFs during chemotherapy treatment in ovarian cancer patients."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;SLC2A9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC2A9 is a gene linked to serum urate levels and HUA risk, particularly in females."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;SLC22A12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC22A12 is associated with serum uric acid (sUA) levels but not significantly with HUA risk."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;RS3733591 SLC2A9&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs3733591 variant of the SLC2A9 gene is associated with increased sUA levels and HUA risk, especially in females."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;RS2231142 ABCG2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs2231142 variant of the ABCG2 gene significantly affects sUA levels and increases HUA risk across both genders."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;RS893006 SLC22A12&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant in SLC22A12 shows a minor effect on sUA level but lacks significant association with HUA risk."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HYPERTENSION TREATMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Treatment for hypertension, such as the use of diuretics, may influence uric acid levels and related conditions like HUA."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;URIC ACID METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway involving uric acid is influenced by genetic factors such as ABCG2, SLC2A9, and SLC22A12 variants."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 21}]</data>
    </node>
    <node id="&quot;HYPERURICEMIA (HUA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HUA is a condition characterized by elevated serum urate levels which can lead to various health issues."&lt;SEP&gt;"Hyperuricemia is a condition characterized by elevated levels of uric acid in the blood, leading to various health risks."&lt;SEP&gt;"Hyperuricemia, a condition characterized by high levels of uric acid in the blood, is associated with cardiovascular disease and can be influenced by genetic factors such as rs2231142 T allele carriers."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;SERUM CREATININE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum creatinine is a measure of kidney function that was found to be higher in HUA cases."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;TRIGLYCERIDES (TG)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Triglyceride levels were also elevated in the HUA group compared to controls."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;LOW-DENSITY LIPOPROTEIN (LDL)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Levels of LDL cholesterol were higher among individuals with hyperuricemia."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;HIGH-DENSITY LIPOPROTEIN (HDL)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"HUA cases had lower HDL levels compared to controls, indicating poorer lipid profile."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;GENDER DIFFERENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differences observed in genetic associations between males and females for certain variants."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 23}]</data>
    </node>
    <node id="&quot;SLC2A9 RS3733951&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the SLC2A9 gene that influences serum uric acid (sUA) levels."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;ABCG2 RS2231142&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the ABCG2 gene associated with high uric acid levels and hyperuricaemia risk, especially under cardiovascular risk conditions such as obesity, hypertension, higher triglycerides (TG), lower HDL."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;SLC22A12 RS893006&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the SLC22A12 gene that does not show significant differences in sUA levels according to posthoc Bonferroni test."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;SUA LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Serum uric acid (sUA) levels are a physiological process influenced by genetic variants and cardiovascular risk factors such as obesity, hypertension, TG levels, LDL levels, and HDL levels."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cardiovascular risk factors such as obesity, hypertension, higher TG and LDL levels, lower HDL levels significantly influence the genetic risk of hyperuricaemia (HUA) associated with ABCG2 rs2231142 variants."&lt;SEP&gt;"Various physiological processes contribute to cardiovascular health risks, including metabolic disorders such as HUA."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;HYPERURICAEMIA RISK (HUA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hyperuricaemia (HUA) is a disease state characterized by elevated serum uric acid levels, influenced by genetic risk factors and cardiovascular conditions."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;SLC2A9 C/C CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals with the C/C genotype of SLC2A9 rs3733951 have higher serum uric acid (sUA) levels compared to T/T carriers in females and the whole population."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;T ALLELE OF ABCG2 RS2231142&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The presence of a single T allele in ABCG2 rs2231142 increases hyperuricaemia (HUA) risk, especially under cardiovascular risk conditions such as obesity and hypertension."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;SUA LEVELS INCREASE WITH RISK ALLELES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Serum uric acid levels increase linearly with the number of specific risk alleles in SLC2A9, ABCG2, and SLC22A12 genes across both males and females."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;TG LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Triglyceride (TG) levels are a cardiovascular risk factor significantly associated with increased hyperuricaemia risk and higher sUA levels in both males and females."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;URIC ACID (SUA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SUA level represents the concentration of uric acid in serum, which is a physiological process indicator associated with HUA risk among certain genotypes."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;SERUM URIC ACID (SUA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SUA level measures the concentration of uric acid in serum and serves as an indicator for HUA risk."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;RS2231142 T ALLELE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the rs2231142 T allele have a genetic predisposition to hyperuricemia and higher serum uric acid levels."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;SUA LEVEL&quot;">
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d1">"The level of serum uric acid is influenced by carrying the rs2231142 T allele, affecting the risk of hyperuricemia in carriers."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 22}]</data>
    </node>
    <node id="&quot;LRP2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LRP2 gene has been identified as a locus associated with kidney function and eGFR across different ancestry groups."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NFATC1 gene is another locus found to be associated with kidney function and eGFR in various ethnic populations, especially those of European and East Asian descent."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS57989581&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant within the LRP2 locus (rs57989581) shows genome-wide significant association with eGFR in trans-ethnic meta-analysis."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS8096658&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant at the NFATC1 locus (rs8096658) has also been reported to be significantly associated with eGFR across different ancestries."&lt;SEP&gt;"This SNP is found at the NFATC1 locus overlapping fetal kidney cell DHSs, involved in gene regulation."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;UNCX GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The UNCX gene is identified as a locus with significant association signals for both eGFR and CKD risk in diabetic individuals."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ALMS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALMS1 gene, known to be associated with Bardet-Biedl syndrome, also shows evidence of association with kidney function and CKD development."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;PDILT-UMOD LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A locus including PDILT and UMOD genes is associated with eGFR and has been identified as a strong signal in CKD risk assessment."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS62435145&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant (rs62435145) at the UNCX gene locus shows significant association with reduced eGFR and increased CKD risk."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS7587577&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An allele variant within ALMS1 is associated with a decrease in kidney function (eGFR) and an increase in the incidence of chronic kidney disease."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;CKD DEVELOPMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which chronic kidney disease develops includes reduced eGFR levels, often influenced by genetic factors such as SNPs at specific loci."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;T2D AND T1D DIABETES TYPES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 diabetes (T2D) and Type 1 diabetes (T1D) are both associated with kidney dysfunction and reduced eGFR levels, especially when influenced by genetic variants at loci like PDILT-UMOD."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS77924615&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant (rs77924615) within the PDILT gene is a strong indicator of reduced eGFR and increased risk for chronic kidney disease in both general populations and diabetics."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;PRKAG2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PRKAG2 gene locus shows evidence of association with eGFR levels, particularly in individuals diagnosed with diabetes."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;MANTRA ALGORITHM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An algorithm used for fine-mapping genetic loci involved in influencing kidney function and disease states by identifying credible sets of variants."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NFATC1 is a gene that plays a central role in inducible gene transcription during immune response and is targeted by cyclosporine A."&lt;SEP&gt;"NFATC1 is involved in kidney function and its expression is altered during disease states such as high-salt exposure and chronic kidney disease (CKD)."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SLC34A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC34A1 is involved in calcium absorption and transport, with genetic variants associated with eGFR impact."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;DCDC5-MPPED2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"DCDC5-MPPED2 refers to a genomic region with variants associated with kidney function but specific mechanisms unclear."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;PIP5K1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PIP5K1B is a gene located at one of the five loci with genetic variations influencing eGFR, though its exact role in kidney function is less defined."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;P.PRO446LEU (RS1260326)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This missense variant in GCKR gene leads to increased synthesis and export of triglycerides and cholesterol, impacting plasma glucose concentration."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;KIDNEY DHSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Dynamic regions in kidney cells where DNA is exposed and accessible for regulatory proteins, influencing gene expression."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;HDAC8 BINDING SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Binding sites on the genome for HDAC8 transcription factor, involved in modifying chromatin structure."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;KIDNEY FUNCTION REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulation of kidney function through genetic and epigenetic mechanisms."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;HISTONE DEACETYLASES (HDACS)&quot;">
      <data key="d0">"PROTEIN FAMILY"</data>
      <data key="d1">"Enzymes involved in modification of chromatin structure, playing a role in kidney development and functioning."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;TRANSPLANT IMMUNOSUPPRESSION DRUG CYCLOSPORINE A&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used to suppress immune response after organ transplantation, targeting NFATC1 gene downstream."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;REGULATOR OF G PROTEIN SIGNALING FAMILY (RGS)&quot;">
      <data key="d0">"PROTEIN FAMILY"</data>
      <data key="d1">"Family of proteins involved in modulating the activity and signaling of heterotrimeric G-proteins, including RGS14."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCO LOSS-OF-FUNCTION VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in Drosophila orthologs of mammalian RGS14 gene that influence salt sensitivity and stress resistance."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;SALT SENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological response to changes in dietary sodium chloride, influencing lifespan and survival rates under stress conditions."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;OSMOTIC REGULATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Regulation of the internal osmotic balance within organisms or cells, potentially influenced by genes like NFATC1."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;INCREASED SALT SENSITIVITY&quot;">
      <data key="d0">"DISEASE SYMPTOM"</data>
      <data key="d1">"A condition where an organism's response to dietary salt leads to increased sensitivity and potential health issues."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RS35716097&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant in SLC34A1 gene located within DHSs in RPTECs and HRCEs cells along with HDAC8 binding site."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RGS14 (MIM: 602513)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Regulator of G protein signaling family member with an unknown function in kidneys but expressed as eQTL at SLC34A1 locus."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells from kidney tissues where DHSs play a role in gene regulation of genetic variants impacting eGFR."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RENAL CORTICAL EPITHELIAL CELLS (HRCES)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Kidney cells associated with significant effects on posterior probability for kidney-specific DHSs."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;FETAL KIDNEY CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells from developing kidneys showing significant association with genetic variants impacting eGFR."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCOD06164&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The loco gene has a role in resistance to salt stress as observed in heterozygous mutants."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;RGS14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RGS14 is a gene involved in kidney function whose mRNA expression is significantly decreased under conditions of high salt diet and CKD."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HIGH-SALT DIET&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A high-salt diet can alter the expression levels of genes such as NFATC1 and RGS14 in renal tissue, contributing to kidney dysfunction."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;GLOMERULOSCLEROSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Glomerulosclerosis is a disease condition that affects kidney function and may involve altered gene expression patterns such as those seen with NFATC1 and RGS14."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CHRONIC KIDNEY DISEASE (CKD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CKD, induced by sub-total nephrectomy, alters the renal mRNA expression of genes like NFATC1 and RGS14, potentially contributing to kidney dysfunction."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SUB-TOTAL NEPHRECTOMY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process that induces chronic kidney disease (CKD) by reducing kidney mass and altering gene expression patterns such as those of NFATC1 and RGS14 in renal tissue."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;LOCOEY-P283/+&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant of the loco gene, contributing to salt-resistance phenotype when compared with isogenic controls."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;Y1W1&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"An isogenic background used for control in experiments studying the effect of NaCl supplementation on survival rates of mutants."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NACL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Sodium chloride (NaCl) supplements are introduced into the diet to study salt tolerance and resistance mechanisms in loco mutants."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;129S6 MOUSE STRAIN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A mouse strain known to be salt-sensitive, used for investigating the role of NFATC1 and RGS14 in kidney function under stress conditions."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;DISEASE RISK CKD&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"The missense variant of GCKR impacts triglyceride and cholesterol synthesis, linking to risk factors for chronic kidney disease."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GCKR P.PRO446LEU (RS1260326)&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"The missense variant of GCKR impacts triglyceride and cholesterol synthesis, linking to risk factors for chronic kidney disease."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE REGULATION KIDNEY FUNCTION&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Dynamic regions in kidney cells where DNA is exposed can influence gene regulation relevant to kidney function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATOR OF G PROTEIN SIGNALING FAMILY (RGS14)&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Reduced expression or loss-of-function variants in RGS14 orthologs in Drosophila are associated with improved salt sensitivity and stress resistance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NFATC1 LOSS-OF-FUNCTION VARIANTS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Loss of NFATC1 function results in increased salt sensitivity in Drosophila, suggesting its role in ionic or osmotic regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NFATC1 LOCUS DHSS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"This variant overlaps dynamic regions in fetal kidney cells of NFATC1 locus, influencing gene expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS8096658 (ΠC = 0.877)&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"This variant overlaps dynamic regions in fetal kidney cells of NFATC1 locus, influencing gene expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATOR OF G PROTEIN SIGNALING&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Encodes a member of RGS family modulating downstream effects of Gα subunits with unknown function in kidneys."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DYNAMIC REGIONS KIDNEY GENES&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"Cells involved in gene regulation through DHSs, impacting kidney-specific genetic variants and their effects on eGFR."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DHS ANNOTATIONS&quot;">
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d1">"These cells show significant posterior probability for DHS annotations linked to kidney-specific variants affecting gene regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NACL SUPPLEMENTATION&quot;">
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d1">"Genomic variant of the loco gene shows improved survival rate when supplemented with sodium chloride compared to controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAMPYLOBACTER INFECTION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Campylobacter infection is a bacterial disease caused by Campylobacter bacteria, often resulting in diarrhea."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT CAMPYLOBACTER ISOLATES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Quinolone-resistant isolates of Campylobacter are strains that have developed resistance to quinolone antibiotics."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;ERYTHROMYCIN-RESISTANT ISOLATES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Erythromycin-resistant isolates are Campylobacter strains that exhibit resistance to the antibiotic erythromycin."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;C. COLI&quot;">
      <data key="d0">"GENE/PROTEIN"</data>
      <data key="d1">"C. coli, another species within the Campylobacter genus, also causes infections related to campylobacteriosis."&lt;SEP&gt;"Campylobacter coli is a species of bacteria causing gastrointestinal infections, some of which have developed resistance to antibiotics like quinolone and erythromycin."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;C. JEJUNI&quot;">
      <data key="d0">"GENE/PROTEIN"</data>
      <data key="d1">"Campylobacter jejuni is another species of bacteria responsible for many cases of gastroenteritis, with strains showing varying levels of antibiotic resistance."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE RESISTANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"Quinolone resistance refers to the ability of Campylobacter strains to survive in the presence of quinolone antibiotics due to genetic changes."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;ERYTHROMYCIN RESISTANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"A genomic variant indicating resistance to erythromycin, an antibiotic used for treating bacterial infections including those caused by Campylobacter species."&lt;SEP&gt;"Erythromycin resistance is a similar process but specific to erythromycin, another antibiotic used against bacterial infections."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;TRAVEL TO SPAIN AND PORTUGAL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Traveling to Spain or Portugal represents an environmental exposure linked to the acquisition of quinolone-resistant Campylobacter strains."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;FOREIGN TRAVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR/ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Foreign travel is a lifestyle factor that increases the risk of acquiring antibiotic-resistant bacteria such as those resistant to quinolones and erythromycin."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;SOUTHERN EUROPE AND SOUTHEAST ASIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Traveling to Southern Europe or Southeast Asia can increase the likelihood of exposure to quinolone-resistant Campylobacter strains."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;DIARRHEA, BLOOD IN STOOL, ABDOMINAL PAIN, FEVER, VOMITING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY/DISEASE SYMPTOMS"</data>
      <data key="d1">"These are symptoms commonly associated with Campylobacter infections and can vary in severity depending on the strain's antibiotic resistance status."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;FLUOROQUINOLONES&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A class of antibiotics used to treat bacterial infections, including those caused by Campylobacter species."&lt;SEP&gt;"Fluoroquinolones are a class of antibiotics used to treat bacterial infections, including those caused by Campylobacter."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE SUSCEPTIBILITY CATEGORY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The susceptibility of Campylobacter strains to quinolones can change due to genetic mutations, affecting treatment outcomes."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;MIC OF QUINOLONE = 2 MG/L&quot;">
      <data key="d0">"MOLECULAR INTERACTION/MEASUREMENT"</data>
      <data key="d1">"This measurement indicates the sensitivity of a bacterial strain to quinolone antibiotics (Minimum Inhibitory Concentration)."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;THREE SILENT MUTATIONS IN GYRA&quot;">
      <data key="d0">"GENOMIC VARIANT/MOLECULAR INTERACTION"</data>
      <data key="d1">"Silent mutations in the gyrA gene do not change the amino acid sequence but may indicate genetic instability or resistance development."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;NORMAL CONSENSUS SEQUENCE IN THE FORMER STRAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION/MEASUREMENT"</data>
      <data key="d1">"The presence of a normal consensus sequence indicates that the bacterial strain has no mutations conferring antibiotic resistance."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;THRE SILENT MUTATIONS IN GYRA IN THE LATTER STRAIN&quot;">
      <data key="d0">"GENOMIC VARIANT/MOLECULAR INTERACTION"</data>
      <data key="d1">"Silent mutations in gyrA gene can suggest genetic changes related to quinolone resistance, even without altering the amino acid sequence."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;CAMPYLOBACTER JEJUNI&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Campylobacter jejuni is a bacterial genus that can cause campylobacteriosis."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT C. JEJUNI ISOLATES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Quinolone resistance in C. jejuni isolates is a genomic variant that impacts treatment options and infection patterns."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;MACROLIDES&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Another class of antibiotics that can be used in the treatment of campylobacteriosis."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;NALIDIXIC ACID RESISTANCE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Indicates resistance to nalidixic acid, a drug commonly used in laboratory settings to assess quinolone susceptibility of bacteria like Campylobacter."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;FRESH POULTRY INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The dietary pattern involving the consumption of fresh poultry other than chicken and turkey was identified as potentially contributing to infection risk."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;DOMESTICALLY ACQUIRED INFECTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Infections that occur within a country rather than from imported sources, often linked with local food consumption patterns."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CAMPYLOBACTERIOSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An infection caused by the bacteria Campylobacter species, typically characterized by gastrointestinal symptoms."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;RETAIL FOOD PRODUCTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Food products sold in retail stores that may serve as a source of Campylobacter infections."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;BROILER CHICKENS FECAL SAMPLES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Samples from the feces of broiler chickens, which can be used to track and study the spread of Campylobacter species."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the gene in C. jejuni showing quinolone resistance is influenced by environmental factors like diet and location."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;PROTEIN&quot;">
      <data key="d0">"PROTEIN RESIDUES (E.G., PRO21-VAL22 IN WRNIP1, PRO398-LYS399 IN NEMO-UBZ, GLU636-LYS637 IN POLΗ)"</data>
      <data key="d1">"Proteins produced from genes associated with antibiotic resistance play a role in bacterial survival and transmission."&lt;SEP&gt;"Specific residues such as Pro21-Val22, Pro398-Lys399, and Glu636-Lys637 play crucial roles in protein-protein interactions involving Ub binding."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;NUTRIENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary nutrients may influence the expression of genomic variants leading to antibiotic resistance in Campylobacter species."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process involved in acquiring quinolone-resistant C. jejuni infections through dietary intake of poultry is under investigation."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The molecular interaction between Campylobacter bacteria and the human host can be influenced by dietary factors."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Environmental factors such as food handling practices and antibiotic use in animal farming contribute to the spread of resistant strains."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Campylobacteriosis is a disease caused by Campylobacter bacteria, often linked with quinolone resistance."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;C. COLI/E. JEJUNI&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Some strains of Campylobacter coli exhibit erythromycin resistance, highlighting the complexity and variability in antibiotic resistance among different species."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ERYTHROMYCIN-CRESTANT CAMPYLOBACTER ISOLATES&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Traveling to Spain or Portugal is associated with a higher risk of acquiring erythromycin-resistant Campylobacter coli strains."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Consuming fresh poultry other than chicken and turkey is associated with an increased risk of acquiring quinolone-resistant C. jejuni infections."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9534511&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs9534511) located on the HTR2A gene is significantly associated with social disinhibition risk."&lt;SEP&gt;"A minor allele for rs9534511 is associated with an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;HTR2A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HTR2A gene, harboring the SNP rs9534511, plays a role in serotonin pathway which influences social behavior and cognitive processes."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS4938056&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A minor allele for rs4938056 is associated with an increased risk of social disinhibition."&lt;SEP&gt;"Another genomic variant (rs4938056) on HTR3B is linked to an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;HTR3B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HTR3B gene, which contains the SNP rs4938056, contributes to serotonin pathway regulation affecting behavior and cognitive functions."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1998220&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs1998220) found in an intronic region of OPRM1 is associated with social disinhibition risk."&lt;SEP&gt;"A minor allele for rs1998220 is associated with an increased risk of social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;OPRM1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The opioid receptor gene OPRM1, with rs1998220 located within it, impacts pathways involved in reward and addiction behaviors."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1003921&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP (rs1003921) residing in an intronic region of KCNC1 is significantly associated with increased social disinhibition risk."&lt;SEP&gt;"A minor allele for rs1003921 is associated with a protective effect against increased social disinhibition score."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;KCNC1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The KCNC1 gene, harboring the SNP rs1003921, contributes to potassium channel function and neural excitability."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16116&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs16116) located in an intergenic region downstream of NPY is linked to social disinhibition risk."&lt;SEP&gt;"A minor allele for rs16116 is associated with a protective effect against increased social disinhibition score."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;NPY GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NPY gene, with rs16116 downstream, influences neuropeptide Y levels affecting various physiological processes such as stress and appetite regulation."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16870286&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP (rs16870286) part of LINC00518 is significantly associated with social disinhibition risk, where LINC00518 codes for an uncharacterized protein."&lt;SEP&gt;"A minor allele for rs16870286 is associated with a protective effect against increased social disinhibition score."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;LINC00518 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The miscellaneous RNA gene LINC00518, containing rs16870286 and coding for an uncharacterized protein, impacts physiological processes not fully elucidated."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SEROTONIN PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The serotonin pathway involves the synthesis, uptake, metabolism, and receptor signaling of serotonin molecules that influence mood, behavior, and cognitive functions."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Social disinhibition refers to a reduced inhibitory control over social behavior, often observed in conditions or contexts affecting neurological regulation."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;LINGUISTIC ACCULTURATION SCORE (TAS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A linguistic acculturation score measures the degree to which individuals adopt cultural norms of a new culture, impacting behavior and health outcomes such as social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;DEPRESSION ANXIETY STRESS SCALES (DAS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The DAS scale assesses stress levels in individuals and is associated with psychological conditions that may influence behaviors including social disinhibition."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;REWARD AND ADDICTION BEHAVIORS&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"The OPRM1 gene, with SNP rs1998220 located within it, impacts pathways involved in reward and addiction behaviors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEURAL EXCITABILITY&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"The KCNC1 gene, harboring SNP rs1003921, contributes to potassium channel function and neural excitability."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS AND APPETITE REGULATION&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"The NPY gene, with SNP rs16116 downstream, influences neuropeptide Y levels affecting physiological processes such as stress and appetite regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UNCHARACTERIZED PROTEIN FUNCTION&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"The LINC00518 gene, containing SNP rs16870286 and coding for an uncharacterized protein, impacts physiological processes not fully elucidated."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARENTAL EDUCATION&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CNR1 gene encodes for cannabinoid receptor type 1, which is involved in modulating neurocircuitry and has been linked to alcohol-related behaviors."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;RS2023239 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant (rs2023239) located upstream of exon 3 of the CNR1 gene, which is associated with CB1 receptor binding levels and differential activation in brain regions involved in alcohol craving."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CB1 RECEPTOR PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The CB1 receptor protein, encoded by the CNR1 gene, plays a critical role in modulating mesocorticolimbic neurocircuitry associated with drug-seeking behavior and is influenced by genetic variations such as rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL CUE EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to alcohol cues elicits craving behaviors, and differential activation in brain regions between genotypes suggests a role for genetic factors like rs2023239 in modulating these responses."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;NACC (NUCLEUS ACCUMBENS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The NAcc is part of the mesocorticolimbic pathway and shows differential activation in response to alcohol cues, particularly among individuals with a specific genetic variant (rs2023239)."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;VMPFC (VENTROMEDIAL PREFRONTAL CORTEX)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The VMPFC exhibits differential activity related to the rs2023239 genotype when alcohol cues are presented, and this is linked to subjective craving measures."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;VTA (VENTRAL TEGMENTAL AREA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The VTA shows altered activation in response to alcohol cues among individuals with the CT genotype of rs2023239 compared to those with the TT genotype, influencing reward processing."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;OFC (ORBITAL PREFRONTAL CORTEX)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The OFC shows differential activation in response to alcohol cues among individuals based on their rs2023239 genotype, correlating with subjective craving measures."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUDIT SCORE&quot;">
      <data key="d0">"DISEASE/MEASUREMENT TOOL"</data>
      <data key="d1">"An AUDIT score is used as a measure of alcohol use disorder and correlates with brain activity in the NAcc and VMPFC among individuals with certain genotypes."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUQ (ALCOHOL URGE QUESTIONNAIRE)&quot;">
      <data key="d0">"DISEASE/MEASUREMENT TOOL"</data>
      <data key="d1">"The AUQ measures the urge to consume alcohol, which is significantly correlated with activation in specific brain regions like OFC for individuals carrying a particular genetic variant."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CNR1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of CNR1 is studied for its association with a specific genomic variant (rs2023239) in regulatory regions upstream of exon 3."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;MESOCORTICOLIMBIC NEUROCIRCUITRY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"This neurocircuitry, involving areas like NAcc and VTA, is modulated by CB1 receptors and plays a role in drug-seeking behavior influenced by genetic variations such as rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;POSTMORTEM HUMAN PREFRONTAL CORTEX (PFC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION"</data>
      <data key="d1">"The PFC tissue is used to quantify CB1 binding levels and study the effects of genomic variant rs2023239 on receptor protein expression."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;LITCHI JUICE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Used as an appetitive control in experiments, contrasting with alcohol to observe differential brain activation patterns influenced by genetic factors such as rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;REWARD AND POSITIVE AFFECT SCALES (POMS)&quot;">
      <data key="d0">"DISEASE/MEASUREMENT TOOL"</data>
      <data key="d1">"These scales are used to measure subjective reward experiences after alcohol consumption, showing significant differences based on genotype (rs2023239)."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;OLANZAPINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Olanzapine is a medication that targets the dopamine system and is used in clinical trials for treatment-seeking alcohol-dependent individuals."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CNR1 VARIATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CNR1 variation refers to genetic differences within the CNR1 gene, which may interact with olanzapine to influence craving and alcohol consumption behaviors."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Cyproheptadine hydrochloride is used as a control medication in studies comparing its effects to olanzapine on rewarding effects of alcohol consumption."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;REWARD AND POSITIVE AFFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which individuals experience increased reward and positive affect after consuming alcoholic beverages, influenced by genotype and medications."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CUE-ELICITED CRAVING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which cues related to alcohol elicit craving in individuals, particularly those with certain genotypes under different medication conditions."&lt;SEP&gt;"This is the process where cues related to alcohol elicit craving in treatment-seeking individuals under different medication conditions."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The measure of how many drinks an individual consumes per day they drink, which can be influenced by genotype and medication interactions."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;RS2023239&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2023239 is a specific genetic marker or variant associated with variations influencing alcohol consumption behaviors."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;LPL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LPL gene encodes lipoprotein lipase (LPL), an enzyme crucial for the breakdown of triglyceride-rich lipoproteins."&lt;SEP&gt;"The LPL gene encodes lipoprotein lipase, a protein essential for lipid metabolism through the hydrolysis of chylomicrons."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;CHYLOMICRON HYDROLYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Chylomicron hydrolysis is a physiological process in which lipoprotein lipase breaks down chylomicrons to release fatty acids and monoglycerides for use by tissues."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL DEFICIENCY DISORDER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"LPL deficiency disorder is an autosomal recessive condition characterized by decreased LPL activity, leading to severe hypertriglyceridemia in homozygous individuals or compound heterozygotes and normal lipids in simple heterozygote carriers."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ERUPTIVE XANTHOMAS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Eruptive xanthomas are a clinical feature of LPL deficiency disorder, representing skin lesions due to the deposition of cholesterol esters in the epidermis."&lt;SEP&gt;"Eruptive xanthomas are skin lesions that appear when TG levels exceed 2000 mg/dl due to accumulation of lipid-laden macrophages in the dermis."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ABDOMINAL PAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abdominal pain is one of the symptoms associated with LPL deficiency disorder, often resulting from high triglyceride levels causing pancreatitis or gallstones."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HEPATOSPLENOMEGALY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Enlargement of liver and spleen (hepatosplenomegaly) can occur in patients with LPL deficiency due to accumulation of lipids within these organs."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;RECURRENT PANCREATITIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Recurrent pancreatitis is a severe complication that may occur in individuals with LPL deficiency due to high triglyceride levels causing inflammation and damage to the pancreas."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPEMIA RETINALIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition where lipids accumulate in retinal vessels, visible as a diffuse milky appearance when TG levels exceed 2500 mg/dl."&lt;SEP&gt;"Lipemia retinalis, characterized by milky white appearance of the retina caused by lipid droplets in blood vessels, is a clinical sign seen in patients with severe hypertriglyceridemia."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIETARY FAT RESTRICTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A therapeutic approach to manage hypertriglyceridemia by limiting dietary intake of fats, particularly saturated and trans-fats."&lt;SEP&gt;"Restricting dietary fat intake is recommended for managing LPL deficiency to reduce plasma triglyceride levels and alleviate symptoms such as pancreatitis or xanthomas."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GENE THERAPY TRIALS&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Ongoing gene therapy trials aim to treat patients with LPL deficiency by introducing a functional copy of the LPL gene into affected individuals' cells."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MEDIUM-CHAIN TRIGLYCERIDES (MCT)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Medium-chain triglycerides are fats with shorter chain lengths that can be metabolized more easily than long-chain fatty acids, and thus may be used in dietary management of LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GPIHBP1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"GPIHBP1 binds to lipoprotein lipase, facilitating its transport to the capillary lumen for lipid metabolism."&lt;SEP&gt;"GPIHBP1 is a protein responsible for transporting lipoprotein lipase to the capillary lumen where it can hydrolyze chylomicrons, essential for proper lipid metabolism."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPID METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A metabolic pathway involving the breakdown, synthesis, and transport of lipids within cells, regulated by various genes including RP genes."&lt;SEP&gt;"The metabolic pathway of lipid metabolism involves processes such as synthesis and breakdown of fatty acids and triglycerides in the body's tissues."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CHROMOSOME 8P21.3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant refers to the location on chromosome 8 where the LPL gene is situated, spanning approximately 30 kb with ten exons."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Lipoprotein lipase hydrolyzes triglycerides in chylomicrons and very-low-density lipoproteins to release fatty acids for tissue uptake."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MUTATION P.G215E&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous mutation in exon 5 of the LPL gene (c.644G→A), resulting in a substitution of glycine to glutamic acid at amino acid position 215, causing LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MUTATION P.Q240H&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A novel heterozygous mutation in exon 5 of the LPL gene (c.721G→T), resulting in a substitution of glutamine to histidine at amino acid position 240, causing LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;P.Q240H MUTATION IN EXON 5 OF THE LPL GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutation is a novel variant causing severe hypertriglyceridemia due to its impact on the function or expression of LPL gene products."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPOPROTEIN LIPASE (LPL) PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by the LPL gene, lipoprotein lipase, is essential for breaking down triglyceride-rich lipoproteins to release free fatty acids and glycerol."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by high levels of triglycerides in the blood, often associated with genetic factors such as mutations in LPL gene."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PANCREATITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammation of the pancreas associated with elevated triglyceride levels due to hyperviscosity and lipid deposits in pancreatic tissue."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;MCT (MEDIUM-CHAIN TRIGLYCERIDES)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A dietary supplement used for fat restriction therapy in patients with LPL deficiency, absorbed directly into the portal vein without requiring lipoprotein lipase action."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ORLISTAT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An oral medication that inhibits pancreatic and gastrointestinal lipases to reduce fat absorption, thereby lowering blood triglyceride levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GEMFIBROZIL&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A fibrate drug used for reducing triglycerides and increasing HDL cholesterol in patients with hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An enzyme involved in the final step of triglyceride synthesis, being a potential target for therapeutic intervention in managing high TG levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;TRIGLYCERIDE-RICH LIPOPROTEINS (TRL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Lipoprotein particles rich in triglycerides, which are transported by lipoprotein lipase to release free fatty acids and glycerol for cellular uptake."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LINEAR GROWTH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Normal growth patterns observed in children with LPL deficiency when dietary fat restriction is adhered to."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PUBERTY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of physical changes leading to sexual maturity, typically occurring normally despite dietary restrictions in individuals with LPL deficiency."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;FAT ABSORPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Process by which fats are taken up and metabolized by the body, often targeted for intervention in therapies addressing hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;TOPIRAMATE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Topiramate is a drug used in clinical trials to treat conditions such as alcohol use disorder."&lt;SEP&gt;"Topiramate is a drug used to treat conditions such as alcohol use disorder and epilepsy."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407 GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs2832407 is a gene variant that moderates the effect of topiramate in European-American patients."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;NO HEAVY DRINKING DAYS (HDDS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No HDDs refers to a period where no heavy drinking occurred, indicating efficacy of treatment in reducing alcohol consumption."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ADVERSE EVENTS (AE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adverse events are unwanted effects or negative health outcomes that occur as a result of drug therapy."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;NO HDDS (EFFICACY)&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"Topiramate treatment is effective in reducing heavy drinking days, indicating its efficacy for treating alcohol use disorder."&lt;SEP&gt;"Topiramate treatment leads to a reduction in heavy drinking days, indicating efficacy."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP2D6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP2D6 is a gene associated with the metabolism of certain drugs, including anti-emetics."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ABCB1 ALLELE RS1045642&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant at position rs1045642 in the ABCB1 gene influences drug transport and can alter patient response to medications."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PATIENT-REPORTED ACUTE NAUSEA SEVERITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Acute nausea severity as reported by patients is a physiological process influenced by various factors including genetic variants."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CTCAE GRADE OF ACUTE NAUSEA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CTCAE grade of acute nausea reflects the severity and impact of nausea on patient quality of life during chemotherapy treatment."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PATIENT-REPORTED DELAYED NAUSEA SEVERITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Delayed nausea severity as reported by patients is a physiological process influenced by factors such as type of chemotherapy administered."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CTCAE GRADE OF DELAYED NAUSEA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CTCAE grade of delayed nausea measures the severity and impact of nausea after initial treatment phase in cancer patients undergoing chemotherapy."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ADVANCED STAGE CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Advanced stage cancer indicates later stages of disease progression, characterized by a higher tumor burden and metastasis potential."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A chemotherapy regimen that has a high likelihood of causing nausea and vomiting as side effects."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HTR3B (RS45460698)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant at position rs45460698 in the HTR3B gene is studied for its influence on patient response to certain drugs or therapies."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ABCB1 GENOTYPE &quot;">
      <data key="d0">"GENETIC CHARACTERIZATION"</data>
      <data key="d1">"An individual's ABCB1 genotype, influenced by variations such as rs1045642, affects drug transport and efficacy."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HTR3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HTR3B is a gene involved in serotonin receptor function, which can influence patient response to certain drugs or therapies."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ABC1 GENOTYPE (RS1045642)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant at position rs1045642 in the ABCB1 gene influences drug transport and can alter patient response to medications, particularly anti-emetics."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PALONOSETRON&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An antiemetic medication commonly prescribed for preventing nausea during chemotherapy treatment."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DEXAMETHASONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A steroid used as an anti-inflammatory and anti-emetic agent in chemotherapy regimens."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;PROCHLORPERAZINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Another drug used to treat nausea and vomiting, often prescribed alongside other antiemetics."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ONDANSETRON&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An antiemetic medication commonly used for preventing nausea in chemotherapy patients."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;FOSAPREPITANT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used to prevent acute and delayed nausea and vomiting associated with cancer treatments."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN &quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Patients receiving highly emetogenic chemotherapy regimens are more likely to report higher CTCAE grades for delayed nausea compared to less aggressive treatment plans."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DELAYED CINV&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Patients receiving highly emetogenic chemotherapy are more likely to experience delayed nausea and vomiting, highlighting the relationship between treatment type and patient outcomes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE GENE (LCT)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The lactase gene (LCT) is involved in the production of lactase enzyme responsible for digesting lactose in dairy products. The regulation and expression of this gene can vary between individuals, influencing lactose tolerance."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;GENOMIC VARIANT C/T-13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant (C/T-13910) located within the MCM6 intron 13-exon 13 region has been linked to lactase persistence and non-persistence in humans."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LCT MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Levels of LCT mRNA were effectively regulated by LOC100507600 lncRNA in cells relevant to lactase persistence."&lt;SEP&gt;"The LCT gene transcript whose expression changes significantly with age depending on the genetic variants (CC vs. TT) at position -13910, influencing lactose digestion ability in humans."&lt;SEP&gt;"The LCT mRNA represents the transcript of the lactase gene which is expressed in intestinal epithelial cells. Its levels can vary significantly between individuals, influencing lactose digestion capabilities."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"Epigenetic modifications, such as DNA methylation and histone modification, influence the expression of the LCT gene by altering its regulatory regions and affecting transcriptional processes."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;DIETARY PATTERN (LACTOSE INTAKE)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The dietary pattern involving lactose intake influences the regulation and expression levels of the lactase gene in individuals, impacting their ability to digest dairy products effectively."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS: TRANSCRIPTIONAL REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Transcriptional regulation is a physiological process that controls the production of LCT mRNA by modulating epigenetic factors and other regulatory elements within the gene's promoter regions."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY: LACTOSE METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Lactose metabolism is a metabolic pathway involving enzymes produced from genes like LCT. The efficiency of this pathway can be influenced by genetic variations and dietary patterns affecting lactase production."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR (AGE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The environmental factor, age, influences the expression levels of the LCT gene in humans and mice, with a decrease in lactase activity observed post-infancy."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Lactase non-persistence is a condition where individuals lose their ability to digest milk efficiently after infancy due to reduced expression of the LCT gene."&lt;SEP&gt;"The condition in which lactase enzyme activity declines after weaning, usually linked to specific genetic variants (e.g., C allele)."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LCT MRNA LEVELS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The levels of LCT mRNA represent the expression level of the lactase gene transcript in enterocytes. Variations in these levels correlate with differences in lactose digestion capabilities."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;DNA MODIFICATION DENSITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"DNA modification density refers to the degree of DNA methylation within specific regions affecting transcriptional regulation and gene expression, particularly LCT mRNA levels."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MCM6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MCM6 gene is closely associated with the lactase gene (LCT) and harbors a key SNP at C/T-13910 that influences lactose persistence."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;BISULFITE PADLOCK PROBE SEQUENCING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A molecular interaction technique used for high-resolution mapping of DNA methylation patterns within specific genomic regions, aiding in the study of epigenetic regulation."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LCT MRNA LEVELS IN MICE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The levels of Lct mRNA in mice represent expression from the mouse lactase gene (Lct), which decreases with age post-infancy, similar to humans."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LCT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LCT is a gene involved in the cell-type specific expression of lactase."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;MCM6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MCM6 is a gene located near LCT and exhibits regulatory functions with respect to DNA modifications and chromatin structure."&lt;SEP&gt;"MCM6 is a gene that plays a role in the regulation of DNA modifications and protein interactions involved in lactase activity."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;CPG SITES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Significant differences in DNA modification were observed at 35 CpG sites, indicating specific genomic regions involved in cell-type-specific expression of LCT."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNA MODIFICATION PROFILES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of measuring and comparing the methylation status across different tissues (e.g., enterocytes vs. jejunum) to understand gene regulation."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;ENTEROCYTE-DEFICIENT JEJUNUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Jejunum lacking functional enterocytes serves as a control in studies examining cell-type-specific DNA modifications and gene expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;WHITE BLOOD CELLS&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"Used to assess whether the observed DNA modifications are unique to intestinal tissues or present across different tissue types."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNASE I HYPERSENSITIVITY SITES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sites within the genome that are more accessible to DNase I due to open chromatin structure, indicating potential regulatory elements."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;H3K4ME1 AND H3K27AC&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Histone modifications indicative of active enhancers, found in specific regions of LCT and MCM6 genes."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENCE AND PERSISTENCE&quot;">
      <data key="d0">"DISEASE STATE"</data>
      <data key="d1">"Conditions characterized by the decline or maintenance of lactose digestion capability into adulthood."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;MCM6 SNPS (RS4988235, RS182549)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms in MCM6 that correlate with LCT mRNA levels and are linked to lactase persistence or non-persistence."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;INSERTION-DELETION IN THE 3′ REGION OF LCT INTRON 1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variation in the intron 1 region of the LCT gene, contributing to differential DNA modification and mRNA levels."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;INTRON 5 OF LCT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant within intron 5 of the LCT gene showing significant DNA modification differences."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;INTRON 3 OF LCT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region identified with differential DNA modifications compared to other tissues."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;INTRON 2 OF LCT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another region within intron 2 showing significant differences in DNA modification profiles."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;EXON 1 OF LCT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The exon 1 of the LCT gene also showed differential DNA modifications compared to other tissues."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;INTRON 13 OF MCM6&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region within intron 13 showing significant changes in DNA modification profiles."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;EXON 17 OF MCM6&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An exon within the MCM6 gene overlapping with a long non-coding RNA (lncRNA) LOC100507600."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;EXON 16 OF MCM6&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic region that overlaps with the lncRNA and showed differential DNA modifications."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulation of lactase persistence involves genetic and epigenetic factors affecting the expression of LCT mRNA in cells such as Caco-2."&lt;SEP&gt;"The state where lactase enzyme activity remains high into adulthood, typically associated with certain genotypes (e.g., T allele)."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;AGE-DEPENDENT REGULATION OF LCT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Refers to the regulation of LCT gene expression that changes with age, often influenced by epigenetic modifications."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LCT GENE (LACTASE GENE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LCT gene encodes for lactase, an enzyme crucial for digesting lactose. The regulation of this gene is associated with age-dependent changes in DNA modification leading to lactase non-persistence or persistence."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;C-13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant located at position -13910, which influences the expression and activity of genes such as MCM6 and LCT through epigenetic mechanisms."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;T-13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another specific genomic variant located at position -13910, which is associated with lactase persistence in individuals due to its influence on DNA modifications over age."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;DNA MODIFICATION CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Process through which DNA modifications accumulate or decrease over time and contribute to the downregulation of LCT gene expression in individuals with specific genetic variants."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTOSE INTOLERANCE&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"A condition characterized by the inability to digest lactose due to insufficient production of lactase enzyme, often influenced by genetic factors such as variants at position -13910 in the LCT gene."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;METHYLATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process involving the addition of a methyl group to DNA or proteins that can lead to changes in gene expression and contribute to lactase persistence or non-persistence."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;HISTONE MODIFICATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in histones that affect chromatin structure and gene expression, playing a role in regulating lactase activity through interaction with MCM6 and LCT genes."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;DIETARY LACTOSE CONSUMPTION&quot;">
      <data key="d0">"EXTERNAL FACTOR"</data>
      <data key="d1">"The amount and frequency of dietary lactose intake, which can influence genetic expression related to lactose digestion efficiency."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;ENTEROCYTES&quot;">
      <data key="d0">"TISSUE TYPE"</data>
      <data key="d1">"Cells in the intestinal lining responsible for absorbing nutrients and digesting lactose, where genetic and epigenetic factors interact to regulate lactase production."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;CACO-2 CELL LINE&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Human intestinal epithelial cell line Caco-2, which has the TT genotype at SNP -13910."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LOC100507600 LNCRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The mRNA of LOC100507600 was transfected with small-interfering RNAs, resulting in a 20% reduction and concomitant 25% reduction in LCT mRNA."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;MCM6 MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The mRNA of MCM6 remained unchanged after silencing of LOC100507600 (Fig. 5b)."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CTCF BINDING SITE&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"A CTCF binding site overlapping the lncRNA promoter is nearly ubiquitous across human tissues."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT INTRONIC REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Intronic regions in Lct or Mcm6 were deleted using CRISPR-Cas9 technology to determine their impact on steady-state Lct mRNA levels."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;MCM6 INTRONIC REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A region in Mcm6 intron 13 was targeted, which is important for human LCT regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT PROMOTER ELEMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Deletion of the Lct promoter element resulted in a significant downregulation of Lct mRNA levels (Fig. 6b, c)."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9 GENOME EDITING TECHNOLOGY&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Used to determine whether differentially modified DNA regions contribute to Lct regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ADULT INTESTINE&quot;">
      <data key="d0">"PHYSIOLOGICAL CONDITION"</data>
      <data key="d1">"The mutation in Lct intron 2 produced a significantly greater loss in Lct mRNA in adult intestine compared to infant intestine."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;EVOLVING CONSERVED REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Lct intron 2 establishes stronger control of Lct mRNA expression in adulthood, corroborating aging mouse findings."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;SNP -13910 TT GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Caco-2 cell line has a TT genotype at SNP -13910."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;SIRNAS DIRECTED TO LOC100507600&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Small-interfering RNAs directed to LOC100507600 reduced its expression by 20% in Caco-2 cells."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ENHANCER-PROMOTER INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased DNA methylation facilitates enhancer-promoter interactions, which can affect gene regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT INTRONIC REGION 13 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A region in Mcm6 intron 13 was targeted for deletion using CRISPR-Cas9 technology to study LCT regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9 OFF-TARGET ACTIVITY SURVEY&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Surveyed and did not find any off-target activity of the CRISPR-Cas9 system in 46 candidate regions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ADULT INTESTINE VS INFANT INTESTINE REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The mutation in Lct intron 2 causes a significant difference in Lct mRNA levels between adult and infant intestines."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;EPIGENETICALLY-REGULATED REGIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Impact of epigenetically-regulated regions on human LCT expression was examined in cultured Caco-2 cells."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE AND NON-PERSISTENCE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The regulatory region within intron 5 influences the persistence or decline of lactose digestion capability into adulthood based on genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE/NON-PERSISTENCE CONDITION&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"The genomic variant C-13910 is linked to lactase non-persistence, as it correlates with increased DNA modification changes and decreased LCT mRNA expression over age."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT INTRON 2 AND 8 IN MICE&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"The lncRNA LOC100507600 is involved in the regulation of LCT mRNA, similar to regulatory elements identified at intron 2 and 8 in mice."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT–MCM6 EPIGENETIC INTERACTION&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"The epigenetic interaction between LCT and MCM6 involves age-related DNA modification changes that regulate lactase expression and persistence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;H3K27AC, H3K4ME1, H3K4ME3, POLR2A CHROMATIN MARKS&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"These chromatin marks are key histone modifications that contribute to the regulation of lactase expression and persistence by influencing transcriptional activity at specific genomic regions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENTEROCYTE SAMPLES&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"The study of enterocytes provides crucial insights into how epigenetic interactions between MCM6 and LCT genes influence lactase persistence or non-persistence conditions in humans."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HUMAN LCT REGULATION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The deletion of a region in Mcm6 intron 13 is crucial for human LCT expression regulation, as shown by CRISPR-Cas9 experiments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT INTRONIC REGION 2 &quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The intronic region influences LCT expression differently between adults and infants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE PERSISTENT ALLELE (T)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The T allele of the rs4988235 variant is linked to lactase persistence, a trait allowing continued digestion of lactose into adulthood."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT ALLELE (C)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C allele of the rs4988235 variant is associated with lactase non-persistence, indicating reduced ability to digest milk in adults."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by the consumption or avoidance of milk, influenced by genetic and environmental factors such as lactase persistence genotype."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RENAL CELL CARCINOMA (RCC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of cancer that begins in the lining of very small tubes (tubules) in the kidney. Individuals with different levels of milk consumption may have varying risks associated with RCC."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Level of education attained by individuals, which can influence dietary patterns and lifestyle choices such as milk intake."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A principle in population genetics that describes an ideal condition for gene and genotype frequencies to remain constant from one generation to the next."&lt;SEP&gt;"A principle in population genetics used to analyze genetic variation and equilibrium, relevant for understanding allele frequencies."&lt;SEP&gt;"A principle used in population genetics to test if the observed genotype frequencies fit expected values, indicating no natural selection acting on the gene in question."&lt;SEP&gt;"A principle stating the expected genotype frequencies in a large, randomly mating population remain constant from generation to generation in the absence of other evolutionary influences."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-3cf4e094a5312845a1cc4da4304d4bdf&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;DESCRIPTIVE CHARACTERISTICS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Characteristics such as age, sex, ethnicity which may influence dietary patterns and genetic studies."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;EASTERN EUROPEAN POPULATIONS&quot;">
      <data key="d0">"GEOGRAPHIC REGION"</data>
      <data key="d1">"Populations residing in Eastern Europe with specific allele frequencies reflecting intermediate frequencies for lactase persistence genotype at rs4988235."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;BCL11A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BCL11A gene harbors SNPs that are associated with baseline, MTD (maximum tolerated dose), and delta hemoglobin F levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS1427407 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a specific single nucleotide polymorphism in the BCL11A gene that increases baseline and MTD HbF levels and is associated with increased delta HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS4671393 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another SNP within the BCL11A gene, showing similar associations to rs1427407 for baseline and MTD HbF levels and delta HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS11886868 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a less significant but still associated variant within the BCL11A gene with effects on MTD and delta HbF values."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HMIP-2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HMIP-2 gene carries SNPs that are correlated with baseline hemoglobin F levels, increasing both the baseline and MTD levels of HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS9399137 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An SNP in the HMIP-2 gene showing association with higher baseline and MTD HbF levels but not delta HbF values, losing significance when corrected for baseline HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS9402686 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP within the HMIP-2 gene also increases baseline HbF levels and MTD HbF levels but shows no association with delta HbF, similar to rs9399137."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HEMOGLOBIN F (HBF)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process involving the production of fetal hemoglobin which can be influenced by genetic variants such as SNPs in BCL11A and HMIP-2 genes."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HYDROXYUREA TREATMENT (HU)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A treatment that leads to improvements in several hematological parameters and is correlated with HbF levels before and after treatment, indicating a role of HU in enhancing hemoglobin F production."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HEMOGLOBIN (HB)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Hemoglobin is a protein responsible for oxygen transport in red blood cells, closely related to the study of hemoglobin F levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;NEUTROPHIL COUNT (ANC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The absolute neutrophil count is used as a covariate in assessing the impact of genetic variants on HbF levels and hematological parameters."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;MAXIMUM TOLERATED DOSE (MTD)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Maximum tolerated dose refers to the highest level of hydroxyurea treatment that can be administered without unacceptable side effects."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;ALLELE FREQUENCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The frequency of an allele within a gene pool, important for studying the impact of specific SNPs like rs1427407 and rs9399137."&lt;SEP&gt;"The frequency of occurrence or distribution of different alleles in a population, measured across various genetic loci and polymorphisms such as BDNF rs6265 and rs2049046."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784&lt;SEP&gt;chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HMIP-2 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific single nucleotide polymorphism (SNP) within the HMIP-2 locus that has been analyzed for its association with MTD HbF."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;MTD HBF&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Maternal to fetal transfer of hemoglobin F (HbF), a physiological process influenced by genetic factors such as genomic variants in HMIP-2."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;C-A HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An observed haplotype consisting of combinations of alleles from the HMIP-2 genomic region."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;FANCA GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FANCA gene is one of the known Fanconi anemia genes involved in DNA repair processes."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;C.2574C&gt;G/P.SER858ARG MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A mutation in the FANCA gene, c.2574C&gt;G/p.Ser858Arg, previously described in FA patients but not identified as a causative factor in this subject."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The UBE2T gene encodes for an enzyme involved in ubiquitination processes necessary for Fanconi anemia pathway activation."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;G.202332626_202341295DEL DELETION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A paternally derived deletion of the UBE2T gene, leading to loss of function."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;G.202332626_202341295DUP DUPLICATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A maternally derived duplication in the UBE2T gene region due to recombination between two AluYa5 repeats."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T TRANSCRIPT (C.-64_468DUP)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A transcript of the UBE2T gene with a duplicated exon 2 spliced to exon 6, resulting in a frameshift and premature stop codon."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Monoubiquitination of FANCD2 is a critical process for the activation of Fanconi anemia pathway and cellular response to DNA damage."&lt;SEP&gt;"The monoubiquitination of FANCD2 is a physiological process that is restored upon overexpression of UBE2T, which is crucial for the FA pathway's function in response to DNA damage."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f&lt;SEP&gt;chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CHROMOSOMAL BREAKAGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An elevated level of chromosomal breakage in cells treated with crosslinking agents, indicating impaired repair mechanisms."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCONI ANEMIA PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A cellular pathway involved in DNA repair and maintenance, activated by the core FA complex proteins including FANCA and UBE2T."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FIBROBLASTS (RA2627)&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Fibroblast cells derived from a patient with Fanconi anemia, displaying cellular phenotypes consistent with deficiencies in the FA pathway."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;LYMPHOBLASTOID CELL LINE (RA2946)&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A cell line derived from blood of the same patient showing reversion to normal FANCD2 monoubiquitination, indicative of somatic mosaicism."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCONI ANEMIA (FA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A genetic disorder characterized by bone marrow failure, developmental abnormalities, and cellular hypersensitivity to DNA crosslinking agents."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"UBE2T is a gene responsible for the expression of wild type UBE2T protein, which plays a critical role in rescuing cellular defects associated with Fanconi Anemia-T (FA-T) subtype."&lt;SEP&gt;"Ube2T is an E2 ubiquitin-conjugating enzyme that binds the RING domain of proteins like FANCL for substrate binding and ubiquitination processes."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RA2627 FIBROBLASTS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"RA2627 fibroblasts are cells derived from an individual with UBE2T deficiency and used to model FA-T cellular defects."&lt;SEP&gt;"RA2627 fibroblasts are cells derived from an individual with UBE2T deficiency used to model FA-T cellular defects."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;WILD TYPE UBE2T EXPRESSION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression of wild type UBE2T protein rescues the phenotype associated with UBE2T deficiency, including hypersensitivity to crosslinking agents and G2 arrest following DNA damage."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCI MONOUBIQUITINATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The monoubiquitination of FANCI is another physiological process that is recovered with the overexpression of UBE2T, which contributes to the repair of interstrand DNA crosslinks."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCONI ANEMIA-T (FA-T)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fanconi anemia-T subtype is a genetic disorder caused by mutations in the UBE2T gene leading to cellular hypersensitivity and defects in DNA repair pathways, specifically FANCD2 monoubiquitination."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CROSSLINKING AGENTS (MMC, DEB, CISPLATIN)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"These agents are environmental factors that cause DNA crosslinks, challenging the FA pathway's function. Overexpression of UBE2T restores cell survival and DNA repair efficiency following treatment with these agents."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;G2 ARREST&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"G2 arrest is a physiological process induced by DNA damage that prevents cells from entering mitosis with unrepaired DNA. The overexpression of UBE2T rescues G2 arrest in RA2627 fibroblasts."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;BJ CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"BJ cells are normal human fibroblast cell lines used as controls to demonstrate the effects of wild type UBE2T expression in comparison with RA2627 cells."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RPS19 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The RPS19 gene is associated with Diamond-Blackfan Anemia (DBA) and mutations in this gene cause defects leading to DBA."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MISSENSE MUTATION P.ARG62TRP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense mutation in the RPS19 gene at position Arg62Trp that causes a change from arginine to tryptophan and is associated with DBA."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MISSENSE MUTATION P.ARG101HIS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense mutation in the RPS19 gene at position Arg101His that leads to a change from arginine to histidine, which causes DBA."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;FRAMESHIFT MUTATION C.58DELG&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A frameshift mutation in the RPS19 gene characterized by deletion of guanine at position 58 leading to premature termination and associated with DBA."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;SPLICE SITE MUTATION C.1-1G&gt;A&quot;">
      <data key="d0">"GENETIC VARIATION"</data>
      <data key="d1">"A splice site mutation affecting the acceptor splice site of intron 1 in the RPS19 gene, resulting in exon skipping and reduced protein function, leading to DBA."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS TRANSCRIPTOME&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcriptome of dermal fibroblasts isolated from patients with mutations in RPS19 shows differential expression patterns compared to healthy controls."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;NMD (NONSENSE-MEDIATED DECAY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A cellular process that targets and degrades mRNAs containing premature stop codons, affecting the levels of RPS19 mRNA in patients with certain mutations."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AMINOACYL-TRNA BIOSYNTHESIS PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The pathway involved in synthesizing charged tRNA molecules carrying amino acids which are essential for protein synthesis and is enriched in DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;GLYCINE, SERINE, AND THREONINE METABOLISM PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathways responsible for the metabolism of glycine, serine, and threonine amino acids which are essential for various cellular functions."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DEATH RECEPTOR SIGNALING PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A signaling pathway activated by death receptors such as TNF-R1 and Fas leading to apoptosis, enriched in genes related to DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Pathways involving the protein kinase R (PKR) in interferon induction and antiviral response that are enriched with genes related to DBA pathogenesis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RAR ACTIVATION PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The pathway associated with retinoic acid receptor activation, involved in various cellular functions including differentiation and proliferation."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RP GENES (RIBOSOMAL PROTEIN)&quot;">
      <data key="d0">"GENE CLUSTER"</data>
      <data key="d1">"A cluster of genes encoding ribosomal proteins which are critical for protein synthesis and show differential expression patterns in DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;LIPID METABOLISM PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The pathway involved in lipid metabolism, enriched with differentially expressed genes among DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RPL22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL22 is a gene within a large cluster of ribosomal protein genes (RP genes) involved in molecular functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL27A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL27A is part of a cluster of RP genes related to cellular processes and bio-functions such as cell death, lipid metabolism, and molecular transport."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL29&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL29 is an RP gene involved in various cellular functions including the regulation of molecular transport and cellular development."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL31&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL31 is a ribosomal protein gene contributing to cell death, lipid metabolism, and tissue development processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL14 is an RP gene implicated in cellular functions such as molecular transport and developmental roles within tissues."&lt;SEP&gt;"RPL14 is an RP gene involved in cellular functions such as molecular transport, cell death regulation, and developmental roles within tissues."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL18A is a ribosomal protein gene involved in various cell processes including development, death, and lipid metabolism."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPS3 is an RP gene important for cellular functions such as molecular transport and cell death regulation."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL18 is a ribosomal protein gene involved in cellular development and lipid metabolism processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL13 is an RP gene contributing to molecular transport, cell death regulation, and tissue developmental functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL3 is a ribosomal protein gene involved in cellular development processes and lipid metabolism."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL34 is an RP gene contributing to molecular transport, cell death regulation, and tissue developmental functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPS2 is a ribosomal protein gene involved in various cellular processes including molecular transport and development."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPS12 is an RP gene implicated in cell death regulation, lipid metabolism, and tissue developmental functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL15 is a ribosomal protein gene contributing to molecular transport, cellular development, and lipid metabolism processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL28&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL28 is an RP gene involved in cell death regulation, lipid metabolism, and tissue developmental functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;AMPD3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"AMPD3 is a gene that is up-regulated in Diamond-Blackfan Anemia (DBA) patients relative to controls as shown by RT-PCR validation of microarray data."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CCND2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CCND2 is a gene that shows elevated expression levels in DBA patients compared to healthy control subjects, according to qRT-PCR analysis."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SOD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SOD2 is an up-regulated gene in Diamond-Blackfan Anemia (DBA) patients as determined by RT-PCR validation of microarray data."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;TNFAIP3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFAIP3 is a gene that demonstrates increased expression in DBA patients relative to controls according to RT-PCR analysis and microarray results."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;COMP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"COMP is a gene with decreased expression levels in Diamond-Blackfan Anemia (DBA) patients compared to healthy control subjects, as evidenced by qRT-PCR validation of microarray data."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;WARS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"WARS is a gene that shows reduced expression in DBA patients relative to controls based on RT-PCR analysis and microarray results."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;ZIC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ZIC1 is down-regulated in Diamond-Blackfan Anemia (DBA) patients compared to healthy control subjects according to qRT-PCR validation of microarray data."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RIBOSOMAL PROTEIN GENES (RP GENES)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A large cluster of genomic variants associated with ribosomal protein genes contributing to various biological functions including molecular transport, lipid metabolism, and cellular development."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CELLULAR DEVELOPMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of cellular development influenced by genetic factors such as RP genes and involved in tissue growth and differentiation."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process involved in the movement of molecules across cell membranes, influenced by cellular functions such as those associated with ribosomal protein genes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;TOP BIO FUNCTIONS CATEGORY MOLECULAR AND CELLULAR FUNCTIONS&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"A category that includes molecular and cellular biological pathways involved in various physiological processes and disease conditions, including cancer-related genes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CANCER RELATED GENES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genes associated with the development of cancers and related diseases within biological systems."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;HAEMATOLOGICAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Disorders affecting blood cells or components, including genetic factors contributing to these conditions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;IMMUNOLOGICAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Conditions that affect the immune system, with genetic contributions to their development and progression."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RENAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Disorders affecting kidney function, potentially involving genetic influences on disease manifestation."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Conditions impacting bone health, possibly influenced by genetic factors contributing to skeletal development and integrity."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;DEVELOPMENT OF EMBRYONIC TISSUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process involving the formation and growth of embryonic tissues during early stages of development."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;DEVELOPMENT OF SKELETAL TISSUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Processes involved in the formation, growth, and maintenance of skeletal tissues throughout life."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;QUANTITATIVE RT-PCR VALIDATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A technique used to validate gene expression levels detected by microarray analysis through quantitative real-time PCR experiments."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MICROARRAY DATA ANALYSIS&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"The method of analyzing large-scale gene expression data from microarrays to identify differentially expressed genes and pathways involved in diseases such as Diamond-Blackfan Anemia (DBA)."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;QRT-PCR RESULTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Quantitative real-time PCR results used for the validation of gene expression patterns observed in microarray data analysis."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;DIAMOND-BLACKFAN ANEMIA (DBA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A rare congenital disorder characterized by bone marrow failure, leading to a lack of red blood cells and associated with genetic factors affecting ribosomal protein genes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS19 GENE MUTATIONS&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"The transcriptome of dermal fibroblasts from patients with RPS19 gene mutations shows differential expression patterns compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPLICE SITE MUTATION C.1-1G&gt;A IN RPS19 GENE&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"The splice site mutation in the RPS19 gene leads to NMD targeting and degradation of mutant mRNA, affecting protein levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d1">"Genes involved in aminoacyl-tRNA biosynthesis show differential expression patterns among DBA patients indicating potential functional alterations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BDNF GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BDNF gene is implicated in the development of neurological disorders, including migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS6265 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism (G/A) located within the BDNF gene that has been associated with an increased risk or decreased susceptibility to migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS2049046 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism (A/T) in the BDNF gene that is also associated with susceptibility to migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;MIGRAINE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurological disorder characterized by severe headaches, often accompanied by nausea and sensitivity to light or sound."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;NOS SCORE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Quality assessment tool for observational studies, indicating good quality of the included studies if scores are no less than 6."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;CAUCASIAN POPULATION GROUPS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Five distinct Caucasian groups included in the studies, each contributing to the analysis of BDNF gene polymorphism and migraine association."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;AUSTRALIAN-BASED INDEPENDENT COHORTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Two specific cohorts from Australia that were part of the five population groups included in the study."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;STUDY QUALITY ASSESSMENT&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"A high NOS score indicates that the quality of observational studies included in the meta-analysis is good, supporting robust analysis and conclusions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Psoriasis is a chronic inflammatory disease characterized by skin lesions such as erythemato-scallous plaques and pustular eruptions."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HIDRADENITIS SUPPURATIVA (HS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HS is a severe, debilitating skin condition characterized by nodules, fistulas, and sinus tracts in the inguinal, perianal regions among others."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These are unexpected reactions where patients develop psoriasis-like symptoms after being treated for HS with biological agents like adalimumab."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ADALIMUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An anti-TNF-α biologic drug used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, and moderate to severe plaque psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ANTI-TNF-Α THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment with drugs that block the TNF-α protein which is involved in causing inflammation."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD15+ NEUTROPHILS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Neutrophils with surface marker CD15, a type of white blood cell involved in the immune response and inflammation."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;BDCA2+ PDCS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Plasmacytoid dendritic cells expressing BDCA2, known for their role in innate immunity responses."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD68+ MACROPHAGES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Macrophages that express CD68 marker involved in phagocytosis and immune response."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;TNF-Α&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Tumor Necrosis Factor alpha is an inflammatory cytokine involved in systemic inflammation and immune responses."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HURLEY STAGE III&quot;">
      <data key="d0">"DISEASE SEVERITY CLASSIFICATION"</data>
      <data key="d1">"A classification stage for hidradenitis suppurativa (HS) characterized by severe disease with multiple interconnected abscesses and sinus tracts."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;SARTORIUS SCORE&quot;">
      <data key="d0">"DISEASE SEVERITY CLASSIFICATION"</data>
      <data key="d1">"A scoring system used to assess the severity of HS based on clinical findings such as nodules, sinuses, and fistulas."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;EPIDERMAL HYPERPLASIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An increase in cell number within the epidermis layer of skin tissue, often seen in psoriasis and other inflammatory conditions."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PARAKERATOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The retention of nuclei in keratinocytes within the stratum corneum, typically observed in various dermatological diseases like psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PAPILLARY VESSEL ECTASIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Enlargement and dilation of blood vessels in the papillary dermis layer, commonly seen in inflammatory skin conditions such as psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PERIVASCULAR INFILTRATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An accumulation of immune cells around small blood vessels, often indicative of an inflammatory response in the skin."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD3+ CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD3+ cells are T lymphocytes expressing CD3 surface antigen, involved in cell-mediated immunity."&lt;SEP&gt;"T lymphocytes expressing CD3 protein, involved in cellular immunity and activation of T-cell receptors."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;IL-36Γ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Interleukin 36 gamma, a cytokine released by neutrophils that plays a role in inflammation and immune responses."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;C-KIT/CD117+ MAST CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Mast cells expressing c-kit (also known as CD117), involved in allergic reactions and inflammatory responses."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;FACS ANALYSIS&quot;">
      <data key="d0">"LABORATORY TECHNIQUE"</data>
      <data key="d1">"Fluorescence-activated cell sorting used to isolate and analyze different types of cells based on their fluorescent markers."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD8+&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD8 is a transmembrane protein found on the surface of cytotoxic T cells and helper/inducer T cells."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CD4+&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD4 is a transmembrane glycoprotein expressed mainly by helper T lymphocytes, macrophages, monocytes, and dendritic cells."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IFN-Β&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interferon-beta is a cytokine that plays an important role in the innate immune response against viral infections."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IFN-Κ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interferon-kappa, another type I interferon produced by keratinocytes."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IFN-Α2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interferon-alpha 2A is a cytokine involved in the innate immune response and antiviral activity."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IFN-Λ1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interferon-lambda 1, also known as IL-29, is a type III interferon with roles in host defense against viral infections."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LL-37&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LL-37 is an antimicrobial peptide produced by epithelial cells and neutrophils."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LT-Α AND LT-Β (TNF-Β AND TNF-C)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Lymphotoxins, also known as tumor necrosis factor-beta and -C, are cytokines involved in immune responses."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ERAP1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ERAP1 gene encodes a protein that functions in the processing of peptides for MHC class I antigen presentation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HLA-C REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"HLA-C is a region within the major histocompatibility complex on chromosome 6, important in immune responses and disease susceptibility."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CDSN GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cornified Envelope Precursor Protein CDSN involved in skin barrier formation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CCHCR1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Corneodesmosin, a gene important for the integrity of the cornified envelope layer in keratinocytes and corneocytes."&lt;SEP&gt;"The CCHCR1 gene contains three SNPs (rs1576/rs130079/rs746647) according to Table 1."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;TNFAIP (A20) GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tumor necrosis factor alpha-induced protein 3, also known as A20, is an inhibitor of NF-kappaB signaling pathway."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"PBMCs include monocytes, lymphocytes and immature dendritic cells collected from the peripheral blood."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HLA-B REGION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The HLA-B region is part of the major histocompatibility complex on chromosome 6, involved in immune response regulation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNF-Α GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tumor Necrosis Factor Alpha (TNF-alpha) gene encodes a cytokine that plays a critical role in systemic inflammation and cell signaling."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL-17F, IL-17RA, IL-23R, IL-12B GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These genes encode proteins involved in immune responses, such as interleukins and cytokine receptors."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IKBΖ GENE (NFKBIZ)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IKBζ gene encodes a protein that regulates the NF-κB pathway."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;A20 BINDING PROTEIN GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Encodes an inhibitor of TNF-induced apoptosis and is part of negative feedback mechanisms in immune signaling pathways."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TYK2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tyrosine kinase 2, a member of the Janus kinases (JAK) family involved in cytokine signaling."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNFAIP GENE (A20)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Encodes A20 protein which functions as an anti-inflammatory regulator by inhibiting NF-kappaB activation."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;SNP RS1576&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1576 is a SNP located in the CCHCR1 gene."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;SNP RS130079&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs130079 is a SNP located in the CCHCR1 gene."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;SNP RS746647&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs746647 is a SNP located in the CCHCR1 gene."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL23R gene contains SNPs that have been previously associated with paradoxical psoriasiform reactions to anti-TNF drugs and was detected in HS patients."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;SNP RS11209026&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs11209026 is a SNP located in the IL23R gene that has been previously associated with paradoxical psoriasiform reactions to anti-TNF drugs but was not found in HS patients."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;SNP RS72676067&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs72676067 is a SNP located in the IL23R gene that was detected in patient 2."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;SNP RS1004819&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1004819 is a SNP located in the IL23R gene that was detected in patient 1."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;INNATE IMMUNITY&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"Mast cells expressing c-kit play important roles in innate immune responses and allergic inflammation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KERATINOCYTES&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Type I IFN-β expression is mainly observed in keratinocytes of paradoxical psoriasis skin lesions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SKIN T CELLS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"CD3+ skin T cells from HS patients are enriched in CD8+, reflecting a distinct inflammatory infiltrate pattern."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP VARIANTS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Patients developing paradoxical psoriasis carry variants of the ERAP1 gene, indicating a genetic predisposition to such reactions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Variants in the HLA-C region are found consistently among HS patients with paradoxical psoriasis, suggesting an association with disease susceptibility."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-C REGION SNPS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Variants in the HLA-C region are found consistently among HS patients with paradoxical psoriasis, suggesting an association with disease susceptibility."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDSN GENE &quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Polymorphisms in CDSN gene may affect skin barrier integrity and contribute to the pathogenesis of inflammatory skin conditions like psoriasis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SKIN BARRIER FUNCTION&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Polymorphisms in CDSN gene may affect skin barrier integrity and contribute to the pathogenesis of inflammatory skin conditions like psoriasis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAGNOSTIC MARKER&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Levels of IL-22 in PBMCs can serve as a diagnostic marker, showing reduction compared to psoriasiform lesions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B REGION SNPS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Variants in the HLA-B region are associated with genetic predisposition to autoimmune diseases including psoriasis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNF-Α GENE VARIANTS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Polymorphisms of TNF-α gene affect inflammatory responses and may contribute to disease susceptibility."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-23R, IL-17F, IL-17RA GENES &quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Variants in these genes influence immune regulation pathways and are associated with autoimmune conditions such as psoriasis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FANCL gene encodes a protein that plays an essential role in the Fanconi Anemia pathway."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DRWD DOMAIN (HUMAN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The DRWD domain is a part of the human FANCL central region, characterized by its fused bilobal structure with dimensions 70 × 25 × 20 Å."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DMFANCL PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Drosophila melanogaster (Dm) FANCL is a structural homologue of the human FANCL central domain, differing in secondary structure elements and surface conservation."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;E2 UBC ENZYMES&quot;">
      <data key="d0">"PROTEIN FAMILY"</data>
      <data key="d1">"E2 ubiquitin-conjugating enzymes are structurally similar to both lobes of the human central FANCL domain but predominantly to its C-terminal lobe."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;URD (UBC-RWD DOMAIN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The UBC-RWD domain is a vertebrate-specific feature in FANCL, characterized by an intermediary position between E2 folds and RWD-like folds due to a β-element swap for the N-terminal lobe's helix."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CYSTEINE&quot;">
      <data key="d0">"AMINO ACID RESIDUE"</data>
      <data key="d1">"The cysteine residue within the human FANCL domain's β-element is structurally similar to E2 enzyme catalytic sites but does not form a thioester bond with ubiquitin."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;THIOESTER CHARGE ASSAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An assay used to test whether the cysteine residue within URD can form a thioester linkage, revealing it is unable to do so in this case."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HYDROPHOBIC CORE RESIDUES&quot;">
      <data key="d0">"PROTEIN INTERACTION SITE"</data>
      <data key="d1">"Residues forming the hydrophobic core between N- and C-terminal lobes of FANCL are highly conserved but show differences between vertebrate and invertebrate forms."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DMDRWD (PROTEIN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The Drosophila melanogaster DRWD domain is structurally similar to the human FANCL central domain but contains a helix after the four-stranded β-meander in both lobes."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;UBQ ACTIVATION PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Refers to the process of activating ubiquitin, which involves thioester bond formation between E2 enzymes and ubiquitin."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;TRIPLE TURN YPXXXP MOTIF (AMINO ACID MOTIF)&quot;">
      <data key="d0">"AMINO ACID MOTIF"</data>
      <data key="d1">"A motif found in RWD folds that is present in the human FANCL central domain but not in Drosophila's DRWD domain."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HPXXXP MOTIF (AMINO ACID MOTIF)&quot;">
      <data key="d0">"AMINO ACID MOTIF"</data>
      <data key="d1">"A variant of the YPXXXP motif, located in the C-terminal lobe of the human URD."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;Β-FLAP STRUCTURE (PROTEIN STRUCTURE ELEMENT)&quot;">
      <data key="d0">"PROTEIN STRUCTURAL FEATURE"</data>
      <data key="d1">"A structural element found in E2 enzymes and present in the N-terminal lobe of the human FANCL central domain."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;RWD-LIKE FOLD (PROTEIN STRUCTURAL FEATURE)&quot;">
      <data key="d0">"PROTEIN STRUCTURAL FEATURE"</data>
      <data key="d1">"Refers to the C-terminal lobe of the URD, which lacks a β-flap and is more similar to RWD folds than E2 enzymes."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CATALYTIC THIOESTER BOND FORMATION (MOLECULAR INTERACTION)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The formation of thioester bonds between cysteine residues in E2 enzymes and ubiquitin."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;THIOESTER LINKAGE STABILITY TEST (PHYSIOLOGICAL PROCESS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An assay used to test the stability of a proposed catalytic site, revealing that URD's cysteine cannot form stable thioester linkages with ubiquitin."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;URD&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The URD is a protein that contains hydrophobic patches and grooves important for its function."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;DMDRWD&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"DmDRWD, the Drosophila DRWD, interacts with the human URD to form part of the FANCL complex."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;RING DOMAIN (HUMAN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The human RING domain is a protein region essential for binding Ube2T and participating in E3 ligase activity."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FANCI&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCI is a protein involved in the FA pathway and binds to URD."&lt;SEP&gt;"FANCI is part of the Fanconi Anemia pathway and interacts with the URD to form complexes involved in DNA repair processes."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCD2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCD2 is another protein that interacts with FANCI in the FA pathway."&lt;SEP&gt;"FANCD2 protein forms a complex with FANCI, playing a crucial role in the regulation of genome stability."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCHES/GROOVES (URD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Hydrophobic patches and grooves on the URD are critical for substrate binding and protein-protein interactions."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;ELECTROSTATIC POTENTIAL DIFFERENCES (URD/DMDRWD)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The electrostatic potential differences between the surfaces of human URD and Drosophila DRWD influence their interaction dynamics."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;SIZE-EXCLUSION CHROMATOGRAPHY/ISOTHERMAL TITRATION CALORIMETRY (ITC)&quot;">
      <data key="d0">"EXPERIMENTAL METHOD"</data>
      <data key="d1">"Techniques used to assess protein-protein interactions, such as binding affinity and complex formation between URD and Ube2T."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FOUR-STRANDED Β-MEANDER (URD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A structural element in URD involving four β-strands crucial for protein-protein interactions."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;N-TERMINAL LOBE OF THE URD &quot;">
      <data key="d0">"PROTEIN REGION"</data>
      <data key="d1">"The N-terminal lobe of the URD contains hydrophobic patches and residues important for substrate binding."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;C-TERMINAL DOMAIN OF DMDRWD &quot;">
      <data key="d0">"PROTEIN REGION"</data>
      <data key="d1">"This domain of DmDRWD interacts with human URD, contributing to protein-protein interactions."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;HYDROPHOBIC GROOVES (URD)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Hydrophobic grooves on the C-terminal region of URD are essential for binding substrates like Ube2T and FANCI/FANCD2."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;URD (UBIQUITIN-RICH DOMAIN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"URD, or Ubiquitin-Rich Domain, is a mutant protein subjected to pulldown arrays with FANCI and FANCD2."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;L248A/F252A/L254A/I265A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant represents specific mutations in the C-terminal lobe of URD that reduce binding affinity for both FANCI and FANCD2."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;W212A/L214A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These variants represent specific mutations in the N-terminal lobe of URD but behave as wild type compared to other mutants."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCH (C-TERMINAL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The hydrophobic patches on the C-terminal lobe are critical for binding substrates like FANCI and FANCD2, indicating their role in the FA pathway."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCH (N-TERMINAL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Mutations within the hydrophobic patches of the N-terminal lobe do not affect substrate binding as much as those in the C-terminal lobe."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;HPXXXP MOTIF&quot;">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"While both motifs are found in RWD folds, only the human FANCL central domain (URD) contains an HPXXXP motif rather than YPXXXP."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRIPLE TURN YPXXXP MOTIF&quot;">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"While both motifs are found in RWD folds, only the human FANCL central domain (URD) contains an HPXXXP motif rather than YPXXXP."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CATALYTIC THIOESTER BOND FORMATION&quot;">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"The β-flap structure in E2 enzymes facilitates thioester bond formation with ubiquitin, a process not observed in the URD due to lack of catalytic cysteine activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Β-FLAP STRUCTURE&quot;">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"The β-flap structure in E2 enzymes facilitates thioester bond formation with ubiquitin, a process not observed in the URD due to lack of catalytic cysteine activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYSTEINE RESIDUE (URD)&quot;">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"The test was conducted to determine if the cysteine residue in the human FANCL domain could form thioester bonds with ubiquitin, which it cannot."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THIOESTER LINKAGE STABILITY TEST&quot;">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"The test was conducted to determine if the cysteine residue in the human FANCL domain could form thioester bonds with ubiquitin, which it cannot."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCI/FANCD2 BINDING&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Specific hydrophobic patches on the C-terminal lobe of URD are crucial for binding to FANCI and FANCD2."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UBE2T BINDING&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"Specific hydrophobic grooves on the C-terminal lobe of URD facilitate binding to Ube2T for E3 ligase activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR4 RS351855 (GLY388ARG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FGFR4 rs351855 variant is a functional genetic variant associated with differential effects of colesevelam on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;COLESEVELAM TREATMENT EFFECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Colesevelam treatment affects the time to peak concentration (t1/2) and the area under the curve for 24 hours (GC24)."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;CT DELAY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The effect of colesevelam on CT is related to changes in AC t1/2 and GC24 values."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS4975017&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant associated with differential treatment effects on CT, leading to lower GC24 value compared to placebo in the CA/AA genotype group."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS17618244 (ARG728GLN)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The KLB rs17618244 variant shows modest effects on AC t1/2 and GC24, though not statistically significant."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;GC24 VALUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GC24 values are measured to assess the impact of colesevelam treatment on drug metabolism."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;AC T1/2 VALUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"AC t1/2 represents the time to peak concentration after administration of a substance, which is affected by genetic variants."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FGFR4 gene contains functional variants such as rs351855 (Gly388Arg) that influence drug metabolism responses."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The KLB gene includes functional variants like rs4975017 and rs17618244 (Arg728Gln), impacting the response to colesevelam treatment."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;HEALTHY CONTROL PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A group of participants used as controls in genetic studies, presumed free from specific conditions relevant to the study."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 AND KLB GENES &quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"Genetic studies involving healthy control patients assess the impact of FGFR4 and KLB variants on drug responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT &quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"The Hardy-Weinberg equilibrium is used to evaluate whether genomic variant frequencies in a population are consistent with random mating, impacting genetic study reliability."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGF19&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FGF19 is a protein involved in the regulation of bile acid synthesis and metabolism."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;SERUM C4 (C4)">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Serum C4 refers to circulating concentrations of C4, an indicator related to cholesterol 7-alpha-hydroxylase activity, which plays a role in bile acid biosynthesis."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;BILE ACIDS (BA)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway of bile acids involves their synthesis and excretion for digestion and absorption processes."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;FGFR4 RS1966265, FGFR4 RS351855, FGFR4 RS376618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genetic variants within the fibroblast growth factor receptor 4 gene that may influence physiological processes such as bile acid metabolism."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;KLB RS17618244&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in Klotho, a gene involved in aging and metabolic regulation, potentially affecting pathways related to FGFR4 signaling."&lt;SEP&gt;"A genetic variant in Klotho, which is involved in aging and metabolic regulation."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;CHOLECYSTECTOMY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A surgical procedure involving the removal of the gallbladder, which can impact bile acid synthesis and excretion pathways."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by chronic abdominal pain or discomfort associated with diarrhea."&lt;SEP&gt;"IBS-D is a condition characterized by chronic abdominal pain or discomfort associated with defecation or changes in stool frequency and appearance, often involving diarrhea."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;IBS-C (IRRITABLE BOWEL SYNDROME WITH CONSTIPATION)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A condition characterized by chronic abdominal pain or discomfort associated with constipation."&lt;SEP&gt;"A dietary pattern often adopted by individuals suffering from IBS-C to manage symptoms such as bloating and constipation."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;HV (HEALTHY VOLUNTEERS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Individuals who do not have any diagnosed medical conditions, used in studies as a control group for comparison with disease groups like IBS-D and IBS-C."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SERUM FGF19&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"FGF19 circulating in the blood serum, which is involved in regulating bile acid synthesis and metabolism."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL BA (BILE ACIDS)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway for bile acids that are excreted through stool."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;SERUM C4&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"Increased BMI is positively correlated with higher serum C4, suggesting a relationship between body fat and cholesterol metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;FAAP20&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20 is a 20 kDa protein that binds to FANCA through its N-terminal region and contains a conserved UBZ domain in its C-terminal extremity."&lt;SEP&gt;"FAAP20 is a protein that localizes to interstrand crosslink (ICL) sites via its UBZ domain after ICL formation due to DNA damage."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FANCA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FANCA is a gene encoding for a protein that interacts with FAAP20, particularly within the context of binding K63-linked ubiquitin chains."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;K63-LINKED UB2 (K63-UB2)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"K63-linked Ub2 represents a type of molecular interaction involving two ubiquitins linked at Lysine 63, which interacts specifically with the UBZ domain of FAAP20."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBZ DOMAIN (OF FAAP20)&quot;">
      <data key="d0">"PROTEIN REGION"</data>
      <data key="d1">"The UBZ domain is a specific region within FAAP20 that binds to ubiquitin chains and plays a role in cellular processes such as DNA repair and cell cycle regulation."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITIN (UB)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Ubiquitin is a small protein that interacts with the UBZ domain of FAAP20 to facilitate its recruitment to DNA damage sites after ICL formation."&lt;SEP&gt;"Ubiquitin, commonly referred to as Ub, is involved in protein degradation and signaling pathways through interactions with other proteins like FAAP20-UBZ."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20-UBZ (RESIDUES 143–180)&quot;">
      <data key="d0">"PROTEIN FRAGMENT"</data>
      <data key="d1">"A specific fragment of FAAP20 that includes residues 143 to 180, which binds specifically to K63-linked Ub2."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;CENTRAL Α-HELIX (RESIDUES 160–173)&quot;">
      <data key="d0">"PROTEIN REGION"</data>
      <data key="d1">"The central region of the FAAP20-UBZ fragment is an α-helix that interacts with one ubiquitin in a K63-linked Ub2 chain."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;TWO LOOPS (RESIDUES 143–159 AND 174–180)&quot;">
      <data key="d0">"PROTEIN REGION"</data>
      <data key="d1">"These two loop regions of FAAP20-UBZ interact with the α-helix and zinc ion, respectively, contributing to its structural stability."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ZINC ION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A zinc ion coordinated by specific residues (Cys147, Cys150, His166, Cys170) that bridges the first loop and α-helix of FAAP20-UBZ."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ILE44 PATCH&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A hydrophobic patch in ubiquitin centered around Ile44, which interacts with FAAP20-UBZ through hydrophobic interactions."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITINATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A post-translational modification involving the covalent attachment of ubiquitin to target proteins, which is crucial for cellular processes like protein degradation and DNA repair."&lt;SEP&gt;"The process of adding ubiquitin to proteins to tag them for degradation or to modify their function, often involved in pathways such as DNA repair and cell cycle regulation."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FAAP20-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20-UBZ is a protein whose interaction with Ub involves specific hydrophobic and charged residues crucial for binding."&lt;SEP&gt;"The FAAP20-UBZ protein binds ubiquitin (Ub) through a series of intermolecular interactions, including hydrogen bonds and hydrophobic patches."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;LEU8, ILE44, VAL70, THR66, HIS68 (UB)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These residues form a hydrophobic patch on ubiquitin that interacts with FAAP20-UBZ via specific hydrogen bonds and hydrophobic contacts."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ASP164, TRP180 (FAAP20-UBZ)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These residues of the FAAP20-UBZ protein form key interactions with ubiquitin, including hydrogen bonding with main-chain amide groups and side chains."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ARG72, GLN49 (UB)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Arginine 72 and glutamine 49 of ubiquitin participate in specific molecular interactions with FAAP20-UBZ, contributing to the protein's binding affinity for ubiquitin."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;DNA DAMAGE SITES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sites of DNA damage where FAAP20 accumulates, requiring the interaction between the UBZ domain and ubiquitin for proper localization."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;C150S&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutation at residue Cys150 to Ser150 in FAAP20-UBZ disrupts the bridging between loops and destabilizes the protein structure."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;L161A, A172L, D177A (MUTATIONS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These mutations reduce binding affinity but do not completely eliminate it; they demonstrate partial functionality in cellular localization."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;D164A, A168L, W180A (MUTATIONS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Complete loss of Ub binding observed with these mutations indicating their critical role in the interaction between FAAP20-UBZ and ubiquitin."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ICL FORMATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which interstrand crosslinks are formed, leading to DNA damage and repair mechanisms being activated."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;WRNIP1-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A protein domain that binds ubiquitin, structurally similar to the FAAP20-UBZ but with different specific interactions."&lt;SEP&gt;"WRNIP1-UBZ is a protein that interacts with Ub through its β-loop, differing from Polη-UBZ in key binding residues."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;RAD18-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Another protein domain involved in binding ubiquitin, showing structural conservation with WRNIP1-UBZ and differing from FAAP20-UBZ in certain residues."&lt;SEP&gt;"RAD18-UBZ is a protein whose interaction with Ub is distinct from Polη-UBZ and NEMO-UBZ due to its unique β-loop structure."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;POLΗ-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A UBZ domain associated with the DNA polymerase eta (Polη), involved in nucleotide excision repair, has a distinct mode of ubiquitin binding compared to WRNIP1 and RAD18."&lt;SEP&gt;"Polη-UBZ is a protein whose interaction with Ub resembles FAAP20-UBZ but differs significantly from NEMO-UBZ due to the presence of charged residues and different hydrophobic interactions."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;NEMO-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NEMO-UBZ is a protein that interacts with Ub in a manner different from RAD18-UBZ and WRNIP1-UBZ."&lt;SEP&gt;"The Ubiquitin Binding Zinc Finger domain from the NF-kappa-B essential modulator (NEMO) protein, involved in signaling pathways; shows different structural features when binding ubiquitin compared to WRNIP1 and RAD18."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;CONFOCAL IMAGING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A technique used to visualize and quantify the localization of GFP-tagged FAAP20 at DNA damage sites after irradiation with psoralen-UVA."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;UB&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Ub (ubiquitin) interacts with various UBZ domains in different manners, specifically involving the Ile44 residue of Ub in these interactions."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;CHARGED RESIDUES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The presence of charged residues such as Lys399 and Asp652 disrupts hydrophobic interactions, influencing the manner in which proteins interact with Ub."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;K63-UB2&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP20-UBZ specifically binds K63-linked Ub2, which suggests a role in cellular signaling and regulation of protein stability."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAAP20-UBZ RESIDUES&quot;">
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d1">"The conservation or replacement of specific FAAP20-UBZ residues in Polη-UBZ (e.g., Asp652, Phe655, Ala656) indicates a similar mode of interaction with Ub."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DQ2.5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The HLA-DQ2.5 haplotype is a genomic variant significantly associated with an increased risk of celiac disease in the patient group compared to healthy controls."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ8&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The HLA-DQ8 haplotype, particularly DQ8/DQX, shows a high frequency among CD patients and is significantly different from control groups."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS2395182&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant rs2395182 with the minor 'G' allele more prevalent in healthy controls compared to CD patients, suggesting a protective role against celiac disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7775228&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SNP rs7775228 has a significant difference in frequency of the minor 'C' allele between healthy controls and CD patients, indicating its relevance to disease susceptibility."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS2187668&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant rs2187668 with the minor 'T' allele significantly more prevalent in CD patients than in controls, associated with an increased risk of celiac disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ2.2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The HLA-DQ2.2 haplotype is observed to be frequent among both healthy control and patient groups but more significantly so in the control group than patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;CELIAC DISEASE (CD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by chronic diarrhea, abdominal pain, anorexia, and other autoimmune manifestations like type 1 diabetes mellitus, autoimmune thyroiditis, systemic lupus erythematosus, osteomalacia, seizure disorders, and Down syndrome."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;AUTOIMMUNE MANIFESTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Autoimmune manifestations are physiological processes resulting from the immune system attacking body tissues leading to conditions such as type 1 diabetes mellitus, autoimmune thyroiditis, and systemic lupus erythematosus in celiac disease patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ HAPLOTYPE ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis of HLA-DQ haplotypes involves molecular interactions between genetic variants and immune responses in the context of celiac disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7454108&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant rs7454108 with no significant difference in minor allele frequency between case and control groups."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HOMOZYGOUS DQ2.5 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The homozygous form of the HLA-DQ2.5 haplotype is a molecular interaction involving genetic variants that significantly increases risk in CD patients compared to healthy controls."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DQ8/DQX HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific combination of DQ8 and DQX haplotypes showing significant difference between patient and control groups, higher frequency among CD patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HOMOZYGOUS DQ2.2 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The homozygous form of the HLA-DQ2.2 haplotype is a molecular interaction showing higher frequency in healthy controls compared to CD patients, suggesting protection against celiac disease."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HETEROZYGOUS DQ2.2 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The heterozygous form of the HLA-DQ2.2 haplotype is a molecular interaction with similar frequency in both CD patients and healthy controls, indicating no significant risk or protective role."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;EXTREMELY LOW RISK GROUP (DQX)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The extremely low-risk group characterized by the absence of all high-risk HLA alleles is a physiological process showing lower incidence among both patient and control groups."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS1128503&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs1128503 variant in the ABCB1 gene is significantly associated with grade 3–4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS12762549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs12762549 variant in the ABCC2 gene is significantly associated with grade 3–4 anemia and has a lower odds ratio compared to other variants for this condition."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS363717&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs363717 variant in the ABCA1 gene is significantly linked to grade 3-4 anemia, increasing the risk of developing this type of toxicity."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS11615&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs11615 variant in the ERCC1 gene shows a significant correlation with grade 3–4 anemia and is associated with higher odds ratios for hematological toxicities."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS4986910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This CYP3A4 rs4986910 variant correlates significantly with thrombocytopenia grade 3-4, before and after adjusting for covariates."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS2074087&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs2074087 variant in the ABCC1 gene is associated with increased use of erythropoiesis-stimulating agents (ESAs) after correction for covariates."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS2073337&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs2073337 variant in the ABCC2 gene is significantly correlated with CSF use during chemotherapy treatment, adjusting for relevant covariates."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1695&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This GSTP1 variant (rs1695) shows a significant association with increased use of colony-stimulating factors (CSFs)."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1799793&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ERCC2 rs1799793 variant is significantly linked to CSF usage and progression-free interval (PFI) in patients undergoing chemotherapy."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ABCB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ABCB1 gene harbors the rs1128503 variant which is associated with hematological toxicities such as anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ABCC2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ABCC2 gene has two variants (rs12762549 and rs4986910) significantly linked to grade 3-4 anemia and thrombocytopenia respectively, after adjusting for covariates."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ABCA1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ABCA1 gene contains the variant (rs363717), which is associated with hematological toxicity specifically grade 3-4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ERCC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ERCC1 harbors the rs11615 variant, significantly linked to an increased risk of grade 3–4 anemia in patients undergoing chemotherapy."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;CYP3A4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CYP3A4 gene is associated with thrombocytopenia through its variant rs4986910, which has a strong association even after covariate adjustment."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ABCC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ABCC1 gene's variant (rs2074087) is linked to increased use of ESAs during chemotherapy treatment in ovarian cancer patients."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;GSTP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GSTP1 gene harbors the rs1695 variant, which is significantly correlated with CSF usage after covariate adjustment."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ERCC2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ERCC2 gene's variant (rs1799793) affects both CSF use and progression-free interval in patients undergoing chemotherapy for ovarian cancer."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ERYTHROPOIESIS-STIMULATING AGENTS (ESA)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"ESAs are used to manage hematological toxicity such as anemia during chemotherapy, with their use being predicted by genetic variants like rs2074087 in ABCC1."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;COLONY-STIMULATING FACTORS (CSF)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"CSFs are administered to manage blood cell counts; the need for CSFs is influenced by genetic factors such as those found in variants like rs1695 and rs1799793."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ANEMIA&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Grade 3-4 anemia is a significant hematological toxicity observed among patients, whose risk can be predicted by genetic variants such as rs12762549 in ABCC2 and rs11615 in ERCC1."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIA&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Grade 3-4 thrombocytopenia is a hematological toxicity associated with the CYP3A4 variant (rs4986910) before and after adjusting for covariates."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;NEUTROPENIA&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"While neutropenia was examined, no significant associations were found between genetic variants and grade 4 or febrile neutropenia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;SENSORY NEUROPATHY&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"No significant association was observed between the genetic variants studied and sensory neuropathy in patients receiving chemotherapy for ovarian cancer."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS3739087&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant (rs3739087) in ABCC1 is significantly associated with neutropenia grade 4 and febrile neutropenia, despite no significant association found for other hematological toxicities."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;SLCO1B1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLCO1B1 gene harbors the rs4149048 variant which is associated with thrombocytopenia grade 2-3 and anemia grade 3-4 after adjusting for covariates."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;ERCC2 G&gt;A (RS1799793)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in ERCC2 gene, specifically G &gt; A at position rs1799793, is significantly correlated with Platinum-Free Interval (PFI) in patients."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ABCC2 A&gt;G (RS12762549)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in ABCC2 gene, specifically A &gt; G at position rs12762549, is significantly associated with PFI in the fully-adjusted model."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;SERPINB2 C&gt;G (RS6104)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in SERPINB2 gene, specifically C &gt; G at position rs6104, is significantly associated with PFI in the fully-adjusted model."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Platinum-free interval refers to the time from the last day of platinum-based chemotherapy until recurrence or progression of cancer. It is a critical measure used in clinical trials and patient prognosis analysis."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ERCC2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ERCC2 gene (also known as XPD) plays an essential role in DNA repair and transcription."&lt;SEP&gt;"The ERCC2 gene, also known as XPD, encodes for a DNA helicase that plays a role in nucleotide excision repair and transcription regulation."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ABCC2 GENE (MRP2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ABCC2 gene is involved in the ATP-binding cassette transporter superfamily and is known to play a role in drug resistance by transporting various drugs out of cells, including platinum-based chemotherapy drugs."&lt;SEP&gt;"The ABCC2 gene, also known as MRP2, encodes a protein involved in the transport of various drugs out of cells, including those used for chemotherapy."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;SERPINB2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SERPINB2 gene encodes for members of the serine peptidase inhibitor family that are involved in inflammation and tissue remodeling."&lt;SEP&gt;"The SERPINB2 gene is associated with inflammation and tissue remodeling processes."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;TUMOR GRADE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Tumor grade indicates the level of differentiation or malignancy of a tumor based on cell appearance under microscopy."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RESIDUAL DISEASE AFTER DEBULKING SURGERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"The amount and extent of cancer remaining after surgery is termed residual disease, influencing prognosis and treatment decisions."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;FIGO STAGE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"FIGO stage refers to the classification system used for gynecological cancers to indicate tumor size, involvement of nearby organs, lymph node spread, and metastasis."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;UMPS GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"UMPS is a RefSeq gene located within a deletion on chromosome 3 that potentially contributes to phenotypic changes observed in patients."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;DELETION CHR3:121233326-127618464&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A de novo deletion spanning over 6.4 Mb on chromosome 3, containing more than 40 RefSeq genes including UMPS."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.302DELA (P.LYS101ARGFS*9)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous alteration in the UMPS gene leading to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay, found in individual I4."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.385G&gt;T (P.GLY129*) &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous alteration in the UMPS gene leading to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay, found maternally inherited in individual I7 and also present in their healthy brother."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.889G&gt;T (P.GLU297*) &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous alteration in the UMPS gene leading to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay, found maternally inherited in individual I10 and paternally inherited in individual I11."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.224C&gt;A (P.PRO75HIS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous missense alteration predicted to be pathogenic by software programs, found in 12 family members from pedigree 2."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.286A&gt;G (P.ARG96GLY) AND C.1285G&gt;C (P.GLY429ARG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Two heterozygous missense alterations found in the UMPS gene of individual I3 and his healthy mother M3, likely on the same allele."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.310G&gt;A (P.GLY104ARG)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A heterozygous missense alteration predicted to be pathogenic by software programs found in individual I5."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.689G&gt;A (P.ARG230HIS) AND C.688C&gt;T (P.ARG230CYS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Two heterozygous missense alterations predicted to be pathogenic by software programs found maternally inherited in individuals I6 and I7."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.857T&gt;A (P.ILE286ASN) AND C.451G&gt;A (P.VAL151MET)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Two heterozygous missense alterations predicted to be pathogenic by software programs found in individuals I9 and I11 respectively."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.360A&gt;G (P.LEU120LEU)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous change variant inherited maternally, identified additionally in individual I6."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;UMPS PROTEIN TRUNCATION AND NMD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Protein truncation or nonsense-mediated mRNA decay processes that occur due to genomic variants leading to a premature stop codon in UMPS gene."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Software programs used to predict the pathogenicity of missense alterations found in the UMPS gene."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Conservation studies showing that amino acids affected by mutations are well-preserved across species from humans to fruit flies and roundworms indicating their importance in protein function."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;EXAC BROWSER VARIANTS FREQUENCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The Exac browser database used for checking the frequency of identified variants, with most variant frequencies below 0.001."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.857T&gt;A (P.ILE286ASN)&quot;">
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d1">"Software programs predict the pathogenicity of missense alterations in UMPS gene including c.857T&gt;A."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C.451G&gt;A (P.VAL151MET)&quot;">
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d1">"Software programs predict the pathogenicity of missense alterations in UMPS gene including c.451G&gt;A."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 GENE (RS4073)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-8 gene contains a polymorphism at rs4073 in its promoter region."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS4073 T/A POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in the IL-8 gene, located at position rs4073, involves a transition from thymine to adenine."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-10 GENE (RS1800896)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-10 gene has a polymorphism in its promoter region identified by the SNP rs1800896."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1800896 A/G POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in the IL-10 gene, located at position rs1800896, involves a transition from adenine to guanine."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-22 GENE (RS1179251)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-22 gene contains a polymorphism in its promoter region identified by the SNP rs1179251."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1179251 C/G POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in the IL-22 gene, located at position rs1179251, involves a transition from cytosine to guanine."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-22 GENE (RS2227485)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-22 gene contains another polymorphism in its promoter region identified by the SNP rs2227485."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS2227485 C/T POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in the IL-22 gene, located at position rs2227485, involves a transition from cytosine to thymine."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-27 GENE (RS17855750)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-27 gene has a polymorphism in its promoter region identified by the SNP rs17855750."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS17855750 T/G POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in the IL-27 gene, located at position rs17855750, involves a transition from thymine to guanine."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;TGFSS1 GENE (RS1800469)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TGF-β1 gene has a polymorphism in its promoter region identified by the SNP rs1800469."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1800469 C/T POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in the TGF-β1 gene, located at position rs1800469, involves a transition from cytosine to thymine."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;CRC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colorectal cancer (CRC) is a disease characterized by uncontrolled cell growth in the colon or rectum."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colorectal cancer (CRC) is a disease associated with certain genotypes and alleles, particularly the CC genotype according to this text."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;OCCURRENCE OF CRC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The occurrence of colorectal cancer is influenced by genomic variants such as the CC genotype and T allele."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;TSLP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TSLP gene is implicated in asthma susceptibility through specific SNPs and haplotypes."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;RS1898671&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the TSLP gene (rs1898671) shows a significant association with asthma risk, particularly among ex-smokers."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TSLP PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The TSLP protein, encoded by the TSLP gene, is involved in immune responses and plays a role in asthma pathogenesis."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic inflammatory disorder of the airways characterized by variable airflow obstruction and bronchospasm."&lt;SEP&gt;"Asthma is a chronic respiratory condition that affects lung function and was considered in sub-analyses for genetic associations."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;EX-SMOKERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Individuals who have previously smoked but are no longer smoking, a factor influencing asthma risk with TSLP gene variants."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NEVER-SMOKERS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Individuals who have never smoked and show different asthma susceptibility patterns compared to ex-smokers in relation to the TSLP gene."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;IGE (IMMUNOGLOBULIN E)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An antibody involved in allergy and asthma pathogenesis. The total IgE levels were significantly higher among cases compared to controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;FEV1/FVC RATIO (FORCED EXPIRATORY VOLUME IN ONE SECOND/ FORCED VITAL CAPACITY RATIO)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of lung function that is reduced in asthmatic patients compared to healthy individuals."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;PRINCIPAL COMPONENT ANALYSIS (PCA)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A statistical method used for identifying patterns within a dataset, here applied to detect population stratification among the study participants."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;STRUCTURE METHOD&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A computational approach used in population genetics for estimating ancestry and detecting genetic admixture. Used alongside PCA in this analysis."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;FEV1/FVC RATIO&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"FEV1/FVC ratio is a measure used to assess lung function, particularly for diagnosing obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD)."&lt;SEP&gt;"Reduced FEV1/FVC ratio is a hallmark sign of obstructive airway disease, such as asthma."&lt;SEP&gt;"The FEV1/FVC ratio is used to diagnose and monitor conditions such as asthma and chronic obstructive pulmonary disease (COPD)."</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;POPULATION STRATIFICATION&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"PCA is used to identify and quantify population stratification in genetic association studies."&lt;SEP&gt;"The signal from population stratification was negligible, with lambda (λ) = 1.001 indicating no significant inflation."</data>
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
    </node>
    <node id="&quot;PTPN2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PTPN2 gene is associated with autoimmune diseases such as celiac disease, inflammatory bowel disease, rheumatoid arthritis and type 1 diabetes."&lt;SEP&gt;"The gene associated with the SNP rs478582."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN22 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene associated with SNPs including rs2476601."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the PTPN2 gene found significant in Crohn's Disease (CD) subjects compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the PTPN22 gene that is not significant in CD but is relevant for other inflammatory autoimmune diseases."&lt;SEP&gt;"This is a risk variant in the PTPN22 gene associated with autoimmune disorders."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the PTPN2 gene, which showed lower expression levels in Crohn's Disease subjects compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN22 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the PTPN22 gene that also showed lower expression levels in CD subjects relative to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;IFN-Γ GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Expression level of IFN-γ, which was evaluated for its relationship with SNPs rs478582 and rs2476601 but no specific data on differential expression is provided in the given text."&lt;SEP&gt;"The expression level of IFN-γ increases in CD subjects with both MAPbacteremia and specific genotypes (e.g., heterozygous or minor alleles at rs478582) compared to those without these conditions."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic inflammatory condition of the gastrointestinal tract that affects individuals with specific genetic predispositions."&lt;SEP&gt;"A chronic inflammatory condition of the gastrointestinal tract, characterized by a higher prevalence of certain genotypes and increased susceptibility to MAPbacteremia."&lt;SEP&gt;"An inflammatory bowel disease that shows significant genetic variations compared to healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN2:RS478582 HAPLOTYPE T-G&quot;">
      <data key="d0">"HAPLOTYPE COMBINATION"</data>
      <data key="d1">"The haplotype combination involving major alleles of PTPN2 SNP rs478582 (T) and PTPN22 SNP rs2476601 (G), found more significantly in healthy controls than CD subjects."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2:RS478582 HAPLOTYPE C-G&quot;">
      <data key="d0">"HAPLOTYPE COMBINATION"</data>
      <data key="d1">"The haplotype combination involving heterozygous or minor alleles of PTPN2 SNP rs478582 (C) and major allele of PTPN22 SNP rs2476601 (G), found more significantly in CD subjects than healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2:RS478582 HAPLOTYPE T-A&quot;">
      <data key="d0">"HAPLOTYPE COMBINATION"</data>
      <data key="d1">"The haplotype combination involving major alleles of PTPN2 SNP rs478582 (T) and heterozygous or minor allele of PTPN22 SNP rs2476601 (A), found less in CD subjects compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2:RS478582 HAPLOTYPE C-A&quot;">
      <data key="d0">"HAPLOTYPE COMBINATION"</data>
      <data key="d1">"The haplotype combination involving heterozygous or minor alleles of both PTPN2 SNP rs478582 (C) and PTPN22 SNP rs2476601 (A), found more significantly in CD subjects than healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;GENE EXPRESSION LEVEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The level of gene expression, measured here as relative gene expression levels of PTPN2/PTPN22 and IFN-γ, showing differential patterns between Crohn's Disease (CD) patients and healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2:RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at the PTPN2 gene locus with heterozygous (TC) or minor (CC) alleles is associated with decreased average relative gene expression and increased susceptibility to MAP infection in Crohn's Disease (CD) subjects."&lt;SEP&gt;"A genomic variant located at rs478582 on the PTPN2 gene associated with increased susceptibility to MAPbacteremia in Crohn's disease (CD) subjects."&lt;SEP&gt;"A genomic variant located within the PTPN2 gene, influencing T-cell functionality and IFN-γ expression."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN22:RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at the PTPN22 gene locus with heterozygous (GA) or minor (AA) alleles is associated with decreased average relative gene expression of PTPN22 in CD subjects but does not significantly change IFN-γ relative gene expression."&lt;SEP&gt;"A genomic variant located at rs2476601 on the PTPN22 gene associated with increased susceptibility to MAPbacteremia in Crohn's disease (CD) subjects."&lt;SEP&gt;"Another genomic variant that affects T-cell proliferation response in CD subjects with MAPbacteremia."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN2 GENE EXPRESSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Expression levels of the PTPN2 gene are significantly reduced in CD subjects compared to healthy controls irrespective of MAPbacteremia status."&lt;SEP&gt;"Relative gene expression of the PTPN2 transcript is lower in Crohn's Disease (CD) subjects compared to healthy controls with similar genotypes, especially those carrying heterozygous or minor alleles at rs478582."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN22 GENE EXPRESSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Expression levels of the PTPN22 gene show a reduction in CD subjects with MAPbacteremia presence and certain genotypes."&lt;SEP&gt;"Relative gene expression of the PTPN22 transcript is lower in CD subjects with heterozygous (GA) or minor (AA) alleles compared to healthy controls, particularly for IFN-γ expression."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;IFN-Γ RELATIVE GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The relative gene expression of IFN-γ is increased in CD subjects carrying the PTPN2:rs478582 heterozygous (TC) or minor (CC) alleles compared to those with normal alleles."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;MAP INFECTION SUSCEPTIBILITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Crohn's Disease (CD) subjects are more susceptible to Mycobacterium avium subspecies paratuberculosis (MAP) infection, especially when carrying the PTPN2:rs478582 heterozygous or minor alleles."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS (MAP)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"MAP is an environmental factor that can cause bacteremia and is more prevalent in CD subjects with specific genotypes at PTPN2:rs478582."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;PTPN2 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by PTPN2 is influenced by genomic variants at rs478582, affecting physiological processes in Crohn's Disease (CD) subjects."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;PTPN22 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by PTPN22 is affected by genomic variants at rs2476601, influencing gene expression patterns and disease susceptibility."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;HAPLOTYPE C-G&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The haplotype combination of heterozygous or minor/major alleles at rs478582 and rs2476601 increases the risk of MAPbacteremia in CD subjects compared to healthy controls."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;HAPLOTYPE T-A&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The haplotype combination of major/heterozygous or minor alleles at rs478582 and rs2476601 shows a higher prevalence of MAPbacteremia in CD subjects compared to healthy controls."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;HAPLOTYPE C-A&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The haplotype combination of heterozygous or minor/heterozygous or minor alleles at rs478582 and rs2476601 has a moderate prevalence in CD subjects with MAPbacteremia."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN2/22 GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The expression of PTPN2 and PTPN22 genes is significantly lower in CD subjects compared to healthy controls regardless of the presence or absence of MAPbacteremia, indicating a relationship between these variants and disease susceptibility."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;MAPBACTEREMIA PRESENCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The presence of Mycobacterium avium subsp. Paratuberculosis (MAP) bacteria in blood samples from CD patients is associated with specific genetic variants and altered gene expression patterns."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;IFN-Γ EXPRESSION LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Higher IFN-γ expression is observed in CD patients with both MAPbacteremia and specific genotypic variants compared to those without these conditions."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;T-CELL PROLIFERATION RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which T-cells multiply and grow, influenced by genetic variants and environmental factors like MAPbacteremia."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITH SNPS IN PTPN2:RS478582 OR PTPN22:RS2476601&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A specific group of individuals carrying certain genetic variants that affects their immune response and T-cell functionality."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAPBACTEREMIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The presence of Mycobacterium avium subspecies paratuberculosis bacteria, which can influence the expression of IFN-γ in CD subjects."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PHA TREATMENT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A treatment involving phytohemagglutinin to stimulate T-cell proliferation and response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAP PPD-LIKE TREATMENT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A treatment simulating the presence of MAP bacteria to test T-cell responses."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;T-CELLS FUNCTIONALITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The overall functionality of T-cells, affected by genetic variants and environmental exposures such as MAPbacteremia."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITHOUT MAPBACTEREMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Subjects with Crohn’s disease (CD) who do not exhibit evidence of Mycobacterium avium subspecies paratuberculosis (MAP)."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;HEALTHY CONTROL SUBJECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Individuals without any known genetic or environmental factors affecting T-cell functionality."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PTPN22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PTPN22 is a gene that is more highly expressed in regulatory T cells (Treg) compared to conventional T cells (Tconv)."&lt;SEP&gt;"PTPN22 is a gene whose expression varies among different lymphocyte subsets and activation states."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;LYMPHOCYTE SUBSET&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Lymphocyte subsets, including naïve, memory, and regulatory CD4+ T cell subsets, exhibit differential PTPN22 expression patterns at rest and following in vitro activation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;ACTIVATION STATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The activation state of lymphocytes influences the transcriptional profile and expression levels of PTPN22."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;T1D NON-RISK ALLELE (LYP-620R)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This allele, encoding LYP-620R, is associated with a lower risk for type 1 diabetes compared to the risk variant."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TCR SIGNALING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The interaction between TCR and its ligands initiates downstream signaling pathways like calcium flux and MAPK/ERK pathway in lymphocytes."&lt;SEP&gt;"The process of T cell receptor activation and subsequent intracellular signaling events."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CALCIUM FLUX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Calcium flux is a physiological process initiated by TCR ligation, which is modulated differently by the risk (LYP-620W) and non-risk (LYP-620R) variants of PTPN22."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MAPK/ERK PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The MAP kinase ERK pathway is involved in signal transduction initiated by TCR ligation and modulated by PTPN22 variants."&lt;SEP&gt;"The MAPK/ERK pathway is a downstream signaling pathway activated following TCR ligation, influenced by the expression levels of LYP (PTPN22)."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;ACTIVATION MARKERS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Surface expression of activation markers such as CD69, ICOS, and CD226 on lymphocytes indicates their level of activation following TCR ligation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TRANSCRIPT OF PTPN22&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript levels of PTPN22 vary among different T cell subsets at rest and after activation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TCONV (NAÏVE CD4+ T CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Naïve CD4+ T cells exhibit specific patterns of PTPN22 expression which change with activation state."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MEMORY TCONV CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Memory CD4+ T cells have distinct patterns of PTPN22 expression compared to other subsets at rest and during activation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TREGS (REGULATORY CD4+ T CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulatory CD4+ T cells exhibit unique characteristics regarding the level of PTPN22 transcription and function in response to activation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;RISK VARIANT LYP-620W&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The risk variant LYP-620W is associated with less effective regulation of TCR signaling pathways compared to the non-risk variant LYP-620R."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TCR (T CELL RECEPTOR)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The T cell receptor initiates downstream signaling upon ligand binding, influencing various cellular functions and processes."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;LAT SIGNALOSOME&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The assembly of the LAT signalosome is a critical step in initiating downstream signaling following TCR ligation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CALCIUM SIGNALING PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Calcium signaling pathway is activated after TCR stimulation, influencing various cellular processes including activation and proliferation."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD69&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD69 is a protein expressed on activated T cells and other immune cells."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;ICOS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Inducible Costimulator (ICOS) is a protein that plays a role in the activation of T cells and B cells."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD25&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CD25, also known as IL-2 receptor alpha chain gene, encodes the high-affinity interleukin 2 receptor."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD226&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD226 is a protein involved in T cell activation and adhesion to antigen-presenting cells."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PD-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Programmed Death-1 (PD-1) gene encodes the PD-1 receptor, which plays a role in inhibiting immune responses."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TCONV&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Conventional T cells (Tconv) are compared to regulatory T cells in terms of PTPN22 expression levels."&lt;SEP&gt;"Conventional T cells (Tconv) are contrasted with regulatory T cells for expression levels of PTPN22."&lt;SEP&gt;"Tconv represents the process of conventional T cell activation and proliferation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREGS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Tregs refers to regulatory T cells that suppress immune responses."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP-620R&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LYP-620R is a variant of the LYP protein that significantly represses Tresp proliferation."&lt;SEP&gt;"LYP-620R is a variant of the LYP protein with a specific amino acid change at position 620."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;PTPN22 RISK VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the PTPN22 gene that increases risk for autoimmune disorders."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;T CELL ACTIVATION MARKERS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Markers expressed on T cells during their activation process, such as CD69 and ICOS."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;APC-MEDIATED PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of T cell proliferation induced by antigen-presenting cells (APCs)."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PMA/IONOMYCIN-INDUCED PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Proliferation induced in T cells through stimulation with phorbol myristate acetate and ionomycin."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;MICROBEAD ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Activation of T cells using beads coated with antibodies against CD3 and CD28."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IL-2 ACCUMULATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway involving the net accumulation of IL-2 in response to T cell activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IFNΓ SECRETION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Secretion of interferon gamma, an important cytokine involved in immune responses."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CTLA-4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CTLA-4 gene encodes the cytotoxic T lymphocyte-associated protein 4, a key molecule involved in regulating immune responses."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP-620W&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LYP-620W is another variant of the LYP protein with different functional properties compared to LYP-620R."&lt;SEP&gt;"LYP-620W is another variant of the LYP protein with reduced capacity to suppress Tresp proliferation compared to LYP-620R."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;RS2476601 RISK VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with autoimmune disorders, specifically within the PTPN22 gene."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CA&lt;SUP&gt;2+&lt;/SUP&gt; AND PERK SIGNALING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Signaling pathways involving calcium ions (Ca&lt;sup&gt;2+&lt;/sup&gt;) and phosphorylated extracellular signal-regulated kinases (pERK) in T cell activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CELL TRACKING DYE DILUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A method used to assess cell proliferation by monitoring the dilution of a fluorescent dye over time."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IL-4, IL-5, IL-9, IL-10, AND IL-13&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Cytokines produced by T cells involved in regulating immune responses."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TH1 AND TH2-ASSOCIATED IMMUNITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Immune responses mediated by Th1 (T helper 1) and Th2 (T helper 2) subsets of CD4+ effector T cells."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LYP is a protein whose variants (LYP-620R and LYP-620W) influence the proliferation of Tresp cells."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;RISK VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A risk variant of the PTPN22 gene, specifically rs2476601, has been implicated in autoimmune disorders."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;IFNΓ&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Interferon gamma (IFNγ) secretion was not altered by overexpression of either LYP variant according to the data presented."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG-MEDIATED SUPPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This refers to the interaction where regulatory T cells suppress effector T cell responses, which is influenced by PTPN22 and its variants."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Several autoimmune diseases are associated with the risk variant of PTPN22 (rs2476601)."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TRESP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Tresp represents effector T cells whose proliferation and activation is regulated by LYP variants."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;APCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Antigen-presenting cells (APCs) are used in the co-culture experiments involving Treg and Tresp cells."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Regulatory T cells (Treg) are involved in suppressing effector T cell responses and their function is influenced by PTPN22 variants."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TH1 SIGNATURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Th1 signature, involved in immune responses, has been implicated in several autoimmune disorders linked to the rs2476601 variant."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;PTPN22 KNOCKOUT MICE&quot;">
      <data key="d0">"EXPERIMENTAL MODEL"</data>
      <data key="d1">"Studies on Ptpn22 knockout mice have shown that overexpression of LYP variants does not alter IFNγ secretion, supporting similar findings in human cells."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;EFFECTOR CYTOKINE SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This process refers to the secretion of cytokines by effector T cells (Tresp), which is shown to be unaffected by LYP variant overexpression."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;AUTOLOGOUS APCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Autologous antigen-presenting cells used in co-culture experiments to assess the effects of LYP variants on T cell responses."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;T CELL CYTOKINE PRODUCTION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Net accumulation of IL-2 is influenced by LYP variant expression, affecting T cell cytokine production dynamics.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRESP PROLIFERATION&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The overexpression of LYP-620R significantly represses the proliferation of effector T cells (Tresp)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG SUPPRESSIVE CAPACITY&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Overexpressing LYP-620W in regulatory T cells slightly enhances their suppressive capacity over basal levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22 RISK VARIANT (RS2476601)&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The risk variant of PTPN22 is associated with an increased risk for autoimmune disorders due to its influence on Treg-mediated suppression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP VARIANTS&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Neither LYP-620R nor LYP-620W variants significantly altered the secretion of IFNγ according to experimental data."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22 GENE EXPRESSION LEVELS&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The expression level of PTPN22 in regulatory T cells (Treg) is higher than that in conventional T cells (Tconv), influencing the suppressive capacity of Tregs."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRESP ACTIVATION&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Overexpressing LYP-620W leads to reduced control over activation, proliferation, and effector mechanisms in conventional T cells (Tconv)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG SUPPRESSION ASSAY&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"APCs are used in the Treg suppression assay to assess the suppressive capacity of regulatory T cells when co-cultured with effector T cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAG72&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TAG72 is a gene encoding a glycoprotein (tumor-associated antigen) that is highly expressed in ovarian cancer cells."&lt;SEP&gt;"TAG72 is a gene that encodes for a protein expressed in various cancers, used as a target for CAR T cell therapy."&lt;SEP&gt;"The TAG72 gene is identified as a potential target antigen in ovarian cancer therapy."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The 4-1BB intracellular co-stimulatory domain is part of the second-generation TAG72-BBζ CAR construct that enhances T cell activation and anti-tumor activity."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CC49 SCFV&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Humanized single-chain variable fragment (scFv) derived from CC49 antibody, used in the construction of the TAG72-BBζ CAR to recognize TAG72 antigen on tumor cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD3Ζ CYTOLYTIC DOMAIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The CD3ζ cytosolic domain is part of the T cell receptor complex and is included in the TAG72-BBζ CAR construct for cytotoxic activity against tumors expressing TAG72 antigen."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CAR T cells engineered to express TAG72-specific chimeric antigen receptors (BBζ) for targeting and killing ovarian cancer cells expressing TAG72."&lt;SEP&gt;"CAR T cells engineered to express the BBζ signaling domain and target the TAG72 antigen, used in this study for treating ovarian cancer."&lt;SEP&gt;"CAR T cells modified with a chimeric antigen receptor (CAR) targeting the TAG72 antigen, containing components such as CC49 scFv and 4-1BB co-stimulatory domain for enhanced anti-tumor activity."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TAG72 EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of expressing the TAG72 protein on the surface or intracellularly in various cancer cells, particularly ovarian and colon cancers, as a target for CAR T cell therapy."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVARIAN CANCER CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cells derived from tumors originating in the ovaries that express TAG72 antigen and can be targeted by TAG72-BBζ CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;SKOV3, OVCAR8, COV362.4, OVCAR3, OV90, LS174T&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Specific cell lines derived from ovarian and colon cancers that express varying levels of TAG72 antigen used in experiments to assess the efficacy of TAG72-BBζ CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;ASCITES CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cells obtained from fluid accumulated in the peritoneal cavity of patients with advanced-stage ovarian cancer, expressing TAG72 and targeted by TAG72-BBζ CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS (DPBMC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Peripheral blood mononuclear cells derived from healthy donors that are used as a source for generating CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD14+ AND CD25+&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Cell types depleted from peripheral blood mononuclear cells to generate CAR T cells, representing specific cell populations."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TRUNCATED CD19 (CD19T)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A truncated version of the CD19 protein used as a marker for tracking CAR T cells during their manufacturing process."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CAR TRANSDUCTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The process of introducing the TAG72-BBζ CAR construct into target cells, typically through viral vectors, to generate CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CO-CULTURE ASSAYS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Experimental method used to assess the anti-tumor activity and specificity of TAG72-BBζ CAR T cells by co-culturing them with tumor targets."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;E:T RATIO&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The ratio of effector (CAR) T cells to target (tumor) cells used in assays to evaluate the cytotoxic activity of CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OAS3, OAS4, OAS7&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patient ascites samples from individuals with ovarian cancer used in vitro assays to evaluate the cytolytic activity of CAR T cells against TAG72-positive and negative tumor cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVCAR3 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A human ovarian cancer cell line used for establishing tumors in immune-compromised mice to assess the therapeutic potential of TAG72-BBζ CAR T cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;I.P. (INTRAPERITONEAL) INJECTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of delivering substances directly into the abdominal cavity, commonly used for treating peritoneal tumors in ovarian cancer models."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;I.V. (INTRAVENOUS) DELIVERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The method of administering therapeutic agents such as CAR T cells through the bloodstream to reach target organs and tissues."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;NSG MICE&quot;">
      <data key="d0">"MODEL ORGANISM"</data>
      <data key="d1">"NOD-scid IL2rγnull (NSG) mice, used in research for xenograft studies due to their highly compromised immune system allowing human cell engraftment."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;EGFP/FFLUC&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Enhanced Green Fluorescent Protein and firefly luciferase proteins, transduced into OVCAR3 cells for non-invasive imaging of tumor growth in mice."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;REGIONAL I.P. DELIVERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The therapeutic strategy involving the intraperitoneal injection of CAR T cells directly to the abdominal cavity where peritoneal tumors are located, enhancing anti-tumor efficacy."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;REPEAT DOSING OF TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Administering multiple doses of CAR T cells over an extended period to achieve more durable and effective anti-tumor responses in mice models."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;CAR T CELL THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A form of immunotherapy where T cells are engineered to express chimeric antigen receptors for targeted cancer treatment."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;IFNΓ (INTERFERON GAMMA)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Cytokine produced by CAR T cells after interacting with TAG72-positive tumor cells, indicating anti-tumor activity."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;IL-2 (INTERLEUKIN 2)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A cytokine secreted by activated T and NK cells that supports their proliferation and function in immune responses."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;HUMAN OVARIAN CANCER ASCITES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fluid accumulated within the peritoneal cavity due to cancer, often containing malignant cells and proteins indicative of disease progression."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVCAR3 TUMORS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A mouse xenograft model using human OVCAR3 ovarian cancer cells transplanted into NSG mice for studying therapeutic efficacy."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OV90 MODEL&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"An aggressive ovarian cancer xenograft model used in the study."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OVCAR3 MODEL&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"A less aggressive ovarian cancer cell line model used in the study for comparison with OV90."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC1, MUC16&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes encoding cell surface antigens that are also potential targets for ovarian cancer immunotherapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;CAR T CELLS EFFICACY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The effectiveness of CAR T cells in targeting and suppressing tumor growth in xenograft models."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR ANTIGEN HETEROGENEITY&quot;">
      <data key="d0">"DISEASE FEATURE"</data>
      <data key="d1">"A characteristic of solid tumors where they can express varying levels or lose expression of specific antigens over time, leading to resistance against targeted therapies."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TAG72 EXPRESSION REDUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The observed decrease in TAG72 antigen expression on tumor cells following TAG72-BBζ CAR T cell therapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;SOLID TUMORS AND ASCITES&quot;">
      <data key="d0">"DISEASE FEATURE"</data>
      <data key="d1">"Sites where residual or recurrent cancer can be found, characterized by the presence of solid tumors and fluid accumulation (ascites) in abdominal cavities."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;I.P. INJECTION&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Intraperitoneal injection of tumor cells into NSG mice is used to establish models for evaluating the therapeutic potential of TAG72-BBζ CAR T cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;I.P. DELIVERY&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Regional intraperitoneal delivery of TAG72-BBζ CAR T cells exhibits potent anti-tumor activity, extending survival in ovarian ascites-bearing mice compared to systemic i.v. delivery."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFNΓ, IL-2&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Upon interaction with TAG72-positive tumor cells, TAG72-BBζ CAR T cells produce cytokines like IFNγ and IL-2 as part of their anti-tumor activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at this locus is associated with FEV1/FVC in the Hutterite population."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;RS12441227&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP explains a significant portion of the residual variance in FEV1/FVC among Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;C10ORF11 GENE ON CHROMOSOME 10Q22.3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The C10orf11 gene is associated with FEV1 and its downstream SNPs are associated with FEV1/FVC in Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;CCL23-CCL18 ON CHROMOSOME 17Q12&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant at this locus shows evidence of association with FEV1/FVC."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;PITPNC1 LOCUS ON CHROMOSOME 17Q24.2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The PITPNC1 locus is associated with FEV1/FVC in Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;CHAF1B ON CHROMOSOME 21Q22.13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A genomic variant near this gene shows evidence of association with FEV1/FVC."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;IL37 GENE ON CHROMOSOME 2Q13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL37 gene is associated with reduced FEV1 in Hutterites."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;ASXL3 ON CHROMOSOME 18Q12.1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A genomic variant within the ASXL3 gene shows evidence of association with FVC."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FEV1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Forced Expiratory Volume in one second (FEV1) is a measure of lung function used to assess airway obstruction."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FVC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Forced Vital Capacity (FVC) measures the total volume of air that can be exhaled after full inhalation, another key indicator of lung health."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;GENETIC VARIATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Genetic variation contributes significantly to the heritability of lung function measures such as FEV1, FVC, and FEV1/FVC ratio."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;LOW FEV1/FVC ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Alleles associated with low FEV1/FVC ratio contribute to genetic predisposition towards reduced lung function."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;Β-DEFENSIN GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A family of genes encoding small cysteine-rich peptides that play a role in the innate immune system by defending against invading pathogens."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CHEMOKINE GENES (CCL18 AND CXCL12)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes coding for chemokines, which are cytokines that induce directed chemotactic migration of inflammatory cells towards a site of inflammation or infection."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;TNFRSF13B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene encoding the transmembrane protein Tumor Necrosis Factor Receptor Superfamily Member 13B, involved in immune responses and regulation of B-cell development and function."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic locus identified as part of a genetic association study (GWAS) showing potential for being linked with specific traits or diseases related to lung function."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;C10ORF11 GENE/LOCUS&quot;">
      <data key="d0">"GENE/LOCUS"</data>
      <data key="d1">"A gene or chromosomal region associated with particular phenotypes, in this case identified through GWAS but not found to be functionally connected to other genes of interest."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CCL23-CCL18 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic locus that includes both CCL23 and CCL18 genes and is associated with lung function variance, notably through interaction with β-defensin genes and CXCL12."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;HUTTERITES&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">"An isolated population originating from the Anabaptist tradition, known for their unique genetic background and consistent lifestyle."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;RESIDUAL FEV1/FVC VARIANCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The variability in FEV1/FVC ratio that remains unexplained after accounting for major factors like age and sex."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;GRAIL ALGORITHM&quot;">
      <data key="d0">"ALGORITHM/TOOL"</data>
      <data key="d1">"An algorithm designed for mining gene ontology databases to find functional connections between genes based on their molecular and cellular functions, biological processes, and subcellular locations."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;FEV1/FVC&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The PITPNC1 locus shows evidence of association with FEV1/FVC in Hutterites, indicating genetic influence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FVC AND FEV1/FVC&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"This genomic variant is associated with both FVC and FEV1/FVC, indicating a role in lung function genetics."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FEV1, FVC, FEV1/FVC RATIO&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"Genetic variation explains a significant portion of the variance in these physiological measures."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FVC AND FEV1/FVC RATIO&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"Sub-analyses excluding individuals with asthma showed persistent genetic associations, indicating disease independence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE ONTOLOGY DATABASE&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"The GRAIL algorithm was used to analyze the Gene Ontology database for functional connections between genes near predictive SNPs identified through GWAS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTLA4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CTLA4 gene is associated with autoimmune diseases such as Type 1 Diabetes and Rheumatoid Arthritis, playing a role in immune regulation."&lt;SEP&gt;"The CTLA4 gene is associated with susceptibility to primary biliary cholangitis (PBC)."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS231775&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the CTLA4 gene is significantly associated with PBC susceptibility, showing an increased risk in various genetic models."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS231725&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another SNP within the CTLA4 gene that also shows significant association with PBC susceptibility, though less frequently reported than rs231775."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS3087243&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant in the CTLA4 gene does not show a significant association with PBC susceptibility according to this analysis."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS5742909&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Yet another SNP within the CTLA4 gene, found not to be significantly associated with PBC risk in this study."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PBC SUSCEPTIBILITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Primary biliary cholangitis (PBC) is a liver disease that may have genetic components influencing susceptibility."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The phenomenon where certain combinations of genetic variants are observed more or less often than would be expected by chance alone due to physical proximity on a chromosome."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A method for assessing the robustness of study results by excluding one study at a time and observing how much this exclusion affects overall findings."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PUBLICATION BIAS &quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A form of bias in meta-analysis studies where there is an imbalance between published positive or negative results, affecting overall conclusions."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS3087243 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This polymorphism in CTLA4 does not show significant association with PBC susceptibility but was extensively studied."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS5742909 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism in CTLA4 that does not show a significant association with PBC susceptibility but was investigated."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PRIMARY BILIARY CHOLANGITIS (PBC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic liver disease characterized by the destruction of small bile ducts within the liver, with genetic factors playing a role in susceptibility."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;GENOTYPES OF CONTROLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The genotypes observed in control groups were generally consistent with Hardy-Weinberg equilibrium expectations."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RANDOM-EFFECT MODEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Used to generate confidence intervals when heterogeneity is present among studies, such as for rs231775, rs3087243, and rs5742909 polymorphisms."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;FIXED-EFFECTS MODEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Used when there is little to no heterogeneity among studies for other polymorphisms like rs231725."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM TABLE (TABLE 4)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A table summarizing the linkage disequilibrium values among four SNPs in CTLA4."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSIS RESULTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The findings from sensitivity analysis indicate that results are stable and reliable for rs231775 and rs231725 when excluding individual studies."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;EGGER'S TEST&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A statistical test used to detect publication bias in meta-analysis, with p-values indicating the lack of significant bias for most SNPs."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;BEGG'S FUNNEL PLOT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A visual representation used to assess publication bias in meta-analysis, showing no evidence of bias for the majority of SNPs."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;RS231775, RS231725, RS3087243, AND RS5742909&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"There is no significant linkage disequilibrium observed between these four SNPs in the CTLA4 gene."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS231775, RS231725&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"Results from sensitivity analyses suggest that associations of rs231775 and rs231725 with PBC susceptibility are robust to the exclusion of individual studies."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STABILITY OF FINDINGS FOR RS231775 AND RS231725&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"The findings from sensitivity analysis indicate that results are stable and reliable for these two SNPs when excluding individual studies."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PUBLICATION BIAS ASSESSMENT&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"A statistical test used to detect publication bias in meta-analysis, showing no significant evidence of bias for most SNP analyses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VISUAL REPRESENTATION OF PUBLICATION BIAS&quot;">
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d1">"A visual representation used to assess publication bias in meta-analysis, indicating the lack of significant bias for the majority of SNPs."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS231775 (+49A/G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with T1D and RA and influences the expression levels of CTLA4."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;RS3087243 (CT60A/G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in strong linkage disequilibrium with rs231806, influencing CTLA4 mRNA expression."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;RS231806 (MH30C/G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP is strongly linked to rs3087243 and affects the expression of the CTLA4 gene in T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;RS231735 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant associated with autoimmune diseases, showing strong linkage disequilibrium with MH30 and CT60 SNPs."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CTLA4 PROTEIN &quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The CTLA4 protein is involved in immune regulation and plays a critical role in T cell function and differentiation."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;INHIBITORY IMMUNE CHECKPOINT GENE EXPRESSION LEVELS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Expression levels of inhibitory checkpoint genes like CTLA4 are regulated by genetic factors and influence immune responses."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;T1D &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 1 Diabetes, an autoimmune disease influenced by genetic variants affecting the expression of CTLA4 in T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;RA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Rheumatoid Arthritis, another autoimmune condition associated with genetic regulation and expression of CTLA4 in T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;3’UTR OF CTLA4 &quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The 3' untranslated region (UTR) of the CTLA4 gene includes a variable number of AT repeats that influence mRNA stability and expression levels."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CD4+ T CELLS &quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD4+ T cells are involved in immune regulation and express genes like CTLA4 which play roles in autoimmune responses."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CD8+ T CELLS &quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These T cells also express genes such as CTLA4, but their expression levels may differ due to differential DNA methylation compared to CD4+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CIS-EQTLS &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"cis-eQTLs represent genetic variations in close proximity that influence gene expression within a 1Mb interval, impacting cellular functions like immune regulation."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;IGG FCΓ RECEPTOR IIIB (FCGR3B)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FCGR3B gene encodes for a receptor involved in immune cell activation and regulation."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CPG SITE (CG26091609)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A specific CpG site near the second exon of CTLA4 that influences its expression through methylation patterns."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;LONG CODING RNA RP11−534L20.5 &quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"RP11−534L20.5 is a long non-coding RNA located downstream of the IKBKE gene, which regulates inflammatory responses."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;IKBKE GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IKBKE gene plays an essential role in regulating immune responses to viral infections."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;STAT6 &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"STAT6 is a transcriptional activator involved in T cell differentiation and function."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;STX2 (SYNTAXIN 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"STX2 encodes for syntaxin 2, which is involved in intracellular vesicle transport within cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CTLA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CTLA4 is a gene whose expression levels are inversely correlated with DNA methylation in CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CG26091609&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific CpG site (cg26091609) associated with CTLA4 expression levels in T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CD4+ AND CD8+ T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Processes involving differentiation and function of CD4+ and CD8+ T lymphocytes are influenced by the expression patterns of various genes, including CTLA4."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;TRANS-EQTL EFFECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process where genetic variation affects the expression of a gene located at a distant chromosomal location compared to the variant's physical location."&lt;SEP&gt;"Transcriptional regulation influenced by distant genetic variants that affect gene expression patterns in specific cell types, such as T1D-related genes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;RS1131017&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located within the 5’UTR of RPS26 and associated with broad-range effects on hundreds of genes in CD4+ and CD8+ T cells, influencing diseases like Type 1 Diabetes (T1D)."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RPS26 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ribosomal small subunit protein RPS26 gene is affected by the trans-eQTL SNP rs1131017."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CHR12Q13.2 LOCUS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A genomic region impacting hundreds of genes in T cells, with SNPs implicated in autoimmune and inflammatory diseases due to their strong linkage disequilibrium (LD) with GWAS SNPs associated with these conditions."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL27 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-27 gene is associated with a trans-eQTL effect linked to lower expression of IRF1, STAT1, and REC8 in CD4+ T cells and reduced risk for Type 1 Diabetes (T1D)."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RS4788084[T]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP near the IL27 gene associated with lower expression of IRF1 and STAT1, contributing to a decreased risk for T1D in CD4+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IRF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IRF1 is a gene involved in immune response and is regulated by signaling pathways such as STAT1."&lt;SEP&gt;"Interferon regulatory factor 1 (IRF1) is downregulated by the trans-eQTL effect of rs4788084[T] near IL27 and rs181206[G], indicating its role in T1D susceptibility."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;STAT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"STAT1 is a gene that encodes the signal transducer and activator of transcription 1, which plays a role in cytokine signaling and regulation of immune responses."&lt;SEP&gt;"Signal Transducer and Activator of Transcription 1 (STAT1) is downregulated by the trans-eQTL effect of rs4788084[T] near IL27, contributing to lower risk for T1D in CD4+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;RS181206[G]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense SNP within the IL-27 gene causing an amino acid change from Leu119Pro, associated with reduced IRF1 and STAT1 expression in CD4+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;T1D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 1 Diabetes (T1D) is influenced by genetic variants like rs181206[G] and the IL-27 gene, contributing to altered immune function."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CDK2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located in the trans-acting region identified at chr12q13.2, involved in cell cycle regulation."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RAB5B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene within the trans-acting region at chr12q13.2 that affects multiple genes' expression levels in T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;SUOX GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Sulfite oxidase (SUOX) is a gene found in the broad-range regulatory locus at chr12q13.2, influencing various downstream genes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IKZF4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located within the trans-acting region at chr12q13.2 that influences the expression of multiple genes in T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;ERBB3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Epidermal growth factor receptor 3 (ERBB3) is part of the regulatory locus affecting hundreds of genes' expression in CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;GZMA, GZMB, GZMH, GNLY, CD8A GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes highly expressed in T cells that are influenced by the trans-acting locus at chr12q13.2."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL27 MISSENSE VARIANT RS181206[G]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant within IL27 causing a Leu119Pro change, significantly influencing IRF1 and STAT1 expression levels in CD4+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;SNP RS181206[G]&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense SNP located at position rs181206 that influences the expression levels of IRF1 and STAT1 genes."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27RA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The receptor for IL-27, which together with gp130 (encoded by IL6ST) forms a complex necessary for the signal transduction of IL-27."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;GP130 (IL6ST)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A subunit protein that along with IL27RA acts as a receptor for the IL-27 cytokine to activate downstream signaling pathways."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;EBI3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Encodes one component of the IL-12 family cytokines, which heterodimerizes with IL-27 to form a functional cytokine involved in immune regulation."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INTERFERON-INDUCED GENES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A group of genes activated by interferons and their signaling pathways, including IRF1 and STAT1, play critical roles in antiviral defense and immunomodulation."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;STAT1/STAT3 PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The signal transducer and activator of transcription 1/3 pathway is a key mediator of cytokine signaling, involved in cell growth, differentiation, survival, and immune responses."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CD4+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Helper T cells that play a central role in immune regulation, including the production of cytokines such as IL-27."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CD8+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cytotoxic T lymphocytes that directly kill virus-infected and tumor cells; distinct from CD4+ T helper cells which regulate immune responses."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;T1D SUSCEPTIBILITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The genetic predisposition towards developing type 1 diabetes, influenced by variants in genes such as IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL-27 (LEU119)&quot;">
      <data key="d0">"PROTEIN VARIANT"</data>
      <data key="d1">"The wild-type variant of IL-27 with Leucine at position 119, involved in signaling through the IL-27 receptor to activate downstream pathways."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL-27 (PRO119)&quot;">
      <data key="d0">"PROTEIN VARIANT"</data>
      <data key="d1">"A missense variant of IL-27 where Proline replaces Leucine at position 119, leading to decreased STAT1 and IRF1 expression levels."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;PBMCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Peripheral blood mononuclear cells, which include lymphocytes such as T cells, B cells, and NK cells, used in experiments for studying immune responses."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CTLA4 GENE &quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"Methylation at this CpG site inversely correlates with CTLA4 mRNA expression levels in CD4+ and CD8+ T cells, affecting immune function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T CELL DIFFERENTIATION &quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"STAT6 plays a critical role in T cell differentiation, with genetic variants influencing this process through eQTL effects."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTRACELLULAR VESICLE TRANSPORT &quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"The gene STX2 encodes syntaxin 2, which is essential for the proper functioning of vesicle transport within cells, impacting various cellular processes including immune responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STX2 (SYNTAXIN 7)&quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"The gene STX2 encodes syntaxin 2, which is essential for the proper functioning of vesicle transport within cells, impacting various cellular processes including immune responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 GENE&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"The IL-27 gene region harbors genetic variants that influence the expression of IRF1 and STAT1, contributing to reduced risk for Type 1 Diabetes (T1D)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPTIONAL REGULATION IN T CELLS&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"The CDK2 gene within the regulatory locus at chr12q13.2 influences transcriptional regulation, affecting multiple genes' expression levels in T cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 SNP RS181206[G]&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The IL-27 missense SNP influences the activation of STAT1 and STAT3 pathways, affecting downstream gene expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-8 gene encodes the Interleukin-8 protein, which is involved in immune and inflammatory responses."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS4073 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism located within the IL-8 gene that influences asthma risk when present as a homozygous TT genotype."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS2227306 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism in the IL-8 gene, associated with increased risk of developing asthma when certain genotypes are present."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin-8 protein is elevated in serum levels among individuals suffering from asthma compared to healthy controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic respiratory condition characterized by increased IL-8 expression and severity associated with certain genetic variants."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 MRNA EXPRESSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The level of IL-8 mRNA is significantly higher in patients than in healthy controls, correlating with the clinical severity of asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 MRNA LEVELS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The level of IL-8 mRNA is significantly higher in patients than in controls, especially among those with moderate-to-severe asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;PBMC COMPOSITION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Peripheral blood mononuclear cells (PBMCs) composition was analyzed for differences between asthmatic and healthy children, but no significant difference was found."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 GENOTYPE DISTRIBUTION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The distribution of genotypes for IL-8 gene polymorphisms (rs4073 and rs2227306) differed significantly between asthmatic children and healthy controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;HAPLOTYPE FREQUENCIES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Frequencies of haplotypes derived from the analysis of IL-8 gene polymorphisms were assessed for their association with asthma risk in the study population."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASAH1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ASAH1 gene is located on chromosome 8p22-p21.3 and consists of 86 HapMap SNPs and 14 typed SNPs."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A SNP-set test using a kernel machine approach that evaluates the combined effect of multiple SNPs in a gene region."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;MIN TEST (SINGLE SNP-BASED)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A single SNP-based test that identifies the minimum p-value among individual SNPs within a set."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;NAT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NAT2 gene is located on chromosome 8p22 and consists of 22 HapMap SNPs with only 4 typed SNPs (rs1390358, rs1112005, rs7832071, and rs1208)."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;FGFR2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located on a chromosome, for which the SNP-set test performance was compared with min tests in regions of high and weak LD."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HLA-B GENE (HUMAN LEUKOCYTE ANTIGEN B)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-B gene is part of the human leukocyte antigen complex located on 6p21.3, involving only 6 HapMap SNPs with 2 typed SNPs."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;MAF (MINOR ALLELE FREQUENCY)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The frequency of the less common allele for a particular SNP within a population used to weight rare alleles in genetic studies."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;LD (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure that reflects how often two SNPs are inherited together, indicating a non-random association between gene variants."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HAPMAP SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A set of single nucleotide polymorphisms identified in the HapMap project for genetic variation studies."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;ILLUMINA HUMANHAP550 ARRAY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A genotyping chip used to identify and measure genetic variations across multiple SNPs."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;TYPE 1 ERROR RATE (Α = 0.05)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The probability of incorrectly rejecting a true null hypothesis at the significance level α = 0.05."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;EMPIRICAL POWER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A measure indicating how well a statistical test can correctly identify a true effect, typically evaluated through simulations."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;LINEAR KERNEL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A type of kernel function used in machine learning algorithms for SNP-set analysis, reflecting linear genetic effects."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;IBS KERNEL AND WEIGHTED IBS KERNEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Kernels used in SNP-set tests to measure similarity between individuals based on their genotypes."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;ASAH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ASAH1 gene is involved in simulations testing genetic effects and interactions."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;ASAH1 GENE EFFECT&quot;">
      <data key="d0">"DISEASE, GENE"</data>
      <data key="d1">"The ASAH1 gene effect is studied in simulations for testing genetic effects and interactions."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;IBS KERNEL POWER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The power of the IBS kernel is used to measure genetic effect sizes accurately."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;WEIGHTED IBS KERNEL RARE VARIANTS IMPORTANCE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Incorporating rare variants importance into the weighted IBS kernel enhances its performance in detecting genetic effects."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;DOWNWEIGHTED COMMON CAUSAL SNPS MAF HIGHER SNP&quot;">
      <data key="d0">"GENOMIC VARIANT, PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Downweighting common causal SNPs with higher minor allele frequency affects the power of the weighted IBS kernel."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;LINEAR KERNEL POWER LOSS&quot;">
      <data key="d0">"DISEASE, PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The linear kernel and min test suffer from significant loss in power when the genetic model is mis-specified."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;MIN TEST EMPIRICAL TYPE 1 ERROR RATES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Empirical type 1 error rates for the min test are influenced by the choice of kernel functions used in simulations."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;GOOD LD STRUCTURE ASAH1 GENE SNP-SET TEST&quot;">
      <data key="d0">"MOLECULAR INTERACTION, PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The overall effect testing for the ASAH1 gene shows that the kernel machine SNP-set test outperforms other methods when there is a good linkage disequilibrium structure."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;TYPED SNPS&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"This array includes typed SNPs from the ASAH1 and NAT2 genes used in SNP-set tests."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RARE VARIANTS IMPORTANCE&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"Incorporating rare variants importance into the weighted IBS kernel increases its effectiveness."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"Incorporating rare variants importance into the weighted IBS kernel increases its effectiveness."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1893217&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP (Single Nucleotide Polymorphism) mapped to the PTPN2 gene that shows a significant association with non-response to anti-CTLA-4 treatment in metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-CTLA-4 TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment involving immune checkpoint inhibitors targeting CTLA-4, used for treating metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;RS17388568&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in the genomic region containing IL2, ADAD1 and IL21 genes, showing a significant association with response to anti-PD-1 treatment."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;IL2/ADAD1/IL21 LOCUS&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"A genomic locus associated with allergy, colitis, and type 1 diabetes, where the SNP rs17388568 is located."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-PD-1 TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment involving immune checkpoint inhibitors targeting PD-1, used for treating metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;COMBINATION THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A therapeutic approach combining anti-CTLA-4 and anti-PD-1 treatments for metastatic melanoma patients."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;METASTATIC MELANOMA PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The population under study includes patients diagnosed with metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-CTLA-4 TREATMENTS (IPILIMUMAB, TREMELIMUMAB)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A type of immunotherapy targeting the CTLA-4 protein in order to boost the immune system's ability to fight cancer."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-PD-1 TREATMENTS (NIVOLUMAB, PEMBROLIZUMAB)&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Immunotherapies that block the PD-1 receptor to enhance T cell activity against tumors."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;NYULH, UCLA, MGH&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR - TREATMENT LOCATION"</data>
      <data key="d1">"Locations where samples were collected from patients receiving treatment for metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;AGE DISTRIBUTION (62.85 YEARS MEDIAN AGE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS - AGE FACTOR"</data>
      <data key="d1">"The median age of the patients in the study was 62.85 years, with a range spanning from 19 to 90.2 years old."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;SEX DISTRIBUTION (67% MALE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS - SEX FACTOR"</data>
      <data key="d1">"A larger proportion of metastatic melanoma patients in the study were males (67%)."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ICI EFFICACY TESTING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS - TREATMENT RESPONSE EVALUATION"</data>
      <data key="d1">"Testing the efficacy of Immune Checkpoint Inhibitors (ICIs) in patients with metastatic melanoma."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-CTLA-4, ANTI-PD-1 AND COMBINATION-THERAPY TREATED PATIENTS GROUPING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The grouping of patients treated with anti-CTLA-4, anti-PD-1, and combination therapies for pooled association analysis adjusted for age, sex, and treatment drugs."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;TREATMENT RESPONSE ASSOCIATION ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis aimed to find associations between genomic variants (SNPs) and treatment response in patients treated with different immunotherapies."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;COMBINATION THERAPY COHORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A cohort of patients treated with a combination therapy for immunotherapy analysis."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;AGE, SEX AND TREATMENT DRUGS ADJUSTMENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Adjustments made in the pooled association analysis to control for age, sex, and treatment drugs as environmental factors."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;WIDE CONFIDENCE INTERVALS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Indication of limited statistical power due to small sample size shown through wide confidence intervals."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;PTPN2 GENE, IL2/ADAD1/IL21 LOCUS&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"Specific SNPs are mapped to genomic regions such as the PTPN2 gene and the IL2/ADAD1/IL21 locus, indicating their potential influence on disease susceptibility or treatment response."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"EBNA2 is a gene that interacts with MS risk loci and alters allelic expression based on genotype."&lt;SEP&gt;"EBNA2 is a protein that binds chromatin at multiple sclerosis (MS) risk loci dependent on the MS risk allele."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TRAF3/RCOR1 SNP (RS1258869)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located in TRAF3/RCOR1, associated with increased EBNA2 binding at a MS risk locus when carrying the risk allele."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;CD40 SNP (RS1883832)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in CD40, linked to preferential EBNA2 binding to the risk allele compared to protective alleles."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFAIP8 LOCUS SNP (RS32658)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP at the TNFAIP8 locus with preferential EBNA2 binding to the protective allele, implicated in MS risk."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFRSF1A LOCUS SNP (RS180069)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP located at TNFRSF1A locus showing preferential EBNA2 binding to the protective allele relative to the risk allele."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TBX6 SNP (RS3809627)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant within TBX6, associated with EBNA2 binding preference towards the protective allele at a MS risk locus."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBV LATENCY III GROWTH PROGRAM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The EBV latency III growth program is significantly inhibited by EBNA2-TAT treatment in LCLs, affecting cell proliferation and morphology."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBNA2-TAT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"EBNA2-TAT inhibits the EBNA2 transcriptional function and affects expression of MS risk genes without causing cytotoxicity at moderate concentrations."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LMP1 GENE EXPRESSION REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulation of LMP1 gene expression by EBNA2, inhibited by EBNA2-TAT treatment indicating disruption of EBV latency III growth program."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TRAF3, CD40, CLECL1, TNFAIP8, AND TNFRSF1A GENE EXPRESSION REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gene expression regulation by EBNA2 for MS-associated genes in LCLs is affected upon inhibition of EBNA2 interaction with RBP-Jκ."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBV DNA COPY NUMBER STABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"EBV DNA copy number serves as a stable phenotype in LCLs and its alteration can be influenced by genetic factors and transcriptional regulation."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;MS RISK GENES (TRAF3, CD40, CLECL1, TNFAIP8, AND TNFRSF1A)&quot;">
      <data key="d0">"GENE EXPRESSION REGULATION"</data>
      <data key="d1">"Expression of these genes in LCLs is regulated by EBNA2, with alterations observed upon inhibition."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;RBP-JΚ SITE BINDING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"EBNA2 interacts with RBP-Jκ to regulate gene expression, inhibited by EBNA2-TAT treatment."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TRAF3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TRAF3 is a gene that has an altered expression due to EBNA2 preferential binding, which could contribute to increased immune evasion in the context of MS risk."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;CD40&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CD40 is a gene whose allelic expression changes directionally with EBNA2 interaction compared to B cells, affecting immune evasion and MS risk."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TNFAIP8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFAIP8 is a gene that shows altered expression due to preferential binding by EBNA2, influencing the host's immune response in the context of multiple sclerosis (MS) risk."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TNFRSF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TNFRSF1A is a gene with an allelic association altered by EBNA2 interaction, which may affect MS risk through immune evasion mechanisms."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TBX6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TBX6 is a gene mentioned in the text as having its expression affected by EBNA2 binding preferences but without providing specific details about the nature of this alteration."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;RCOR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RCOR1 is a gene with altered expression due to preferential EBNA2 binding, impacting immune evasion and MS risk."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;CLECL1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CLECL1 shows increased expression due to the effect of EBNA2 on risk alleles, potentially contributing to enhanced immune evasion in multiple sclerosis (MS) context."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBV LATENCY III PROGRAM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The EBV latency III program is a physiological process involving key genes like LMP1 and LMP2 that are influenced by the interaction between EBNA2 and MS risk loci, potentially contributing to immune evasion."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;MS RISK LOCI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"MS risk loci are genomic variants associated with an increased risk of multiple sclerosis (MS), which interact with EBNA2 leading to altered gene expression and potential immune evasion mechanisms."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBV INFECTION CYCLE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The EBV infection cycle, particularly latency III, is a physiological process influenced by the regulation of MS risk genes through EBNA2 interaction, affecting immune response evasion."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBNA2-TAT TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment with EBNA2-TAT inhibits the effect of EBNA2 on gene expression, demonstrating its role in altering MS risk loci."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LMP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LMP1 is a gene involved in the EBV latency III program that interacts proximally to MS risk genes regulated by EBNA2."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LMP2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LMP2 is a gene involved in the EBV latency III program, interacting with MS risk genes influenced by EBNA2 binding."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;IMMUNE EVASION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of immune evasion involves mechanisms by which pathogens, such as EBV, avoid or suppress host immune responses."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBNATBXTAT TREATMENT&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The effect of EBNA2-TAT treatment on MS risk loci suggests that EBNA2's interaction with these genomic variants is crucial for regulating gene expression involved in immune evasion."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MS RISK GENES&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2/risk gene interactions within the EBV latency III program are proposed to increase or decrease gene expression, influencing the virus's ability to evade host immunity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE EXPRESSION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"Treatment with EBNA2-TAT modulates gene expression in a way that suggests it affects the interaction between EBNA2 and MS risk alleles."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VIRAL SURVIVAL STRATEGY&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"Increased TNFAIP8 expression due to EBNA2 interaction may serve as a viral survival strategy by altering host inflammatory responses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE DEFENSE SUPPRESSION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"Decreased TNFRSF1A expression from preferential EBNA2 binding may suppress immune defense mechanisms, aiding in the virus's evasion of detection."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMMUNE EVASION MECHANISM&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"Proximal interactions of LMP2 with MS risk genes, regulated by EBNA2, suggest roles in immune evasion mechanisms."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS3842787&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the COX-1 gene that was examined for its association with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20417&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with differences in percentage of CAD between patients and controls."&lt;SEP&gt;"A genomic variant in the COX-2 gene associated with increased risk of aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;RS20118426&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant that was examined for its association with aspirin insensitivity, but no significant findings were reported."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS1126643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with the averaged platelet number, contributing significantly to heterogeneity."&lt;SEP&gt;"A genomic variant in the ITGA2 gene associated with a high risk of aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by an inadequate response to aspirin therapy, which can increase cardiovascular risks."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CAUCASIAN PATIENTS AND CONTROLS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Individuals of Caucasian ethnicity used as controls or subjects in the studies examining genetic polymorphisms associated with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CHINESE PATIENTS AND CONTROLS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Individuals of Chinese ethnicity used as controls or subjects in the studies examining genetic polymorphisms associated with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;COX-1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The COX-1 gene is one of the genes examined for its polymorphisms' association with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;COX-2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The COX-2 gene contains a polymorphism (rs20417) that has been shown to be significantly associated with increased risk of aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ITGA2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene containing the rs1126643 variant, which is strongly associated with higher risks for aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;CAD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Coronary Artery Disease (CAD) is a condition characterized by the buildup of plaque inside the heart's arteries, leading to reduced blood flow."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;AVERAGED PLATELET NUMBER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The averaged platelet number is a physiological measure that contributes to heterogeneity in genomic variant rs1126643."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;META-REGRESSION MODEL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The meta-regression model is used to analyze and interpret data from multiple studies to understand the relationship between variables."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;STUDY-LEVEL CONTINUOUS COVARIATES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Continuous covariates at the study level, such as patient characteristics or environmental factors, are included in the analysis to account for variability."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;RS1126643-T ALLELE&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"The T allele of the rs1126643 variant is strongly associated with a higher risk of aspirin insensitivity, especially under dominant genetic models."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM DEVIATIONS&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"Deviations from Hardy-Weinberg equilibrium were observed for the genomic variants rs20118426 and rs1126643 in some comparisons."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS20118426 AND RS1126643&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"Deviations from Hardy-Weinberg equilibrium were observed for the genomic variants rs20118426 and rs1126643 in some comparisons."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK ESTIMATES&quot;">
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d1">"The risk estimates associated with the T allele of rs1126643 were notably high for aspirin insensitivity, especially under a dominant genetic model."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STAT5B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The STAT5B gene is a critical gene involved in growth hormone signaling and immune regulation."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;C.1892G&gt;A VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A homozygous nonsense variant (p.W631*) located at c.1892G&gt;A in the STAT5B gene that results in a truncated protein lacking critical functional domains."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used to treat growth hormone insensitivity syndrome by improving growth and immune function in patients with STAT5B mutations."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by low levels of IGF-1, IGF-BP3, and ALS, leading to severe short stature and immunological impairments."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SERUM GH LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The measurement of growth hormone (GH) levels in the blood, which were found to be normal in patients despite their clinical phenotype indicative of GHI."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;IGF-1 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process indicating the level of insulin-like growth factor 1, crucial for proper growth and development."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An autoimmune condition characterized by inflammation in the thyroid gland, treated with levothyroxine to manage symptoms."&lt;SEP&gt;"An autoimmune condition where the immune system attacks the thyroid gland, leading to inflammation and typically treated with levothyroxine."&lt;SEP&gt;"Autoimmune thyroiditis is characterized by the presence of autoantibodies such as anti-thyroglobulin and anti-thyroid peroxidase antibodies, which are found in patients with STAT5B deficiency."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;LYMPHADENOPATHY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process indicating an abnormal enlargement of lymph nodes, observed in some patients but not all three siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;CHRONIC ECZEMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic skin condition characterized by inflammation and irritation, often associated with atopic conditions such as asthma or allergic rhinitis."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;REACTIVE AIRWAY DISEASE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A physiological process indicative of inflammation and hyperreactivity in the airways, often treated with corticosteroids."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SEVERE SHORT STATURE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by significantly below average height relative to age and gender peers due to genetic or other medical causes."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;INFECTIONS (SKIN, URINARY TRACT, PULMONARY)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Processes indicating recurrent infections of various body parts requiring antibiotic treatments."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GASTROESOPHAGEAL REFLUX DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by the backflow of stomach acid into the esophagus, causing heartburn and discomfort."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;FIBROBLAST CULTURES&quot;">
      <data key="d0">"BIOLOGICAL SAMPLE"</data>
      <data key="d1">"Samples derived from skin cells used to confirm genetic mutations in siblings."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;IN-VITRO FERTILIZATION (IVF)&quot;">
      <data key="d0">"MEDICAL PROCEDURE"</data>
      <data key="d1">"A medical procedure used for fertility treatment that involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm in a laboratory setting."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;PREMATURE BIRTH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The birth of an infant before 37 weeks of gestation, which can affect growth and development."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;PNEUMONIA WITH SEPSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A serious medical condition characterized by inflammation of the lungs (pneumonia) and systemic infection (sepsis)."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SUPPLEMENTAL OXYGEN&quot;">
      <data key="d0">"MEDICAL TREATMENT"</data>
      <data key="d1">"Additional oxygen supplied to help patients with respiratory difficulties breathe more easily."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;LEVOTHYROXINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A medication used to treat hypothyroidism by providing an adequate amount of thyroxine hormone."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GROWTH HORMONE (GH)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A hormone responsible for stimulating growth, cell reproduction, and regeneration in humans and other animals."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;IGF BINDING PROTEIN-3 (IGFBP3)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A protein that binds to IGFs and regulates their activity by controlling the availability of free IGFs."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ACID LABILE SUBUNIT (ALS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A glycoprotein that forms a ternary complex with IGF-I/II and IGFBPs, playing a role in regulating the bioavailability of these growth factors.")</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS&quot;">
      <data key="d0">"BIOLOGICAL SAMPLE"</data>
      <data key="d1">"Skin cells that produce collagen and other fibers to maintain skin structure."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SRC HOMOLOGY 2 (SH2) DOMAIN&quot;">
      <data key="d0">"PROTEIN STRUCTURE"</data>
      <data key="d1">"A conserved protein domain involved in signal transduction processes through interactions with phosphotyrosine-containing peptides."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;TRANSACTIVATION DOMAIN (TAD)&quot;">
      <data key="d0">"PROTEIN STRUCTURE"</data>
      <data key="d1">"The region of a transcription factor that binds to DNA and promotes gene expression."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;HETERODIMER FORMATION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"A process where two different molecules or proteins bind together to form a heterodimer, often involved in signal transduction pathways."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;HEK-GHRS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Human Embryonic Kidney cells expressing the growth hormone receptor used for research purposes."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;STAT5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"STAT5B is a gene important for immune cell function, including the maintenance of T cells and NK cells."&lt;SEP&gt;"The STAT5B gene plays a critical role in the regulation of CD8+ T cell activation and homeostasis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;P.W631* VARIANT STAT5B&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The p.W631* variant in STAT5B leads to reduced expression and impaired phosphorylation or trafficking into the nucleus upon GH stimulation."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;B CELL HYPERACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sustained B cell hyperactivity is associated with atopy and autoimmunity, particularly in individuals with a loss-of-function (LOF) STAT5B variant."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;ATOPY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Atopy refers to a genetic tendency towards developing allergic reactions. In the context of the text, it's linked to elevated IgE levels and chronic eczema/reactive airway disease in individuals with a LOF STAT5B mutation."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;T CELL LYMPHOPENIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A reduction in T cells, particularly CD3+, CD4+, and CD8+ T cells, is observed in individuals with a loss-of-function (LOF) STAT5B variant. This may be due to impaired thymic T cell production or peripheral destruction."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;MEMORY CD8+ T CELLS DYSREGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"STAT5B deficient patients often exhibit pronounced dysregulation in memory CD8+ T cells, including reductions in naïve T cells and increases in effector memory cells with age."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;GH (GROWTH HORMONE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Growth hormone regulates various physiological processes, including cell growth and reproduction; in this context, it affects the expression and phosphorylation state of STAT5B protein variants."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;NK CELLS (NATURAL KILLER CELLS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"NK cells are immune cells that play a crucial role in the host's defense against tumors and virally infected cells. Reductions in NK cell counts are observed in individuals with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;THYROGLOBULIN&quot;">
      <data key="d0">"MOLECULAR TARGET"</data>
      <data key="d1">"An autoantigen in autoimmune thyroiditis, identified by anti-thyroglobulin antibodies in patients with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IGG, IGA, IGM, IGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Different classes of antibodies involved in immune responses; IgE levels are particularly elevated and associated with allergic conditions like chronic eczema in individuals with a LOF (loss-of-function) STAT5B variant."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IL-2 SIGNALING PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A molecular interaction pathway activated by interleukin 2 that leads to the induction of FOXP3 and regulatory T cell functions, impaired in patients with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;LOF STAT5B VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A loss-of-function (LOF) variant of the STAT5B gene that leads to dysregulation of CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ TEM CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The CD4+ effector memory T cell subset remains unaffected by alterations in the STAT5B variant, maintaining its proportion normally."&lt;SEP&gt;"The proportion of CD4+ effector memory (TEM) T cells remains within normal ranges in patients with a genomic variant in the STAT5B gene."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEM CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increases in the percentage of CD8+ TEM cells become clinically significant with age, indicating a dysregulation specific to this cell type."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEMRA CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Elevations in the percentage of CD8+ terminally differentiated effector memory (TEMRA) T cells are detected during infancy but normalize around age 4."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;DYSREGULATION OF CD8+ T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A dysregulation noted despite normal CD4+ memory T cell subsets, indicating a specific issue with the regulation and function of CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ MEMORY T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Elevated proportions of these cells beginning in infancy suggest an essential role for STAT5B in their activation and maintenance."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;P2 AND P3&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"Patients 2 and 3 experienced elevations in the percentage of CD8+ TEMRA cells during infancy."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;P1&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"Patient 1 had normalized proportions of CD8+ TEMRA cells from early childhood onwards, indicating stability post-infancy."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;PHYSICAL COMFORT&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"This disease affects physical comfort, impacting quality of life in patients with STAT5B mutations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANT IDENTIFICATION&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Used to identify and confirm the presence of genetic variants, including those affecting STAT5B."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATION CONFIRMATION&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Fibroblast cultures from affected individuals confirmed the homozygous mutation in STAT5B through sequencing."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STAT5B FUNCTIONALITY&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The SH2 domain is crucial for STAT5B activation and function; mutations affecting it impair protein activity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE EXPRESSION REGULATION&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"TADs regulate gene expression by binding to DNA and promoting transcription, which is affected in the p.W631* variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-THYROGLOBULIN ANTIBODIES&quot;">
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d1">"The presence of anti-thyroglobulin antibodies is a hallmark of autoimmune thyroiditis, which can develop in individuals with STAT5B deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NORMAL RANGE&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Proportion of CD4+ TEM cells remains within normal ranges despite the genomic variant, indicating no significant impact on this subset."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DYSREGULATION&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Increase in CD8+ TEM cell proportions with age is clinically significant and linked to dysregulation due to STAT5B deficiency."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NORMALIZATION&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Elevations during infancy normalize around age 4, suggesting a developmental impact of the LOF variant on CD8+ TEMRA cell regulation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO ALTERATION&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Proportion of CD4+ TEM cells does not alter with age, indicating that the STAT5B variant has no significant impact on these T cell subsets."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HLA-DRB1*07:01 is a specific allele within the HLA-DRB1 gene that plays a significant role in determining susceptibility to certain diseases."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172, RS2395182, RS4713586, RS7775228&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are SNPs (Single Nucleotide Polymorphisms) that are being studied as potential predictors for HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DQA1, HLA-DQB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These genes are part of the human leukocyte antigen (HLA) complex and encode proteins that play a crucial role in immune responses."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM (LD)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Linkage disequilibrium refers to the non-random association of alleles at different loci that are in close proximity on the same chromosome, which can influence genetic analysis and interpretation of genotyping results."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This specific HLA haplotype is associated with certain diseases and can be used as a marker for disease susceptibility."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;CUSTOM TAQMAN SNP GENOTYPING ASSAY, KASPAR-ON-DEMAND PREVALIDATED ASSAYS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These are molecular interaction techniques used to genotype SNPs in DNA samples."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;EXON 2 OF HLA-DRB1 GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"This specific exon in the HLA-DRB1 gene is targeted for genotyping to determine its association with disease susceptibility."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;EXONS 2 AND 3 OF HLA-DQB1 GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"These specific exons in the HLA-DQB1 gene are studied alongside exon 2 of HLA-DRB1 for their potential role in determining genetic predispositions to certain diseases."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These are specific alleles within the HLA complex that form part of the haplotype being studied for its association with disease susceptibility."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant represents a specific haplotype involving the genes DRB1, DQA1, and DQB1."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"E. coli ASP hypersensitivity is a disease characterized by an allergic reaction to E. coli-derived antigenic substances."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SNP-GENOTYPED SUBPOPULATION&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"A subpopulation of individuals genotyped for single nucleotide polymorphisms (SNPs) in the context of evaluating genetic markers."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;2-SNP TAGGING ALGORITHM V&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"An algorithm designed to identify tagging SNPs within a genomic region, used as part of a screening test for E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM II&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"One of several algorithms evaluated in the context of identifying genetic markers and screening tests for disease."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM III&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"An algorithm compared to others for its performance in identifying genetic markers relevant to E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM IV&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"A comparative algorithm used to evaluate the effectiveness of different approaches to tagging SNPs and screening for disease."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;EXON 2 OF HLA-DRB1 GENE, EXONS 2 AND 3 OF HLA-DQB1 GENE&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"The genetic variants in these exons are crucial for determining the carrier status of the specific haplotype associated with certain diseases."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS28383172 AG OR GG GENOTYPES&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"The presence of these genotypes is associated with a high likelihood of being a carrier for the specific HLA haplotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2395182 TT OR TG AND RS4713586 TT AND RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"These specific combinations of genotypes are strongly associated with the HLA haplotype carrier status."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01 ALLELE CARRIER STATUS&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"The G allele of rs28383172 is in perfect concordance with the HLA-DRB1*07:01 allele carrier status."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES, RS28383172, RS2395182, RS4713586, RS7775228&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"These genotyping techniques are used to accurately determine the presence of specific SNPs and alleles within the HLA complex."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 (RS179008)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism rs179008 in the TLR7 gene was found to follow Hardy-Weinberg equilibrium and show significant genotype distribution differences between HIV-infected individuals and healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 (RS179009)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism rs179009 in the TLR7 gene also followed Hardy-Weinberg equilibrium but showed significant genotype distribution differences between HIV-infected individuals and healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TLR7 gene is involved in the immune response and has polymorphisms that show different distributions among HIV-infected individuals compared to healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;HIV DISEASE STAGE &quot;">
      <data key="d0">"DISEASE STAGE"</data>
      <data key="d1">"Different stages of HIV disease are associated with varying frequencies of specific genotypes, such as TLR7 rs179009 AG and GG genotypes."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORS (TOBACCO &amp; ALCOHOL)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to tobacco or alcohol did not significantly alter the distribution of TLR7 polymorphisms in HIV-infected individuals compared to non-users, though some trends were observed."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 RS179008 AA GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The AA genotype of TLR7 rs179008 showed similar distribution among tobacco-consuming HIV-infected individuals compared to non-users."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 RS179008 CC GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype of TLR7 rs179008 showed similar distribution between tobacco-consuming and non-consuming HIV-infected individuals."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 RS179008 CT GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CT genotype of TLR7 rs179008 was present in both tobacco-consuming and non-consumers with similar frequency among HIV-infected individuals."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 RS179009 AA GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The distribution of the AA genotype for TLR7 rs179009 was almost identical between alcohol-consuming and non-consuming HIV-infected individuals."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 RS179009 AG GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Higher frequency of the AG genotype in tobacco consumers compared to non-users among HIV-infected individuals, though not statistically significant."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7 RS179009 GG GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GG genotype for TLR7 rs179009 was less common in advanced HIV disease stages compared to healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TLR7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TLR7 is a gene associated with immune response and has polymorphisms that are studied in relation to HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;RS179008&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs179008 is a genomic variant within the TLR7 gene that is investigated for its role in HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;RS179009&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs179009 is another genomic variant within the TLR7 gene studied in connection with HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TOBACCO USAGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tobacco usage is an environmental factor that may influence the risk of HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;ALCOHOL USAGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol usage, as another environmental factor, is examined for its potential impact on HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;BASELINE CD4 COUNTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CD4 counts at baseline are a critical physiological measurement used to assess the stage of HIV infection and predict disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HIV disease progression refers to how quickly HIV advances from initial infection to AIDS, influenced by genetic and environmental factors."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;CORRELATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Statistical association or correlation is a measure indicating how two variables are related."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;RISK FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A risk factor is any attribute, characteristic, or exposure of an individual that increases the likelihood of developing a disease or injury."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TABLE NOT SHOWN&quot;">
      <data key="d0">"DISEASE PROGRESSION ASSESSMENT TOOL"</data>
      <data key="d1">"Refers to a table containing detailed data about various factors and their correlation with HIV disease progression not presented in the text."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179008)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The distribution of rs179008 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEALTHY CONTROL &quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The distribution of rs179008 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179009)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The distribution of rs179009 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179008 AA)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The AA genotype of TLR7 rs179008 is distributed similarly among tobacco-consuming and non-consuming HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179008 CC)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The CC genotype of TLR7 rs179008 did not show significant differences in distribution among tobacco-using and non-consuming HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179008 CT)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The CT genotype of TLR7 rs179008 was present with similar frequency in both tobacco-using and non-consumers among HIV-infected individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179009 AA)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The distribution of the AA genotype for TLR7 rs179009 was similar between alcohol-consuming and non-consuming HIV-infected individuals, indicating no significant environmental impact.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179009 AG)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Higher frequency of the AG genotype in tobacco consumers compared to non-users among HIV-infected individuals, although not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (RS179009 GG)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The GG genotype for TLR7 rs179009 showed reduced frequency in advanced stages of HIV disease compared to healthy controls, suggesting potential association with progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR FOR HIV DISEASE PROGRESSION&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"Polymorphisms within the TLR7 gene were examined but not found to be significant independent risk factors for HIV disease progression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISMS (RS179008, RS179009)&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"Polymorphisms within the TLR7 gene were examined but not found to be significant independent risk factors for HIV disease progression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"CD4 counts are a key variable analyzed using multivariate logistic regression in studies of HIV disease progression."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 26}]</data>
    </node>
    <node id="&quot;RISK FACTOR ASSESSMENT RESULTS FOR HIV DISEASE PROGRESSION&quot;">
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d1">"The table not shown contains results of risk factor assessment concerning factors like TLR7 polymorphisms and CD4 counts."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK R1275Q&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An activating mutation in the ALK gene at position R1275Q."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NRAS Q61K&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A well-known activating mutation in the NRAS gene, present in melanoma and other cancers."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;PROTECT SOFTWARE&quot;">
      <data key="d0">"TOOL/SOFTWARE"</data>
      <data key="d1">"A software tool used for identifying neoepitopes generated by mutations in cancer samples."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NBL (NEUROBLASTOMA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Neuroblastoma is a type of cancer that typically develops from immature nerve cells and often affects children."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-B*15:01&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HLA-B*15:01 is a protein involved in presenting peptides to T-cell receptors (TCRs) and plays a crucial role in immune recognition."&lt;SEP&gt;"HLA-B*15:01 is a protein that forms part of the major histocompatibility complex (MHC) and binds to tumor neoepitopes."&lt;SEP&gt;"HLA-B*15:01 is another protein encoded by the HLA-B gene, which also forms p/MHC complexes but with different stability characteristics compared to HLA-A*01:01."&lt;SEP&gt;"Human leukocyte antigen B15:01, an HLA allele involved in immune responses to certain peptides."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;MAQDIYRASY (NEOEPITOPE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A neoepitope derived from the ALK R1275Q mutation that binds HLA-B*15:01."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;AQDIYRASYY (NEOEPITOPE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A neoepitope arising from the ALK R1275Q mutation that has a strong binding affinity for HLA-B*15:01."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;GMAQDIYRA (NEOEPITOPE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A nonamer neoepitope arising from the ALK R1275Q mutation, predicted to bind HLA-A*02:01."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ILDTAGKEEY (NEOEPITOPE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An NRAS-derived neoepitope that binds HLA-A*01:01 and is associated with a specific T cell response in melanoma cells."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-A*02:01&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Human leukocyte antigen A2:01, an allele commonly found in Caucasian populations."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ZNF717 Q716 MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A mutation in the ZNF717 gene observed in a subset of neuroblastoma samples."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ALK F1174L/I/C MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Multiple mutations in the ALK gene at position 1174, observed in different samples within the cohort."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-B*15:03&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Human leukocyte antigen B15:03, a close relative of HLA-B*15:01, found to bind certain peptides."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ARDIYRASYY (SELF-ANTIGEN)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A self-antigen derived from the ALK mutation that is less likely to form stable complexes with HLA proteins compared to neoepitopes."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-A*01:01&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HLA-A*01:01 is a protein encoded by the HLA-A gene that forms p/MHC complexes with ALK-derived peptides for structural and functional studies."&lt;SEP&gt;"Human leukocyte antigen A1:01, an allele involved in immune responses to specific peptides."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;SEC (SIZE EXCLUSION CHROMATOGRAPHY)&quot;">
      <data key="d0">"TOOL/SOFTWARE"</data>
      <data key="d1">"A technique used for separating molecules based on size and shape, applied here to purify p/MHC complexes."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;LC–MS (LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY)&quot;">
      <data key="d0">"TOOL/SOFTWARE"</data>
      <data key="d1">"An analytical method combining liquid chromatography with mass spectrometry used to confirm the presence of peptides in MHC samples."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE AQDIYRASY&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">"The nonamer peptide AQDIYRASY binds to HLA-B*15:01 with a canonical extended conformation."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE AQDIYRASYY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A decamer peptide derived from ALK that binds to HLA proteins and is recognized by CD8+ T cells."&lt;SEP&gt;"The decamer peptide AQDIYRASYY binds to HLA-B*15:01 in a short 310 helical backbone conformation, replacing the C-terminal anchor residue compared to its nonamer counterpart."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;NEOEPITOPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Neoepitopes are peptides derived from tumor cells that can be recognized by T-cells through their interaction with HLA molecules."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;T-CELL RECEPTORS (TCRS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TCRs are proteins on the surface of T-cells that recognize and bind to antigen-MHC complexes, including neoepitopes bound to HLA-B*15:01."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;EPSTEIN–BARR VIRUS EPITOPE LEKARGSTY&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">"This epitope from Epstein–Barr virus binds in an extended conformation within the HLA groove, similar to the nonamer peptide AQDIYRASY."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">"This epitope from human ubiquitin-conjugating enzyme-E2 binds in an extended conformation within the HLA groove, similar to the nonamer peptide AQDIYRASY."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;SARS CORONAVIRUS EPITOPE VQQESSFVM&quot;">
      <data key="d0">"PEPTIDE"</data>
      <data key="d1">"This epitope from SARS coronavirus binds in an extended conformation within the HLA groove, similar to the nonamer peptide AQDIYRASY."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;NONAMER BINDING MODE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The nonamer peptide binding mode involves a canonical extended conformation within the HLA groove."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DECAMER BINDING MODE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The decamer peptide binding mode involves a short 310 helical backbone conformation with residues buried deeper in the MHC groove."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;T-CELL RECOGNITION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"TCRs recognize neoepitopes presented by HLA-B*15:01, leading to an immune response against tumor cells."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;EPSTEIN–BARR VIRUS EPITOPE LEKARGSTY BINDING MODE&quot;">
      <data key="d0">"PEPTIDE-MHC COMPLEX"</data>
      <data key="d1">"This epitope binds in a canonical extended conformation within the HLA groove similar to other nonamer peptides."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY BINDING MODE&quot;">
      <data key="d0">"PEPTIDE-MHC COMPLEX"</data>
      <data key="d1">"This epitope also adopts an extended backbone conformation when bound in the MHC groove, similar to other nonamer peptides."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;SARS CORONAVIRUS EPITOPE VQQESSFVM BINDING MODE&quot;">
      <data key="d0">"PEPTIDE-MHC COMPLEX"</data>
      <data key="d1">"Similar binding mode as previously mentioned peptides within HLA-B*15:01 groove."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;ALK R1275Q NEOEPITOPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The ALK R1275Q neoepitope is a molecular interaction involving the mutated peptide sequence that can be recognized by T cells and forms stable complexes with HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SELF-PEPTIDE ARDIYRASY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The self-peptide ARDIYRASY represents a molecular interaction within the context of immune tolerance mechanisms where its binding to HLA-B*15:01 is structurally compromised due to steric hindrance."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TERTIARY STRUCTURE COMPACTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process involving the compaction of peptide tertiary structure, leading to changes in hydrogen bonding and hydrophobic interactions that improve stability with HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLA ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"HLA alleles play a critical role in determining the outcome of targeted cancer immunotherapies, particularly with regard to peptide/HLA interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;ALK R1275Q NEOEPITOPES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Neoepitopes derived from ALK (Anaplastic Lymphoma Kinase) are peptides that can be recognized by T cells in cancer immunotherapy, specifically the variant at position 1275."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;TCRS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"T cell receptors (TCRs) play a role in recognizing and binding to neoepitopes presented by HLA molecules, which is crucial for immune response against cancers."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15:01 STRUCTURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The high-resolution X-ray structure of the HLA-B*15:01 allele provides a template for predicting peptide/HLA interactions and understanding surface features of peptides poised for TCR interaction."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PEPTIDE DOCKING APPROACH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A method used to predict how peptides bind to HLA molecules, critical in understanding the presentation of neoepitopes and immune response."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NONAMER/HLA-B*15:01 STRUCTURES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"X-ray crystallographic structures of nonamers bound to HLA-B*15:01 alleles, which demonstrate consistent peptide backbone conformations essential for docking models."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;EXTENDED AND 310 HELICAL CONFORMATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Peptide conformations that are maintained in the context of HLA molecules when bound to ALK-derived peptides, important for T cell recognition."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15 ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific alleles within the HLA-B*15 group showing high binding affinities with nonamer and decamer peptides derived from ALK R1275Q neoepitopes."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-A*01:01 BINDING POCKET RESIDUES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific residues in the HLA peptide-binding groove that play a crucial role in binding to and stabilizing peptides, affecting immune response specificity."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;POLAR CONTACTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Interactions between specific amino acid residues within the HLA peptide-binding pockets, which are critical for stable binding of peptides and thus immune recognition."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-A ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific alleles within the HLA-A group that exhibit binding affinities with ALK-derived peptides."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific alleles within the HLA-B group that exhibit binding affinities with ALK-derived peptides."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-C ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific alleles within the HLA-C group that exhibit binding affinities with ALK-derived peptides."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE &quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A peptide of nine amino acids derived from the ALK protein, which interacts with various HLA molecules to be presented on cell surfaces for immune recognition."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE &quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A peptide of ten amino acids derived from the ALK protein, also interacting with HLA molecules and contributing to immune response specificity."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15:84&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An allele within the HLA-B group that shows a low binding energy for the decamer peptide."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-B*15:107&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An allele within the HLA-B group that shows a low binding energy for the nonamer peptide."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;MOCK POLYALA HLA &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A control model used to study peptide binding, characterized by all residues in the MHC-binding groove being mutated to alanine."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;KULLBACK–LEIBLER SEQUENCE LOGO &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A method for visualizing preferred residue frequencies at specific positions within HLA peptide-binding grooves, aiding in understanding binding specificity."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;ALK GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALK gene encodes the anaplastic lymphoma kinase, which can produce neoepitopes recognized by CD8+ T cells."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE (NOT SPECIFIED)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Another shortened version of an ALK-derived peptide that forms stable complexes with MHC molecules and is also recognized by immune cells."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;MHC COMPLEX FORMATION &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of forming peptide-MHC (p/MHC) complexes, which are crucial for the presentation of antigens to T cells."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;CD8+ T CELL RECOGNITION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The recognition and response by CD8+ T cells to altered-self neoepitopes presented via MHC tetramers in immune assays."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific molecular interactions between peptides, HLA proteins, β2-microglobulin (β2m), and T cell receptors during antigen presentation and recognition."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;SARS CORONAVIRUS-DERIVED EPITOPE VQQESSFVM &quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A well-characterized peptide from SARS-CoV that serves as a positive control in tetramer staining experiments for identifying CD8+ T cells reactive to specific epitopes."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;Β2-MICROGLOBULIN (Β2M)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"An integral component of MHC class I molecules involved in peptide binding and presentation on the cell surface."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;TETRAMER STAINING ASSAY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A technique used to detect and quantify T cells specific for a given antigen by staining them with labeled MHC tetramers."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;MULTICHANNEL FLOW CYTOMETRY ANALYSIS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An analysis method that allows the simultaneous measurement of multiple parameters on individual cells, often used in conjunction with tetramer staining to identify T cell populations reactive to specific antigens."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A population of blood cells isolated from whole blood that includes lymphocytes and monocytes, essential for conducting immune assays such as tetramer staining."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;AQDIYRASY (NEOEPITOPE)&quot;">
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d1">"LC-MS confirmed the presence of AQDIYRASYY in HLA-B*15:01 complexes, validating its binding affinity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B*15:01 BINDING MOTIF&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The nonamer peptide fits established HLA-B*15:01-binding motifs with preferred anchor residues at positions 2 and 9."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE AQDIYRASY BINDING MODE&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The decamer peptide forms a more compact helical structure compared to the extended backbone of the nonamer peptide, indicating distinct binding modes within HLA-B*15:01."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B*15:01 BINDING GROOVE&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The binding groove accommodates the extended conformation of nonamer peptides, with specific anchor residues deeply embedded in pockets."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE AQDIYRASYY BINDING MODE&quot;">
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d1">"The binding groove adapts to accommodate the compact 310 helical conformation of decamer peptides, with a more buried and amphipathic structure."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NONAMER/DECAMER PEPTIDES &quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"HLA-C alleles also exhibit lower binding energies than initial templates for both nonamer and decamer peptides, contributing to the broader HLA display of ALK-derived neoepitopes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-B*15:84 AND HLA-B*15:107 &quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The sequence logo reveals key residues that allow peptides to be accommodated in the MHC groove, including those specific for high-affinity binders like HLA-B*15:84 and B*15:107."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE AQDIYRASYY &quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"Formed stable p/MHC complexes with the decamer peptide for structural and functional characterization."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD8+ T CELL RECOGNITION &quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"The formation of p/MHC complexes is essential for the presentation and recognition by CD8+ T cells."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-A*01:01, HLA-B*15:01 &quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"Binds to HLA proteins as part of the MHC class I complex for peptide presentation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS74420772&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) rs74420772 in 3p14.1 achieved genome-wide significance in the TwinGene study."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS35923643-G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The leading SNP rs35923643-G in 11q24.1 has an allelic effect size (β) of 0.19 [95% CI 0.13–0.24, P = 4.3 × 10−11] on the rank order normalized standard deviation of IgM anti-PC per allele."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GRAMD1B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The six SNPs in strong linkage disequilibrium within a 131 kb block overlap with the GRAM domain containing 1B (GRAMD1B) gene."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;CLL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chronic lymphocytic leukemia (CLL) is associated with genetic variants such as rs35923643-G."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS735665-A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A proxy SNP for rs35923643-G, which has also been recognized as a risk allele for CLL and is associated with general IgM levels."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGM ANTI-PC LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The levels of IgM anti-PC are influenced by genetic variants such as rs35923643-G and rs735665-A."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;POLYGENIC RISK SCORE (PRS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A method to quantify the cumulative effect of multiple genetic risk factors on disease susceptibility or physiological processes like IgM anti-PC levels."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGM ANTI-PC DISCOVERY GWAS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The discovery phase of GWAS focusing on IgM anti-PC levels identified several significant SNPs."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;1P31.3 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs located in the 1p31.3 region were not replicated in the validation cohort."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;11Q24.1 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Six SNPs located in the 11q24.1 region achieved genome-wide significance and were successfully validated."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;CLL GWAS META-ANALYSIS&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A meta-analysis of six GWASs identified the top risk allele for CLL as rs35923643-G or its proxy SNP rs735665-A."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GENERAL IGM LEVELS GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The latest GWAS on general immunoglobulin levels found that rs735665-A is a main genetic variant specific for general IgM, distinguishing it from other immunoglobulins like IgA and IgG."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PRS ANALYSIS OF IGM ANTI-PC&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Polygenic risk score (PRS) analysis was used to investigate the association between IgM anti-PC levels and CLL risk."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;NOMINAL SIGNIFICANCE IN GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Some SNPs like rs2476601 and rs735665 achieved nominal significance in the GWAS of general IgM, suggesting their potential roles in disease susceptibility."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;NAGELKERKE R^2 &quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"The Nagelkerke r^2 statistic was used to measure the variance explained by PRSs on CLL risk."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;HISTONE MARK H3K4ME1 AND DNASEI HYPERSENSITIVITY&quot;">
      <data key="d0">"FUNCTIONAL PREDICTION"</data>
      <data key="d1">"These marks were scanned in leukemia- or immune-cell lines to predict regulatory functions of variants at the 11q24.1 locus."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS35923643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant located in the LD block at locus 11q24.1 shared between IgM anti-PC and CLL."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;H3K4ME1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Monomethylated histone H3 lysine 4, a chromatin mark associated with regulatory regions in GM12878 cells."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;DNASEI HYPERSENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Peaks of DNaseI hypersensitivity identified at the genomic position of rs35923643 in cell lines, indicating regulatory potential."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTORS (TFS)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Binding sites for 22 different transcription factors were found within ~700bp region around rs35923643 in ENCODE ChIP-seq experiments."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RUNX3 BINDING MOTIF&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A binding motif for the RUNX3 transcription factor including SNP rs35923643, with reduced predicted binding affinity due to an allele switch from T/A to C/G."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;SPI1 (PU.1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Binding motifs identified by FIMO tool, showing strong signals for SPI1 transcription factor in the region around rs35923643."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;IGM ANTI-PC AND CLL ASSOCIATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Phenotypic association between IgM anti-PC levels being lower in prevalent CLL cases compared to matched controls, but not significantly different for incident cases."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;LD BLOCK AT 11Q24.1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A linkage disequilibrium block located at chromosome 11 position q24.1 shared between IgM anti-PC levels and Chronic Lymphocytic Leukemia (CLL)."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CHROMATIN IMMUNOPRECIPITATION-SEQUENCING (CHIP-SEQ)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A technique used to identify the genomic binding sites of DNA-associated proteins, such as transcription factors."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;ENCYCLOPEDIA OF DNA ELEMENTS (ENCODE)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A comprehensive catalog of functional elements encoded in the human genome that includes data from ChIP-seq experiments on regulatory regions and TF binding sites."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;FIND INDIVIDUAL MOTIF OCCURRENCES (FIMO)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A tool used to find occurrences of motifs from a JASPAR or Transfac matrix database within a set of sequences, in this case identifying the strongest signals for RUNX3 and SPI1 binding."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;REGULOMEDB DATABASE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A database that provides an integrated model predicting transcription factor binding motifs across various genomic regions, providing evidence for rs35923643 affecting TF binding."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;GENERAL IGM LEVELS&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The rs735665-A SNP is a key genetic variant specific for general IgM, as identified in GWAS analyses."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VALIDATION COHORT&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"SNPs in the 1p31.3 region were not replicated, indicating a lack of consistent association across different cohorts."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS RESULTS INTERPRETATION&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"Negligible population stratification ensures accurate interpretation of GWAS results for genetic variants like rs35923643-G and rs735665-A."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS735665-A RISK ALLELE&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The meta-analysis of CLL GWASs identified the risk allele rs735665-A, contributing to understanding genetic predisposition to CLL."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS735665-A SPECIFICITY FOR GENERAL IGM&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The GWAS results indicate that rs735665-A is specific for general IgM levels, distinguishing it from other immunoglobulin types."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLL RISK PREDICTION&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"PRS analysis based on IgM anti-PC increasing alleles predicts higher risk of CLL, linking physiological processes to disease susceptibility."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANCE EXPLAINED BY PRSS&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The Nagelkerke r^2 statistic measures how well PRSs explain variance in CLL risk, indicating the cumulative impact of genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY FUNCTION PREDICTION&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"These marks predict potential regulatory functions of genetic variants within the 11q24.1 locus, aiding in understanding their roles in physiological processes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <edge source="&quot;METABOLIC SYNDROME&quot;" target="&quot;MICROBIOTA DYSBIOSIS&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"An imbalance in the gut microbiota is associated with an increased risk of developing metabolic syndrome, indicating a link between microbiome composition and systemic diseases."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM TOTAL CHOLESTEROL&quot;" target="&quot;GENDER DIFFERENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Women have higher serum total cholesterol and LDL levels than men in this study.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LDL CONCENTRATIONS&quot;" target="&quot;GENDER DIFFERENCES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Females exhibit higher LDL concentrations compared to males, contributing to gender-specific cardiovascular risk profiles.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM TRIGLYCERIDE CONCENTRATIONS&quot;" target="&quot;GENDER DIFFERENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Men have higher serum triglyceride levels than women in this study, reflecting sex-based differences in lipid metabolism.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HDL CONCENTRATIONS&quot;" target="&quot;GENDER DIFFERENCES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Women show higher HDL concentrations compared to men, indicating gender-specific variations in cholesterol transport and cardiovascular risk.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOOD PRESSURE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher blood pressure is observed in obese groups across both genders, suggesting a strong link between obesity and hypertension risk.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;OBESITY STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Estimated glomerular filtration rate is lower in the obese group than nonobese participants, indicating potential kidney function issues associated with obesity.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAILY ENERGY INTAKE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased daily energy intake is associated with a higher risk of obesity in both men and women.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN INTAKE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher protein intake correlates with elevated obesity risk, particularly in women.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARBOHYDRATE INTAKE&quot;" target="&quot;IRS1 GENE (RS2943641)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The rs2943641 variant in the IRS1 gene shows interaction with carbohydrate intake on T2D risk, though lacking validation."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARBOHYDRATE INTAKE&quot;" target="&quot;GLUT2 GENE (RS545389)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs545389 variant in GLUT2 shows interaction with carbohydrate intake on T2D risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT INTAKE&quot;" target="&quot;SEX DIFFERENCES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Intake of fats like saturated fatty acids shows sex-specific associations, being higher among men and contrasting patterns among women.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRIED-FOOD INTAKE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher intake of fried foods is associated with increased obesity risk in both genders.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRIED-FOOD INTAKE&quot;" target="&quot;BMI&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Higher fried-food intake is associated with higher BMI and offsets the impact of PRS on obesity risk."</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUGAR-CONTAINING FOODS INTAKE&quot;" target="&quot;GENDER DIFFERENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Women exhibit higher consumption of sugar-containing foods compared to men, affecting dietary patterns and health outcomes differently between sexes.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KOREAN BALANCED DIET AND WESTERN-STYLE DIET INTAKE&quot;" target="&quot;OBESITY STATUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Men's diets are more likely to include a Korean balanced diet and Western-style meals, contributing to higher obesity risk compared to plant-based or rice-based diets.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET AND RICE-BASED DIET INTAKE&quot;" target="&quot;GENDER DIFFERENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Women show distinct dietary patterns with lower intake of plant-based foods and higher consumption of Korean balanced diet compared to men.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL INTAKE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher alcohol consumption is linked to increased obesity risk, more pronounced in men.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL INTAKE&quot;" target="&quot;GENETIC RISK SCORE (T2D-GRES)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Moderate to high alcohol intake increasing T2D risk among individuals with high genetic predisposition."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CURRENT SMOKERS&quot;" target="&quot;GENDER DIFFERENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Men exhibit a higher rate of current smoking than women, which may influence obesity and other health risks differently between sexes.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULAR EXERCISE&quot;" target="&quot;OBESITY STATUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Women who engage in regular exercise show lower incidence of obesity compared to men where no significant association is observed.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNAJC27 (RS713586)&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A DNAJC27 genetic variant contributes to the risk of obesity through modulation of transcription factors influencing metabolic processes."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1 (RS9356744)&quot;" target="&quot;ENERGY REGULATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CDKAL1 genomic variant affects energy regulation by modulating transcriptional mechanisms involved in metabolic pathways."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TFAP2B (RS2206277)&quot;" target="&quot;TRANSCRIPTION FACTOR AP-2 BETA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variation in TFAP2B impacts the function of Transcription factor AP-2 Beta, influencing energy intake and obesity risk."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF (RS6265)&quot;" target="&quot;METABOLIC PROCESSES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A BDNF genetic variant influences metabolic processes through modulation of transcriptional regulatory networks related to energy balance."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MYL2 (RS3782889)&quot;" target="&quot;MUSCLE FUNCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variation in MYL2 impacts muscle function and contributes to obesity risk through effects on energy expenditure."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OLFM4 (RS9568856)&quot;" target="&quot;ENERGY REGULATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The OLFM4 gene influences energy regulation by genetic variants, contributing to the risk of obesity."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO (RS1421085)&quot;" target="&quot;TRANSCRIPTION FACTORS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A FTO genetic variant modulates transcription factors related to energy regulation, affecting the risk of obesity."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MC4R (RS6567160)&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MC4R gene affects metabolic pathways and is a hub gene influencing obesity risk through genetic variation."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GIPR (RS1444988703)&quot;" target="&quot;ENERGY BALANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variation in GIPR impacts energy balance by modulating the effects of gastric inhibitory polypeptide."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of one or two A-alleles in the FTO SNP is associated with higher BMI in individuals without university education but not in those with a university degree.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;MEDITERRANEAN DIET (MD)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is associated with lower BMI values."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FADS1/2 HAPLOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variation within FADS1/2 was associated with a lower BMI, suggesting genetic effects on body composition factors independent of dietary patterns."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SEX STRATIFIED GWAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"GWAS stratified by sex revealed that adjusting for BMI slightly reduces SNP heritability of snoring in both males and females."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;COLORECTAL CANCER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher BMI levels in colorectal cancer patients suggest that obesity may be a risk factor for this type of cancer."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;CHI3LI TG SNPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The analysis included examination of the relationship between Body Mass Index and CHI3L1 genomic variants in relation to type 2 diabetes risk."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;ALDH2 RS671 GENOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variations such as the rs671 polymorphism can influence BMI through their impact on metabolic processes and physiological responses to environmental factors."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SERUM C4&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased BMI is positively correlated with higher serum C4, suggesting a relationship between body fat and cholesterol metabolism."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FGF19&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was no significant association between fasting serum FGF19 and subgroup classifications suggesting no direct link in the context of IBS subtypes."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The BMI in IBS-D was approximately 4 higher than in other subgroups like IBS-C, indicating a relationship between body mass index and the disease."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS&quot;" target="&quot;EARLY MENARCHE AGE&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Individuals with early menarche age show a higher impact of PRS on BMI compared to those with late menarche age."</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;DIETARY PATTERNS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Different dietary patterns have varying impacts on BMI, especially in combination with genetic factors (PRS)."</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;TCF7L2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Body Mass Index (BMI) was assessed in relation to the genetic effects from the TCF7L2 gene without finding a significant interaction effect."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;IFG/IGT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Impaired Fasting Glucose and Impaired Glucose Tolerance (IFG/IGT) status at baseline is positively associated with BMI levels but negatively correlated with changes in BMI during follow-up periods."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;RS4771122&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Additional copies of the minor (G) allele in SNP rs4771122 were associated with larger percentage weight loss after adjustment for pre-surgical BMI, indicating a genetic influence on weight loss trajectories.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SNORING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Body Mass Index positively correlates with habitual snoring prevalence in both sexes."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;T2D&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"None of the CHI3L1 tgSNPs showed any associations with BMI or other T2D-related quantitative traits such as HbA1c, fasting glucose, and 2-hour post-load glucose levels.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SUA LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Body mass index (BMI) is associated with higher serum uric acid (sUA) levels in both males and females carrying T alleles of the ABCG2 rs2231142 variant."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High plant-based diet intake can mitigate the obesity risk in individuals with high PRS."</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;SERUM ALT AND AST CONCENTRATIONS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher liver enzymes (ALT and AST) are observed in obese groups compared to nonobese individuals across genders, highlighting the impact of obesity on liver health.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;NUTRIENT INTAKE&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Various nutrient intakes can influence the relationship between PRS and obesity risk."</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;EDUCATION LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher education level is associated with a lower risk of obesity, indicating that lifestyle factors including education can influence genetic susceptibility to diseases like obesity.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;AGE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Age acts as an environmental factor influencing obesity risk; different age groups exhibit varying levels of genetic susceptibility to diseases like obesity due to polymorphisms in the FTO gene."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FTO SNP is associated with increased risk of obesity, especially in individuals without university education."&lt;SEP&gt;"The presence of the FTO SNP is associated with increased obesity risk."</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER DIFFERENCES&quot;" target="&quot;DII&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Men have a higher DII score compared to women, indicating a more inflammatory diet for males.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Proteins involved in antibiotic resistance interact with metabolic pathways to maintain bacterial survival.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902&quot;" target="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The high-protein diet interacts with the risk allele (A) of the FTO rs1558902 to result in greater weight loss compared to those on a low-protein diet."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902&quot;" target="&quot;WEIGHT LOSS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of the risk allele (A) in FTO rs1558902 is associated with greater weight loss when participants follow a high-protein diet."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;LEAN MASS CHANGES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Participants on a high-protein diet, particularly those carrying the risk allele (A), experienced more significant changes in lean muscle mass compared to non-carriers."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;TOTAL FAT LOSS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"When individuals follow a high-protein diet and carry the risk allele (A) of FTO rs1558902, they experience more significant reductions in total body fat."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;AA GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with the AA genotype showed greater decreases in fat distribution when following a high-protein diet compared to those without this genotype, indicating an interaction between genotype and dietary pattern.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;FAT DISTRIBUTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Participants with the AA genotype experienced less loss in TAT and SAT when on a low-protein diet compared to other genotypes, showing differential effects of protein intake on fat distribution based on genetic variation.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;GLUD1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A low-protein diet is prescribed as a therapeutic intervention for patients who have genetic defects in the GLUD1 gene leading to hyperinsulinism and hypoglycemia."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT LOSS&quot;" target="&quot;BARIATRIC SURGERY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Weight loss is a physiological process significantly influenced by bariatric surgery procedures which induce metabolic and structural changes in the digestive system.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL FAT LOSS&quot;" target="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals carrying the risk allele of the FTO rs1558902 show greater loss in total fat when following a high-protein diet compared to those on low-protein diets."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEAN MASS CHANGES&quot;" target="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genotype of FTO rs1558902 influences changes in lean muscle mass, especially when combined with high-protein dietary interventions."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;WAIST CIRCUMFERENCE CHANGES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic variant affects the change in waist circumference, particularly in response to dietary protein intake."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WC (WAIST CIRCUMFERENCE)&quot;" target="&quot;MEDITERRADIAN DIET (MD)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Individuals adhering more closely to the MD tend to have smaller waist circumferences."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;TOTAL FAT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There is an interaction between the AA genotype and dietary patterns (low-fat diets), influencing changes in total body fat over time.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-FAT DIET&quot;" target="&quot;FM%&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Participants with the AA genotype showed differential responses to low-fat diet interventions, specifically affecting their fat mass percentage compared to other genotypes.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-FAT DIET&quot;" target="&quot;TRUNK FAT DISTRIBUTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Changes in trunk fat distribution were observed in individuals with the AA genotype in response to low-fat dietary patterns.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;OBESITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The A-allele carriers of FTO SNP have an increased risk of obesity, especially among subjects lacking higher educational attainment.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;FTO GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The FTO gene harbors a polymorphism (rs9939609) that influences anthropometric variables such as weight, BMI and waist circumference."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;ANTHROPOMETRIC VARIABLES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of one or two A-alleles in the FTO SNP is associated with increased values for anthropometric variables like weight, BMI and waist circumference."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;SEX&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Statistical adjustments for sex differences reveal that the impact of the FTO SNP on anthropometric variables is consistent across different genders."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;SMOKING STATUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Adjustments for smoking status in statistical models help isolate the independent effect of the FTO SNP on BMI and obesity risk, showing its significant influence even after controlling for environmental factors like smoking."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;DIABETES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Adjustments for diabetes status in models reveal that the FTO SNP influences obesity risk independently of pre-existing conditions, highlighting its role in genetic predisposition to obesity."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Statistical interaction between PA levels and the FTO SNP indicates that physical activity modifies the effect of the polymorphism on BMI and obesity risk, showing lifestyle factors' importance."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;PRIMARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with primary studies education level exhibit a significant interaction between educational attainment and FTO SNP in determining higher BMI compared to university-level educated individuals."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;SECONDARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Similarly, secondary studies education level shows a significant association with the impact of FTO SNP on obesity risk in contrast to higher educational attainment levels."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;UNIVERSITY-LEVEL EDUCATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with university-level education exhibit lessened or reversed effects of the FTO SNP on obesity risk, indicating that lifestyle factors like education can mitigate genetic predisposition to obesity."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;APOBR&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Variants in the APOBR gene are associated with an increased risk of obesity, particularly in children and adolescents."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;BMI PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Effects of the FTO gene on cardiometabolic phenotypes diminish significantly after adjustment for BMI, indicating mediation through this physiological process.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The FTO gene is associated with cardiometabolic traits and diseases through its influence on snoring predisposition.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;TCF7L2 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"No significant interaction was observed between the degree of age and the genetic effects from the TCF7L2 gene."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The mean age of both cases and controls was almost identical, indicating no significant difference in age-related risks for IA."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;SNORING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The prevalence of habitual snoring increases slightly with age."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;GUT MICROBIOTA DYNAMICS&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The composition of the gut microbiota changes with age, impacting its role in health and disease."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age is a significant factor that correlates with and influences the rate of HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;TCF7L2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Testing for sex as an environmental factor did not reveal a significant influence on the genetic risk associated with the TCF7L2 gene."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"No significant association was found between sex and IA risk based on the study conducted."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;SNORING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Being male significantly increases the risk of being a habitual snorer due to physiological reasons."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The impact of sex on disease progression in HIV patients is under investigation to determine its role as an independent risk factor."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The smoking status (smoker vs. non-smoker) was analyzed for its role in gene-diet interactions affecting health outcomes.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;GENE X&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Smoking status may modify the effect of Gene X on health outcomes through gene-diet interactions.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;HYPERTENSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Smoking status is a physiological process that can increase the risk of developing hypertension, influencing overall cardiovascular health."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;HEALTH CARE RECORDS (HCR)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"HCR data can influence the assessment of PA's impact on health outcomes, including obesity risk."</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;FIBER INTAKE&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Both fiber intake and physical activity are lifestyle factors that interact with specific genetic variants to influence type 2 diabetes risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;DIETARY PATTERN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Physical activity and dietary patterns are lifestyle factors that often interact to influence health outcomes such as type 2 diabetes risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;T2D-GRS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The protective effect of physical activity against T2D is weaker in individuals with high genetic risk score."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;IGF2BP2 VARIANT RS11075984&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The protective effect of physical activity against T2D is lessened in individuals carrying this genetic variant."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There is a significant interaction between educational level and the FTO SNP in determining obesity risk."</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;UNIVERSITY STUDIES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with university studies show no significant association between the FTO SNP and obesity, indicating a modifying effect."</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISM (GP)&quot;" target="&quot;OBESITY RISK ASSESSMENT (OHP)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The GP interacts with OHP to determine obesity risk in populations."</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TCF7L2 gene is significantly associated with the development of Type 2 Diabetes, which can progress to End Stage Renal Disease."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;AFRICAN ANCESTRY DEGREE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant interaction between the degree of African ancestry and the genetic risk associated with the TCF7L2 gene was observed."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT (G × D)&quot;" target="&quot;WHOLE GRAINS&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"The consumption of whole grains interacts with genetic variants associated with the development of type 2 diabetes."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBER INTAKE&quot;" target="&quot;TCF7L2 GENE (RS7903146)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The rs7903146 variant in the TCF7L2 gene shows interaction with dietary fiber intake, modifying its association with Type 2 Diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBER INTAKE&quot;" target="&quot;NOTCH2 GENE (RS10923931)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs10923931 variant in the NOTCH2 gene shows interaction with dietary fiber intake, impacting T2D risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBER INTAKE&quot;" target="&quot;ZBED3 GENE (RS4457053)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs4457053 variant in ZBED3 gene interacts with dietary fiber intake on T2D risk, though replication was not observed."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;GLYCEMIC LOAD (GL)&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"High glycemic load, in conjunction with specific genetic variants, increases the risk of developing type 2 diabetes."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Elevated FPG levels are indicative of pre-diabetic conditions like IFG and are predictive markers for the development of T2D in follow-up studies."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;KETONE BODIES (KBS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of high KB levels is a risk factor for T2D development, especially after adjustment for confounders like age and BMI."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;INSULIN SENSITIVITY (IS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Lower IS measured by Matsuda ISI correlates with higher levels of KBs, increasing the risk of converting to T2D after a five-year follow-up."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These genetic variations are linked to an increased risk of developing T2D and correlate with elevated levels of AcAc and BHB, contributing to the metabolic phenotype."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;GLUCOSE AREA UNDER THE CURVE (AUC)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher AUC values measured over time predict an increased risk of developing T2D, especially when combined with elevated AcAc and BHB levels."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NURSES' HEALTH STUDY (NHS)&quot;" target="&quot;HEALTH PROFESSIONALS FOLLOW-UP STUDY (HPFS)&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Both NHS and HPFS are cohort studies that investigate the interaction of dietary patterns with genetic factors affecting health outcomes."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MALMÖ DIET AND CANCER STUDY (MDCS)&quot;" target="&quot;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER (EPIC)‐INTERACT &quot;">
      <data key="d4">1.5</data>
      <data key="d5">"These cohort studies, MDCS and EPIC-Interact, explore the interaction of environmental factors with genetic predispositions in relation to disease risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHANGHAI DIABETES GWAS STUDY &quot;" target="&quot;KOREAN GENOME AND EPIDEMIOLOGY STUDY (KOGES)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both studies investigate genetic variants associated with diabetes but focus on different ethnic populations, providing insights into genetic-environment interactions."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FINISH DIABETES PREVENTION STUDY (DPS)&quot;" target="&quot;AMERICAN DIABETES PREVENTION PROJECT (DPP)&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"These RCTs evaluate the effectiveness of lifestyle interventions in preventing type 2 diabetes across different populations and settings."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREVENCIÓN CON DIETA MEDITERRÁNEA (PREDIMED)&quot;" target="&quot;STUDY IN ITALIANS FROM ASTI &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both studies assess dietary patterns and their interaction with metabolic factors to prevent cardiovascular diseases and diabetes risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GIPR GENE (RS10423928)&quot;" target="&quot;FAT INTAKE (TOTAL AND SATURATED)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The rs10423928 variant in the GIPR gene interacts with fat intake on T2D risk, lacking consistent evidence."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPARΓ GENE (RS1801282)&quot;" target="&quot;FAT INTAKE (TOTAL AND SATURATED)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The rs1801282 variant in the PPARγ gene shows a trend for interaction with dietary fat intake on T2D risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFE GENE (RS1799945)&quot;" target="&quot;HEME IRON INTAKE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The rs1799945 variant in the HFE gene modifies the association of heme iron with T2D incidence, particularly among women."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADH1C GENE (*1/*2)&quot;" target="&quot;ALCOHOL CONSUMPTION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The *1/*2 variants in the ADH1C gene modify the association between alcohol consumption and T2D risk, specifically in US women carrying allele *2."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE GRAIN CONSUMPTION&quot;" target="&quot;TCF7L2 GENE (RS7903146)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The rs7903146 variant in the TCF7L2 gene interacts with whole grain intake, impacting Type 1 Diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC40A1 RS744653 VARIANT&quot;" target="&quot;HEME IRON INTAKE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Interaction between this genetic variant and dietary heme iron intake influencing T2D risk in men."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 VARIANTS (ZINC TRANSPORTER)&quot;" target="&quot;ZINC INTAKE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Intake of zinc interacts with SLC30A8 variants but without clear trend for type 2 diabetes association."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RED MEAT&quot;" target="&quot;T2D-GRS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"High intake of red meat increases T2D risk among individuals with high genetic risk score (T2D-GRS)."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;CLOCK VARIANT RS4580704&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Interaction between consumption of a Mediterranean diet and CLOCK variant to lower type 2 diabetes incidence."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;COLON AA CONCENTRATIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Mediterranean diet impacts arachidonic acid concentrations in the colon, especially in individuals with no minor alleles in FADS1/2."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LTPA (LEISURE-TIME PHYSICAL ACTIVITY)&quot;" target="&quot;TYPE 2 DIABETES RISK&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Change in LTPA modifies the risk of type 2 diabetes incidence based on specific genetic variants."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D INCIDENCE&quot;" target="&quot;CLOCK VARIANT RS4580704&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Interaction between CLOCK variant and dietary patterns to modify the incidence rate of type 2 diabetes."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRUITS AND VEGETABLES&quot;" target="&quot;TYPE 2 DIABETES INCIDENCE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Consumption of fruits and vegetables showing a significant interaction with genetic factors to lower the incidence rate of type 2 diabetes."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLYCEMIC LOAD INTAKE&quot;" target="&quot;TCF7L2 GENE (RS12255372)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs12255372 variant in the TCF7L2 gene interacts with glycemic load intake, affecting T2D risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT INTAKE (SATURATED)&quot;" target="&quot;SLC30A8 GENE (RS13266634)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs13266634 variant in SLC30A8 shows interaction with saturated fat intake on T2D risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT INTAKE (TOTAL)&quot;" target="&quot;KCNQ1 GENE (RS2237892)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs2237892 variant in KCNQ1 interacts with total fat intake, affecting insulin resistance and T2D risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WFS1 GENE&quot;" target="&quot;RS10010131 GENOMIC VARIANT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A specific variant (rs10010131) in the WFS1 gene is associated with an increased risk of developing T2D-ESRD, although this association was weaker compared to European populations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WFS1 GENE&quot;" target="&quot;TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The WFS1 gene is implicated in the progression from Type 2 Diabetes towards End Stage Renal Disease, though its association varies across populations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1 GENE&quot;" target="&quot;RS10946398 GENOMIC VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs10946398 variant in the CDKAL1 gene is associated with an increased risk of developing T2D-ESRD, consistent with previous findings in European samples."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1 GENE&quot;" target="&quot;TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The CDKAL1 gene is associated with an increased risk of developing Type 2 Diabetes, which can progress to End Stage Renal Disease."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;JAZF1 GENE&quot;" target="&quot;RS864745 GENOMIC VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs864745 variant in the JAZF1 gene is associated with an increased risk of developing T2D-ESRD, similar to results observed in European populations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;JAZF1 GENE&quot;" target="&quot;TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The JAZF1 gene is associated with an increased risk of developing Type 2 Diabetes, which can progress to End Stage Renal Disease."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9 GENE&quot;" target="&quot;RS4607103 GENOMIC VARIANT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A variant (rs4607103) in the ADAMTS9 gene is associated with T2D-ESRD risk, but this association differs directionally from that found in European populations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9 GENE&quot;" target="&quot;TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ADAMTS9 gene has a variant that affects the risk of developing Type 2 Diabetes, which can progress to End Stage Renal Disease."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)&quot;" target="&quot;AFRICAN ANCESTRY PROPORTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The proportion of African ancestry in individuals' genetic makeup did not significantly affect the risk of developing T2D-ESRD, suggesting similar susceptibility across ethnic backgrounds."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK ALLELE COUNT&quot;" target="&quot;TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The count of risk alleles is associated with the TCF7L2 risk variant rs7903146 in association analyses."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNWEIGHTED OR (ODDS RATIO)&quot;" target="&quot;TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The unweighted odds ratio analysis results indicate the interaction between risk alleles and TCF7L2 variant for disease association."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHTED OR (ODDS RATIO)&quot;" target="&quot;TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The weighted odds ratio analysis results provide adjusted interaction measures considering genetic background with the TCF7L2 variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;IFG/IGT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both IFG/IGT and T2D represent pre-diabetic or diabetic states that influence metabolic pathways related to obesity, such as BMI levels and changes."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;EAST ASIAN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In East Asian populations, there's a specific distribution pattern of Type 2 Diabetes (T2D), showing lower prevalence compared to some other ethnic groups."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;NATIVE NORTH AMERICAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals from Native North America exhibit specific rates of T2D which differ from those observed in other populations, indicating unique risk factors."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;SOUTH ASIAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The South Asian population has higher rates of T2D compared to other groups, indicating genetic and lifestyle factors contributing to increased risk."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS4950928&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Similarly, the genomic variant rs4950928 also did not show a significant association with T2D when adjusted for age, sex, BMI and glucose tolerance.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;CEP55&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Association found between methylation levels of CEP55 gene and T2D risk, though not statistically significant after permutation test."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;HIST1H4D 3'-UTR METHYLATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Lower methylation levels in the HIST1H4D 3' UTR region are linked to a higher risk of developing T2D."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;NGT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with normal glucose tolerance (NGT) represent the baseline against which impaired fasting glucose/impaired glucose tolerance (IFG/IGT) status is assessed for changes in BMI and other metabolic parameters."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;AFRICAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with African ancestry have a higher incidence of Impaired Fasting Glucose and Impaired Glucose Tolerance (IFG/IGT), indicating significant ethnic differences in metabolic conditions."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;EUROPEAN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Europeans show distinct patterns in the prevalence of IFG/IGT compared to other ethnicities, reflecting genetic and environmental influences on metabolic health."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;LATINO AMERICAN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Latino Americans have a particular prevalence rate for IFG/IGT, highlighting the importance of considering ethnic background in metabolic health assessments."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FEMALES&quot;" target="&quot;MALES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In the context of glycemic status and BMI changes, females generally show higher percentages across all categories, while males have a higher likelihood of IFG/IGT or T2D compared to normal glucose tolerance (NGT)."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI BASELINE&quot;" target="&quot;FTO RS9939609&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The FTO gene variant, rs9939609, is significantly associated with an elevated baseline body mass index (BMI).")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI BASELINE&quot;" target="&quot;TAL1 RS2984618&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"rs2984618 in TAL1 shows significant association with increased BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI BASELINE&quot;" target="&quot;TCF7L2 RS7903146&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The TCF7L2 gene variant, rs7903146, is associated with an elevated body mass index (BMI) at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI BASELINE&quot;" target="&quot;GRS&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Genotype risk score (GRS), derived from multiple obesity-associated SNPs, is significantly linked to increased BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI BASELINE&quot;" target="&quot;GLYCEMIC STATUS TRAITS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Traits related to glycemic status significantly interact with obesity predisposing SNPs to affect BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;GENOMIC VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The analysis focused on 23 SNPs as potential genomic variants associated with treatment response."</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;COMBINATION THERAPY COHORT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The combination therapy cohort included 43 patients, with no significant associations found for SNPs tested in the study."</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTA, PEGDH, PEGNDH, DIG, CFL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The GRS is significantly associated with performance on TMTA and TMTB but not with other assessments such as PEGDH or DIG."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;DIVERGT BATTERY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"There is no observed association between Genetic Risk Score (GRS) and performance on the DIVERGT battery despite its relevance to assessing neurotoxicity-related impairments."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Higher Genetic Risk Score (GRS) values are associated with increased risk of MTX-related neurotoxicity as evidenced by lower scores on specific cognitive tests."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTB (TRAIL MAKING TEST PART B)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Higher GRS values are associated with significantly lower scores on TMTB, indicating poorer executive function and processing speed."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEPR RS1011527&quot;" target="&quot;FPG&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The interaction effect of LEPR variant rs1011527 and fasting plasma glucose (FPG) on baseline body mass index (BMI) is significant, indicating a potential genetic-environmental interaction.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEPR RS1011527&quot;" target="&quot;FPG LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The interaction between fasting plasma glucose (FPG) levels and the LEPR gene variant, rs1011527, is significant for predicting changes in body mass index (BMI).")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2HPG&quot;" target="&quot;FPG&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG) are measures of blood sugar regulation, where high values in both correlate positively with baseline BMI but negatively predict changes in BMI over time."</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 1298A&gt;C&quot;" target="&quot;DIVERGT BATTERY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Survivors with the MTHFR 1298AC/CC genotypes have a significantly higher likelihood of meeting criteria for impairment on the DIVERGT battery."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS 2756A&gt;G&quot;" target="&quot;PEGNDH&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Individuals with the MS 2756AA genotype demonstrate lower PEGNDH scores compared to those with other genotypes."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTRR 66A&gt;G&quot;" target="&quot;CFL&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Survivors with MTRR 66AA genotype perform worse on CFL test compared to those with the MTRR 66AG/GG genotypes."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSER POLYMORPHISMS&quot;" target="&quot;TMTB&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Individuals with TSER 2R/3R and 3R/3R genotypes score lower on TMTB than those with the 2R/2R genotype."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIVERGT BATTERY&quot;" target="&quot;EARLY MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Early MTX-related neurotoxicity is predictive of long-term neurocognitive impairment as assessed by the DIVERGT battery."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIVERGT BATTERY&quot;" target="&quot;ALL (ACUTE LYMPHOBLASTIC LEUKEMIA)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The Divergt battery is used for assessing long-term neurological and cognitive impacts of ALL treatment, particularly in children."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EARLY MTX-RELATED NEUROTOXICITY&quot;" target="&quot;MTX (METHOTREXATE)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Administration of methotrexate early in treatment can lead to neurotoxic effects which may impact long-term cognitive function."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC RISK SCORE (GRS)&quot;" target="&quot;NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Higher genetic risk scores correlate with worse performance on certain cognitive tests and a higher likelihood of neurocognitive impairment."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRATHECAL MTX EXPOSURE&quot;" target="&quot;CUMULATIVE IV MTX EXPOSURE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Both intrathecal and cumulative IV exposures to methotrexate are environmental factors that contribute to the risk of neurotoxicity but do not necessarily correlate with cognitive impairment as measured by certain tests."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYMORPHISM&quot;" target="&quot;GENOMIC VARIANT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A polymorphism contributes to the calculation of GRS, which in turn predicts neurotoxicity-related cognitive impairment."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SURVIVORS&quot;" target="&quot;COGNITIVE IMPAIRMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Survivors show varying levels of cognitive impairment based on their Genetic Risk Score (GRS)."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;FADS1/2 GENE CLUSTER&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A genomic variant within the FADS1/2 gene cluster modulates the response to dietary interventions affecting fatty acid metabolism."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Each genomic variant evaluated for its association with ovarian cancer risk was checked against Hardy-Weinberg equilibrium to ensure genetic data consistency within control populations."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SLC30A8 variant is associated with higher fasting proinsulin levels at baseline, which decrease after intervention."</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;GENOTYPE × TREATMENT INTERACTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The presence of the SLC30A8 risk allele did not interact with treatment type to modify proinsulin reduction, indicating consistent efficacy across genotypes."</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;TROGLITAZONE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Treatment with troglitazone reduced fasting proinsulin levels, though not as effectively as lifestyle intervention."</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE INTERVENTION&quot;" target="&quot;METFORMIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The lifestyle intervention was more effective than metformin in reducing proinsulin levels after one year of treatment."</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE INTERVENTION&quot;" target="&quot;PLACEBO GROUP&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The comparison between placebo and lifestyle intervention shows a significant reduction in proinsulin levels with active intervention."</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING INSULIN&quot;" target="&quot;PROINSULIN LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Adjusting for fasting insulin helps isolate the effect of SLC30A8 risk alleles on proinsulin levels."</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE, SEX, ETHNICITY&quot;" target="&quot;PROINSULIN LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Controlling for demographic factors ensures that the observed effects are due to interventions rather than confounding variables."</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;LIPID EMULSION (LE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Inclusion of lipid emulsion attenuates the induction of PNPLA3 mRNA levels caused by a high carbohydrate diet."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is a positive correlation between the mRNA levels of PNPLA3 and SREBP1c, indicating they are co-regulated in mouse liver."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;ACC-1 (ACETYL-COA CARBOXYLASE 1)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Similarly, there is a positive correlation between the mRNA levels of PNPLA3 and ACC-1, suggesting their co-regulation in mouse liver."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;HEPG2 CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In HepG2 cells exposed to glucose depletion-refeeding conditions, PNPLA3 gene expression is regulated by glucose levels."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;CHREBP (CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"PNPLA3 and ChREBP exhibit similar patterns of expression in response to glucose changes in HepG2 cells, indicating a possible regulatory relationship."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)&quot;" target="&quot;2-DEOXY-D-GLUCOSE (2DG)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Treatment with 2-deoxy-D-glucose suppresses SREBP1c gene expression, indicating its role in glucose metabolism."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)&quot;" target="&quot;NON-METABOLIZABLE GLUCOSE ANALOG (2DG)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Treatment with 2-deoxy-D-glucose suppresses SREBP1c gene expression, indicating it blocks the induction by high glucose."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH FAT DIET (HF)&quot;" target="&quot;PHYSICAL ACTIVITY (EXERCISE)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Voluntary exercise reduces PNPLA3 expression in mice fed a high fat diet."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH FAT DIET (HF)&quot;" target="&quot;FATTY LIVER&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Mice fed a high fat diet develop fatty liver, characterized by increased hepatic triglyceride content."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (EXERCISE)&quot;" target="&quot;FATTY LIVER&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Voluntary exercise significantly reduces PNPLA3 mRNA levels and inhibits the development of fatty liver caused by a high fat diet."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FATTY LIVER&quot;" target="&quot;TG (TRIGLYCERIDES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased hepatic TG content is associated with the development of fatty liver in mice fed a high fat diet."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEPG2 CELLS&quot;" target="&quot;INSULIN RECEPTOR PROTEIN&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Expression of the insulin receptor protein does not lead to upregulation of the PNPLA3 gene upon insulin treatment in HepG2 cells, suggesting a lack of direct response mechanism."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHREBP (CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN)&quot;" target="&quot;DEPLETION-REFEEDING CONDITIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Under depletion-refeeding conditions, ChREBP gene expression shows a similar pattern to PNPLA3 in HepG2 cells."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINOLEIC ACID (LA)&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Treatment with LA suppresses the expression of PNPLA3 in HepG2 cells, demonstrating a regulatory role for this fatty acid on PNPLA3 levels."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OLEIC ACID (OA)&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Similar to LA treatment, OA also suppresses the expression of PNPLA3, indicating that both types of unsaturated fatty acids have a similar effect on PNPLA3 regulation."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EICOSAPENTAENOIC ACID (EPA)&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Treatment with EPA led to reduced expression levels of the PNPLA3 gene, indicating EPA's regulatory role in suppressing PNPLA3 mRNA."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Like EPA, DHA treatment also resulted in reduced levels of PNPLA3 mRNA expression under both high and low glucose conditions."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH GLUCOSE CONDITION&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Under high glucose condition, although lipid accumulation increased, there was no significant effect on PNPLA3 mRNA levels as opposed to expected upregulation of FAS or ACC-1."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH GLUCOSE DIET (HC-DIET)&quot;" target="&quot;MOUSE LIVER&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Induced PNPLA3 gene expression which was reversed by Intralipid® treatment, demonstrating dietary effects on hepatic lipid metabolism."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRALIPID®&quot;" target="&quot;FATTY ACIDS (OA, LA, ALA)&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"When combined with OA and LA but not ALA, significantly suppressed PNPLA3 mRNA levels in HepG2 cells under both glucose conditions, indicating a complex interaction."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KNOCKDOWN OF FAS (FASN)&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Knockdown of FAS did not affect the expression level of PNPLA3, highlighting specificity in regulatory pathways."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OIL RED O STAINING&quot;" target="&quot;HEPG2 CELLS WITH KNOCKED DOWN PNPLA3&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"No difference was observed in lipid accumulation between knocked down PNPLA3 cells and controls, indicating that knockdown did not affect lipid storage capacity."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAS PROTEIN&quot;" target="&quot;INSULIN TREATMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"FAS protein is upregulated by insulin treatment, contrasting with no change observed for the PNPLA3 gene expression under similar conditions."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNS&quot;" target="&quot;HIPPOCAMPUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The hippocampus displays increased FoxO1 expression following PNS (Psychological stress)."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIPPOCAMPUS TRANSCRIPTOME&quot;" target="&quot;MIRNOME CHANGES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Prenatal stress-induced changes in miRNA levels directly target hippocampal transcripts identified from transcriptomics analysis.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AXONAL GUIDANCE SIGNALING PATHWAY&quot;" target="&quot;PROTEIN KINASE A SIGNALING PATHWAY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both signaling pathways are part of neurodevelopment processes and were affected by PNS exposure according to pathway analysis.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUTAMATE RECEPTOR SIGNALING PATHWAY&quot;" target="&quot;WNT/Β-CATENIN SIGNALING PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These two pathways, involved in neuronal development, have been found altered due to prenatal stress exposure according to the pathway analysis performed.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 SIGNALING PATHWAY&quot;" target="&quot;STAT3 PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both inflammatory signaling pathways were affected by PNS according to pathway analysis and are part of a broader immune response system.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6 SIGNALING PATHWAY&quot;" target="&quot;RAG1−/− MICE&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"In Rag1−/− mice, IL-6 signaling appears more critical compared to IL-1 for inducing colonic inflammation due to IL-10 suppression.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EARLY LIFE TRAUMA EXPOSURE&quot;" target="&quot;ENOS SIGNALING PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Exposure to early life trauma influences the eNOS signaling pathway, a critical pathway involved in inflammation and cardiovascular health.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;42 PATHWAYS INVOLVED IN NEURODEVELOPMENT AND INFLAMMATION&quot;" target="&quot;BLOOD TRANSCRIPTOMICS OF EARLY LIFE TRAUMA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The pathway list includes pathways found in both rat studies after PNS exposure and human blood transcriptome analysis after early life trauma exposure, indicating shared biological mechanisms.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;528 SIGNIFICANT GENES PANEL&quot;" target="&quot;PRENATAL STRESS MODEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Panel of significant genes from the PNS model's combined mRNA-miRNA analysis that were also modulated in individuals exposed to early-life trauma.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTEGRATED DATA SET FROM ANIMAL AND HUMAN STUDIES&quot;" target="&quot;REAL-TIME PCR VALIDATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Validation of integrated data sets through real-time PCR confirmed the directionality of gene expression changes identified in microarray studies for 22 common genes.")</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISOC1&quot;" target="&quot;TGF-Β1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both ISOC1 and TGF-β1 show modulated expression patterns under similar conditions, indicating possible interaction or common pathways."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LDLRAP1&quot;" target="&quot;FOXO1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"LDLRAP1 and FoxO1 are both part of gene networks involved in cellular signaling processes under stress conditions."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGF-Β1&quot;" target="&quot;A2M&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both TGF-β1 and A2M play roles in immune response pathways, indicating a possible interaction or overlapping functions."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGF-Β1&quot;" target="&quot;GXE INTERACTION STUDIES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Transforming growth factor beta 1 (TGF-β1) is involved in GxE interaction studies, showing significant associations with emotional stress and depressive symptoms in adulthood."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;SNP RS17592371&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FoxO1 gene interacts with SNP rs17592371 to predict depressive symptoms in adulthood due to childhood emotional stress."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;CORTISOL EXPOSURE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"FoxO1 activation occurs in hippocampal progenitor stem cells following cortisol exposure, indicating its role as a mediator between stress and neurogenesis."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;CORTISOL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FoxO1 expression and activity are regulated by cortisol exposure, affecting neurogenesis and neuronal proliferation."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;CHILDHOOD TRAUMA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Exposure to childhood trauma leads to elevated levels of the FoxO1 gene in blood samples, indicating a link between psychological trauma and brain function."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL&quot;" target="&quot;SGK-1 (SERUM GLUCOCORTICOID KINASE 1)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Cortisol upregulates the expression of SGK-1, a gene involved in mediating some effects of glucocorticoids on brain function."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL&quot;" target="&quot;NEUROGENESIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Cortisol negatively affects neurogenesis through the mediation of FoxO1, impacting neuronal proliferation and differentiation."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHILDHOOD TRAUMA&quot;" target="&quot;FOXO1 SNPS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Single nucleotide polymorphisms within the FoxO1 gene interact significantly with childhood trauma to predict higher levels of depressive symptoms in adulthood."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AS1842856&quot;" target="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The inhibitor AS1842856 blocks cortisol-induced reduction of neuronal proliferation by inhibiting FoxO1 activity."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1 PROTEIN&quot;" target="&quot;HIPPOCAMPAL PROGENITOR STEM CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The activation of the FoxO1 protein in hippocampal progenitor stem cells leads to changes affecting neurogenesis."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1 PROTEIN&quot;" target="&quot;BASELINE CONDITIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Under baseline conditions, the FoxO1 protein does not significantly affect neuronal proliferation, indicating its activity is stress-dependent."</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINES SIGNALING PATHWAY&quot;" target="&quot;TGF-Β1 SIGNALING PATHWAY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The TGF-β1 signaling pathway is involved in cytokine signaling, indicating interconnected pathways that play a role in cellular communication and stress responses."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;LONG-TERM WEIGHT LOSS AFTER BARIATRIC SURGERY&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The minor (G) allele of SNP rs4771122 is associated with larger percentage weight lost after bariatric surgery, adjusted for several variables including pre-surgical BMI.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;PRE-SURGICAL WEIGHT&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Additional copies of the minor (G) allele in SNP rs4771122 were significantly associated with increased pre-surgical weight, indicating a relationship between genotypic variation and baseline characteristics.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROBAND&quot;" target="&quot;CLINICAL INFORMATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Clinical information for a subset of probands with GCK variants was available and analyzed."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROBAND&quot;" target="&quot;DE NOVO MUTATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A de novo mutation in the proband was identified without it being present in parental DNA."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROBAND&quot;" target="&quot;FASTING HYPERGLYCEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The proband exhibits stable levels of fasting hyperglycemia associated with GCK variants."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK GENE&quot;" target="&quot;SANGER SEQUENCING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Sanger sequencing is used to identify variants in the GCK gene."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SANGER SEQUENCING&quot;" target="&quot;UNIVERSITY OF CHICAGO&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The University of Chicago uses Sanger sequencing to identify GCK variants."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SANGER SEQUENCING&quot;" target="&quot;HRMA (HIGH RESOLUTION MELTING ANALYSIS)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"HRMA and Sanger sequencing are both utilized for verifying genetic variants, with HRMA providing a rapid method for initial genotyping while Sanger sequencing offers precise validation."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SANGER SEQUENCING&quot;" target="&quot;GENETIC VARIANT IDENTIFICATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Used to identify and confirm the presence of genetic variants, including those affecting STAT5B."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACMG GUIDELINES&quot;" target="&quot;PATHOGENIC VARIANTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"ACMG guidelines are used to classify and interpret the significance of pathogenic variants in clinical settings."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIKELY PATHOGENIC VARIANTS&quot;" target="&quot;VUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants not meeting criteria for pathogenicity or benign but classified as VUS based on limited evidence."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IN-SILICO TOOLS&quot;" target="&quot;VUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Computational tools predict the impact of VUS on protein function but do not classify them as pathogenic."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK-MODY&quot;" target="&quot;HBA1C LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"HbA1c levels in individuals with GCK-MODY may be lower than expected due to mild hyperglycemia."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONSENSE VARIANT&quot;" target="&quot;PROTEIN FUNCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Nonsense variants can lead to truncated proteins, impacting their function and contributing to disease."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MISSENSE VARIANT&quot;" target="&quot;AMINO ACID CHANGE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Missense variants result in single amino acid changes that may alter protein structure or function."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SPLICE SITE VARIANT&quot;" target="&quot;PROTEIN SYNTHESIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Splice site variants can affect mRNA splicing and subsequently impact the efficiency of protein synthesis."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IN-FRAME DELETION/DUPLICATION&quot;" target="&quot;READING FRAME&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These genomic changes maintain the reading frame but may alter amino acid sequence, potentially affecting protein function."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSERTION/DELETION (INDEL)&quot;" target="&quot;AMINO ACID SEQUENCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Indels can introduce frameshift mutations or simply alter amino acid sequences without disrupting the coding frame."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET (MD)&quot;" target="&quot;HDL-C (HIGH-DENSITY LIPOPROTEIN CHOLESTEROL)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Adherence to the Mediterranean diet positively correlates with higher HDL cholesterol levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET (MD)&quot;" target="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The apoB:apoA-1 ratio is significantly lower in individuals adhering more closely to the Mediterranean diet."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET (MD)&quot;" target="&quot;HBA1C (GLYCATED HEMOGLOBIN)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Adherence to the Mediterranean diet has been shown to reduce HbA1c concentrations, reflecting improved glycemic control."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET (MD)&quot;" target="&quot;PHYSICAL ACTIVITY LEVEL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals who are more physically active tend to adhere better to dietary patterns like the Mediterranean diet, impacting metabolic health."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET (MD)&quot;" target="&quot;TC (TOTAL CHOLESTEROL)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Adherence to the MD positively influences total cholesterol levels by improving HDL and lowering LDL cholesterol."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET (MD)&quot;" target="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Adherence to MD significantly reduces the odds of developing hypertriacylglycerolaemia compared to lower adherence."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG (TRIGLYCERIDES)&quot;" target="&quot;GENETIC VARIANT (RS780094 SNP IN GCKR GENE)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic variant rs780094 within the GCKR gene is associated with higher triglyceride concentrations compared to other genotypes."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT (RS780094 SNP IN GCKR GENE)&quot;" target="&quot;LDL-C (LOW-DENSITY LIPOPROTEIN CHOLESTEROL)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic variant rs780094 is also associated with higher levels of LDL cholesterol, contributing to cardiovascular risk."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT (RS780094 SNP IN GCKR GENE)&quot;" target="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals carrying the AA genotype of rs780094 are at a greater risk for hypertriacylglycerolaemia compared to GG individuals."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;TAG LEVELS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genotypes can influence TAG levels, which may differ based on an individual's diet and genetic predisposition.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;DIETARY FACTOR Y&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The interaction between a specific genotype and dietary factor Y can influence TAG levels.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCC8 GENE&quot;" target="&quot;DIAZOXIDE THERAPY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Diazoxide is used in the treatment of CHI by targeting ABCC8 gene mutations for better insulin regulation and glucose metabolism."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCC8 MUTATION C.3224-3226DELACC INS CAGCCAGGAACTG (P.THR1042GLNFSX75)&quot;" target="&quot;GLUD1 MUTATION P.ARG322 HIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both mutations contribute to CHI but affect different genes, illustrating the genetic complexity of this condition."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUD1 MUTATION P.ARG322 HIS&quot;" target="&quot;HYPOGLYCEMIA (HI)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This mutation leads to hyperinsulinism, which is associated with hypoglycemia in CHI patients."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MACROSOMIC PATIENTS&quot;" target="&quot;ABCC8 GENE MUTATIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Patients with high birth weight are more likely to have mutations affecting the ABCC8 gene."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;18F-DOPA PET/CT SCAN&quot;" target="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The scan can detect focal lesions in the pancreas, which may indicate diffuse pancreatic disease in CHI patients."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI (CONGENITAL HYPERINSULINISM)&quot;" target="&quot;NEONATAL PERIOD SYMPTOMS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Symptoms of CHI can begin to appear during the neonatal period, characterized by episodes of hypoglycemia."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANCY PERIOD (1-12 MONTHS)&quot;" target="&quot;CHILDHOOD (&gt;12 MONTHS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"CHI symptoms persisting beyond infancy may continue or worsen into early childhood."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FREQUENT FEEDING THERAPY (SOLIDS AND COW'S MILK)&quot;" target="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This therapy is used to manage hypoglycemic episodes by maintaining consistent blood glucose levels through regular feeding."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNCOOKED CORNSTARCH THERAPY (1.6 G/KG)&quot;" target="&quot;LONG-TERM BLOOD GLUCOSE CONTROL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Used in combination with frequent feedings, this therapy helps maintain stable blood sugar levels over extended periods, preventing hypoglycemic episodes at night or during fasting."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATIC Β-CELL NUCLEI ENLARGEMENT&quot;" target="&quot;GENETIC MUTATIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The enlargement of pancreatic cells' nuclei is often a result of specific genetic mutations found in CHI patients, particularly those with compound heterozygous ABCC8 mutations."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.SER498LEU MUTATION&quot;" target="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both mutations are distinct genomic variants in the GLUD1 gene, each identified in separate patients with HI/HA syndrome."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPOGLYCAEMIA&quot;" target="&quot;DIAZOXIDE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Diazoxide is used to manage hypoglycemia caused by mutations affecting the GLUD1 gene."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPOGLYCAEMIA&quot;" target="&quot;SERUM AMMONIA CONCENTRATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High serum ammonia levels are indicative of hypoglycaemia in patients with GLUD1 gene mutations, highlighting metabolic dysfunction."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERINSULINISM (HI)&quot;" target="&quot;PANCREATECTOMY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In cases where HI does not respond well to medical management, surgical intervention such as pancreatectomy may be necessary."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE&quot;" target="&quot;DIAZOXIDE THERAPY SIDE EFFECTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The use of diazoxide therapy leads to various side effects such as gastrointestinal disturbances and hypertrichosis."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OCTREOTIDE&quot;" target="&quot;OCTREOTIDE TREATMENT FAILURE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Some patients do not respond well to octreotide treatment, suggesting its limited efficacy in managing hypoglycaemia caused by GLUD1 mutations."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATECTOMY&quot;" target="&quot;DIABETES MELLITUS POST-SURGERY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Surgical intervention such as pancreatectomy may result in the development of diabetes mellitus in some patients."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE THERAPY SIDE EFFECTS&quot;" target="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Severe side effects like thrombocytopenic purpura can occur with diazoxide therapy, impacting patient care."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACETOACETATE (ACAC)&quot;" target="&quot;BETA-HYDROXYBUTYRATE (BHB)&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"These two molecular entities are closely related in the metabolic pathway of ketone body formation and breakdown, highlighting their interdependence in metabolic regulation."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BETA-HYDROXYBUTYRATE (BHB)&quot;" target="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Levels of BHB increase in IGT subjects and are predictive indicators for the development of type 2 diabetes over time."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPAIRED FASTING GLYCAEMIA (IFG)&quot;" target="&quot;INSULIN SENSITIVITY (IS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with IFG show higher levels of AcAc and BHB, inversely correlated with IS as measured by Matsuda ISI."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPAIRED FASTING GLYCAEMIA (IFG)&quot;" target="&quot;GLUCOSE TOLERANCE TEST (GTT)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GTT can identify individuals at risk for IFG by assessing their blood glucose levels after fasting and consuming a sugary drink."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;" target="&quot;HYPERGLYCEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Persistent hyperglycemia is a precursor to IGT and further development into full-blown type 2 diabetes, often correlated with rising ketone body levels."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KETONE BODIES (KBS)&quot;" target="&quot;INSULIN RESISTANCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased insulin resistance correlates with higher levels of AcAc and BHB, as cells fail to use glucose effectively leading to greater reliance on ketone bodies for energy."</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN RESISTANCE&quot;" target="&quot;HFD&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"High-fat diet induces insulin resistance in both control mice and those deficient for SENP1, but the phenotype is more pronounced in the latter group.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERGLYCEMIA&quot;" target="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Deletion of the SENP1 gene specifically in adipocytes leads to increased hyperglycemia compared to control NOD mice at similar age stages.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERGLYCEMIA&quot;" target="&quot;SENP1-AP2KO&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Mice deficient for the SENP1 gene exhibit an earlier onset and more severe hyperglycemia when exposed to a high-fat diet.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCKR GENE&quot;" target="&quot;BHB LEVELS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The C allele of the GCKR gene variant rs780094 shows a significant increase in BHB levels, suggesting its role in regulating ketone body metabolism."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCKR GENE&quot;" target="&quot;FXR/RXR PATHWAY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The FXR/RXR pathway is enriched in the analysis of GCKR and other pleiotropic genes involved in metabolic pathways.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1 GENE&quot;" target="&quot;ACAC LEVELS&quot;">
      <data key="d4">1.8</data>
      <data key="d5">"Variants in FADS1 have been associated with the level of AcAc, indicating their involvement in fatty acid and lipid metabolism."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 GENE&quot;" target="&quot;HEIGHT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The HMGA2 gene is significantly associated with height and impacts dental development through this association.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 GENE&quot;" target="&quot;NUMBER OF TEETH GWAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The HMGA2 gene shows evidence of association with the number of teeth, though this relationship is not as strong after removing specific SNPs.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KETOGENESIS&quot;" target="&quot;3-OXOACID COA TRANSFERASE 1 PROTEIN (OXCT1)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The enzyme catalyzed by OXCT1 is involved in ketone body synthesis as part of the metabolic pathway known as ketogenesis."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPT1A GENE (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;" target="&quot;GLUCOSE AUC PARAMETER&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Expression levels of CPT1A are positively correlated with glucose AUC, suggesting a link between fatty acid metabolism and glucose regulation."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAT1 GENE (ACETYL-COA ACETYLTRANSFERASE 1)&quot;" target="&quot;INSULIN SENSITIVITY PARAMETER (MATSUDA ISI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Expression of ACAT1 is positively correlated with insulin sensitivity, indicating its role in maintaining metabolic health."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDH1 GENE (BHB DEHYDROGENASE, TYPE 1)&quot;" target="&quot;GLUCOSE AUC PARAMETER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Inverse correlation between BDH1 expression and glucose AUC suggests a protective effect of ketolysis on insulin resistance or impaired glucose tolerance."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;3-OXOACID COA TRANSFERASE 1 PROTEIN (OXCT1)&quot;" target="&quot;FATTY ACIDS (FFAS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"OXCT1 plays a role in the catabolism of short-chain fatty acids, linking its activity to the metabolism and regulation of FFAs."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;PREDIABETES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with prediabetes have an increased risk of progressing to type 2 diabetes if left untreated or unmanaged."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;MINOR ALLELE OF SNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele of each SNP shows an inverse relationship with type 2 diabetes risk."</data>
      <data key="d6">chunk-b803830d07bff8ae14550f6458048707</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP GWAS SNPS&quot;" target="&quot;HNF1A GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The HNF1A locus has a SNP that influences CRP but also inversely impacts LDL-cholesterol and total cholesterol levels."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1 GENE&quot;" target="&quot;LDL-CHOLESTEROL AND TOTAL CHOLESTEROL LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNPs in the APOC1 gene increase CRP while decreasing levels of LDL-cholesterol and total cholesterol, indicating complex regulatory interactions."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1 GENE&quot;" target="&quot;TOTAL CHOLESTEROL AND TRIGLYCERIDES LEVELS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"SNPs in APOC1 gene influence both total cholesterol and triglyceride levels inversely to CRP levels, indicating complex regulatory pathways."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1 GENE&quot;" target="&quot;T2D DISEASE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNP rs4420638 near APOC1 increases CRP levels but reduces the risk of type 2 diabetes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A GENE&quot;" target="&quot;CRP LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The HNF1A locus shows a SNP that influences both CRP and cardiometabolic traits like lipid levels."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A GENE&quot;" target="&quot;CAD DISEASE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HNF1A gene's variant rs1183910 is linked to increased serum CRP and lower risk of CAD.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6R GENE&quot;" target="&quot;CARDIOMETABOLIC PHENOTYPES GWAS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Lower linkage disequilibrium between top SNPs of the IL6R gene in CRP GWAS compared to CAD GWAS indicates different functional relevance."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6R GENE&quot;" target="&quot;CRP PROTEIN&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The IL6R gene shows biological pleiotropy in association with CRP and cardiometabolic phenotypes after adjusting for mediators like BMI, cholesterol levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF4A GENE&quot;" target="&quot;CARDIOMETABOLIC PHENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The HNF4A gene is involved in the regulation of cardiometabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMEM18 GENE&quot;" target="&quot;BMI PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The effects observed from TMEM18 are mainly mediated by BMI, suggesting its role in metabolic phenotypes through body mass index.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLTP GENE&quot;" target="&quot;CRP PROTEIN&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Similar to MC4R, PLTP does not show a significant relationship with CRP levels after correction.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MC4R GENE&quot;" target="&quot;CRP PROTEIN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"No significant association found between MC4R and CRP levels after correction for multiple testing.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOMETABOLIC PHENOTYPES GWAS&quot;" target="&quot;CRP LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"GWAS for cardiometabolic traits and CRP levels show significant overlap, indicating shared genetic basis."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOMETABOLIC PHENOTYPES GWAS&quot;" target="&quot;FASTING GLUCOSE AND INSULIN LEVELS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic variants influencing fasting glucose and insulin also affect cardiometabolic traits such as cholesterol levels, illustrating pleiotropy."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;BCL7B GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNPs near BCL7B show associations with CRP, indicating its involvement in metabolic pathways regulating inflammation markers."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1F10 GENE&quot;" target="&quot;CARDIOMETABOLIC TRAITS GWAS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"This gene was newly identified through the analysis of SNPs affecting both CRP and specific cardiometabolic phenotypes such as cholesterol levels."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1F10 GENE&quot;" target="&quot;GWAS STUDY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The IL1F10 gene was not identified in a previous GWAS for association between SNPs and CRP, but has been found to be significant with cholesterol levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B GENE&quot;" target="&quot;CRP PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Effects on CRP levels from BCL7B decrease significantly when adjusted for CRP, indicating potential mediation through lipids.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOMETABOLIC TRAITS GWAS&quot;" target="&quot;CRP SNPS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The association of 18 CRP SNPs with cardiometabolic traits is significant across multiple phenotypes, suggesting shared genetic underpinnings."</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLESTEROL LEVELS&quot;" target="&quot;GENETIC LOCI MEDIATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Lipids, particularly cholesterol levels, mediate pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1 GENE AND T2D DISEASE RELATIONSHIP&quot;" target="&quot;HBA1C PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Adjustment for HbA1c leads to significant reduction in the association between APOC1 and type 2 diabetes, indicating mediation through glycemic control.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PABPC4 GENE AND METABOLIC PHENOTYPE RELATIONSHIP&quot;" target="&quot;TRIGLYCERIDES PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Adjustment for triglyceride levels leads to significant reduction in the association between PABPC4 gene and metabolic phenotypes, indicating mediation through this physiological process.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B GENE AND METABOLIC PHENOTYPE RELATIONSHIP&quot;" target="&quot;HDL-CHOLESTEROL PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Adjustment for HDL-cholesterol levels leads to significant reduction in the association between BCL7B gene and metabolic phenotypes, indicating mediation through this physiological process.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI ADJUSTMENT PHYSIOLOGICAL PROCESS&quot;" target="&quot;PLEIOTROPIC EFFECTS OF GENETIC LOCI&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Adjusting for BMI significantly affects the pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The CC genotype of miR-34b/c rs4938723 is significantly associated with a decreased risk of IA compared to the TT genotype."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;NUMBER OF ANEURYSMS&quot;">
      <data key="d4">-2.0</data>
      <data key="d5">"No significant association between the number of aneurysms and miR-34b/c rs4938723 genotypes was observed."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">-2.0</data>
      <data key="d5">"No association was observed between TP53 Arg72Pro and IA risk for genotypic or allelic analysis."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;NUMBER OF ANEURYSMS&quot;">
      <data key="d4">-2.0</data>
      <data key="d5">"No significant association between the number of aneurysms and TP53 Arg72Pro genotypes was observed."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723 CC&quot;" target="&quot;TP53 ARG72PRO CG/CC/GG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The combined genotype of miR-34b/c rs4938723 CC and TP53 Arg72Pro CG/CC/GG is associated with a decreased risk of IA compared to the combined genotypes CT/TT + CG/CC/GG."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C21ORF34&quot;" target="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A SNP in C21orf34's intronic region was detected for respiratory quotient during sleep."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPL7P3&quot;" target="&quot;LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A variant in RPL7P3’s 5′UTR region is associated with accelerometer-measured light activity."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCFL&quot;" target="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants in CTCFL's 3′UTR region were linked to sedentary-light activity."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATK&quot;" target="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Significant variants for MATK on chromosome 19 are associated with total energy expenditure after adjusting for body weight."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHRNA3&quot;" target="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants in CHRNA3 on chromosome 15 are linked to sleeping energy expenditure, after controlling for body weight."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRONIC VARIANT OF ARHGAP11A&quot;" target="&quot;SLEEP DURATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"An intronic variant in the gene ARHGAP11A on chromosome 15 is associated with sleep duration."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP IN C21ORF34 INTRONIC REGION&quot;" target="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This SNP is linked to respiratory quotient during sleep, indicating a genetic influence on metabolic rate during rest."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VARIANT IN 5′UTR OF RPL7P3&quot;" target="&quot;LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A variant in the 5′UTR region of RPL7P3 is associated with accelerometer-measured light activity, reflecting genetic impact on physical activity levels during sedentary periods."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VARIANT IN 3′UTR OF CTCFL&quot;" target="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The variant influences sedentary-light activity levels through its effect on the expression or regulation of the CTCFL gene."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL ENERGY EXPENDITURE VARIANTS FOR MATK&quot;" target="&quot;BODY WEIGHT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"After adjusting for body weight, variants in MATK are associated with total energy expenditure, indicating a complex genetic and environmental interaction affecting metabolic rate."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEPING ENERGY EXPENDITURE VARIANTS FOR CHRNA3&quot;" target="&quot;BODY WEIGHT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants in the gene CHRNA3 influence sleeping energy expenditure, suggesting that body weight adjustment can reveal significant genetic associations related to resting metabolism."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS3833080: P.GLY369_ASP370DEL9, RS180743: P.PRO428ALA, AND RS368546180: P.THR321_GLY329DEL9&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"APOBR gene variants affect the protein sequence of APOBR which influences lipid metabolism."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3833080: P.GLY369_ASP370DEL9, RS180743: P.PRO428ALA, AND RS368546180: P.THR321_GLY329DEL9&quot;" target="&quot;MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, PROVEAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Bioinformatics tools are used to predict the functional impact of these protein variants."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FATTY ACIDS (LIPIDS)&quot;" target="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS DIETARY PATTERN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The dietary pattern contributing to obesity may include excessive intake of fatty acids affecting lipid metabolism."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAMILY-BASED ASSOCIATION STUDIES (FBAT)&quot;" target="&quot;RS3833080 AND RS180743&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These studies confirm associations between genetic variants and obesity in families."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASE-CONTROL ASSOCIATION ANALYSIS&quot;" target="&quot;RS180743: P.PRO428ALA AND RS3833080: P.GLY369_ASP370DEL9&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This analysis showed nominal associations between these genetic variants and obesity."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A1 GENE&quot;" target="&quot;P.PRO200 = (RS3176926)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The synonymous variant predicted to affect splicing and transcription factor binding sites, altering the gene’s regulatory regions."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2 GENE&quot;" target="&quot;RS4149403: P.ILE7THR, RS10797300: P.PRO19LEU, ETC.&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These variants in SULT1A2 were studied for their potential functional impact on the gene's activity and protein binding sites."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM GENE&quot;" target="&quot;C.3536C&gt;G VARIANT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The variant in TUFM predicted to alter splicing regulator or transcription factor binding sites, indicating a role in regulatory function."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS61737565: C.922+29C&gt;G&quot;" target="&quot;TUFM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The TUFM gene harbors a variant rs61737565 that is predicted to lead to altered splicing regulator or transcription factor binding sites."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS8061877&quot;" target="&quot;SRY, HFH 2, HMG-IY TRANSCRIPTION FACTORS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant rs8061877 disrupts a transcription factor binding site for SRY, HFH 2, and HMG-IY proteins."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICE ENHANCER BINDING SITES&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The variant g.28854194C/G alters splice enhancer binding sites according to in silico predictions."&lt;SEP&gt;"The variant g.28854194C/G alters splice enhancer binding sites, impacting splicing efficiency and mRNA maturation."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICING SILENCER SITES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"In silico predictions suggest that the variant g.28854194C/G changes splicing silencer sites, affecting RNA processing."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;3’ UTR OF TUFM&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genomic variant g.28854194C/G is located in the non-coding 3' UTR region of the TUFM transcript."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 SNP RS743507&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This SNP in nitric oxide synthase 3 is associated with a decreased risk of ovarian cancer, showing an odds ratio of 0.79 at p=0.003."</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1A SNP RS17561&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This missense variant in the IL1A gene is associated with a decreased risk of ovarian cancer, showing an odds ratio of 0.90 at p=0.005."</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B SNP RS7596684&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This variant in IL1B is associated with increased risk of ovarian cancer, showing a significant result (p=0.02)."</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;CDX-2 (RS11568820)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Cdx-2 genomic variant is studied to understand its potential association with the increased risk of developing ovarian cancer.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;TAQI (RS731236)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The TaqI genomic variant has been investigated for its role in influencing the risk of ovarian cancer, though no significant association was found under certain genetic models.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;GG CARRIERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with GG genotype at a specific locus have a different risk profile compared to A allele carriers for ovarian cancer.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;A ALLELE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Carrying the A allele in certain genomic variants is associated with an increased risk of ovarian cancer relative to GG carriers.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B (INTERLEUKIN 1, BETA)&quot;" target="&quot;RS7596684&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant rs7596684 in IL1B is associated with ovarian cancer risk."&lt;SEP&gt;"The genomic variant rs7596684 in IL1B is suggested to be associated with an increased risk of ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B (INTERLEUKIN 1, BETA)&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A study suggests a variant in the IL1B gene may associate with an elevated risk for ovarian cancer."&lt;SEP&gt;"A study suggests that a variant within IL1B gene may be linked to higher risks of ovarian cancer development."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)&quot;" target="&quot;RS2282169&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant rs2282169 in PTGS1 is associated with ovarian cancer risk."&lt;SEP&gt;"The genomic variant rs2282169 in PTGS1 is suggested to be associated with an increased risk of ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A study indicates that a variant in PTGS1 could contribute to an increased risk for ovarian cancer."&lt;SEP&gt;"A study indicates that a variant within PTGS1 might be linked to higher risks of ovarian cancer development."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALOX15&quot;" target="&quot;INFLAMMATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The ALOX15 gene plays a role in inflammation and lipid metabolism, influencing the body's inflammatory response."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL2 (CHEMOKINE LIGAND 2)&quot;" target="&quot;IMMUNE RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"CCL2 is involved in immune cell recruitment during inflammation and infection responses."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP (C-REACTIVE PROTEIN)&quot;" target="&quot;INFLAMMATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CRP protein levels increase in response to inflammatory stimuli, indicating an active inflammatory process."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL18 (INTERLEUKIN 18)&quot;" target="&quot;IMMUNE RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IL18 is a cytokine that modulates immune responses and inflammation-related processes."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;CRP SNP &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A genetic variant in the CRP gene, which codes for C-reactive protein, shows an association with ovarian cancer risk."</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;IL1B SNP RS7596684 &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This variant in IL1B is associated with increased ovarian cancer risk, showing a significant result (p=0.02)."</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;FOKI (RS2228570 OR RS10735810)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The FokI variant is significantly associated with an increased risk of ovarian cancer according to the meta-analysis conducted."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;APAI (RS7975232)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was no significant association found between ApaI and ovarian cancer risk in the evaluated studies."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;BSMI (RS1544410)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant BsmI showed no significant association with ovarian cancer risk, according to the meta-analysis results."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;CAUCASIANS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The association of certain genomic variants with ovarian cancer risk varied when analyzing data restricted to Caucasian populations compared to broader ethnic groups."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATION&quot;" target="&quot;IL-6&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The production of IL-6 is associated with increased inflammation, particularly in relation to Th17 cell activity and immune response regulation."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATION&quot;" target="&quot;IL-1Β (INTERLEUKIN 1 BETA)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The elevated expression of IL-1β is associated with enhanced inflammatory processes, particularly in immune-mediated pathologies."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATION&quot;" target="&quot;LPMΦS (LY6C+ PERITONEAL MACROPHAGES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Macrophage populations such as LPMϕs contribute to the production of pro-inflammatory cytokines and thus play a significant role in driving inflammatory processes."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATION&quot;" target="&quot;ARGINASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Reduced arginase expression can indicate a shift towards pro-inflammatory macrophage phenotypes and increased inflammatory activity."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMMUNE RESPONSE&quot;" target="&quot;TNF-Α (TUMOR NECROSIS FACTOR ALPHA)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High TNF-α levels contribute to the amplification of inflammatory responses and cellular damage during disease states."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMMUNE RESPONSE&quot;" target="&quot;IL-23P19&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The upregulation of IL-23p19 is indicative of an enhanced immune response, particularly in the context of Th17 cell-mediated inflammation."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMMUNE RESPONSE&quot;" target="&quot;CD40&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"EBNA2's effect on CD40 expression influences the host's immune response, potentially aiding viral survival through altered gene regulation."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD2 GENE&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Analysis of SNPs within MTHFD2 indicates potential associations with increased risk of developing childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BHMT2 GENE&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"SNPs in BHMT2 were analyzed for their association with the disease, suggesting a possible genetic link to increased risk of developing childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 GENE (RS3918186)&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"The SNP rs3918186 in the NOS3 gene was found to have a significant association with an increased risk of childhood ALL, suggesting a direct genetic influence on disease susceptibility."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 GENE (RS3918186)&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"The SNP rs3918186 in NOS3 gene, involved in the nitric oxide synthesis pathway, was found to significantly increase the risk of childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 GENE (RS1051266)&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs1051266 in the SLC19A1 gene was found to have a less strong but still notable association with an increased risk of childhood ALL, indicating potential genetic influence on disease development."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 GENE (RS1051266)&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP rs1051266 in SLC19A1 gene, associated with folate transport and metabolism, was found to increase the risk of childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;" target="&quot;FOLATE METABOLIC GENES SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNPs in folate metabolic genes were analyzed for their associations with an increased risk of developing childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC GENES&quot;" target="&quot;BAYESIAN ANALYSIS MODEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Bayesian analysis model was applied to evaluate the SNPs in folate metabolic genes for their associations with childhood ALL, aiming to uncover genetic risk factors linked to the disease."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC GENES&quot;" target="&quot;FOLATE METABOLIC GENES SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The 16 folate metabolic genes were the source of tagging SNPs analyzed for their association with childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1/2 HAPLOTYPE&quot;" target="&quot;MEDITERRANEAN DIET GROUP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Similar to the Healthy Eating group, genetic variation in FADS1/2 had an impact on serum AA and 18:3 n-3 concentrations in this dietary pattern."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1/2 HAPLOTYPE&quot;" target="&quot;AA (ARACHIDONIC ACID)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The baseline concentration of AA was significantly influenced by the number of minor alleles within FADS1/2 haplotype SNPs, reflecting a genetic effect on its level."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1/2 HAPLOTYPE&quot;" target="&quot;EPA (EICOSAPENTAENOIC ACID)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"No significant association was found between the genotype and EPA concentration at baseline or after dietary intervention."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY EATING DIET GROUP&quot;" target="&quot;LONG CHAIN N-3 FATTY ACIDS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Dietary intake of long chain n-3 fatty acids was a strong predictor of serum levels in this diet group, highlighting the role of nutrition over genetics."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET GROUP&quot;" target="&quot;LONG CHAIN N-3 FATTY ACIDS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Similar to the Healthy Eating group, dietary intake significantly predicted baseline concentrations of long chain n-3 fatty acids in this diet pattern."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYUNSATURATED FAT:SATURATED FAT RATIO&quot;" target="&quot;HEALTHY EATING DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Healthy Eating dietary pattern aims to improve the polyunsaturated fat:saturated fat ratio, though results were non-significant."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;18:2 N-6&quot;" target="&quot;MUFA AND N-3 PUFA&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Decreased 18:2 n-6 levels are associated with increased MUFA and n-3 PUFAs in the Mediterranean diet intervention."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;N-3 PUFA&quot;" target="&quot;LONG CHAIN N-3 PUFA&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The increase of n-3 PUFA leads to an increase in long chain n-3 PUFA, impacting inflammatory processes and cardiovascular health."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE BY DIET INTERACTION&quot;" target="&quot;LINEAR MIXED MODEL RESULTS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Statistical analysis reveals significant interactions between genotype (FADS1/2 gene cluster) and diet interventions affecting fatty acid concentrations in the colon."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;SES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Lower SES is associated with higher risk of habitual snoring, especially among males."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;SMOKING FREQUENCY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher smoking frequency correlates positively with the prevalence of habitual snoring in females and to a lesser extent in males."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;ALCOHOL CONSUMPTION FREQUENCY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Frequency of alcohol consumption is correlated more strongly with snoring in males than in females."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;WHOLE-BODY FAT MASS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher whole-body fat mass is positively associated with habitual snoring prevalence."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;GENOMIC RISK LOCI &quot;">
      <data key="d4">8.0</data>
      <data key="d5">"These loci contain genetic variants that increase the risk of being a habitual snorer."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;SELF-REPORTED SLEEP APNOEA &quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Habitual snoring has high genetic correlation with self-reported sleep apnea, indicating shared genetic factors."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC RISK LOCI &quot;" target="&quot;ODDS RATIO (OR)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Risk loci identified through GWAS contain variants with specific odds ratios indicating the increased likelihood of snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-REPORTED SLEEP APNOEA &quot;" target="&quot;GENETIC CORRELATION (RG)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is a high genetic correlation between self-reported sleep apnea and habitual snoring, suggesting shared underlying genetic risk factors (rG=0.78)."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATION &quot;" target="&quot;BMI AND HEART DISEASE &quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Traits like BMI and heart disease are genetically correlated to habitual snoring, suggesting common underlying genetic risk factors."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS STUDY &quot;" target="&quot;SNORING &quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The GWAS study uncovered 127 independent genome-wide significant associations across 41 genomic risk loci for snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ODDS RATIO (OR)&quot;" target="&quot;SYNERGY INDEX (SI)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Synergy Index measures the interaction effect in terms of odds ratios, evaluating how two factors together influence disease risk compared to their individual effects."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ODDS RATIO (OR)&quot;" target="&quot;AMD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Odds Ratio is used to quantify the relationship between AMD and various risk factors such as genetic variants and lifestyle scores."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP HERITABILITY (H2SNP)&quot;" target="&quot;SNORING &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The overall SNP heritability for habitual snoring was 9.9% on the liability scale, indicating a substantial genetic component to the trait."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXYHEMOGLOBIN SATURATION &quot;" target="&quot;SNORING &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Measures of oxyhemoglobin saturation during sleep show moderate significant genetic correlations with habitual snoring, indicating their importance as proxies for sleep-disordered breathing."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MSRB3 GENE&quot;" target="&quot;SNORING (PHYSIOLOGICAL PROCESS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The MSRB3 gene contributes to genetic predisposition towards snoring and its associated traits.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (GENOMIC VARIANT)&quot;" target="&quot;EQTL MAPPING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Specific SNPs are identified through eQTL mapping as influencing gene expression relevant to snoring.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EQTL MAPPING&quot;" target="&quot;CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genes identified through eQTL mapping are associated with cardiometabolic traits and diseases, suggesting shared genetic predispositions.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (ENVIRONMENTAL FACTOR)&quot;" target="&quot;SNORING (PHYSIOLOGICAL PROCESS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"BMI is an environmental factor that influences the genetic predisposition towards snoring, indicating complex interactions between genetics and environment.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING (PHYSIOLOGICAL PROCESS)&quot;" target="&quot;BLOOD VESSEL TISSUE EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Gene expression in blood vessel tissues is linked to the physiological process of snoring, after adjusting for BMI.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING (PHYSIOLOGICAL PROCESS)&quot;" target="&quot;PULSE RATE (PHYSIOLOGICAL PROCESS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is a genetic correlation between pulse rate and snoring, suggesting physiological interdependence.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNP (GENOMIC VARIANT)&quot;" target="&quot;CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Specific genomic variants are associated with cardiometabolic diseases through their impact on snoring predisposition.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS199797821&quot;" target="&quot;RECENT SNORING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This genomic variant is associated with recent snoring in males, suggesting a genetic predisposition to the condition."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS200391180&quot;" target="&quot;RECENT SNORING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This genomic variant is associated with recent snoring in females, indicating a sex-specific genetic influence on the condition."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PGS (POLYGENIC SCORE)&quot;" target="&quot;RECENT SNORING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The polygenic score derived from GWAS summary statistics significantly predicts the prevalence of recent snoring in an independent sample."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PGS (POLYGENIC SCORE)&quot;" target="&quot;AGDS (AUSTRALIAN GENETICS OF DEPRESSION STUDY)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The AGDS sample was used to derive PGS for recent snoring, demonstrating predictive power independent of discovery GWAS."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;PROBABLE OSA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Severe cases of recent snoring may indicate probable obstructive sleep apnea, characterized by breathing cessation and choking during sleep."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;TOP HITS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic loci with significant associations in GWAS are critical in predicting recent snoring and its severity."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;" target="&quot;H2SNP (SNP HERITABILITY)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The GWAS identifies genetic variants that contribute to the SNP heritability of snoring, indicating a strong genetic component."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;" target="&quot;MEQTL SNPS&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"GWAS can be used to investigate the association of genetic variants (including meQTL SNPs) with disease phenotypes, providing insights into epigenetic influences on diseases."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;" target="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"GWAS studies use SNPs to identify genomic regions associated with specific traits or diseases, such as lung function in this case."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;" target="&quot;LD (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In GWAS, understanding LD helps in interpreting genetic associations across the genome."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING &quot;" target="&quot;FEV1 AND FVC &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) show negative genetic correlations with snoring, highlighting their importance in lung function."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDBP&quot;" target="&quot;SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Different single nucleotide polymorphisms within the VDBP gene can influence vitamin D metabolism and binding."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL 25(OH)D&quot;" target="&quot;MATERNAL HEIGHT, PRE-PREGNANCY BMI, TERMINAL BMI, UVB, WEEKS OF GESTATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The levels of total 25(OH)D are adjusted for physiological factors like maternal height and pre-pregnancy BMI to account for their influence on vitamin D status."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL 25(OH)D&quot;" target="&quot;MATERNAL VDBP POLYMORPHISMS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Certain maternal VDBP polymorphisms are associated with higher levels of total 25(OH)D at birth, as shown by the statistical analysis."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL 25(OH)D&quot;" target="&quot;NEONATAL VDBP POLYMORPHISMS &quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Variations in neonates' VDBP gene do not significantly influence their total 25(OH)D levels at birth, based on the data provided."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL 25(OH)D&quot;" target="&quot;VITAMIN D STATUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The level of total 25-hydroxyvitamin D is a primary indicator for assessing an individual's vitamin D status."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL 25(OH)D&quot;" target="&quot;NEONATAL VITAMIN D CUT-OFFS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Threshold values for neonatal total 25-hydroxyvitamin D are used to classify the vitamin D status of newborns at birth."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D STATUS&quot;" target="&quot;MATERNAL VITAMIN D CUT-OFFS &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Cut-off values are used to categorize maternal vitamin D levels as sufficient, deficient, or toxic during pregnancy."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;INSULIN RESISTANCE INDEX (HOMA-IR)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Women with PCOS exhibit higher insulin resistance index as indicated by HOMA-IR measurements."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;SHBG (SEX HORMONE-BINDING GLOBULIN)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Levels of SHBG are significantly lower in women with PCOS than controls, affecting sex hormone bioavailability."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;TOTAL TESTOSTERONE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Total testosterone levels may be elevated in women with PCOS compared to control subjects."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;FREE ANDROGEN INDEX (FAI)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher FAI values are associated with PCOS, indicating elevated free androgen levels."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;TSH (THYROID-STIMULATING HORMONE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"TSH levels may be higher in women with PCOS, though still within the reference range, suggesting thyroid involvement."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;VEGF PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs3025020 SNP in the VEGFA gene influences serum levels of VEGF protein in women with PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;VEGF PROTEIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs2010963 SNP influences serum levels of VEGF protein inversely in women with PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FREE TESTOSTERONE&quot;" target="&quot;BIOACTIVE TESTOSTERONE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Levels of free testosterone are associated with bioactive testosterone in women, reflecting hormonal imbalances seen in PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LH (LUTEINIZING HORMONE)&quot;" target="&quot;FSH (FOLLICLE-STIMULATING HORMONE)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The LH/FSH ratio is often higher in women with PCOS, reflecting hormonal imbalances."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISO HOMOZYGOTE GENOTYPE&quot;" target="&quot;SHOCK INTENSITY SELECTION BEHAVIOR&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Participants with the iso homozygote genotype tend to select lower levels of shock intensity compared to val carriers, suggesting differential sensitivity to aversive stimuli based on genotype.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;STAI SCORES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Behavioral processes such as response bias can influence reported STAI scores under different conditions and over time.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;VAL CARRIER&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Carriers of the val variant show a significant reduction in response bias toward more frequently rewarded stimuli under stressful conditions compared to no-stress conditions."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;ISO HOMOZYGOTE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals homozygous for the isoleucine allele do not show as marked a change in response bias between stress and no-stress conditions."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;CONDITION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Different experimental conditions (stress vs. no-stress) significantly influence the level of response bias towards rewarded stimuli."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;CRHR1 SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Single nucleotide polymorphisms within the CRHR1 gene can influence the degree of reduction in response bias during stressful conditions, independent of other confounding factors."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with certain genetic variants, such as those associated with the COMT and CRHR1 genes, exhibit altered reward learning under stress conditions."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHOCK INTENSITY SELECTION BEHAVIOR&quot;" target="&quot;PANAS NA SCORES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The selection of shock intensity behavior influences the negative affect (NA) experienced during stress tasks, modulated by genotype differences.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAI SCORES&quot;" target="&quot;NON-SPECIFIC SC RESPONSES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased STAI scores correlate with higher non-specific skin conductance responses, indicating a physiological linkage between reported anxiety and arousal levels.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NON-SPECIFIC SC RESPONSES&quot;" target="&quot;PRE-STRESS ASSESSMENT DIFFERENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Minor pre-stress differences suggest baseline physiological arousal, which can influence later skin conductance responses during actual stress conditions.")</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISO HOMOZYGOTE&quot;" target="&quot;CRHR1 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variations within the CRHR1 gene may influence response bias in individuals who are homozygous for a specific allele."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION&quot;" target="&quot;SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased skin conductance responses correlate with heightened stress conditions affecting physiological measures and potentially altering behavioral outcomes."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISCRIMINABILITY&quot;" target="&quot;SHOCK INTENSITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The ability to discriminate between reward contingencies is influenced by the intensity of applied shocks during experimental trials, though not due to genetic differences."</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACNB2 RS10740993&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs10740993 is significantly associated with the age of eruption of primary teeth.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDON RS4937076&quot;" target="&quot;NUMBER OF TEETH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs4937076 is linked to 'number of teeth' and may influence tooth development or number.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALU/OPN1SW RS1799922&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs1799922 has a significant association with the age at which primary teeth erupt, suggesting an influence on tooth development timing.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AJUBA/C14ORF93 RS997154&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs997154 is significantly associated with 'age at first tooth', affecting dental eruption age.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADK RS7924176&quot;" target="&quot;NUMBER OF TEETH AND AGE AT FIRST TOOTH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This SNP affects both the number of teeth and the timing of their emergence, suggesting a role in overall dentition development.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TEX14/RAD51C RS412000&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs412000 is associated with 'age at first tooth' and influences the timing of dental eruption.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DLEU7 RS9316505&quot;" target="&quot;NUMBER OF TEETH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This SNP in DLEU7 affects the number of teeth, impacting overall dentition.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 RS17101923&quot;" target="&quot;NUMBER OF TEETH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs17101923 is linked to 'number of teeth' and influences tooth count in individuals.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KCNJ2 RS17105278 AND RS9788982&quot;" target="&quot;AGE AT FIRST TOOTH AND NUMBER OF TEETH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These SNPs near KCNJ2 are significant for both timing and number, indicating a complex role in dentition.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MSRB3 RS1458991&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs1458991 is associated with 'age at first tooth' and influences dental eruption timing.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGF2BP1 RS10932688 AND RS9894411&quot;" target="&quot;AGE AT FIRST TOOTH AND NUMBER OF TEETH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These SNPs in IGF2BP1 affect both the number and timing of teeth, indicating a role in dentition development.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDA RS2520397 AND RS2804391&quot;" target="&quot;AGE AT FIRST TOOTH AND NUMBER OF TEETH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These SNPs near EDA influence both the number and timing of teeth, suggesting a complex genetic control over dental traits.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAD51L1 RS17105278 AND RS1956529&quot;" target="&quot;AGE AT FIRST TOOTH AND NUMBER OF TEETH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These SNPs in RAD51L1 show suggestive evidence for affecting both the timing and number of teeth.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMEM9 REGION SNP(S)&quot;" target="&quot;NUMBER OF TEETH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNPs in this region are associated with a lower level of significance but may still influence tooth count, suggesting further research needed.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMP4&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The BMP4 gene variant is associated with earlier tooth eruption, indicating a genetic influence on the timing of primary tooth development."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2&quot;" target="&quot;NUMBER OF TEETH&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genomic variants in HMGA2 are significantly linked to both early tooth eruption and higher counts of permanent teeth, suggesting a broad role in dental health."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2&quot;" target="&quot;HEIGHT-ASSOCIATED SNPS IN DENTAL PHENOTYPES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The HMGA2 gene's variants show strong associations with both height and tooth eruption timing, suggesting overlapping genetic influences between these traits."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADK&quot;" target="&quot;FACE WIDTH&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The ADK gene's variant affects the width of the nose, indicating a genetic influence on craniofacial morphology related to tooth eruption timing."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AJUBA&quot;" target="&quot;MID-BROW HEIGHT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genomic variants in AJUBA are linked to increased mid-brow height and prominence, suggesting a role in craniofacial development."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MSRB3&quot;" target="&quot;NUMBER OF PRIMARY TEETH&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The MSRB3 gene's variant is associated with 'number of primary teeth', highlighting its involvement in early dental development."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1472259&quot;" target="&quot;AGE AT FIRST TOOTH AND NUMBER OF PERMANENT TEETH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variant rs1472259 in HMGA2 shows associations with both early tooth eruption and permanent teeth count, suggesting a broad genetic influence on dental health."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS8069452&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant rs8069452 near IGF2BP1 is linked to 'age at first tooth', reflecting its role in the timing of primary tooth development."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7924176&quot;" target="&quot;FACE WIDTH AND TOOTH ERUPTION TIMING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genomic variant rs7924176 in ADK affects both face width and measures related to tooth eruption timing, indicating its role in craniofacial morphology."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS997154&quot;" target="&quot;MID-BROW HEIGHT AND CRANIOFACIAL DEVELOPMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genomic variant rs997154 near AJUBA influences mid-brow height and prominence, highlighting its role in craniofacial development."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMP4 GENE&quot;" target="&quot;BONE AND TOOTH FORMATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The BMP4 gene plays a role in bone and tooth formation, influencing the 'Number of Teeth' trait.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMP4 GENE&quot;" target="&quot;AGE AT FIRST TOOTH GWAS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The BMP4 gene influences age at first tooth development and its variants are associated with height.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNPS&quot;" target="&quot;PMETA SCORE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Significant SNPs for dental traits contribute to PMETA scores which measure association strength with height; removing HMGA2 and BMP4 variants weakens these associations.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNPS&quot;" target="&quot;NUMBER OF TEETH GWAS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Significant SNPs identified in the 'number of teeth' GWAS, though no pathways showed significant over-representation after pathway analysis.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AT FIRST TOOTH GWAS PATHWAYS&quot;" target="&quot;ALLIGATOR SOFTWARE ANALYSIS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Pathway analysis using ALLIGATOR identified significant pathways for 'age at first tooth', indicating over-representation of genes linked to dental development.")&lt;SEP&gt;"Pathway analysis using ALLIGATOR software reveals significant enrichment of certain genes in pathways linked to age at first tooth development.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;PTPN2 GENE, IL2/ADAD1/IL21 LOCUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Specific SNPs are mapped to genomic regions such as the PTPN2 gene and the IL2/ADAD1/IL21 locus, indicating their potential influence on disease susceptibility or treatment response."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;ICI EFFICACY TESTING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Testing for ICI efficacy involves evaluating how specific genetic variations (SNPs) may impact the effectiveness of treatments in metastatic melanoma patients."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUMBER OF TEETH&quot;" target="&quot;FAM155E-EDA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variants in FAM155E-EDA are linked to 'number of teeth', reflecting its role in craniofacial traits related to tooth count."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑ&quot;" target="&quot;IL-10&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Interleukin-10 binds and activates the IL-10 receptor alpha subunit (IL-10Rα), initiating downstream anti-inflammatory signaling pathways."</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELL TRANSFER-COLITIS MODEL&quot;" target="&quot;IL-10RΑ−/−RAG1−/−&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Global deletion of IL-10Rα in Rag1-deficient mice mimics the T cell transfer model but lacks specific cellular targeting, leading to similar disease outcomes as observed with conditional deletions."</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLONIC INFLAMMATION&quot;" target="&quot;IL-10 SIGNALING&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"IL-10 signaling through its receptor is shown to mitigate colonic inflammation, thereby playing a protective role against the progression of colitis."&lt;SEP&gt;"IL-10 signaling through its receptor plays a protective role by mitigating colonic inflammation, thereby reducing the severity of colitis."&lt;SEP&gt;"The IL-10-mediated immunoprotection can largely be attributed to its effects on macrophages, mitigating colonic inflammation and reducing disease severity."</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 SIGNALING&quot;" target="&quot;CX3CR1-CRE DRIVER LINE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The IL-10 signaling pathway is assessed using a CX3CR1-driven Cre line to specifically delete IL-10Rα in myeloid cells, particularly macrophages."&lt;SEP&gt;"The IL-10 signaling pathway's impact is assessed using CX3CR1-driven Cre lines that specifically delete IL-10Rα in myeloid cells, particularly macrophages."</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 SIGNALING&quot;" target="&quot;STAT3&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"STAT3 is a key downstream effector in IL-10 signaling pathways, regulating anti-inflammatory responses through gene expression."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MACROPHAGE (MΦ)&quot;" target="&quot;DSS COLITIS MODEL&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Macrophages are essential in modulating disease severity within the DSS-induced acute colitis model."&lt;SEP&gt;"Macrophages play an important role in modulating disease severity within this toxin-induced model of acute colitis."</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;COLITIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Interleukin-10 plays a critical role in regulating inflammation, and its dysregulation is associated with increased susceptibility to inflammatory diseases such as colitis."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;MΦ (MACROPHAGES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IL-10 modulates macrophage activity, reducing their pro-inflammatory response while enhancing anti-inflammatory functions.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;PRO-IL-1Β PRODUCTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-10 regulates the production of pro-IL-1β by inhibiting it in macrophages from Rag1−/− mice but not IL-10RαMdelRag1−/− mice.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPMΦS (LYMPHOID TISSUE RESIDENT MACROPHAGES)&quot;" target="&quot;CX3CR1-DRIVEN CRE DRIVER LINE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This genetic driver line is used specifically in LPMϕs to assess the role of IL-10Rα deletion on colitis development and inflammation regulation."</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−&quot;" target="&quot;LPMΦS (LAMINA PROPRIA MACROPHAGES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genetic variant IL-10RαMdelRag1−/− leads to an increased number and activation of lamina propria macrophages, contributing to exacerbated disease severity."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−&quot;" target="&quot;TREGS (REGULATORY T CELLS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The IL-10RαMdelRag1−/− genetic variant does not overtly impact the function or suppressive activity of regulatory T cells, indicating that these cells can still suppress disease in this context."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−&quot;" target="&quot;NEUTROPHILS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The IL-10RαMdelRag1−/− genetic variant does not affect the number of circulating neutrophils, indicating that changes in other immune cells are responsible for disease exacerbation."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−&quot;" target="&quot;COLITIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This genomic variant is associated with susceptibility to colitis, as it alters the immune response pathway leading to inflammation in the colon.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−&quot;" target="&quot;IL-6RΑ−/− T CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In IL-10RαMdelRag1−/− mice, the requirement for IL-6 in supporting Th17 cell formation and colitis is lessened compared to other conditions.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−&quot;" target="&quot;WT NAIVE T CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Wild-type naive T cells transferred into IL-10RαMdelRag1−/− mice still show differential responses, indicating specific immune pathway modifications in this model.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXP3+ ITREG&quot;" target="&quot;TREGS (REGULATORY T CELLS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Foxp3+ iTreg represents a subset of regulatory T cells that are induced in response to antigen exposure and play an essential role in maintaining immune tolerance."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREGS (REGULATORY T CELLS)&quot;" target="&quot;IL-10RΒ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The lack of IL-10Rβ disrupts the generation and function of induced regulatory T cells, which are critical for immune regulation."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREGS (REGULATORY T CELLS)&quot;" target="&quot;STAT5B GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"STAT5B gene is essential for the maintenance and function of regulatory T cells, critical for immune tolerance. Deficiency leads to impaired regulation over time.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;RAG1−/−&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mice with the Rag1−/− variant show altered immune system development which can lead to increased susceptibility to colitis, particularly in conjunction with other genetic or environmental factors.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-1Β&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"IL-1β promotes colitis development through its role in innate immunity, particularly in IL-10RαMdelRag1−/− mice where it can compensate for the absence of IL-6 dependence.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;T CELL EXPANSION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-6 is crucial for robust T cell expansion leading to severe disease in Rag1−/− mice but not essential in IL-10RαMdelRag1−/− mice due to compensatory mechanisms like increased IL-1β.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-6RΑ−/− T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Transferring IL-6Rα−/− T cells into mice models reduces the severity of colitis, indicating a critical role for IL-6 signaling in disease progression.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;IL-6&quot;">
      <data key="d4">0.75</data>
      <data key="d5">"The role of IL-6 is more critical than IL-1 in inducing colonic inflammation in Rag1−/− mice due to the suppression by IL-10.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;LPMΦS (LY6G−/LOSIGLECF− MΦ)&quot;">
      <data key="d4">0.92</data>
      <data key="d5">"Colon-resident macrophages are a primary source of IL-1β production in the context of colonic inflammation.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;GUT MICROBIOTA&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The composition and stability of gut microbiota influence susceptibility to colitis, particularly in the absence of CARD9."</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUTROPHILS&quot;" target="&quot;LY6G&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Ly6G serves as a specific surface protein marker to identify neutrophils and other granulocytes in immune responses."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD64&quot;" target="&quot;MACROPHAGES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"CD64 expression on macrophages indicates their activation status and potential role in inflammation or immune response regulation."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD103&quot;" target="&quot;EPITHELIAL T CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression of CD103 marks epithelial tissue-resident T cells, which play a role in immune surveillance and regulation within the gut."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SIGLECF&quot;" target="&quot;EOSINOPHILS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression of SiglecF on eosinophils modulates their functional capabilities, impacting immune responses and inflammation."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD80&quot;" target="&quot;T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Expression of CD80 on antigen-presenting cells facilitates T cell receptor signaling, enhancing the immune response and promoting T cell proliferation."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD86&quot;" target="&quot;T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Expression of CD86 on antigen-presenting cells provides an additional co-stimulatory signal to activate and enhance the proliferation of T cells."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAG2−/−&quot;" target="&quot;IMMUNODEFICIENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The absence of recombination activating gene 2 results in a significant impairment of adaptive immune responses, leading to severe immunodeficiency."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELLS&quot;" target="&quot;IL-10 PRODUCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The production of IL-10 by T cells does not affect disease severity, suggesting that other cell types or mechanisms are more critical for controlling inflammatory processes."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLONIC INFILTRATION&quot;" target="&quot;TH17 CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased numbers and activity of Th17 cells correlate with elevated colonic infiltration in the context of heightened inflammation and disease progression."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-6&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Th17 cells require IL-6 for their development and function, playing a crucial role in autoimmune responses but also dependent on other cytokines like IL-1β.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-6RΑ−/−&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IL-6 receptor alpha subunit is essential for the signaling pathway that supports Th17 cell development and maintenance of autoimmune inflammation.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;RORΓT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"RORγT is essential for the development and function of Th17 cells in autoimmune responses.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-1R−/− T CELLS&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"The transfer of IL-1R−/− T cells resulted in a significant reduction in Th17 cell numbers in the colon, indicating an impact on their response.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;IL-1Β&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Increased levels of IL-1β support Th17 cell responses at sites of autoinflammatory disease.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELLS&quot;" target="&quot;WT T CELLS&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"Wild-type T cells are used as baseline controls to evaluate the effects of genetic alterations on Th17 cell responses.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;TH17 CELL MATURATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IL-6 has a role in promoting Th17 cell development but its effect is modulated by other cytokines such as IL-10."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN-1)&quot;" target="&quot;IMMUNE RECRUITMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"MCP-1 facilitates the recruitment of monocytes and other immune cells to sites of inflammation, contributing to the amplification of inflammatory responses."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-17&quot;" target="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased IL-17 levels are indicative of heightened Th17 cell activity, which is critical for exacerbating inflammatory processes and disease progression."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Γ (INTERFERON GAMMA)&quot;" target="&quot;IMMUNE REGULATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"IFN-γ plays a regulatory role in immune responses but its levels are not increased during Th17-dependent colitis, suggesting other cytokines are more influential."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INOS (INDUCIBLE NITRIC OXIDE SYNTHASE)&quot;" target="&quot;INFLAMMATORY RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased iNOS activity suggests an enhancement in the inflammatory response, contributing to immune-mediated pathology."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB&quot;" target="&quot;IMMUNE RESPONSE REGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"NF-κB activation is crucial for the transcription of pro-inflammatory genes, contributing to inflammation and disease progression."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB&quot;" target="&quot;SENP1-AP2KO MICE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Activation of NF-κB is elevated in the absence of SENP1, contributing to inflammatory processes and disease progression in these mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXP3+ TREGS (REGULATORY T CELLS)&quot;" target="&quot;INFLAMMATION REGULATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Tregs play a critical role in suppressing excessive immune responses and limiting tissue damage during inflammatory conditions like colitis."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27&quot;" target="&quot;TH17 DIFFERENTIATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IL-27 can inhibit Th17 cell differentiation and promote alternative T cell lineages, thus modulating inflammatory processes."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27&quot;" target="&quot;STAT1&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"IL-27 activates the STAT1/STAT3 pathway which induces transcription of several genes including STAT1 itself."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDO (INDOLEAMINE 2,3-DIOXYGENASE)&quot;" target="&quot;IMMUNOSUPPRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"IDO activity leads to tryptophan depletion in the microenvironment, inducing immunosuppressive effects and limiting inflammation."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDEL MICE&quot;" target="&quot;COLITIS SEVERITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The absence of IL-10Rα in these mice leads to severe colitis, highlighting the importance of IL-10 signaling in controlling inflammation."</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22&quot;" target="&quot;INTESTINAL EPITHELIAL CELLS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This protein regulates the expression of antimicrobial peptides by intestinal epithelial cells during inflammation."</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22&quot;" target="&quot;AHR LIGAND PRODUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Interleukin-22 is necessary for the production of AHR ligands by gut microbiota.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAG1−/−&quot;" target="&quot;T CELL EXPANSION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The absence of Rag1 leads to impaired T cell expansion and differentiation in the immune system.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;FOXP3+ CD4+ T CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IL-1β does not significantly skew the maturation pathways of Foxp3+ regulatory T cells, unlike its effects on Th17 cell development and colitis progression.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1R−/− T CELLS&quot;" target="&quot;COLITIS SEVERITY&quot;">
      <data key="d4">0.65</data>
      <data key="d5">"The transfer of these cells resulted in reduced severity of colitis, indicating their role in mediating inflammatory responses.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/− MICE&quot;" target="&quot;PRO-IL-1Β PRODUCTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In IL-10RαMdelRag1−/− mice, the production of pro-IL-1β was increased in colons compared to Rag1−/− controls.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/− MICE&quot;" target="&quot;TGFΒ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of TGFβ affects the maturation of Th17 cells in a context dependent manner, influenced by genetic background and cytokine signaling."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;PRO-IL-1Β PRODUCTION&quot;">
      <data key="d4">0.95</data>
      <data key="d5">"Activation of caspase-1 is necessary for the conversion and release of pro-IL-1β into its active form.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;INFLAMMASOME&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The inflammasome activates caspase-1, which is crucial for processing IL-1β from the inactive precursor pro-IL-1β.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;IL-1Β LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The cleavage and activation of caspase-1 are necessary for processing pro-IL-1β into mature IL-1β, highlighting the relationship between these proteins in inflammation."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRO-IL-1Β PRODUCTION&quot;" target="&quot;IL-1R−/− MICE&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"In these mice, pro-IL-1β levels were higher in colon macrophages, suggesting a role for IL-1 signaling in its regulation.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRO-IL-1Β PRODUCTION&quot;" target="&quot;IL-10 SIGNALING PATHWAY&quot;">
      <data key="d4">0.85</data>
      <data key="d5">"IL-10 signaling pathway regulates pro-IL-1β production in colon macrophages, attenuating inflammatory responses.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 RESPONSE MEDIATION&quot;" target="&quot;COLITIS PATHOGENESIS&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Increased IL-1β levels and Th17 cell activity are associated with the pathogenesis of colonic inflammation.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAG1−/− CULTURES&quot;" target="&quot;IL-10RΑMDELRAG1−/−-DERIVED MΦS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Cultures from Rag1 knockout mice show different responses compared to those with IL-10 receptor mutations, indicating the role of IL-10 signaling in immune regulation."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−-DERIVED MΦS&quot;" target="&quot;LPS AND ATP STIMULATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Stimulation with LPS and ATP leads to differential responses in macrophages from IL-10 receptor mutated mice, demonstrating the importance of IL-10 signaling."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β MATURATION&quot;" target="&quot;CASPASE-1 CLEAVAGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The cleavage of caspase-1 is essential for the maturation of pro-IL-1β into active IL-1β, a process inhibited by IL-10 signaling."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6RΑ BLOCKING ANTIBODY&quot;" target="&quot;TH17 CELL MATURATION IN VIVO&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Blocking IL-6Rα can inhibit Th17 cell development both in vitro and in vivo, showing its importance in immune regulation."</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MACROPHAGES&quot;" target="&quot;INTESTINAL DENDRITIC CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Together, dendritic cells and macrophages play critical roles in the stimulation of IL-22-producing cells through cytokine production such as IL-23.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BRDU (BROMODEOXYURIDINE)&quot;" target="&quot;CELL PROLIFERATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Incorporation of BrdU into DNA is used to measure and quantify cell proliferation, particularly in immune cells like macrophages."</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLAMMATORY RESPONSE&quot;" target="&quot;TNF-Α GENE VARIANTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Polymorphisms of TNF-α gene affect inflammatory responses and may contribute to disease susceptibility."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMMUNE REGULATION&quot;" target="&quot;IL-23R, IL-17F, IL-17RA GENES &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variants in these genes influence immune regulation pathways and are associated with autoimmune conditions such as psoriasis."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMMUNE RESPONSE REGULATION&quot;" target="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The metabolism of tryptophan via IDO1 activity plays a crucial role in regulating immune responses and AHR activation.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BACTEROIDES&quot;" target="&quot;PROTEIN METABOLISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The abundance and distribution of Bacteroides within the gut microbiota can influence protein metabolism processes.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAECALIBACTERIUM&quot;" target="&quot;EUBACTERIUM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both Faecalibacterium and Eubacterium are part of the core microbiota identified in homogeneous clusters, contributing to similar metabolic functions within the gut environment.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLAUTIA&quot;" target="&quot;MICROBIOME HETEROGENEITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of Blautia reflects broader patterns of heterogeneity observed in microbiome studies across different cohorts and populations.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALISTIPES&quot;" target="&quot;RUMINICLOSTRIDIUM 9&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both Alistipes and Ruminiclostridium 9 are bacterial taxa whose abundance might be influenced by genetic factors, showing heritability in certain cohorts.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUSICATENIBACTER&quot;" target="&quot;SHORT-CHAIN FATTY ACIDS PRODUCTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of Fusicatenibacter within core microbiota supports the production of short-chain fatty acids, beneficial for gut health and metabolism.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BUTYRICICOCCUS&quot;" target="&quot;MICROBIOME CORE TAXA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Butyricicoccus is part of the core taxa found in homogeneous clusters, indicating its role in maintaining stable microbial communities under various conditions.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EUBACTERIUM&quot;" target="&quot;ENVIRONMENTAL FACTORS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The distribution and abundance of Eubacterium can be influenced by environmental factors such as diet and geography.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA EXTRACTION METHOD&quot;" target="&quot;HETEROGENEITY IN MICROBIOME STUDIES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The DNA extraction method significantly contributes to heterogeneity in microbiome studies by affecting microbial composition variance across studies.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VEILLONELLA&quot;" target="&quot;CARBOHYDRATE FERMENTATION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Veillonella plays a key role in carbohydrate fermentation, producing short-chain fatty acids that support gut health.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ROSEBURIA&quot;" target="&quot;BUTYRATE PRODUCTION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Roseburia is particularly noted for its ability to produce butyrate, which supports colonic epithelial cell integrity and function.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COPROCOCCUS&quot;" target="&quot;MICROBIOME DIVERSITY&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The presence of Coprococcus within the gut microbiota indicates a more diverse microbial community capable of metabolizing complex carbohydrates.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FIBER&quot;" target="&quot;GUT MICROBIOTA COMPOSITION&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Consumption of dietary fiber influences the diversity and abundance of bacteria in the gut, promoting health benefits.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTIBIOTICS&quot;" target="&quot;MICROBIAL DIVERSITY REDUCTION&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Antibiotic use can reduce microbial diversity within the gut microbiome, affecting core taxa presence and stability.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER&quot;" target="&quot;MICROBIAL ABUNDANCE VARIATIONS&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"Gender differences influence microbial abundance within the gut microbiome, reflecting sex-specific factors."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER&quot;" target="&quot;SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.")</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOME STABILITY&quot;" target="&quot;ENVIRONMENTAL INFLUENCES&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Stability of the gut microbiome is influenced by various environmental factors including diet and antibiotic exposure."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GUT HEALTH&quot;" target="&quot;MICROBIAL COMPOSITION IMPACT&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"Maintaining a healthy gut microbial composition supports overall health, affecting metabolic processes and immune responses."</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT GENE&quot;" target="&quot;FUT2 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both genes are suggested to be functionally relevant variants affecting gut microbiota variation under different studies."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT2 GENE&quot;" target="&quot;LCT LOCUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both loci are functionally relevant and show strong associations with microbial taxa abundance variations."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT2 GENE&quot;" target="&quot;FRUIT INTAKE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Dietary patterns such as fruit intake correlate with the genetic effect on gut microbiota composition through FUT2 gene."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;" target="&quot;MILK PRODUCTS INTAKE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The abundance of Bifidobacterium positively correlates with the intake of milk products, especially in individuals carrying specific genotypes related to low-function LCT haplotype."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;" target="&quot;AGE AND ETHNICITY INTERACTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The effect of age and ethnicity interaction modulates the impact of specific genetic variants on Bifidobacterium abundance, with differential effects seen between adult and younger populations."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;NC_000002.11:G.136616754CC (RS182549)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both genetic variants are associated with higher Bifidobacterium abundance, particularly in adults carrying the CC genotype."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;RS4988235&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These genetic variants are highly correlated, indicating similar functional impacts on gut microbiota composition."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SIMPSON DIVERSITY INDEX&quot;" target="&quot;SHANNON DIVERSITY INDEX&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The Shannon index and Simpson’s index complement each other in evaluating microbial diversity."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MBQTL MAPPING ANALYSIS&quot;" target="&quot;TWIN-BASED HERITABILITY CORRELATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic analyses using mbQTL methods correlate with twin-based heritability data, indicating the genetic basis of microbiota composition."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT LOCUS&quot;" target="&quot;MULTI-ETHNICITY &quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Ethnic heterogeneity significantly influences genetic associations with Bifidobacterium abundance, highlighting the importance of considering ethnic factors in genetic studies."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;MILK CONSUMPTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs4988235 variant is associated with milk consumption patterns in different populations."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235&quot;" target="&quot;EASTERN EUROPEAN POPULATIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Allele frequencies for rs4988235 within Eastern European populations reflect intermediate frequencies consistent with regional genetic profiles."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COPSAC2010 COHORT&quot;" target="&quot;GEM COHORT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both cohorts contribute to the understanding of gene-environment interactions affecting gut microbial diversity and abundance."</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT2 SNP (RS601338)&quot;" target="&quot;MUCUS GLYCANS PRODUCTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variation in rs601338 affects the secretion of mucus glycans, impacting gut microbiota composition."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RUMINOCOCCUS GNAVUS GROUP&quot;" target="&quot;MUCUS GLYCANS PRODUCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The abundance of R. gnavus group is influenced by genetic variation affecting mucus glycans production."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLISONELLA ABUNDANCE&quot;" target="&quot;9Q21 LOCUS (PCSK5, RFK, GCNT1)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genetic variants in 9q21 locus impact the abundance of Allisonella through riboflavin and mucin biosynthesis."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COBALAMIN ABSORPTION AND METABOLISM PATHWAY&quot;" target="&quot;PEPTOSTREPTOCOCCACEAE FAMILY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Genetic variations regulating cobalamin metabolism affect the composition of Peptostreptococcaceae family in gut microbiota."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COBALAMIN ABSORPTION AND METABOLISM PATHWAY&quot;" target="&quot;B12-DEFICIENT ANEMIA&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic regulation of cobalamin absorption is linked to development of B12 deficient anemia."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RUMINOCOCCUS SP.&quot;" target="&quot;COMPLEX CARBOHYDRATES DEGRADATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These bacteria are specialized in breaking down complex carbohydrates, supporting their role in metabolic pathways within the gut."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;9Q21 LOCUS (PCSK5, RFK)&quot;" target="&quot;HOST-MICROBIOME CROSSTALK&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genetic locus involved in regulating riboflavin metabolism and mucin biosynthesis contributes to host-microbiota interactions within the intestine."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUCIN BIOSYNTHESIS PATHWAY&quot;" target="&quot;INTESTINAL MICROBIOTA COMPOSITION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The glycosylation pathway regulated by GCNT1 impacts the composition of intestinal microbiota through mucin production."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHROMOGRANIN A LEVELS&quot;" target="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Decreased chromogranin A levels correlate inversely with ulcerative colitis severity, suggesting an impact of gut microbiota (Peptococcaceae family)."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALPROTECTIN LEVELS&quot;" target="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Negative association between calprotectin levels and the presence of Peptococcaceae suggests a role in mitigating ulcerative colitis symptoms."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ULCERATIVE COLITIS&quot;" target="&quot;BIFIDOBACTERIUM GENUS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher levels of Bifidobacterium are associated with lower risk of developing ulcerative colitis, indicating a protective role for this genus against the disease.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXALOBACTERACEAE FAMILY&quot;" target="&quot;RHEUMATOID ARTHRITIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased abundance of Oxalobacteraceae is linked to reduced likelihood of rheumatoid arthritis, suggesting a protective effect of this microbial family on autoimmune health.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;" target="&quot;GUT MICROBIAL TAXA&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Genetic variants such as SNPs are used to investigate potential causal relationships between host genetics and gut microbial composition.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;" target="&quot;HECTD4, ACAD10, MYL2, CUX2 GENES &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Certain SNPs located within these genes are associated with habitual coffee consumption and may influence the risk of developing type 2 diabetes."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GUT MICROBIAL TAXA&quot;" target="&quot;DIETARY PREFERENCES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Despite the search, no evidence was found for a causal relationship between dietary preferences and changes in gut microbial taxa.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GUT MICROBIAL TAXA&quot;" target="&quot;METABOLIC DISEASES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The abundance or presence of certain microbial taxa can influence metabolic diseases through various physiological processes.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE DISEASES&quot;" target="&quot;HOST GENETICS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The genetic makeup of an individual can influence their susceptibility to autoimmune diseases through interactions with gut microbiota.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR DISEASES&quot;" target="&quot;HOST GENETICS AND GUT MICROBIAL TAXA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"There is a complex relationship between cardiovascular health, host genetics, and the composition of the gut microbiome.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSYCHIATRIC DISORDERS&quot;" target="&quot;GUT MICROBIAL TAXA AND HOST GENETICS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is emerging evidence suggesting a link between gut microbiota, genetic predisposition, and the development of psychiatric disorders.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;16S RRNA GENE SEQUENCING&quot;" target="&quot;MICROBIOME PROFILING&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Sequencing the 16S rRNA gene helps in profiling microbial diversity, identifying core microbiota across different populations and cohorts.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FIBER METABOLISM&quot;" target="&quot;PREVOTELLA&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Prevotella's abundance is often linked to high-fiber diets due to its ability to ferment complex carbohydrates.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALBUMINURIA REGULATION&quot;" target="&quot;COBALAMIN ABSORPTION PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic variation affecting cobalamin absorption via CUBN gene is linked to albuminuria, indicating a role in metabolic regulation."</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1 GENE&quot;" target="&quot;TYPE 2 DIABETES MELLITUS (T2DM)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variation near IRF1 influences susceptibility to T2DM, indicating potential pathways linking gene function with metabolic diseases."</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235 T/T GENOTYPE&quot;" target="&quot;MILK INTAKE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Individuals with the rs4988235 T allele consume more milk compared to those without this variant."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235 T/T GENOTYPE&quot;" target="&quot;HDL CHOLESTEROL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Individuals carrying the rs4988235 T allele have modestly lower HDL cholesterol levels compared to non-carriers."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235 T/T GENOTYPE&quot;" target="&quot;ENERGY INTAKE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No significant association was found between energy intake and the LP genetic variant in this study."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4988235 T/T GENOTYPE&quot;" target="&quot;NON-ALCOHOLIC BEVERAGES INTAKE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"People carrying the rs4988235 T allele consumed fewer non-alcoholic beverages than those without this variant."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LP (LACTASE PERSISTENCE)&quot;" target="&quot;C15:0&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The LP gene influences plasma levels of C15:0, a fatty acid associated with dietary patterns and metabolic pathways."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LP (LACTASE PERSISTENCE)&quot;" target="&quot;POULTRY CONSUMPTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with the LP gene showed a slight reduction in poultry consumption compared to those without it."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAIRY PRODUCTS INTAKE&quot;" target="&quot;C15:0 LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Intake of dairy products is associated with higher plasma C15:0 levels, reflecting metabolic pathways influenced by dietary habits."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES RISK FACTORS&quot;" target="&quot;BASELINE HBA1C LEVELS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"HbA1c levels are a risk factor for diabetes and were not significantly altered by LP genotypes in this study."</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE&quot;" target="&quot;EYEBLINK CONDITIONING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Infants treated with choline showed a higher proportion meeting criteria for conditioning compared to placebo, indicating an effect on learning and memory functions."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE&quot;" target="&quot;FASD DIAGNOSIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Maternal dietary choline intake during pregnancy impacts FASD diagnosis outcomes for infants.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE&quot;" target="&quot;PEMT ENZYME VARIANT (RS12325817)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The PEMT enzyme variant affects endogenous choline synthesis, impacting the effectiveness of dietary choline intake during pregnancy.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FETAL ALCOHOL SPECTRUM DISORDER (FASD)&quot;" target="&quot;MATERNAL ALCOHOL CONSUMPTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"High levels of alcohol consumption during pregnancy are linked to the development of FASD in children."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FETAL ALCOHOL SPECTRUM DISORDER (FASD)&quot;" target="&quot;NOVELTY PREFERENCE SCORE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Infants with FASD may have lower novelty preference scores, indicating impaired visual recognition memory compared to peers without FASD."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EYEBLINK CONDITIONING&quot;" target="&quot;VISUAL RECOGNITION MEMORY FUNCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Performance on eyeblink conditioning tests is indicative of an infant’s visual recognition memory function."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEAVY ALCOHOL CONSUMPTION&quot;" target="&quot;BIRTH WEIGHT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Prenatal exposure to heavy alcohol consumption is associated with a higher incidence of low birth weight in infants."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING&quot;" target="&quot;FETAL DEVELOPMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Maternal smoking can contribute to developmental delays and other adverse outcomes in children exposed to prenatal nicotine."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING&quot;" target="&quot;MALE INFERTILITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Smoking can negatively impact semen quality and fertility by causing oxidative stress, DNA damage, and other physiological changes that impair sperm function."</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING&quot;" target="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Both educational attainment and smoking are lifestyle factors that can influence milk consumption patterns and potentially impact disease risk."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILLICIT DRUG USE&quot;" target="&quot;DEVELOPMENTAL OUTCOMES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Use of illicit drugs during pregnancy may lead to poor developmental outcomes, including lower cognitive abilities in infants."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH WEIGHT&quot;" target="&quot;MMACHC VARIANT (RS12272669)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The MMACHC variant's effect on birth weight is less pronounced during pregnancy at 28 weeks, showing no significant change."&lt;SEP&gt;"The effect of this variant on fetal birth weight at 28 weeks is negligible, indicating limited influence."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH WEIGHT&quot;" target="&quot;MATERNAL SERUM B12 LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High maternal serum B12 levels do not significantly affect offspring birthweight according to the study's findings."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH WEIGHT&quot;" target="&quot;FOLATE LEVELS (MATERNAL)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Positive causal effect of higher maternal folate levels on offspring birth weight, a significant finding in the study."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH WEIGHT&quot;" target="&quot;FOLATE LEVELS (FETAL)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Negative impact of high fetal folate levels on birthweight, though with smaller effect size compared to maternal levels."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH WEIGHT&quot;" target="&quot;MATERNAL SERUM FOLATE LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased maternal serum folate levels positively affect offspring birthweight according to the study findings."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH WEIGHT&quot;" target="&quot;FETAL FOLATE LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher fetal folate levels negatively impact fetal birth weight, though with a smaller effect size compared to maternal levels."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CATCH-UP GROWTH&quot;" target="&quot;CHOLINE SUPPLEMENTATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Infants receiving choline supplementation showed improved growth patterns compared to those without supplementation."</data>
      <data key="d6">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASD DIAGNOSIS&quot;" target="&quot;MATERNAL DIETARY CHOLINE STATUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Inadequate maternal dietary choline status is associated with increased risk for FASD diagnosis in infants.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PEMT ENZYME VARIANT (RS12325817)&quot;" target="&quot;ENDOGENOUS CHOLINE SYNTHESIS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This genomic variant affects the capacity of the PEMT enzyme to synthesize choline endogenously, impacting dietary choline requirements.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAS (FETAL ALCOHOL SYNDROME)&quot;" target="&quot;PFAS (PARTIAL FETAL ALCOHOL SYNDROME)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Both conditions fall under the broader category of Fetal Alcohol Spectrum Disorders but differ in severity and symptoms present.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLACEBO ARM&quot;" target="&quot;CHOLINE-TREATED GROUP&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Comparing outcomes between infants whose mothers received choline supplementation versus a placebo during pregnancy.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRK5 (CA)N POLYMORPHISM&quot;" target="&quot;IFG, IGT, T2DM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of GRK5 (CA)16 allele polymorphisms is significantly associated with increased risk for prediabetes and type 2 diabetes mellitus."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRK5 (CA)N POLYMORPHISM&quot;" target="&quot;CA REPEAT SEQUENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The variation in CA repeat sequences within the GRK5 gene is a form of genomic polymorphism that affects glucose metabolism risk."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRK5 (CA)N POLYMORPHISM&quot;" target="&quot;LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Logistic regression analysis is used to study the association between specific alleles of GRK5 (like (CA)16) and disease risk."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PIC VALUES&quot;" target="&quot;GRK5 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genetic variation within the GRK5 gene is assessed using PIC values to determine polymorphism."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PIC VALUES&quot;" target="(&quot;CA)16, (CA)17 ALLELES&quot;)">
      <data key="d4">4.0</data>
      <data key="d5">"The PIC values indicate significant differences in the frequency distribution of specific alleles like (CA)16 and (CA)17 across different groups."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2DM&quot;" target="&quot;(CA)16 ALLELE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of the (CA)16 allele is significantly negatively correlated with Type 2 Diabetes Mellitus, suggesting a protective effect against developing T2DM."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2DM&quot;" target="&quot;SENP1-AP2KO&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Mice deficient for the SENP1 gene exhibit a heightened susceptibility to Type 2 Diabetes Mellitus phenotypes under conditions of high-fat diet exposure.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;(CA)16 ALLELE&quot;" target="&quot;ABNORMAL BLOOD GLUCOSE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There are no significant associations between the (CA)16 allele and abnormal blood glucose conditions, indicating that this allele does not significantly influence these conditions."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG&quot;" target="&quot;MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The multiple alleles are significantly negatively correlated with Impaired Fasting Glucose, indicating a protective effect against IFG."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG&quot;" target="&quot;CHI3LI TG SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"None of the tag single nucleotide polymorphisms (tgSNPs) in CHI3L1 showed an association with impaired fasting glucose (IFG).")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGT&quot;" target="&quot;MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The multiple alleles are significantly negatively correlated with Impaired Glucose Tolerance, suggesting a protective effect against IGT."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGT&quot;" target="&quot;CHI3LI TG SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A borderline protective association was found between one of the tgSNPs, rs12123883, and impaired glucose tolerance (IGT), though it did not reach statistical significance.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19&quot;" target="&quot;NFG GROUP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The NFG group is used as a control to compare against multiple alleles which show significant negative correlations with IFG, IGT, and T2DM."</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG, IGT, T2DM&quot;" target="&quot;CLINICAL PARAMETERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Abnormal glucose metabolism as seen in IFG, IGT, and T2DM leads to an increase in clinical parameters such as waist circumference, BMI, SBP, DBP, FPG, and 2 h PG."</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX4 GENE&quot;" target="&quot;SNP IN GPX4 GENE (RS8178974)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A specific SNP within the GPX4 gene has been identified as having an impact on the risk of developing colorectal cancer."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENIUM SUPPLEMENTS&quot;" target="&quot;COLORECTAL CANCER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Use of selenium supplements did not show a significant difference in colorectal cancer risk compared to controls."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER&quot;" target="&quot;SERUM SELENIUM CONCENTRATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"While there was no strong evidence for an association between serum selenium and overall colorectal cancer risk, it showed a marginal positive trend with colon cancer specifically."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER&quot;" target="&quot;NSAIDS (NONSTEROIDAL ANTI-INFLAMMATORY DRUGS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Similar NSAID use among cases and controls suggests that these drugs may not play a significant role in modifying the risk of developing colorectal cancer."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER&quot;" target="&quot;POSTMENOPAUSAL HORMONE USE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Less frequent postmenopausal hormone use among cases compared to controls hints at hormonal factors possibly influencing disease development."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Lower physical activity among cases compared to controls implies reduced exercise could increase the likelihood of developing colorectal cancer."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM CONCENTRATION&quot;" target="&quot;COLON CANCER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The positive association between serum selenium concentration and colon cancer was marginally significant, suggesting a possible role for this nutrient in cancer development or detection timing."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM CONCENTRATION&quot;" target="&quot;GENOMIC VARIANTS IN SELENOENZYMES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genetic variants within selenoenzyme genes did not modify the observed association between serum selenium and colorectal cancer."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALCIUM INTAKE&quot;" target="&quot;DIETARY FIBER INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both calcium intake and dietary fiber intake were lower in cases of colorectal cancer compared to controls, indicating potential nutritional factors influencing disease risk."</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;ALDH2 RS671 GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The ALDH2 genotype may indirectly influence physical activity through its effects on alcohol intake and overall health behavior."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B&quot;" target="&quot;DSS-INDUCED COLITIS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Interleukin 1beta gene activity increases as a response to inflammation caused by DSS in colitis."</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REG3G, REG3B, AND IL22&quot;" target="&quot;IMMUNE-RELATED PATHWAYS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"These transcripts are part of immune pathways that become more active during DSS-induced colitis in Card9−/− mice."</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-17A&quot;" target="&quot;PSORIASIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IL-17A positivity is observed in T-cells isolated from patients with psoriasiform lesions, indicating its role in the inflammatory processes associated with this condition."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DSS-INDUCED COLITIS&quot;" target="&quot;WT MICE (WILD-TYPE MICE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Wild-type mice recover better from DSS-induced colitis compared to Card9−/− mice."</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DSS-INDUCED COLITIS&quot;" target="&quot;INDOLE-3-ACETIC ACID (IAA)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Low levels of IAA, a metabolite from gut bacteria tryptophan metabolism, correlate with increased susceptibility to DSS-induced colitis in Card9−/− mice.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD3−CD4−NKP46− SUBSET&quot;" target="&quot;IL-22+ CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The CD3−CD4−NKp46− subset is a subpopulation of IL-22+ cells that plays a crucial role in the immune response to colitis."</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9 GENE&quot;" target="&quot;IL-22 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression of IL-22 is impaired in the context of CARD9 deficiency, suggesting a functional link between these two entities during colitis development and recovery."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GERM-FREE (GF) MICE&quot;" target="&quot;DEXTRAN SODIUM SULFATE (DSS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In GF mice colonized with Card9−/− microbiota and exposed to DSS, the phenotype observed mimics that seen in Card9−/− mice directly."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENE&quot;" target="&quot;CYTOKINES (CXCL1, CXCL5)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"CXCL1 and CXCL5 are downstream effectors of IL-22 signaling pathways, their altered expression indicating a compromised inflammatory response mechanism in Card9−/− mice."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENE&quot;" target="&quot;TRANSCRIPTION FACTOR (FOS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"FOS is a transcription factor that regulates the expression of many genes involved in inflammation. Its decreased expression in Card9−/−→GF mice suggests it plays a role downstream of IL-22 signaling."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENE&quot;" target="&quot;REG3G AND REG3B GENES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"REG3G and REG3B are induced by IL-22 for anti-fungal defense. Their reduced expression in Card9−/−→GF mice indicates a deficiency in this protective mechanism."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERLEUKIN-17 (IL-17)&quot;" target="&quot;CARD9 GENE &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The unaltered levels of IL-17 production indicate that the defect seen in Card9−/−→GF mice might be specific to pathways other than those regulated by IL-17."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INNATE LYMPHOID CELLS (ILCS)&quot;" target="&quot;IL-22 GENE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"ILC function is compromised in the production of IL-22, indicating a critical role for these cells in maintaining gut homeostasis through this cytokine."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INNATE LYMPHOID CELLS (ILCS)&quot;" target="&quot;IL-23 SIGNALING PATHWAY &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"While the IL-23 pathway is intact in Card9−/−→GF mice, the inability of ILCs to produce sufficient IL-22 indicates a specific defect downstream of this pathway."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH22 CELLS&quot;" target="&quot;REG3G AND REG3B GENES &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"TH22 cell dysfunction leads to decreased production of REG3G and REG3B, highlighting the importance of IL-22 for maintaining anti-fungal defense mechanisms in the gut."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADLERCREUTZIA (GENUS)&quot;" target="&quot;CARD9 GENE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The reduction of Adlercreutzia in Card9−/− mice microbiota suggests its important role in maintaining gut homeostasis and immune balance, influenced by CARD9 deficiency."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADLERCREUTZIA (GENUS)&quot;" target="&quot;ACTINOBACTERIA (PHYLUM)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The phylum Actinobacteria includes Adlercreutzia and other bacteria crucial for maintaining a healthy gut microbiota, with deficiencies observed in the absence of CARD9."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTINOBACTERIA (PHYLUM)&quot;" target="&quot;LACTOBACILLUS REUTERI (SPECIES)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The specific reduction of Lactobacillus reuteri within Actinobacteria phylum highlights its unique role in gut health and the regulation by CARD9."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERLEUKIN-1Β (IL-1Β)&quot;" target="&quot;TNF-Α GENE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Together, IL-1β and TNF-α form a cytokine network critical for initiating inflammation in the body. Their roles are intertwined with those of CARD9 during colitis."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOD2 GENE&quot;" target="&quot;CARD9 GENE &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both NOD2 and CARD9 genes play crucial roles in innate immune responses but target different pathogens, highlighting the complexity of gut microbiota regulation."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM LONGUM (SPECIES)&quot;" target="&quot;CARD9 GENE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The reduction or alteration of Bifidobacterium longum in CARD9-deficient mice indicates its role in maintaining a healthy microbial balance influenced by the CARD9 gene."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBROBLAST GROWTH FACTOR 15 (FGF15)&quot;" target="&quot;CARD9 GENE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FGF15 expression changes due to CARD9 deficiency suggest that this factor plays an essential role in regulating intestinal inflammation and metabolism, affected by the presence of CARD9."</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRYPTOPHAN METABOLISM&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Defective tryptophan metabolism leads to reduced activation of Aryl Hydrocarbon Receptor (AHR).")&lt;SEP&gt;"Impaired tryptophan metabolism within the gut microbiota affects AHR activation and consequently influences local IL-22 production.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRYPTOPHAN METABOLISM&quot;" target="&quot;INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IDO1 enzymatic activity is crucial for the conversion of tryptophan into kynurenine in host cells as part of immune regulation.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRYPTOPHAN METABOLISM&quot;" target="&quot;IDO1−/− MICE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Deficiency in Ido1 results in alterations in tryptophan metabolism pathways and affects AHR activity as well as IL-22 production in the gut.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRYPTOPHAN METABOLISM&quot;" target="&quot;GUT MICROBIOTA FUNCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Impaired tryptophan metabolism by the gut microbiota leads to defective AHR activation and increased susceptibility to IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION&quot;" target="&quot;LACTOBACILLUS STRAINS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Supplementation with specific Lactobacillus strains can restore AHR activation and improve IL-22 production, reducing the severity of DSS-induced colitis in Card9−/− mice.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION&quot;" target="&quot;L. REUTERI AND ALLOBACULUM SP.&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"These bacterial strains are pivotal for their ability to activate AHR, contributing significantly to the regulation of colitis susceptibility through IL-22 signaling pathways.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KYNURENINE (KYN)&quot;" target="&quot;IL-22 PRODUCTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The production of Kyn through IDO1 activity modulates IL-22 levels, impacting the susceptibility to DSS-induced colitis in Card9−/− mice.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-23 PRODUCTION&quot;" target="&quot;MICROBIOTA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The microbiota influences intestinal dendritic cells to produce IL-23, which is crucial for the activation and differentiation of immune responses in the gut.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOTA&quot;" target="&quot;IL22−/− MICE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Deficiency in Il22 impacts the gut microbiota composition and function, leading to decreased AHR activity and reduced levels of IAA, affecting susceptibility to DSS-induced colitis.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DSS-INDUCED COLITIS RECOVERY&quot;" target="&quot;KI67 AND CLEAVED CASPASE 3&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Decreased proliferation (Ki-67) and increased apoptosis (cleaved caspase 3) indicate impaired intestinal healing in Card9−/− mice."</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDO1 PROTEIN&quot;" target="&quot;KYNURENINE PRODUCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IDO1 is responsible for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9 GENE EXPRESSION&quot;" target="&quot;IBD-ASSOCIATED SNP (RS10781499)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A specific genetic variant within CARD9 affects the ability of gut microbiota to produce AHR ligands, influencing disease susceptibility in IBD patients.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION &quot;" target="&quot;IBD-DERIVED FECAL SAMPLES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Fecal samples from patients with IBD show reduced ability to activate Aryl Hydrocarbon Receptor (AHR), indicating impaired tryptophan metabolism and microbiota function.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION &quot;" target="&quot;IMMUNE RESPONSE REGULATION &quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Activation of Aryl Hydrocarbon Receptor (AHR) regulates immune responses through metabolites produced by tryptophan metabolism.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9 GENE VARIANT (RS10781499)&quot;" target="&quot;IBD SUSCEPTIBILITY &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"An SNP within CARD9 associated with increased susceptibility to IBD, affecting AHR activation by gut microbiota-derived metabolites.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDO1 ENZYMATIC ACTIVITY&quot;" target="&quot;TRYPTOPHAN METABOLISM &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The enzymatic activity of IDO1 is crucial for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β2M GENE&quot;" target="&quot;SH2B3 PROTEIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SH2B3 protein normally constrains β2M expression in response to hypertensive stimuli.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3184504 POLYMORPHISM&quot;" target="&quot;SH2B3 EXPRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs3184504 polymorphism is genetically linked to decreased SH2B3 expression, which in turn influences β2M levels and hypertension risk.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SH2B3 EXPRESSION&quot;" target="&quot;SH2B3 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variations in the SH2B3 gene influence its expression level, affecting subsequent β2M levels and potentially influencing hypertension development.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;Β2M PROTEIN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Elevated levels of β2M protein are associated with increased risk of developing new-onset hypertension over time.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;ALBUMINURIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of albuminuria is often indicative of kidney damage that can exacerbate or be exacerbated by hypertension.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;LOW EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with low eGFR, indicating poor kidney function, are at higher risk for developing hypertension and its complications.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;STATIN USE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"While statins primarily lower cholesterol levels, their use is often considered in the context of overall cardiovascular health alongside factors like β2M levels.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANGIOTENSIN II-INDUCED HYPERTENSION MODEL&quot;" target="&quot;RENAL/VASCULAR DYSFUNCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The model using angiotensin II induces hypertension and subsequent renal/vascular dysfunctions in mice.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANGIOTENSIN II-INDUCED HYPERTENSION MODEL&quot;" target="&quot;ANGIOTENSIN II&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In experimental settings, Angiotensin II can induce hypertension and is used to study the mechanisms of hypertensive responses in mice models.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CIRCULATING BETA-2-MICROGLOBULIN LEVELS&quot;" target="&quot;SH2B3−/− MOUSE MODEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mice lacking SH2B3 protein show higher β2M levels in response to angiotensin II-induced hypertension, linking to increased hypertensive responses and end-organ damage.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1&quot;" target="&quot;SNP RS2236225&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MTHFD1 gene contains a genomic variant (rs2236225) that is associated with increased risk of neural tube defects in infants with low maternal folate intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1&quot;" target="&quot;SNP RS11627387&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MTHFD1 gene contains a genomic variant (rs11627387) that is associated with increased risk of neural tube defects in infants when maternal folate intake is low."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1&quot;" target="&quot;RS2236225 G ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs2236225 polymorphism in MTHFD1 gene leading to ARG-653-GLN alteration is associated with higher susceptibility to neural tube defects and statistical differences were observed among TMD patients compared to healthy controls."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR&quot;" target="&quot;SNP RS1476413&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MTHFR gene contains a genomic variant (rs1476413) that shows reduced risk of neural tube defects in mothers with high dietary folate intake and heterozygous genotype."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR&quot;" target="&quot;SNP RS1801131&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MTHFR gene contains a genomic variant (rs1801131) that shows reduced risk of neural tube defects in mothers with high dietary folate intake and heterozygous genotype."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR&quot;" target="&quot;SNP RS1801133&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MTHFR gene contains a genomic variant (rs1801133) that shows reduced risk of neural tube defects in mothers with high dietary folate intake and heterozygous genotype."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHMT1&quot;" target="&quot;SNP RS669340 CG&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SHMT1 gene contains a genomic variant (rs669340 CG) associated with reduced risk of neural tube defects in mothers but increased risk in infants, depending on maternal folate intake levels."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHMT1&quot;" target="&quot;SNP RS12939757 AG&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SHMT1 gene contains a genomic variant (rs12939757 AG) associated with increased risk of neural tube defects in infants with low maternal dietary folate intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHMT1&quot;" target="&quot;RS1979277 G ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of the rs1979277 polymorphism associated with Leu435Phe substitution in SHMT1 is linked to increased risk for TMD disease compared to control groups."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHMT1&quot;" target="&quot;RS638416 C ALLELE AND CC GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs638416 polymorphism in the SHMT1 promoter region is associated with significant increases of the C allele and CC genotype among TMD patients compared to healthy controls."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYMS&quot;" target="&quot;SNP RS502396&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TYMS gene contains a genomic variant (rs502396) that reduces the risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYMS&quot;" target="&quot;SNP RS699517&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TYMS gene contains a genomic variant (rs699517) that reduces the risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYMS&quot;" target="&quot;SNP RS2847153 AG&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TYMS gene contains a genomic variant (rs2847153 AG) that reduces the risk of neural tube defects in infants when there is low maternal dietary folate intake."</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;B12 TRANSCOBALAMIN RECEPTOR (TCBLR) GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The availability of vitamin B12 through TCblR gene expression influences folate-dependent processes and impacts health outcomes including infertility risk."</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;SERUM FOLATE MEASUREMENT METHODS (CDC HPLC-MS/MS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CDC HPLC-MS/MS method quantitatively measures folic acid and 5-methylTHF in serum with high accuracy.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;MICROORGANISM EFFECT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Variability in folate measurement results is significantly influenced by differences in microorganisms used as standards in laboratory settings.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;CALIBRATOR EFFECT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The choice of calibrators (such as 10-formyltetrahydrofolate or folic acid) significantly affects the accuracy and variability of folate measurement results in laboratories.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10399931&quot;" target="&quot;C-PEPTIDE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant rs10399931 showed a significant association with the serum C-peptide concentration after two hours, indicating an effect on insulin production.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI3LI TG SNPS&quot;" target="&quot;INTER99 COHORT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Inter99 cohort contributed data on the association between CHI3L1 tgSNPs and T2D-related factors, including BMI and glucose tolerance test results."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI3LI TG SNPS&quot;" target="&quot;STENO DIABETES CENTER INDIVIDUALS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Data from individuals recruited at Steno Diabetes Center were used to study the association between CHI3L1 tgSNPs and T2D-related factors, such as BMI and glucose tolerance."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI3LI TG SNPS&quot;" target="&quot;AGE AND SEX ADJUSTMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Adjustments for age and sex were made to ensure accurate assessment of the association between CHI3L1 tgSNPs and T2D-related factors such as BMI, serum C-peptide levels."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHI3LI TG SNPS&quot;" target="&quot;GLUCOSE TOLERANCE TEST (NGT)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The glucose tolerance test was used to identify individuals without diabetes (Normal Glucose Tolerance - NGT), and their data were analyzed for association with CHI3L1 genomic variants."</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CFH Y402H RISK ALLELE&quot;" target="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The joint effect of poor lifestyle and high-risk CFH genotype increases the odds for AMD more than additive effects, suggesting synergy between genetic risk and poor lifestyle."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A69S RISK ALLELE (ARMS2)&quot;" target="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The A69S risk allele of ARMS2 is associated with increased odds for AMD, especially when combined with low HLS."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A69S RISK ALLELE (ARMS2)&quot;" target="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The combination of low HLS and at least one A69S allele increases AMD risk, though the effect is sub-additive compared to individual effects."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Women with high HLS scores had lower odds of AMD compared to those with low HLS, indicating the protective effect of a healthy lifestyle against genetic risk factors for AMD."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;LUTEIN AND ZEAXANTHIN (LZ)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher status for LZ among women with high HLS partially explains the protective effect of a healthy lifestyle against genetic risk factors for AMD."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;C3 GENE (COMPLEMENT COMPONENT C3)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"While genetic predispositions from the C3 gene exist, dietary stability appears to influence how these genes affect AMD risk."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;INTERACTION BETWEEN CFH GENOTYPE AND HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The joint effect of HLS and high-risk CFH genotype increases AMD risk more than additive effects, indicating synergy between genetic predisposition and lifestyle."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;AMD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is evidence suggesting that adherence to healthy lifestyle patterns can modify the risk of AMD, particularly when considered alongside genetic predispositions."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;ARMS2 GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"No significant interaction was found between the ARMS2 genotype and HLS regarding the additive or multiplicative effects on AMD risk."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY LIFESTYLE SCORE (HLS)&quot;" target="&quot;CFB/C2, C3 RS2230199 AND CFI RS10033900 GENOTYPES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Interactions between these genotypes and HLS had unreliable estimates due to a lack of main effects for the SNPs and variable combinations leading to the lowest odds for AMD."</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OMEGA-3 FATTY ACIDS&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"In combination with dietary changes, omega-3 fatty acids help reduce TG levels and manage hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LUTEIN AND ZEAXANTHIN (LZ)&quot;" target="&quot;INTERACTION BETWEEN ARMS2 GENOTYPE AND HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Higher dietary intake of LZ among women with high HLS partially explains protective benefits against AMD in the context of genetic risk factors."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CFH GENE (COMPLEMENT FACTOR H)&quot;" target="&quot;AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variants in the CFH gene contribute to different risk phenotypes for AMD, particularly when combined with lifestyle factors."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARMS2 GENE (AGE-RELATED MACULOPATHY SUSCEPTIBILITY 2)&quot;" target="&quot;AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ARMS2 gene's impact on risk phenotypes is modified by lifestyle and dietary patterns."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CFI GENE (COMPLEMENT FACTOR I)&quot;" target="&quot;DIETARY STABILITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Variants in CFI do not significantly impact AMD risk even under conditions of stable diet and lifestyle."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES&quot;" target="&quot;MAIN EFFECTS OF AMD GENOTYPES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Risk phenotypes for AMD are influenced by the main effects of genetic variants, which can be modified by additional factors such as lifestyle."</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COFFEE CONSUMPTION&quot;" target="&quot;GENETIC RISK SCORES &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The association between habitual coffee consumption and the risk of developing type 2 diabetes is modified by genetic risk scores."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLACK COFFEE CONSUMPTION &quot;" target="&quot;TYPE 2 DIABETES &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Regular black coffee intake is inversely associated with the risk of developing type 2 diabetes, particularly in individuals with high genetic risk scores."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLACK COFFEE CONSUMPTION &quot;" target="&quot;CONTINUOUS CAFFEINE INTAKE &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The regular intake of caffeine, often through black coffee, is associated with lower risks for type 2 diabetes and prediabetes."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUGARED COFFEE CONSUMPTION &quot;" target="&quot;PREDIABETES &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Consumption of sugared coffee is associated with a reduced risk of prediabetes and type 2 diabetes combined."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUGARED COFFEE CONSUMPTION &quot;" target="&quot;INVERSE TREND &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"An inverse trend suggests that regular consumption of sugared coffee may inversely correlate with the risk of developing prediabetes and type 2 diabetes."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGIONAL ASSOCIATION PLOT &quot;" target="&quot;GWAS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This plot is derived from GWAS data to show associations within a specific genomic region, highlighting potential causal variants."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC INFLATION FACTOR (Λ)&quot;" target="&quot;Q-Q PLOT &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A Q-Q plot helps in the assessment of the inflation factor by comparing observed vs. expected test statistics distribution."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAIRWISE CORRELATIONS &quot;" target="&quot;HIGHLY-CORRELATED GENOTYPED SNPS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The identification and analysis of pairwise correlations aid in selecting highly-correlated genotyped SNPs for genetic risk score calculations."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NON-BLACK COFFEE CONSUMERS &quot;" target="&quot;TYPE 2 DIABETES &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals who do not consume black coffee regularly may have different risks for type 2 diabetes compared to regular consumers."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NON-SUGARED COFFEE CONSUMERS &quot;" target="&quot;PREDIABETES &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Those who don’t consume sugared coffee might exhibit varying degrees of risk for prediabetes depending on their dietary patterns and genetic factors."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISMS RELATED TO COFFEE CONSUMPTION &quot;" target="&quot;COFFEE-RELATED SNPS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These polymorphisms help identify specific SNPs related to habitual coffee intake patterns, influencing genetic risk scores."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;INVERSE RELATIONSHIP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The SNP is associated through its minor allele in an inverse manner with the incidence or progression of type 2 diabetes."</data>
      <data key="d6">chunk-b803830d07bff8ae14550f6458048707</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC RISK SCORES &quot;" target="&quot;GWAS &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genome-wide association studies help in identifying SNPs that contribute to the calculation of genetic risk scores."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES &quot;" target="&quot;GENETIC POLYMORPHISMS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Certain genetic polymorphisms are linked to an increased risk of developing type 2 diabetes."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISMS &quot;" target="&quot;MANHATTAN PLOT &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A Manhattan plot visually represents the association between genetic polymorphisms and traits or diseases across the genome."</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1&quot;" target="&quot;NEMO (IKKΓ)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SENP1 plays a role in the regulation of NEMO SUMOylation status, influencing NF-κB signaling."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1&quot;" target="&quot;T1DM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression level of SENP1 correlates with disease progression in T1DM patients and NOD mouse models, indicating its role in diabetes pathogenesis.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1 PROTEIN&quot;" target="&quot;GLUCOSE METABOLISM REGULATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SENP1 protein plays a role in regulating glucose metabolism by modulating inflammation and diabetes pathways.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1 PROTEIN&quot;" target="&quot;PANCREATIC ISLETS (Β CELLS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The deficiency of SENP1 protein leads to reduced insulin secretion from pancreatic islets contributing to diabetes development.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN SECRETION&quot;" target="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The deficiency of SENP1 affects insulin secretion from pancreatic islets, contributing to the development of diabetes.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1 GENE&quot;" target="&quot;T1DM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SENP1 gene deficiency leads to increased risk and development of Type 1 Diabetes Mellitus."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL MEDIATED DESTRUCTION&quot;" target="&quot;APOPTOSIS OF Β CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The process of T-cell mediated destruction contributes to apoptosis of β-cells, leading to loss of function in the β cell with disrupted vasculatures."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATIC ISLETS STRUCTURE DISRUPTION&quot;" target="&quot;IMMUNE CELL INFILTRATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Immune cells infiltrating into pancreatic tissues cause structural disruption and damages to islet structures."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN AUTOANTIBODY (IAA)&quot;" target="&quot;C-REACTIVE PROTEIN (CRP)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of IAA along with elevated CRP levels are indicative markers for the diagnosis and progression of Type 1 Diabetes Mellitus."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β-HYDROXYBUTYRATE&quot;" target="&quot;IMMUNE SYSTEM REGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Elevated β-hydroxybutyrate levels in SENP1-aP2KO mice suggest metabolic changes that contribute to immune dysregulation, supporting the development of T-cell mediated autoimmune responses."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMMUNE SYSTEM REGULATION&quot;" target="&quot;SKIN-REJECTION RESPONSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of a normal skin-rejection response indicates that the immune system in SENP1-aP2KO mice maintains its ability for immune regulation, despite developing autoimmune diabetes."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE&quot;" target="&quot;IL-6, TNF-Α, IL-1Β&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"These cytokines are upregulated in adipocytes of mice with SENP1 deficiency, contributing to proinflammatory state."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE&quot;" target="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Studying these mice provides insights into the role of adipocyte-specific SENP1 deficiency in T1DM pathogenesis."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE&quot;" target="&quot;SENP1 TRANSCRIPT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Gene knockdown or overexpression affects the levels of SENP1 mRNA, impacting subsequent protein production."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD31+ VASCULAR AREA LOSS&quot;" target="&quot;Β-CELL MASS REDUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The loss of CD31-positive vascular area contributes significantly to the reduction in β-cell mass and function, leading to diabetic phenotypes."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE MEDIATED DAMAGES&quot;" target="&quot;CD8+ T CELLS INFILTRATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Invasion by CD8+ T cells is a critical component of autoimmune mediated damages contributing to pancreatic islet destruction."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MHCII+CD11B+CD11C− MACROPHAGES INCREASE&quot;" target="&quot;REGULATORY T-CELLS REDUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased MHCII+CD11b+CD11c− macrophages contribute to the reduction in regulatory T-cells, leading to a shift towards pro-inflammatory immune responses."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH1 AND TH17 EFFECTOR T-CELL SUBSETS EXPANSION&quot;" target="&quot;ACTIVATED DENDRITIC CELLS INCREASE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expansion of Th1 and Th17 effector T-cell subsets is supported by increased activation of dendritic cells, contributing to the autoimmune response."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULATORY T-CELLS REDUCTION&quot;" target="&quot;NRP-V7 POSITIVE CD8+ T-CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Detection of NRP-V7 positive CD8+ T-cells indicates specific autoantigen recognition and supports the reduced regulatory T-cell population observed in autoimmune responses."</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NRP-V7 POSITIVE CD8+ T CELLS&quot;" target="&quot;ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN PEPTIDE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These cells target the peptide, suggesting an autoimmune response targeting this protein in pancreatic islets."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6, TNF-Α AND IL-1Β&quot;" target="&quot;PROINFLAMMATORY CYTOKINE OVERPRODUCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The overproduction of these cytokines indicates a significant role in breaking immunological tolerance and initiating immune cell expansion early in disease phases."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6, TNF-Α AND IL-1Β&quot;" target="&quot;PERI-PANCREATIC ADIPOSE TISSUE (PATS)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"PATs express high levels of these cytokines before the onset of diabetes, contributing to local inflammation and autoimmune responses."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;" target="&quot;CCL5&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High CCL5 expression in islets recruits immune cells into pancreas, causing damages of β cells that lead to T1DM development."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;" target="&quot;NON-OBESE DIABETIC (NOD) MOUSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The NOD mouse model is relevant to human type 1 diabetes as it spontaneously develops autoimmune destruction of insulin-producing cells."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERI-PANCREATIC ADIPOSE TISSUE (PATS)&quot;" target="&quot;IL-6 TRANSCRIPT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High expression of this transcript contributes to increased production of IL-6 cytokine, leading to inflammatory responses in PATs."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERI-PANCREATIC ADIPOSE TISSUE (PATS)&quot;" target="&quot;TNF-Α TRANSCRIPT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High expression of this transcript leads to elevated levels of TNF-α cytokine, contributing to inflammation and autoimmune processes."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERI-PANCREATIC ADIPOSE TISSUE (PATS)&quot;" target="&quot;IL-1Β TRANSCRIPT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High expression of this transcript results in increased IL-1β production, furthering inflammatory responses and immune cell recruitment."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5&quot;" target="&quot;NF-ΚB INHIBITION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"NF-κB inhibitors reduce CCL5 expression in islets, indicating that NF-κB activity regulates chemokine production which is important for inflammation and immune cell recruitment.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO MICE&quot;" target="&quot;PANCREATIC LYMPH NODES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Detected presence of NRP-V7 positive CD8+ T cells targeting a peptide in these lymph nodes from SENP1-aP2KO mice."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO MICE&quot;" target="&quot;INSULIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Administration of insulin in SENP1-deficient mice only partially ameliorates the development of T1DM phenotypes, suggesting a complex interaction between insulin and disease progression.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO MICE&quot;" target="&quot;NF-ΚB ACTIVATION INHIBITOR II JSH-23&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Treatment with NF-κB inhibitor JSH-23 in SENP1-aP2KO mice ameliorates diabetic phenotypes, indicating a critical role of NF-κB activity mediated by SENP1.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATIC LYMPH NODES&quot;" target="&quot;SPLEEN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both sites are involved in the detection of NRP-V7 positive CD8+ T cells targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5 EXPRESSION&quot;" target="&quot;PANCREATIC ISLETS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Upregulation of CCL5 in these sites leads to recruitment of immune cells and subsequent damage to pancreatic β cells, contributing to T1DM development."</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5 EXPRESSION&quot;" target="&quot;NF-ΚB DEPENDENT INFLAMMATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"NF-κB dependent inflammation upregulates CCL5 expression, which recruits immune cells into the pancreas causing damage to β-cells.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5 EXPRESSION&quot;" target="&quot;SENP1-AP2KO ADIPOCYTE-DERIVED CYTOKINES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Adipocyte-derived cytokines induce upregulation of CCL5 expression in islets, which recruits immune cells into the pancreas causing damage to β-cells.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB DEPENDENT INFLAMMATION&quot;" target="&quot;PPARΓ SUMOYLATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"While PPARγ SUMOylation does not contribute significantly to adipocyte differentiation or cytokine production, NF-κB dependent inflammation is elevated in SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB DEPENDENT INFLAMMATION&quot;" target="&quot;NF-ΚB ACTIVATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased NF-κB activation leads to enhanced NF-κB dependent inflammation in adipose tissues of SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-eaf655c4dd9244523b048a122e232be4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IKK&quot;" target="&quot;IΚBΑ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"IKK phosphorylates IκBα, leading to its degradation and subsequent nuclear translocation of NF-κB."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB P65/RELA&quot;" target="&quot;SENP2&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SENP2 deSUMOylates NEMO, which can inhibit NF-κB activation by modulating p65/RelA activity."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NF-ΚB P65/RELA&quot;" target="&quot;DNA DAMAGE AGENT ETOPOSIDE VP16&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Etoposide VP16 induces phosphorylation and activation of IKK and NF-κB p65/RelA in adipocytes."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6, TNF-Α, IL-1Β&quot;" target="&quot;SENP1-AP2KO&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Proinflammatory cytokines such as IL-6, TNF-α and IL-1β are produced at high levels by peripheral adipose tissues in mice deficient for SENP1.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1DM&quot;" target="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased plasma levels of proinflammatory cytokines are observed in T1DM patients and correlate with disease progression, as well as with the diabetes phenotype seen in SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1DM&quot;" target="&quot;IFN-Γ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Elevated levels of IFN-γ are associated with T1DM pathogenesis, particularly in NOD mouse models where it contributes to inflammation and immune cell activation.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROINFLAMMATORY CYTOKINES&quot;" target="&quot;Β-CELL APOPTOSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased levels of pro-inflammatory cytokines promote β-cell apoptosis, leading to a decline in insulin-producing cells seen in T1DM progression.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;ISLET-REACTIVE T CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These T-cells recognize insulin as a target antigen, leading to the destruction of beta cells and contributing to the autoimmune nature of type 1 diabetes.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-FAT DIET (HFD)&quot;" target="&quot;SENP1 DEFICIENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Under HFD conditions, the phenotype of SENP1-deficient mice is exacerbated, suggesting an interaction between dietary factors and genetic predisposition in diabetes development.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Γ&quot;" target="&quot;TNF-Α&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both IFN-γ and TNF-α are crucial cytokines involved in inflammatory responses; their expression patterns differ between classical psoriasis and paradoxical reactions, indicating differential regulation of immune cells."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Γ&quot;" target="&quot;CD SUBJECTS WITHOUT MAPBACTEREMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression level of IFN-γ in CD subjects is lower compared to those with MAPbacteremia, indicating a relationship between MAP presence and IFN-γ levels."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOGENESIS&quot;" target="&quot;SENP1 DEFICIENCY AND HFD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High-fat diet exacerbates adipocyte hyperplasia in SENP1-deficient mice, suggesting an interaction between genetic predisposition and environmental factors in promoting obesity and inflammation.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOGENESIS&quot;" target="&quot;HFD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High-fat diet (HFD) stimulates adipogenesis in perigonadal fat tissues of SENP1-aP2KO mice compared to control mice under similar conditions.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;GLUCOSE-STIMULATED INSULIN SECRETION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High-fat diet reduces glucose-stimulated insulin secretion in SENP1-aP2KO mice, exacerbating the development of diabetes phenotypes.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;ISLET STRUCTURES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"High-fat diet disrupts islet structures in SENP1-aP2KO mice, contributing to the development of diabetes phenotypes.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ITT ASSAY (INSULIN TOLERANCE TEST)&quot;" target="&quot;SENP1-DEFICIENT MICE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Similar insulin responses were observed between SENP1-deficient and control mice on standard chow; however, HFD induced more severe insulin resistance in SENP1-deficient mice.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOCYTE-SPECIFIC DELETION OF SENP1 (SENP1-AP2KO)&quot;" target="&quot;WATER CONSUMPTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SENP1-deficient mice exhibit increased water consumption, which is associated with their higher blood glucose levels.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO (IKKΓ)&quot;" target="&quot;SUMOYLATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SUMOylation modification of NEMO is critical for the activation of IKK-NF-κB signaling."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOKI (RS2228570 OR RS10735810)&quot;" target="&quot;CAUCASIANS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FokI variant was found to be significantly associated with an increased risk of ovarian cancer in a subgroup analysis limited to Caucasians."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APAI (RS7975232)&quot;" target="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genetic data for ApaI was consistent with Hardy-Weinberg equilibrium within control populations, supporting the validity of its association studies."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BSMI (RS1544410)&quot;" target="&quot;HETEROGENEITY BETWEEN STUDIES&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Significant heterogeneity between studies evaluating BsmI and ovarian cancer risk was observed, particularly in the African American subgroup by Grant et al., which contributed to the overall inconsistency."&lt;SEP&gt;"The heterogeneity observed across studies evaluating BsmI and ovarian cancer risk was likely influenced by population genetics factors affecting the variant's association."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BSMI (RS1544410)&quot;" target="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genetic data for BsmI was inconsistent with Hardy-Weinberg equilibrium in some control populations, indicating potential issues in genetic consistency."</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;BDNF GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genetic studies of BDNF polymorphisms comply with Hardy-Weinberg equilibrium principles, ensuring accurate assessment of allele frequencies."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;ALLELE FREQUENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Assessment of allele frequency in the context of HWE ensures accurate interpretation of genetic variation within populations studied for BDNF polymorphisms."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;" target="&quot;GENOMIC VARIANT &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Hardy-Weinberg equilibrium is used to evaluate whether genomic variant frequencies in a population are consistent with random mating, impacting genetic study reliability."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2 (RS11568820)&quot;" target="&quot;JAPANESE SUBGROUP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Japanese subgroup has been used to assess the association between Cdx-2 variant and ovarian cancer risk, showing deviation from Hardy-Weinberg equilibrium.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2 (RS11568820)&quot;" target="&quot;NECC SUBGROUP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The NECC subgroup also evaluated the impact of Cdx-2 variant on ovarian cancer risk, showing deviation from Hardy-Weinberg equilibrium.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAQI (RS731236)&quot;" target="&quot;NORTHERN SWEDEN SUBGROUP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This subgroup was used to study TaqI variant in relation to ovarian cancer risk and showed deviations from Hardy-Weinberg equilibrium.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS2228570&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The VDR gene harbors a SNP (rs2228570) that has been associated with both lower risk of T. cruzi infection and higher risk of developing Chagas cardiomyopathy."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS731236, RS7975232, RS1544410&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"These SNPs in the VDR gene did not show a significant association with T. cruzi infection or CCC development."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;RS2228570*A ALLELE FREQUENCY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs2228570 SNP, particularly its minor allele (A), shows an increased frequency in seronegative individuals compared to those with T. cruzi infection."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;VDR TAQI (RS731236)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The VDR TaqI (rs731236) polymorphism occurs within the VDR gene."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR GENE&quot;" target="&quot;DEGENERATIVE DISC DISEASE (A CONDITION OFTEN ASSOCIATED WITH HNP)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variants within the VDR gene are examined for their association with degenerative disc disease and possibly HNP."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228570&quot;" target="&quot;T. CRUZI INFECTION SUSCEPTIBILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The minor allele of the rs2228570 SNP was overrepresented in individuals seronegative for T. cruzi infection, suggesting a protective effect."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228570&quot;" target="&quot;CHAGAS CARDIOMYOPATHY (CCC)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The frequency of the rs2228570*A allele was lower in asymptomatic patients compared to those with CCC, indicating an increased risk for CCC development."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAGAS CARDIOMYOPATHY (CCC)&quot;" target="&quot;HAPLOTYPE ACC, GAT, AAC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant associations were found between these haplotypes and either T. cruzi infection or Chagas cardiomyopathy development."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228570*A ALLELE FREQUENCY&quot;" target="&quot;SERONEGATIVE INDIVIDUALS VS SEROPOSITIVE INDIVIDUALS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The minor allele of rs2228570 is overrepresented in seronegative individuals, indicating a protective effect against T. cruzi infection."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228570*A ALLELE FREQUENCY&quot;" target="&quot;ASYMPTOMATIC PATIENTS VS CCC PATIENTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The frequency of rs2228570*A allele is lower in asymptomatic patients compared to those with Chagas cardiomyopathy, suggesting a higher risk for the latter."</data>
      <data key="d6">chunk-6600322cc75094b1c57707e4b9c85954</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1A -889C&gt;T&quot;" target="&quot;HNP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The TT genotype of IL-1A -889C&gt;T was found to be 1.37 times more frequent in HNP patients than in controls, although overall genotypes and alleles showed no significant association with the risk of HNP."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1A -889C&gt;T&quot;" target="&quot;IL-1A GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The IL-1A -889C&gt;T variant occurs within the IL-1A gene."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-A 238G&gt;A&quot;" target="&quot;HNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CT genotype and T allele of TNF-A 238G&gt;A were more frequent in healthy controls than in HNP cases, but no significant association was found between the variant's alleles or genotypes and HNP risk."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-A 238G&gt;A&quot;" target="&quot;TNF-A GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TNF-A 238G&gt;A variant is located in the TNF-A gene."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDR TAQI (RS731236)&quot;" target="&quot;HNP&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No significant associations were observed between VDR TaqI variants and susceptibility to HNP, nor with degenerative disc disease."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1A GENE&quot;" target="&quot;HUMAN NERVE PAIN (HNP)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IL-1A gene variant is investigated for its potential association with Human Nerve Pain (HNP)."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-A GENE&quot;" target="&quot;HUMAN NERVE PAIN (HNP)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TNF-A gene variant is studied in relation to the risk of HNP."</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUT2 VARIANT (RS602662)&quot;" target="&quot;MATERNAL SERUM B12 LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This genomic variant explains part of the variation in maternal serum B12 levels observed in studies."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR SNP RS1801133&quot;" target="&quot;MATERNAL SERUM FOLATE LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Exclusion of the MTHFR variant attenuates the causal effect of maternal serum folate on birth weight, indicating its influence."&lt;SEP&gt;"This variant significantly influences the causal effect of maternal serum folate on birthweight when included in analyses, indicating its importance."</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MR EGGER RESULT&quot;" target="&quot;IVW ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MR Egger result provides information about potential bias or pleiotropy affecting the results of IVW analysis.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;LV&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The MTHFR C677T variant is significantly more common among LV patients compared to general population estimates, indicating a strong link between this genetic variant and the disease."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The MTHFR C677T variant is associated with an increased risk of cardiovascular disease due to elevated homocysteine levels."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR A1298C&quot;" target="&quot;LV&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Like its counterpart at position 677 of MTHFR gene, the A1298C variant also shows an increased carrier rate among LV patients, suggesting genetic predisposition to this condition."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;LV&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"This PAI-1 variant is observed at a very high carrier rate in LV patient populations, making it a key genetic marker for the disease."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;THROMBOSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The PAI-1 -675 4G/5G polymorphism increases the risk of thrombotic events due to its influence on fibrinolysis."&lt;SEP&gt;"The PAI-1 -675 4G/5G variant is associated with an increased risk of thrombotic disorders due to its effect on fibrinolysis."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 A844G&quot;" target="&quot;THROMBOSIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The PAI-1 A844G polymorphism may affect fibrinolysis and thus influences the risk of thrombosis."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;LV&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Prothrombin G20210A variant has one of the lowest carrier rates among LV patients, but is still notable in its association with the condition."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;THROMBOSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The Prothrombin G20210A mutation significantly increases the risk of venous thromboembolism and other thrombotic conditions."&lt;SEP&gt;"The Prothrombin G20210A variant is a well-known genetic risk factor for thrombotic disorders, particularly venous thromboembolism."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;LV&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Although less prevalent than other variants, Factor V G1691A shows an association with LV conditions, indicating a role in disease predisposition."</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;HYPERCOAGULABILITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The Factor V G1691A mutation leads to a hypercoagulable state and increases the risk for venous thromboembolism."&lt;SEP&gt;"The Factor V G1691A mutation leads to hypercoagulability and an increased risk for venous thromboembolism."</data>
      <data key="d6">chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THCY (TOTAL HOMOCYSTEINE)&quot;" target="&quot;MTHFR GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Homocysteine metabolism is regulated by MTHFR activity, impacting tHcy levels in the body."</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA FRAGMENTATION&quot;" target="&quot;MALE INFERTILITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"High levels of DNA fragmentation in sperm are strongly associated with reduced fertility, indicating a link between physiological damage to sperm cells and male infertility."</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MALE INFERTILITY&quot;" target="&quot;BODY MASS INDEX (BMI)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher BMI is associated with an increased risk of male infertility due to metabolic imbalances affecting reproductive health."</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTM1-NULL POLYMORPHISM&quot;" target="&quot;TMD DISEASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The GSTM1-null polymorphism, a deletion of the GSTM1 gene, was found statistically more frequent in TMD patients compared to control groups, suggesting an increased risk for disease."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1801394 A ALLELE&quot;" target="&quot;TMD DISEASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs1801394 genetic variant in MTRR gene leading to reduced enzyme affinity was observed statistically more frequent among TMD patients compared to controls, indicating potential involvement in disease susceptibility."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1801394 A ALLELE&quot;" target="&quot;METHIONINE SYNTHASE REDUCTASE (MTRR)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic variant rs1801394 in MTRR gene producing an enzyme with less substrate affinity was associated with increased disease risk among TMD patients compared to controls."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRD4-48BPTR POLYMORPHISM&quot;" target="&quot;TMD DISEASE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Statistical differences were found for DRD4-48bptr genotype frequencies between TMD and control groups, though no significant increase was observed for S-DRD4 allele in patient group."</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM FOLATE MEASUREMENT METHODS (CDC HPLC-MS/MS)&quot;" target="&quot;5-METHYLTHF (5-METHYLTETRAHYDROFOLATE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CDC HPLC-MS/MS method can specifically measure 5-methylTHF in serum samples.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LABORATORY PROCEDURES (MICROPLATE FORMAT)&quot;" target="&quot;SPECTROPHOTOMETRY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Spectrophotometric measurements are often performed using microplates for precise quantification of calibrators.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC REAGENTS&quot;" target="&quot;MICROORGANISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The use of microorganisms in conjunction with CDC reagents helps in achieving consistency and comparability across different testing environments and laboratories.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC REAGENTS&quot;" target="&quot;DAY 1 AND DAY 2 ANALYSIS RESULTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The use of CDC reagents in day-to-day analysis helps reduce variability between results obtained on different days.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IH REAGENTS&quot;" target="&quot;CDC MBA TARGET VALUE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Results obtained using IH reagents deviate from the CDC MBA target value, indicating a need for standardization with CDC reagents to ensure consistent results across different laboratories.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC MBA TARGET VALUE&quot;" target="&quot;LABORATORY #6 AND #9&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Laboratories #6 and #9 deviated significantly from the CDC MBA target value under harmonized conditions, indicating inconsistencies in measurements.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BREAST CANCER&quot;" target="&quot;G ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Carriers of allele G have a higher frequency in patient populations and are significantly associated with an increased risk of breast cancer."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BREAST CANCER&quot;" target="&quot;RS1138272 POLYMORPHISM&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"The rs1138272 polymorphism is not significantly associated with breast cancer risk based on the provided statistical analysis."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BREAST CANCER&quot;" target="&quot;AG GENOTYPE&quot;">
      <data key="d4">-0.5</data>
      <data key="d5">"While the AG genotype does not significantly increase breast cancer risk, it shows a non-significant trend indicating possible interaction under certain conditions."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BREAST CANCER&quot;" target="&quot;GG GENOTYPE (CASES)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GG genotype in case groups is associated with increased breast cancer risk according to statistical analysis results."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CT GENOTYPE&quot;" target="&quot;REWARD AND POSITIVE AFFECT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Individuals with the CT genotype report significantly greater reward and positive affect after drinking alcohol compared to those without this variant."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CT GENOTYPE&quot;" target="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Individuals with the CT (or CC) genotype who receive placebo report higher drinks per drinking day compared to those receiving olanzapine or having TT genotype."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CT GENOTYPE&quot;" target="&quot;RS2023239&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with the CT genotype have a specific genetic variant rs2023239 that influences their response to alcohol and medications."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T ALLELE&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A lower frequency of the T allele was noted in CRC patients compared to controls, though this did not reach statistical significance."</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILE105VAL SNP&quot;" target="&quot;GSTP1 PROTEIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Ile105Val SNP decreases the amyloid propensity of the GSTP1 protein, as shown by WALTZ analysis."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTP1 PROTEIN&quot;" target="&quot;TT GENOTYPE (CASES)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Homozygote TT genotype in cases affects the amyloid propensity of GSTP1 protein through Ile105Val SNP, as predicted by WALTZ algorithm."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE&quot;" target="&quot;CT GENOTYPE (CASES)&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"The CC genotype has higher frequencies compared to CT genotypes, both showing no significant association with breast cancer risk but indicating population variation."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE&quot;" target="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of a CC genotype was observed to be associated with an increased occurrence of colorectal cancer."</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WALTZ ALGORITHM&quot;" target="&quot;AMYLOID PROPENSITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The WALTZ algorithm predicts and evaluates changes in amyloid propensity due to specific mutations or polymorphisms like Ile105Val SNP in GSTP1 protein."</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;WD PATIENTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The p.R778L variant is one of three prevalent pathogenic variants among WD patients and contributes significantly to the disease."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;C.2333G &gt; T&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant c.2333G &gt; T corresponds to the pathogenic variant p.R778L."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;HAPLOGROUP A&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Haplogroup A is predominantly associated with the pathogenic variant p.R778L in WD patients."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;WD CHROMOSOMES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"WD chromosomes carry the p.R778L variant more frequently compared to control ones."</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.R778L&quot;" target="&quot;CONTROL ONES (CHROMOSOMES)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Control chromosomes show a much lower frequency of the haplogroup A carrying the p.R778L variant in comparison to WD chromosomes."</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;WD PATIENTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The p.P992L variant is a major contributor among WD patients, showing regional variations in allelic frequency."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;ZHEJIANG PROVINCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Patients in Zhejiang province have a lower allelic frequency of p.P992L than those from Jiangxi, indicating regional genetic variations."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;C.2975C &gt; T&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant c.2975C &gt; T is associated with the pathogenic variant p.P992L."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;HAPLOGROUP E (10-9-5)&quot;">
      <data key="d4">4.5</data>
      <data key="d5">"The pathogenic variant p.P992L is most commonly associated with haplogroup E in patients on WD chromosomes compared to controls.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;WD PATIENTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The p.T935M variant is less frequent but shows high aggregation in specific regions among WD patients."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;FUJIAN PROVINCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Patients from Fujian province exhibit a significantly higher allelic frequency of the p.T935M variant compared to other provinces."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;C.2804C &gt; T&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genomic variant c.2804C &gt; T represents the genetic change for the pathogenic variant p.T935M."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;HAPLOGROUP J (12-4-8; 12-5-8)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The pathogenic variant p.T935M is exclusively associated with haplogroup J among WD chromosomes.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;WD CHROMOSOMES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"WD chromosomes are exclusively associated with the uniform state presenting only one kind of haplogroup J for p.T935M."</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;CONTROL ONES (CHROMOSOMES)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Control chromosomes show a significantly lower frequency of haplogroup J carrying the p.T935M variant compared to WD chromosomes."</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;D13S314&quot;" target="&quot;P.R778L, P.P992L, AND P.T935M&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Microsatellite marker D13S314 exhibits significant linkage disequilibrium with the pathogenic variants p.R778L, p.P992L, and p.T935M."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;D13S301&quot;" target="&quot;P.R778L, P.P992L, P.T935M&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Marker D13S301 shows significant association with alleles linked to pathogenic variants p.R778L, p.P992L, and p.T935M."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;D13S316&quot;" target="&quot;P.R778L, P.P992L, P.T935M&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Microsatellite marker D13S316 demonstrates significant linkage distribution for alleles linked to pathogenic variants p.R778L, p.P992L, and p.T935M."</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOGROUP A&quot;" target="&quot;VARIANT A1 (10-7-7)&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"Variant A1 accounts for the largest proportion within haplogroup A, significantly more common on WD chromosomes compared to controls.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOGROUP E (10-9-5)&quot;" target="&quot;VARIANT E1 (10-9-5)&quot;">
      <data key="d4">3.75</data>
      <data key="d5">"The main variant within the common haplogroup for p.P992L on WD chromosomes.")</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOGROUP E (10-9-5)&quot;" target="&quot;WD CHROMOSOMES&quot;">
      <data key="d4">4.5</data>
      <data key="d5">"WD chromosomes are significantly more likely to carry haplogroup E compared to control ones."</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOGROUP E (10-9-5)&quot;" target="&quot;CONTROL ONES (CHROMOSOMES)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Control chromosomes show a much lower frequency of haplogroup E carrying the p.P992L variant in comparison to WD chromosomes."</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WARFARIN DOSING ALGORITHM &quot;" target="&quot;DVT/PE &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The algorithm may be used for patients starting warfarin therapy due to Deep Vein Thrombosis or Pulmonary Embolism (59.7% of cases)."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;" target="&quot;WAA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"There is an inverse correlation between percent WAA and predicted dose within the 20% therapeutic range for IWPC pharmacogenomics algorithm, indicating it performs poorly with varying levels of African ancestry among patients.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM&quot;" target="&quot;WAA&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Our novel AA algorithm does not show an association between percent WAA and predicted dose because it incorporates population-specific variables, providing better performance across different levels of African ancestry.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAA (WHOLE AFRICAN ANCESTRY)&quot;" target="&quot;LINEAR REGRESSION ANALYSIS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Linear regression analysis revealed an inverse correlation between WAA and predicted doses within the therapeutic range for high-dose patients.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREDICTED DOSE&quot;" target="&quot;OBSERVED DOSE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Predicted doses are compared with observed doses to evaluate algorithm accuracy and precision.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THERAPEUTIC DOSE RANGE&quot;" target="&quot;NNG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The NNG is calculated based on the need to prevent a dose from falling outside of the therapeutic range, indicating clinical benefit.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2C9 STAR VARIANT GROUP &quot;" target="&quot;RS1057910 &quot;">
      <data key="d4">1.0</data>
      <data key="d5">"rs1057910 is part of the combined CYP2C9 star variant group due to its low frequency and impact on enzyme activity."</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP27B1 AND CYP24A1 SNPS&quot;" target="&quot;ADVANCED ADENOMA RECURRENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNPs in both the CYP27B1 and CYP24A1 genes are implicated in advanced adenoma recurrence, suggesting a genetic basis for more severe disease outcomes."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP27B1 AND CYP24A1 SNPS&quot;" target="&quot;LARGER OR VILLOUS ADENOMA RECURRENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Specific genotypes in both CYP27B1 and CYP24A1 genes are linked to larger or villous adenomas upon follow-up, indicating a genetic predisposition for more severe outcomes."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D METABOLITES&quot;" target="&quot;ADENOMA RECURRENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The interaction between vitamin D metabolite concentrations and certain SNPs (such as CYP24A1 rs2296241) affects the risk of adenoma recurrence, highlighting a metabolic pathway's role in disease."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D METABOLITES&quot;" target="&quot;CYP27B1 SNP RS2762939&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Interactions between this SNP and 1,25(OH)2D levels affect the risk of adenoma recurrence, showing a complex interplay between genetic and environmental factors."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVANCED ADENOMA RECURRENCE&quot;" target="&quot;VITAMIN D DEFICIENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals deficient in vitamin D have an increased risk for advanced adenomas when carrying specific genetic variants, indicating the combined effect of environmental and genetic factors on disease progression."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VILLOUS HISTOLOGY&quot;" target="&quot;CYP24A1 SNPS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The number of G alleles in CYP24A1 rs2296241 correlates with higher odds for recurrent adenomas with villous histology, suggesting a genetic influence on this feature."</data>
      <data key="d6">chunk-2fb95100a1290b27baae869c6560419a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1 GENE&quot;" target="&quot;C.1186C &gt; T VARIANT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The c.1186C &gt; T variant in CYP24A1 represents a nucleotide substitution that impacts the genotyping results and analysis."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1 GENE&quot;" target="&quot;IIH (IDIOPATHIC INFANTILE HYPERCALCEMIA)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CYP24A1 gene is associated with IIH, where specific genetic variants can influence the disease risk."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP24A1 GENE&quot;" target="&quot;WILD-TYPE (WT)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The wild-type status refers to a CYP24A1 gene without any known variants, used as a control in studies."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.428_430DELAAG VARIANT&quot;" target="&quot;RS777676129 AMPLICON&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs777676129 amplicon is used to detect the c.428_430delAAG variant in HRMA analysis."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.428_430DELAAG VARIANT&quot;" target="&quot;COMPOUND HETEROZYGOUS SAMPLE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A compound heterozygous sample can carry the c.428_430delAAG variant along with another variant in CYP24A1, affecting its genotype."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.428_430DELAAG VARIANT&quot;" target="&quot;MELTING CURVE ANALYSIS (TM)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Tm analysis for the c.428_430delAAG variant reveals specific melting temperatures, allowing differentiation from wild-type samples."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186C &gt; T VARIANT&quot;" target="&quot;RS114368325 AMPLICON&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs114368325 amplicon is used to detect the c.1186C &gt; T variant in HRMA analysis."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186C &gt; T VARIANT&quot;" target="&quot;COMPOUND HETEROZYGOUS SAMPLE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The compound heterozygous sample can also carry the c.1186C &gt; T variant in addition to another variant, influencing its genotype."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1186C &gt; T VARIANT&quot;" target="&quot;MELTING CURVE ANALYSIS (TM)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Tm analysis for the c.1186C &gt; T variant also reveals specific melting temperatures, aiding in genotyping differentiation."</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P1001L MUTATION&quot;" target="&quot;MENKES DISEASE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The P1001L mutation is causative for Menkes disease when present in an individual."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MENKES DISEASE&quot;" target="&quot;COPPER TRANSPORT AND HOMEOSTASIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Disruption of copper transport and homeostasis, due to mutations in the ATP7A gene, leads to Menkes disease."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BRAIN MRI&quot;" target="&quot;ATROPHY AND DELAYED MYELINATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A brain MRI can detect signs of atrophy and delayed myelination in neurological conditions like Menkes disease."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;" target="&quot;NERVOUS SYSTEM FUNCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The median nerve compound motor action potentials test evaluates the function of the nervous system in conducting motor signals."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;" target="&quot;NEUROLOGICAL DISORDERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Conduction velocity measurements help diagnose neurological disorders by assessing nerve health and integrity."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CEREBROSPINAL FLUID (CSF)&quot;" target="&quot;MENKES DISEASE DIAGNOSTIC MARKERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CSF contains biochemical markers that are critical for diagnosing Menkes disease, including copper levels and catecholamine ratios."</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACO-2 CELLS&quot;" target="&quot;ROS LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Measuring ROS levels is crucial for understanding the impact of different genetic variants on cell viability and oxidative stress response in Caco-2 cells."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEIODINASE GENE (IDI)&quot;" target="&quot;GPX4 3′UTR VARIANT (T/C)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant in GPX4 3′ UTR affects the expression of IDI gene transcripts, indicating differential effects on cellular function."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDI-T TRANSCRIPT&quot;" target="&quot;GPX4 PROTEIN&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Expression levels of IDI-T transcript correlate with GPx4 protein content under certain conditions (e.g., selenium supply)."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENIUM (SE)&quot;" target="&quot;GPX4 PROTEIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The level of selenium affects the expression and function of GPX4 protein in cells."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TERT-BUTYLHYDROPEROXIDE (T-BHP)&quot;" target="&quot;ROS LEVELS&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Exposure to t-BHP leads to increased ROS levels in both IDI-C and IDI-T cells, with a greater increase observed in IDI-C cells under low Se conditions."&lt;SEP&gt;"Exposure to tert-butylhydroperoxide increases reactive oxygen species levels as a measure of oxidative stress induced by the compound."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TERT-BUTYLHYDROPEROXIDE (T-BHP)&quot;" target="&quot;OXIDATIVE CHALLENGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Cells are challenged using tert-butylhydroperoxide to induce oxidative stress, impacting ROS production and cell viability."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX4 PROTEIN&quot;" target="&quot;THIOREDOXIN REDUCTASE 1 (TR1)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Both GPX4 and TR1 are selenoproteins involved in redox homeostasis, but their expression levels can be affected differently by selenium supply or oxidative stress."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ROS LEVELS&quot;" target="&quot;TERT-BUTYLHYDROPEROXIDE CHALLENGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Cells exposed to tert-butylhydroperoxide exhibit increased ROS levels, reflecting their response to oxidative stress."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ROS LEVELS&quot;" target="&quot;GPX ACTIVITY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Increased ROS levels correlate with changes in GPx activity, indicating a relationship between cellular antioxidant capacity and oxidative stress management."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENOPROTEIN H MRNA&quot;" target="&quot;IDI-C CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The level of Selenoprotein H mRNA is significantly lower in IDI-C cells compared to IDI-T cells, regardless of Se supply status."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL VIABILITY&quot;" target="&quot;SE (SELENIUM)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Selenium influences cell viability under oxidative stress conditions by modulating the expression and activity of selenoproteins such as GPx4."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENOPROTEIN H PROTEIN&quot;" target="&quot;SELENOPROTEIN H MRNA LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The protein content of selenoprotein H correlates with its mRNA expression levels under different selenium conditions."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENOPROTEIN H PROTEIN&quot;" target="&quot;SE-SUPPLEMENTED MEDIUM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Under conditions of sufficient selenium supply, the expression levels of selenoprotein H protein in cells are maintained or enhanced."</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TR1, GPX1 AND GPX4 MRNAS&quot;" target="&quot;IDI-C CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The mRNA levels of TR1, GPx1, and GPx4 are similar between IDI-C cells grown in Se-depleted or supplemented medium but vary in relation to selenoprotein H expression."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDI-C CELLS&quot;" target="&quot;IDI-T CELLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"IDI-C cells show differential responses to oxidative stress compared to IDI-T cells when grown in different Se concentrations."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX ACTIVITY&quot;" target="&quot;IDI TRANSCRIPT LEVELS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Cells expressing similar IDI transcript levels show marked differences in GPx activity, suggesting that transgene expression impacts endogenous GPx function."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INOSITOL DEMETHYLASE (IDI)&quot;" target="&quot;GLUTATHIONE PEROXIDASES (GPX1, GPX4)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Overexpression of IDI affects the regulation and expression levels of glutathione peroxidases like GPx1 and GPx4 in response to oxidative stress."</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAT GENE&quot;" target="&quot;P.VAL136MET MUTATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The p.Val136Met mutation affects the CHAT gene's protein expression level, contributing to its role in neurotransmitter synthesis."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.ALA557THR MUTATION&quot;" target="&quot;S-TYPE TRANSCRIPT OF CHAT GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"This mutation alters the expression of the S-type transcript, affecting the production and activity of ChAT proteins."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;S-TYPE TRANSCRIPT OF CHAT GENE&quot;" target="&quot;BOSC 23 CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Bosc 23 cells are used to express the S-type transcript, aiding in the study of alternative start sites and protein isoforms."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE ACETYLTRANSFERASE PROTEIN (CHAT)&quot;" target="&quot;NONSENSE MUTATION ON SECOND ALLELE (P.ALA557THR)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The nonsense mutation affects ChAT's functionality by altering its kinetic parameters and thermal stability."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THERMAL STABILITY OF CHAT MUTANT PROTEINS&quot;" target="&quot;MISSENSE MUTATIONS IN CHAT GENE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Mutations in the CHAT gene influence the thermal stability of ChAT proteins, impacting their function at higher temperatures."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MISSENSE MUTATIONS IN CHAT GENE&quot;" target="&quot;HISTIDINE-TAGGED CHAT CDNA EXPRESSION IN E. COLI &quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Expression and purification studies using histidine-tagged CHAT cDNAs reveal the effects of missense mutations on ChAT's kinetic properties."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MISSENSE MUTATIONS IN CHAT GENE&quot;" target="&quot;KINETIC PROPERTIES OF WILD-TYPE AND MUTANT CHAT PROTEINS &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mutations alter kinetic properties, impacting enzyme efficiency and substrate affinity for catalyzing acetylcholine synthesis."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFS7 GENE&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Methylation patterns at CpGs within the NDUFS7 gene are associated with indicators of oxidative stress, suggesting a role in energy metabolism under oxidative conditions."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EIF3J GENE&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The EIF3J gene exhibits methylation site associations with oxidative stress markers like TGSH and GSSG/GSH ratio indicating its involvement in translation initiation regulation during oxidative stress."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZNF761 GENE&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Methylation patterns at ZNF761 promoter region show significant association with GSSG/GSH ratio, an indicator of cellular redox status under oxidative conditions."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSMG3 GENE&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The PSMG3 gene's promoter methylation is correlated with the GSSG/GSH ratio indicating its role in regulating proteasome activity during oxidative stress response."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENTHD1 GENE&quot;" target="&quot;HOMOCYSTEINE LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Methylation patterns at CpGs within ENTHD1 gene are associated with homocysteine levels, a marker of oxidative stress and cardiovascular risk."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LRIG1 GENE&quot;" target="&quot;SIGNAL TRANSDUCTION DYSREGULATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The LRIG1 gene's methylation sites correlate with homocysteine levels indicating its role in signal transduction dysregulation during oxidative stress conditions."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RIPK3 GENE&quot;" target="&quot;HOMOCYSTEINE LEVELS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Methylation patterns at RIPK3 gene CpG sites are associated with HCY levels suggesting a link between methylation and regulation of signal transduction pathways under oxidative stress."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ATP2B4 GENE&quot;" target="&quot;SIGNAL TRANSDUCTION DYSREGULATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The ATP2B4 gene's methylation patterns correlate with homocysteine levels indicating its role in calcium signaling during oxidative conditions."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEMA6A GENE&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"DNA methylation at SEMA6A 5'-UTR is associated with oxidized LDL, an indicator of lipid peroxidation and oxidative stress, suggesting its role in anti-angiogenic function under these conditions."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAPBP GENE&quot;" target="&quot;OXIDATIVE STRESS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The TAPBP gene's methylation level at 3'-UTR is associated with CD marker levels indicating potential involvement of tapasin in immune response regulation during oxidative stress."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKAP5 GENE&quot;" target="&quot;LIPID PEROXIDATION PRODUCTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Methylation patterns at CKAP5 gene CpGs are correlated with BCD-LDL, a marker of lipid peroxidation products and oxidative stress state, suggesting its role in cellular cytoskeletal organization under these conditions."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOSL2 GENE&quot;" target="&quot;INFLAMMATORY RESPONSE REGULATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The FOSL2 gene's methylation patterns are associated with BCD-LDL levels indicating potential involvement of AP-1 transcription factors in inflammatory response regulation during oxidative stress."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRMD6 GENE&quot;" target="&quot;OXIDATIVE STRESS RESPONSE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"DNA methylation patterns at FRMD6 CpG sites show significant association with BCD-LDL, a marker of lipid peroxidation and oxidative stress, indicating its role in cellular functions under these conditions."</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXIDATIVE STRESS&quot;" target="&quot;CPGS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"DNA methylation at CpG sites is associated with oxidative stress markers, indicating a role in oxidative stress regulation."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPGS&quot;" target="&quot;REGULOMEDB SCORE 1A-2C&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"High RegulomeDB scores indicate strong evidence that CpG sites are located within functional regulatory elements, influencing gene regulation."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROMOTER REGION&quot;" target="&quot;TRANSCRIPTION FACTOR (TF)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The promoter region of genes can be regulated by transcription factors to influence gene expression under conditions such as oxidative stress."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROMOTER REGION&quot;" target="&quot;CPG ISLAND SHORES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CpG island shores are often in close proximity to promoter regions and can influence their methylation status, affecting gene expression."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHOSPHORYLATION&quot;" target="&quot;DNA METHYLATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Phosphorylation events can influence DNA methylation patterns, thereby affecting the regulation of cellular processes including those related to oxidative stress."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHOSPHORYLATION&quot;" target="&quot;DAVID FUNCTIONAL ANNOTATION CLUSTERING TOOL&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The DAVID tool can be used to cluster genes involved in phosphorylation processes, identifying pathways and biological functions related to cellular regulation."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION&quot;" target="&quot;MEQTL (METHYLATION QUANTITATIVE TRAIT LOCI)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Genetic variants identified as meQTLs influence DNA methylation levels at specific CpG sites, affecting gene expression patterns in diseases like CHD and T2D."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION&quot;" target="&quot;CTCF BINDING SITE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased DNA methylation inhibits CTCF binding at insulator sites in the promoter region of LOC100507600, affecting gene expression.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION&quot;" target="&quot;LCT INTRONIC REGION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Deletion of intronic regions using CRISPR-Cas9 technology affects Lct mRNA levels and demonstrates the importance of DNA methylation in regulation.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION&quot;" target="&quot;ENHANCER-PROMOTER INTERACTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Increased methylation facilitates enhancer-promoter interactions, impacting gene regulation mechanisms.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHD (CORONARY HEART DISEASE)&quot;" target="&quot;BCL2L11 GENE/PROTEIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The BCL2L11 gene/protein is associated with coronary heart disease through its role in apoptosis and regulation of cardiovascular health."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHD (CORONARY HEART DISEASE)&quot;" target="&quot;ATHEROSCLEROSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Atherosclerosis is a major contributing factor to the development of coronary heart disease through plaque buildup in arteries."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHD (CORONARY HEART DISEASE)&quot;" target="&quot;CARDIOGRAM CONSORTIUM&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The CARDIoGRAM consortium conducts genome-wide association studies to identify genetic risk factors for coronary heart disease."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D (TYPE 2 DIABETES MELLITUS)&quot;" target="&quot;DIAGRAM CONSORTIUM&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The DIAGRAM consortium focuses on GWAS studies for type 2 diabetes mellitus, identifying genetic variants associated with the disease."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;E2F1 TRANSCRIPTION FACTOR BINDING SITES&quot;" target="&quot;ATHEROSCLEROSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Transcription factor binding sites for E2F1 are enriched among genes involved in atherosclerosis pathways."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;E2F1 TRANSCRIPTION FACTOR BINDING SITES&quot;" target="&quot;JASPAR DATABASE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The JASPAR database is used to identify and analyze binding sites for transcription factors such as E2F1 in genes related to diseases like atherosclerosis."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS6750142 (PROXY OF RS726430)&quot;" target="&quot;CHD AND T2D&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The proxy SNP rs6750142 is nominally associated with CHD and T2D in GWAS studies, indicating potential genetic overlap between these diseases."</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPB1&quot;" target="&quot;OXIDATIVE STRESS CPGS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Methylation level at CPB1's CpG site is studied in relation to oxidative stress-associated diseases."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIST1H4D 3'-UTR METHYLATION&quot;" target="&quot;HISTONE CLUSTER 1 H4D (HIST1H4D)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Methylation changes in the 3' UTR of HIST1H4D are directly linked to Type 2 Diabetes risk, highlighting gene-specific epigenetic regulation."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZNF341 CPG CG11842944&quot;" target="&quot;HEART FAILURE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Methylation at ZNF341's CpG site is most predictive for heart failure, indicating its role in cardiovascular disease risk."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZNF341 CPG CG11842944&quot;" target="&quot;ISCHAEMIC STROKE, MYOCARDIAL INFARCTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Methylation levels at ZNF341's cg11842944 site influence risks for cardiovascular events like myocardial infarction and ischaemic stroke."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHR. 4 INTERGENIC SNPS&quot;" target="&quot;T2D, CVD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Multiple intergenic SNPs on chromosome 4 associated with methylation levels in disease contexts suggest a genetic basis for health outcomes."</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ATP6 GENE&quot;" target="&quot;8993T&gt;G VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MT-ATP6 gene contains an 8993T&gt;G variant that is responsible for Leigh syndrome in 10–20% of cases."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ATP6 GENE&quot;" target="&quot;LEIGH SYNDROME&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mutations within the MT-ATP6 gene, like the 8993T&gt;G mutation, are a causative factor for Leigh syndrome."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ATP6 GENE&quot;" target="&quot;COMPLEX V (ATP SYNTHASE)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ATP synthase subunit encoded by MT-ATP6 is part of complex V in the electron transport chain that synthesizes ATP."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;8993T&gt;G VARIANT&quot;" target="&quot;NEXT-GENERATION EXOME SEQUENCING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The next-generation exome sequencing technique detected the 8993T&gt;G variant within the MT-ATP6 gene."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEIGH SYNDROME&quot;" target="&quot;COMPLEX V (ATP SYNTHASE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Deficient activity of complex V in the electron transport chain due to mutations such as 8993T&gt;G leads to Leigh syndrome."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFV1 GENE&quot;" target="&quot;C.736G&gt;A, P.GLU246LYS VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The NDUFV1 gene harbors a variant c.736G&gt;A, p.Glu246Lys that is predicted to be damaging and associated with mitochondrial disease."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFV1 GENE&quot;" target="&quot;C.349G&gt;A, P.ALA117THR VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The NDUFV1 gene also includes a variant c.349G&gt;A, p.Ala117Thr that is highly conserved and linked to mitochondrial disease."</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COQ2 GENE&quot;" target="&quot;C.1159C&gt;T (ARG387X)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The COQ2 gene has another variant that results in premature termination of the protein at position 387, potentially leading to coenzyme Q10 deficiency."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.437G&gt;A (SER146ASN)&quot;" target="&quot;COENZYME Q10 DEFICIENCY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The c.437G&gt;A variant in the COQ2 gene is associated with coenzyme Q10 deficiency, a condition characterized by neurological symptoms and muscle weakness."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ND1 GENE&quot;" target="&quot;3754C&gt;A (MT-ND1)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The MT-ND1 gene contains a novel heteroplasmic variant that may contribute to mitochondrial complex I dysfunction or related disorders."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MT-ND1 GENE&quot;" target="&quot;ELECTRON TRANSPORT CHAIN COMPLEX I (NADH DEHYDROGENASE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MT-ND1 gene encodes for subunits of complex I which is vital to the electron transport chain function."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COQ2 HOMOLOG PRENYLTRANSFERASE PROTEIN&quot;" target="&quot;COENZYME Q10 DEFICIENCY PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Protein encoded by the COQ2 gene functions in coenzyme Q10 biosynthesis, a pathway deficient in certain disease states."</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE SUBJECTIVE RESPONSE &quot;" target="&quot;SUBSEQUENT ALCOHOL EFFECTS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The baseline subjective response influenced how participants subsequently experienced sedation, stimulation, and craving during alcohol intake.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FISHER'S EXACT TEST &quot;" target="&quot;GENOTYPE-DRUG INTERACTION &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This test was used to determine the significance of genotype-drug interactions in causing side effects such as drowsiness and ringing in ears.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SAFTTEE CHECKLIST &quot;" target="&quot;NALTREXONE &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Naltrexone was evaluated using the SAFTTEE checklist to identify adverse effects during alcohol infusion studies.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASN40 HOMOZYGOTES&quot;" target="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The ALDH2 genotype affects alcohol consumption, with Asn40 homozygotes consuming more drinks compared to other genotypes."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;LATENCY TO FIRST DRINK&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"ALDH2 genotype significantly influences the latency to first drink, especially in Asn40 homozygotes."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;NICOTINE SMOKING STATUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Smoking status was associated with marginally shorter latency to drink, but did not significantly moderate the effects of genotype or medication."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;NALTREXONE MEAN DRINKS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The effect of naltrexone on alcohol consumption varies based on the individual's ALDH2 genotype."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;PLACEBO MEAN DRINKS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The mean drinks under placebo conditions are influenced by the ALDH2 genotype of individuals."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NALTREXONE MEAN DRINKS&quot;" target="&quot;PLACEBO MEAN DRINKS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The mean drinks under naltrexone treatment and placebo conditions are compared to evaluate the effect of medication on alcohol consumption."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKERS MEAN DRINKS&quot;" target="&quot;NON-SMOKERS MEAN DRINKS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Comparing smokers' and non-smokers' drink means helps assess how smoking status influences alcohol self-administration."</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL DRINKING BEHAVIOR &quot;" target="&quot;RS671 ALDH2 VARIANT &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Controlling for the rs671 variant in ALDH2 helps refine analyses related to alcohol drinking behaviors and their genetic underpinnings.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DROWSINESS &quot;" target="&quot;NALTREXONE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The use of naltrexone medication resulted in significantly higher incidence of drowsiness compared to placebo, indicating a drug effect on this side effect.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL-INDUCED SEDATION &quot;" target="&quot;RS1229984 ADH1B VARIANT &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This genetic variant is associated with alcohol-induced sedation responses in the presence of rising blood alcohol concentration (BrAC).")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 RS671 GENOTYPE&quot;" target="&quot;ALDH2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ALDH2 gene includes the rs671 polymorphism, influencing alcohol metabolism and related physiological processes."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 RS671 GENOTYPE&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variations in the ALDH2 rs671 genotype affect cortisol levels through their influence on alcohol consumption and metabolic processes."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 RS671 GENOTYPE&quot;" target="&quot;AGE DISTRIBUTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The distribution of age among individuals with different ALDH2 genotypes varies significantly, reflecting differences in lifestyle factors like alcohol consumption."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAILY ALCOHOL CONSUMPTION&quot;" target="&quot;BLOOD CORTISOL LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher daily alcohol consumption is positively associated with increased blood cortisol levels in both men and women, after adjusting for other factors."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAILY ALCOHOL CONSUMPTION&quot;" target="&quot;ALDH2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Alcohol consumption is regulated by genetic factors such as variants in the ALDH2 gene, affecting overall health outcomes."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOOD CORTISOL LEVEL&quot;" target="&quot;GENETICALLY PREDICTED ALCOHOL CONSUMPTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In men, genetically predicted daily alcohol consumption positively associates with blood cortisol levels; however, this relationship was not observed in women."</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCG2&quot;" target="&quot;RS2231142 ABCG2&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The rs2231142 variant of the ABCG2 gene significantly affects sUA levels and increases HUA risk."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCG2&quot;" target="&quot;HYPERURICEMIA (HUA)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Variants in the ABCG2 gene are associated with increased risk and severity of HUA."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC2A9&quot;" target="&quot;RS3733591 SLC2A9&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs3733591 variant in SLC2A9 is associated with increased sUA levels and HUA, particularly in females."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC2A9&quot;" target="&quot;HYPERURICEMIA (HUA)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The SLC2A9 gene variant increases the likelihood and severity of HUA, especially among females."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC2A9&quot;" target="&quot;GENDER DIFFERENCE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The risk allele in SLC2A9 is more significantly linked to HUA and sUA levels in females compared to males."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC22A12&quot;" target="&quot;RS893006 SLC22A12&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The rs893006 variant of SLC22A12 affects sUA levels but does not significantly influence HUA risk."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3733591 SLC2A9&quot;" target="&quot;URIC ACID METABOLISM&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This genomic variant affects uric acid metabolism and levels in the body."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2231142 ABCG2&quot;" target="&quot;URIC ACID METABOLISM&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The rs2231142 variant impacts the metabolic pathway of uric acid, affecting its concentration in blood."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;SERUM CREATININE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher serum creatinine levels are associated with an increased risk of HUA."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;TRIGLYCERIDES (TG)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Elevated triglyceride levels correlate with a higher incidence of hyperuricemia."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;LOW-DENSITY LIPOPROTEIN (LDL)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Increased LDL cholesterol is linked to elevated uric acid and HUA risk."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;HIGH-DENSITY LIPOPROTEIN (HDL)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Lower HDL levels are associated with increased likelihood of hyperuricemia."</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;SUA LEVEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"High levels of serum uric acid are indicative of a higher risk for developing hyperuricemia."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;SERUM URIC ACID (SUA)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High levels of serum uric acid are strongly associated with the risk of developing hyperuricemia."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;RS2231142 T ALLELE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Carrying the rs2231142 T allele increases the risk for hyperuricemia, indicating a genetic influence on disease susceptibility."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICEMIA (HUA)&quot;" target="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Certain cardiovascular risk factors do not influence the association between sUA and hyperuricemia risk among individuals with specific genetic markers."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC2A9 RS3733951&quot;" target="&quot;HYPERURICAEMIA RISK (HUA)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The C allele of SLC2A9 rs3733951 is associated with an increased risk of hyperuricaemia (HUA) due to its influence on serum uric acid levels."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCG2 RS2231142&quot;" target="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The T allele of ABCG2 rs2231142 increases the risk of hyperuricaemia (HUA) when accounting for cardiovascular risks such as obesity, hypertension, higher TG levels and LDL levels, lower HDL levels."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCG2 RS2231142&quot;" target="&quot;SUA LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The T allele in ABCG2 rs2231142 is associated with higher sUA levels, especially among individuals with cardiovascular risk factors such as obesity and high TG."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR RISK FACTORS&quot;" target="&quot;HYPERURICAEMIA RISK (HUA)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Individuals with cardiovascular risk factors have a significantly increased OR of HUA associated with the T allele in ABCG2 rs2231142 compared to those without such risks."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR RISK FACTORS&quot;" target="&quot;T ALLELE OF ABCG2 RS2231142&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of a T allele in ABCG2 rs2231142 increases hyperuricaemia risk significantly when individuals are under cardiovascular risk factors such as obesity and hypertension."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICAEMIA RISK (HUA)&quot;" target="&quot;SUA LEVELS INCREASE WITH RISK ALLELES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"An increase in serum uric acid levels correlates directly with the number of specific genetic risk alleles, thereby increasing hyperuricaemia risk across different populations."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERURICAEMIA RISK (HUA)&quot;" target="&quot;TG LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Higher triglyceride (TG) levels significantly increase hyperuricaemia risk in both males and females carrying T alleles of the ABCG2 rs2231142 variant."</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM URIC ACID (SUA)&quot;" target="&quot;RS2231142 T ALLELE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Carrying the rs2231142 T allele is linked to higher serum uric acid levels, which may exacerbate HUA risk."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2231142 T ALLELE CARRIERS&quot;" target="&quot;SUA LEVEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The level of serum uric acid is influenced by carrying the rs2231142 T allele, affecting the risk of hyperuricemia in carriers."</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LRP2 GENE&quot;" target="&quot;RS57989581&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The LRP2 gene contains a genomic variant (rs57989581) that is significantly associated with eGFR levels, indicating its role in kidney function regulation."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 GENE&quot;" target="&quot;RS8096658&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The NFATC1 gene harbors a significant variant (rs8096658) that influences eGFR levels across diverse ethnic groups, highlighting its importance in kidney health."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 GENE&quot;" target="&quot;CKD DEVELOPMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The NFATC1 gene plays a role in regulating kidney function, with its variants contributing to the risk of developing chronic kidney disease."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNCX GENE&quot;" target="&quot;RS62435145&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The UNCX gene is associated with a specific variant (rs62435145), which impacts eGFR and increases the risk of CKD, particularly in diabetic populations."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNCX GENE&quot;" target="&quot;T2D AND T1D DIABETES TYPES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The UNCX gene locus is associated with eGFR levels in both Type 2 and Type 1 diabetic patients, influencing their risk for CKD development."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALMS1 GENE&quot;" target="&quot;RS7587577&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The ALMS1 gene contains a variant (rs7587577) that is linked to reduced eGFR and heightened CKD risk, indicating its role in kidney function regulation."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALMS1 GENE&quot;" target="&quot;CKD DEVELOPMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ALMS1 gene influences kidney function through its association with reduced eGFR levels, thereby increasing the risk of chronic kidney disease."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PDILT-UMOD LOCUS&quot;" target="&quot;RS77924615&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The PDILT-UMOD locus harbors a key variant (rs77924615) that strongly influences eGFR and CKD risk, particularly in diabetic individuals."&lt;SEP&gt;"The variant rs77924615 within the PDILT gene is part of a credible set identified through fine mapping, indicating its strong role in kidney function regulation at this locus."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKD DEVELOPMENT&quot;" target="&quot;T2D AND T1D DIABETES TYPES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Both Type 2 diabetes and Type 1 diabetes are associated with higher risks of developing chronic kidney disease due to reduced eGFR levels influenced by genetic variants at specific loci."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS77924615&quot;" target="&quot;PRKAG2 GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The PRKAG2 gene locus shows association with eGFR levels influenced by the variant rs77924615, highlighting its importance in regulating kidney function in diabetes patients."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS77924615&quot;" target="&quot;MANTRA ALGORITHM&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The MANTRA algorithm identified precise localization of the PDILT-UMOD locus variant (rs77924615), demonstrating its utility in fine-mapping kidney function-associated loci."</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1&quot;" target="&quot;HIGH-SALT DIET&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"NFATC1 renal mRNA expression is significantly decreased after a 2-week exposure to high-salt diet, indicating its involvement in kidney function under stress conditions.")</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1&quot;" target="&quot;CHRONIC KIDNEY DISEASE (CKD)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Renal mRNA expression of NFATC1 trends downward in chronic kidney disease models, indicating potential involvement in disease progression or response to injury.")</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KIDNEY DHSS&quot;" target="&quot;GENE REGULATION KIDNEY FUNCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Dynamic regions in kidney cells where DNA is exposed can influence gene regulation relevant to kidney function."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HDAC8 BINDING SITES&quot;" target="&quot;HISTONE DEACETYLASES (HDACS)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Binding sites on the genome for HDAC8 transcription factors, playing a role in kidney function through chromatin modification."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTONE DEACETYLASES (HDACS)&quot;" target="&quot;GCKR P.PRO446LEU (RS1260326)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The variant impacts the role of HDAC8 in chromatin modification, affecting gene regulation and expression."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SALT SENSITIVITY&quot;" target="&quot;REGULATOR OF G PROTEIN SIGNALING FAMILY (RGS14)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Reduced expression or loss-of-function variants in RGS14 orthologs in Drosophila are associated with improved salt sensitivity and stress resistance."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INCREASED SALT SENSITIVITY&quot;" target="&quot;NFATC1 LOSS-OF-FUNCTION VARIANTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Loss of NFATC1 function results in increased salt sensitivity in Drosophila, suggesting its role in ionic or osmotic regulation."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)&quot;" target="&quot;DYNAMIC REGIONS KIDNEY GENES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Cells involved in gene regulation through DHSs, impacting kidney-specific genetic variants and their effects on eGFR."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RENAL CORTICAL EPITHELIAL CELLS (HRCES)&quot;" target="&quot;DHS ANNOTATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These cells show significant posterior probability for DHS annotations linked to kidney-specific variants affecting gene regulation."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGS14&quot;" target="&quot;REGULATOR OF G PROTEIN SIGNALING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Encodes a member of RGS family modulating downstream effects of Gα subunits with unknown function in kidneys."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGS14&quot;" target="&quot;HIGH-SALT DIET&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"RGS14 renal mRNA expression is markedly reduced after high salt diet exposure, suggesting its role in kidney dysfunction induced by environmental factors such as dietary changes.")</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGS14&quot;" target="&quot;CHRONIC KIDNEY DISEASE (CKD)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Reduced RGS14 mRNA levels are observed during CKD induced by sub-total nephrectomy, suggesting its role in kidney pathology and function regulation.")</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOCOEY-P283/+&quot;" target="&quot;NACL SUPPLEMENTATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genomic variant of the loco gene shows improved survival rate when supplemented with sodium chloride compared to controls.")</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Y1W1&quot;" target="&quot;NACL SUPPLEMENTATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Isogenic background y1w1 does not show significant changes in viability under non-supplemented food conditions but serves as a control in high NaCl experiments.")</data>
      <data key="d6">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE RISK CKD&quot;" target="&quot;GCKR P.PRO446LEU (RS1260326)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The missense variant of GCKR impacts triglyceride and cholesterol synthesis, linking to risk factors for chronic kidney disease."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1 LOCUS DHSS&quot;" target="&quot;RS8096658 (ΠC = 0.877)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This variant overlaps dynamic regions in fetal kidney cells of NFATC1 locus, influencing gene expression."</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAMPYLOBACTER INFECTION&quot;" target="&quot;FLUOROQUINOLONES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Fluoroquinolones are used to treat campylobacter infections, although resistance may limit their effectiveness in certain cases."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE-RESISTANT CAMPYLOBACTER ISOLATES&quot;" target="&quot;SOUTHERN EUROPE AND SOUTHEAST ASIA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Traveling to southern Europe or Southeast Asia is significantly associated with a higher risk of acquiring quinolone-resistant Campylobacter infections."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERYTHROMYCIN-RESISTANT ISOLATES&quot;" target="&quot;C. COLI/E. JEJUNI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Some strains of Campylobacter coli exhibit erythromycin resistance, highlighting the complexity and variability in antibiotic resistance among different species."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;FOREIGN TRAVEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Foreign travel, particularly to regions with high quinolone-resistant Campylobacter strains, increases the risk of acquiring such infections."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Consuming fresh poultry other than chicken and turkey is associated with an increased risk of acquiring quinolone-resistant C. jejuni infections."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRAVEL TO SPAIN AND PORTUGAL&quot;" target="&quot;ERYTHROMYCIN-CRESTANT CAMPYLOBACTER ISOLATES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Traveling to Spain or Portugal is associated with a higher risk of acquiring erythromycin-resistant Campylobacter coli strains."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRAVEL TO SPAIN AND PORTUGAL&quot;" target="&quot;THRE SILENT MUTATIONS IN GYRA IN THE LATTER STRAIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Traveling to regions with high resistance may expose individuals to strains carrying silent mutations in gyrA gene, affecting treatment."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FLUOROQUINOLONES&quot;" target="&quot;QUINOLONE-RESISTANT C. JEJUNI ISOLATES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Quinolone resistance in C. jejuni isolates affects their response to fluoroquinolone treatments.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIC OF QUINOLONE = 2 MG/L&quot;" target="&quot;NORMAL CONSENSUS SEQUENCE IN THE FORMER STRAIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Strains with a normal consensus sequence typically exhibit sensitivity to quinolones as indicated by low MIC values."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIC OF QUINOLONE = 2 MG/L&quot;" target="&quot;THRE SILENT MUTATIONS IN GYRA IN THE LATTER STRAIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Silent mutations in gyrA can result in higher MIC values for quinolones, indicating resistance despite no change in amino acid sequence."</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRESH POULTRY INTAKE&quot;" target="&quot;DOMESTICALLY ACQUIRED INFECTIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Consumption of fresh poultry other than chicken and turkey is linked with domestically acquired Campylobacter infections.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAMPYLOBACTERIOSIS&quot;" target="&quot;RETAIL FOOD PRODUCTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Infections caused by Campylobacter bacteria can originate from contaminated retail food products, such as chickens or turkeys.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression level of certain transcripts can be modulated by dietary nutrients, affecting antibiotic resistance.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The physiological process of infection is influenced by molecular interactions between Campylobacter bacteria and the human host immune system.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS9534511&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"SNP rs9534511 in the HTR2A gene is significantly associated with increased risk of social disinhibition."&lt;SEP&gt;"The minor allele of rs9534511 increases the risk of social disinhibition.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4938056&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"SNP rs4938056 in the HTR3B gene is linked to an increased risk of social disinhibition."&lt;SEP&gt;"The minor allele of rs4938056 increases the risk of social disinhibition.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HTR3B GENE&quot;" target="&quot;SEROTONIN PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The HTR3B gene, harboring SNP rs4938056, contributes to serotonin pathway regulation affecting behavior and cognitive functions."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1998220&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A minor allele for this SNP is associated with increased risk of social disinhibition."&lt;SEP&gt;"The minor allele of rs1998220 increases the risk of social disinhibition.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OPRM1 GENE&quot;" target="&quot;REWARD AND ADDICTION BEHAVIORS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The OPRM1 gene, with SNP rs1998220 located within it, impacts pathways involved in reward and addiction behaviors."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1003921&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNP rs1003921 in the KCNC1 gene is significantly associated with increased social disinhibition risk."&lt;SEP&gt;"The minor allele of rs1003921 has a protective effect against increased social disinhibition score.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KCNC1 GENE&quot;" target="&quot;NEURAL EXCITABILITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The KCNC1 gene, harboring SNP rs1003921, contributes to potassium channel function and neural excitability."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS16116&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A genomic variant (rs16116) is linked to social disinhibition risk."&lt;SEP&gt;"The minor allele of rs16116 has a protective effect against increased social disinhibition score.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NPY GENE&quot;" target="&quot;STRESS AND APPETITE REGULATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The NPY gene, with SNP rs16116 downstream, influences neuropeptide Y levels affecting physiological processes such as stress and appetite regulation."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS16870286&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNP (rs16870286) is significantly associated with social disinhibition risk."&lt;SEP&gt;"The minor allele of rs16870286 has a protective effect against increased social disinhibition score.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINC00518 GENE&quot;" target="&quot;UNCHARACTERIZED PROTEIN FUNCTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The LINC00518 gene, containing SNP rs16870286 and coding for an uncharacterized protein, impacts physiological processes not fully elucidated."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOCIAL DISINHIBITION SCORE&quot;" target="&quot;PARENTAL EDUCATION&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.")</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CNR1 GENE&quot;" target="&quot;POSTMORTEM HUMAN PREFRONTAL CORTEX (PFC)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CNR1 gene's expression and its variant rs2023239 are studied in PFC tissue to understand the effects on CB1 receptor binding levels."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239 GENOMIC VARIANT&quot;" target="&quot;CB1 RECEPTOR PROTEIN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genetic variation at rs2023239 affects CB1 receptor protein levels, impacting neurocircuitry involved in drug-seeking behavior and alcohol craving."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239 GENOMIC VARIANT&quot;" target="&quot;NACC (NUCLEUS ACCUMBENS)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs2023239 variant is associated with differential activation in the NAcc during exposure to alcohol cues, indicating a genetic influence on reward processing."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239 GENOMIC VARIANT&quot;" target="&quot;VMPFC (VENTROMEDIAL PREFRONTAL CORTEX)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Differences in VMPFC activation are observed based on the rs2023239 genotype, suggesting genetic modulation of craving behavior."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239 GENOMIC VARIANT&quot;" target="&quot;OFC (ORBITAL PREFRONTAL CORTEX)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genetic variation at rs2023239 correlates with differential activation in the OFC, linked to alcohol craving measures."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239 GENOMIC VARIANT&quot;" target="&quot;POSTMORTEM HUMAN PREFRONTAL CORTEX (PFC)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genomic variant rs2023239 impacts CB1 receptor binding levels in PFC tissue, providing insights into its role in neurocircuitry modulation."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CB1 RECEPTOR PROTEIN&quot;" target="&quot;AUDIT SCORE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Alcohol use disorder scores as measured by AUDIT correlate with brain activity related to CB1 receptor signaling influenced by genetic variants like rs2023239."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VTA (VENTRAL TEGMENTAL AREA)&quot;" target="&quot;REWARD AND POSITIVE AFFECT SCALES (POMS)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Activation of VTA during alcohol exposure correlates with subjective reward measures from POMS scales, indicating a role for genetic factors in modulating reward processing."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OFC (ORBITAL PREFRONTAL CORTEX)&quot;" target="&quot;REWARD AND POSITIVE AFFECT SCALES (POMS)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Differential activation of OFC correlates with subjective measures from POMS scales, suggesting a role for genetic variations in reward processing."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUDIT SCORE&quot;" target="&quot;REWARD AND POSITIVE AFFECT SCALES (POMS)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Both AUDIT scores for alcohol use disorder and subjective reward measures from POMS scales are correlated with brain activity patterns in individuals carrying the rs2023239 variant."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CNR1 TRANSCRIPT&quot;" target="&quot;MESOCORTICOLIMBIC NEUROCIRCUITRY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Expression of CNR1 transcript, influenced by variants such as rs2023239, affects neurocircuitries involved in drug-seeking behaviors and alcohol craving."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MESOCORTICOLIMBIC NEUROCIRCUITRY&quot;" target="&quot;LITCHI JUICE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Contrast between alcohol and litchi juice appetitive controls reveals differential activation patterns in mesocorticolimbic areas influenced by genetic variations like rs2023239."</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OLANZAPINE&quot;" target="&quot;CNR1 VARIATION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"There is an interaction between CNR1 variation and olanzapine that influences cue-elicited craving in individuals with the CT genotype."&lt;SEP&gt;"There is an interaction between CNR1 variation and olanzapine, affecting cue-elicited craving in treatment-seeking alcohol-dependent individuals."</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPL GENE&quot;" target="&quot;P.Q240H MUTATION IN EXON 5 OF THE LPL GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The p.Q240H mutation is a specific genomic variant within the LPL gene that causes functional impairment leading to hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHYLOMICRON HYDROLYSIS&quot;" target="&quot;LIPID METABOLISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Chylomicron hydrolysis is an integral part of lipid metabolism, breaking down triglycerides and fatty acids for use by tissues."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHYLOMICRON HYDROLYSIS&quot;" target="&quot;LPL PROTEIN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Lipoprotein lipase (LPL) is crucial in the process of chylomicron hydrolysis, breaking down triglycerides for tissue use."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPL DEFICIENCY DISORDER&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Patients with LPL deficiency disorder often exhibit hypertriglyceridemia due to impaired lipoprotein lipase activity leading to accumulation of chylomicrons in the bloodstream."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPL DEFICIENCY DISORDER&quot;" target="&quot;DIETARY FAT RESTRICTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Restricting dietary fat can help manage LPL deficiency disorder by reducing plasma triglyceride levels and alleviating symptoms such as pancreatitis."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERUPTIVE XANTHOMAS&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High TG levels (&gt; 2000 mg/dl) trigger the formation and appearance of eruptive xanthomas on skin surfaces."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPEMIA RETINALIS&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"When triglyceride concentrations surpass 2500 mg/dl, lipids in peripheral retinal vessels become visible as lipemia retinalis."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;MCT (MEDIUM-CHAIN TRIGLYCERIDES)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Supplementation with MCT allows patients to adhere better to dietary fat restriction while maintaining adequate nutrition."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;ORLISTAT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Orlistat enhances the effectiveness of dietary fat restriction by further limiting fat absorption in the digestive system."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;LINEAR GROWTH&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Despite dietary fat restriction, children with LPL deficiency can maintain normal linear growth patterns."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;PUBERTY&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Individuals with LPL deficiency undergoing dietary fat restrictions often experience normal puberty stages."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPIHBP1&quot;" target="&quot;LIPID METABOLISM&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"GPIHBP1 facilitates the transport of lipoprotein lipase to the capillary lumen, essential for proper lipid metabolism."&lt;SEP&gt;"The protein GPIHBP1 facilitates lipid metabolism through its role in transporting lipoprotein lipase to the capillary lumen for chylomicron hydrolysis."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPID METABOLISM&quot;" target="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The lipid metabolism pathway is involved in the transport of lipids across cell membranes, regulated by physiological processes such as molecular transport."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPL PROTEIN&quot;" target="&quot;MUTATION P.Q240H&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The mutation p.Q240H disrupts normal protein function, leading to decreased lipoprotein lipase activity."</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE (LPL) PROTEIN&quot;" target="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Dysfunction or deficiency of lipoprotein lipase leads to impaired breakdown of triglyceride-rich lipoproteins, resulting in hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPOPROTEIN LIPASE (LPL) PROTEIN&quot;" target="&quot;TRIGLYCERIDE-RICH LIPOPROTEINS (TRL)&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The lipoprotein lipase protein acts on triglyceride-rich lipoproteins to release free fatty acids and glycerol for cellular uptake."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;PANCREATITIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased levels of TG are a major risk factor for the development and exacerbation of pancreatitis."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;GEMFIBROZIL&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Gemfibrozil is used to decrease TG levels and manage hypertriglyceridemia when lifestyle modifications are insufficient."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Inhibition of DGAT1 is being explored as a novel therapeutic strategy to reduce triglyceride synthesis and manage hypertriglyceridemia."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)&quot;" target="&quot;FAT ABSORPTION&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Inhibition of DGAT1 affects the final step of triglyceride synthesis during fat absorption, impacting overall fat metabolism."</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;NO HDDS (EFFICACY)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Topiramate treatment is effective in reducing heavy drinking days, indicating its efficacy for treating alcohol use disorder."&lt;SEP&gt;"Topiramate treatment leads to a reduction in heavy drinking days, indicating efficacy."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2832407 GENE VARIANT&quot;" target="&quot;ADVERSE EVENTS (AE)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of the rs2832407 gene variant affects the occurrence and severity of adverse events in patients treated with topiramate."</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYP2D6&quot;" target="&quot;PATIENT-REPORTED ACUTE NAUSEA SEVERITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variation in CYP2D6 gene activity influences the patient-reported severity of acute nausea during chemotherapy treatment."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCB1 ALLELE RS1045642&quot;" target="&quot;CTCAE GRADE OF ACUTE NAUSEA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variation at position rs1045642 in the ABCB1 gene is associated with CTCAE grade severity for acute nausea."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCB1 ALLELE RS1045642&quot;" target="&quot;ADVANCED STAGE CANCER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of the ABCB1 variant at rs1045642 is not significantly associated with advanced stage cancer, but may influence response to treatment in such patients."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATIENT-REPORTED ACUTE NAUSEA SEVERITY&quot;" target="&quot;HTR3B (RS45460698)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The HTR3B variant at rs45460698 does not show significant associations with patient-reported acute nausea severity, suggesting limited influence on this aspect."&lt;SEP&gt;"While no direct association was found, variations in HTR3B could indirectly affect acute nausea through serotonin pathways."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATIENT-REPORTED ACUTE NAUSEA SEVERITY&quot;" target="&quot;DEXAMETHASONE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Use of dexamethasone is aimed at reducing acute nausea severity as reported by patients during chemotherapy treatment."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATIENT-REPORTED ACUTE NAUSEA SEVERITY&quot;" target="&quot;PROCHLORPERAZINE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Prochlorperazine is used to manage acute nausea severity as reported by patients undergoing chemotherapy."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCAE GRADE OF ACUTE NAUSEA&quot;" target="&quot;PALONOSETRON&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The use of palonosetron is aimed at reducing the CTCAE grade of acute nausea in patients undergoing chemotherapy."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATIENT-REPORTED DELAYED NAUSEA SEVERITY&quot;" target="&quot;ABCB1 GENOTYPE &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genotype of patients at rs1045642 does not influence delayed nausea as strongly as it does acute nausea, indicating differential impact on various phases of treatment."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCAE GRADE OF DELAYED NAUSEA&quot;" target="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Patients receiving highly emetogenic chemotherapy regimens are more likely to report higher CTCAE grades for delayed nausea compared to less aggressive treatment plans."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCAE GRADE OF DELAYED NAUSEA&quot;" target="&quot;ONDANSETRON&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"On the use of ondansetron for managing delayed CINV, indicating its efficacy in reducing CTCAE grade of delayed nausea."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN &quot;" target="&quot;DELAYED CINV&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Patients receiving highly emetogenic chemotherapy are more likely to experience delayed nausea and vomiting, highlighting the relationship between treatment type and patient outcomes."</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE GENE (LCT)&quot;" target="&quot;DIETARY PATTERN (LACTOSE INTAKE)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The dietary pattern involving regular intake of lactose influences the regulatory mechanisms controlling the LCT gene expression levels."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE GENE (LCT)&quot;" target="&quot;ENVIRONMENTAL FACTOR (AGE)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The age-related decline observed in LCT mRNA levels suggests that aging is an environmental factor influencing the expression and regulation of the lactase gene."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE GENE (LCT)&quot;" target="&quot;BISULFITE PADLOCK PROBE SEQUENCING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The technique is used to fine-map regions around the LCT gene for high-resolution analysis of DNA methylation patterns, crucial for understanding its regulatory mechanisms."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT C/T-13910&quot;" target="&quot;MCM6 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The MCM6 gene contains a genomic variant (C/T-13910), which influences lactose persistence and non-persistence by affecting the regulatory mechanism of LCT."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA&quot;" target="&quot;DNA MODIFICATION CHANGES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Changes in LCT mRNA levels are significantly influenced by the accumulation of DNA modifications across regulatory regions in individuals with specific genotypes (-13910 C vs. T)."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA&quot;" target="&quot;DIETARY LACTOSE CONSUMPTION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Increased dietary lactose consumption can lead to higher levels of LCT mRNA expression, although this effect is also heavily dependent on individual genotype at specific loci such as -13910."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA&quot;" target="&quot;LOC100507600 LNCRNA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression of LOC100507600 lncRNA regulates the levels of LCT mRNA in cells relevant to lactase persistence.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA&quot;" target="&quot;SIRNAS DIRECTED TO LOC100507600&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These siRNAs reduced LCT mRNA levels in conjunction with the reduction in LOC100507600 lncRNA expression.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPIGENETIC MODIFICATION&quot;" target="&quot;PHYSIOLOGICAL PROCESS: TRANSCRIPTIONAL REGULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Epigenetic modifications play a crucial role in regulating transcriptional processes that control the production and stability of LCT mRNA."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY: LACTOSE METABOLISM&quot;" target="&quot;LACTASE NON-PERSISTENCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Dysregulation or reduced expression of the lactase gene leads to impaired lactose metabolism, resulting in symptoms associated with lactase non-persistence."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR (AGE)&quot;" target="&quot;LCT MRNA LEVELS IN MICE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age affects the levels of Lct mRNA in mice, similar to humans, indicating a conserved regulation mechanism across species."</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPG SITES&quot;" target="&quot;DNA MODIFICATION PROFILES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The CpG sites identified are crucial for understanding how DNA modifications regulate cell-type-specific expression of LCT."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENTEROCYTE-DEFICIENT JEJUNUM&quot;" target="&quot;WHITE BLOOD CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Comparison between these tissues highlights the cell-type specificity in DNA modification patterns associated with LCT."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNASE I HYPERSENSITIVITY SITES&quot;" target="&quot;H3K4ME1 AND H3K27AC&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These sites often coincide with regions marked by histone modifications indicative of active enhancers, suggesting regulatory functions."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE NON-PERSISTENCE AND PERSISTENCE&quot;" target="&quot;MCM6 SNPS (RS4988235, RS182549)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genotypes defined by these SNPs are associated with lactase persistence or non-persistence conditions."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 SNPS (RS4988235, RS182549)&quot;" target="&quot;INSERTION-DELETION IN THE 3′ REGION OF LCT INTRON 1&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Genetic variations in both MCM6 and LCT influence mRNA levels and are thus related to differential DNA modifications."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRON 5 OF LCT&quot;" target="&quot;LACTASE PERSISTENCE AND NON-PERSISTENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The regulatory region within intron 5 influences the persistence or decline of lactose digestion capability into adulthood based on genetic variants."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRON 13 OF MCM6&quot;" target="&quot;AGE-DEPENDENT REGULATION OF LCT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This genomic variant shows age-dependent changes in DNA modifications, influencing the expression of LCT and affecting lactase persistence/non-persistence."</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENCE&quot;" target="&quot;CACO-2 CELL LINE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Investigations into lactase persistence often utilize Caco-2 cell line models to assess gene regulatory mechanisms.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT GENE (LACTASE GENE)&quot;" target="&quot;LACTOSE INTOLERANCE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The LCT gene's expression level is directly linked to the development of lactose intolerance, particularly in individuals with specific genetic variants such as C-13910 at position -13910."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-13910&quot;" target="&quot;T-13910&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The genomic variants C-13910 and T-13910 at position -13910 are associated with differential DNA modification patterns over age, leading to differences in lactase persistence or non-persistence conditions."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-13910&quot;" target="&quot;LACTASE PERSISTENCE/NON-PERSISTENCE CONDITION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant C-13910 is linked to lactase non-persistence, as it correlates with increased DNA modification changes and decreased LCT mRNA expression over age."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-13910&quot;" target="&quot;LACTASE PERSISTENCE/NON-PERSISTENCE CONDITION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant T-13910 is associated with lactase persistence, characterized by protected MCM6 and LCT regulatory elements from epigenetic inactivation."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA MODIFICATION CHANGES&quot;" target="&quot;LCT–MCM6 EPIGENETIC INTERACTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The epigenetic interaction between LCT and MCM6 involves age-related DNA modification changes that regulate lactase expression and persistence."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA MODIFICATION CHANGES&quot;" target="&quot;METHYLATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The process of methylation is a significant component of DNA modification changes, particularly influencing lactase enzyme production through the LCT gene."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTONE MODIFICATIONS&quot;" target="&quot;H3K27AC, H3K4ME1, H3K4ME3, POLR2A CHROMATIN MARKS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"These chromatin marks are key histone modifications that contribute to the regulation of lactase expression and persistence by influencing transcriptional activity at specific genomic regions."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACO-2 CELL LINE&quot;" target="&quot;EPIGENETICALLY-REGULATED REGIONS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Cells were used to assess the impact of epigenetic regulation on human LCT expression after CRISPR-Cas9 deletions.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOC100507600 LNCRNA&quot;" target="&quot;LCT INTRON 2 AND 8 IN MICE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The lncRNA LOC100507600 is involved in the regulation of LCT mRNA, similar to regulatory elements identified at intron 2 and 8 in mice."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOC100507600 LNCRNA&quot;" target="&quot;MCM6 MRNA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The silencing of LOC100507600 did not affect MCM6 mRNA levels, indicating specific regulation of LCT by this lncRNA.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT INTRONIC REGION&quot;" target="&quot;CRISPR-CAS9 GENOME EDITING TECHNOLOGY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The technology was used to delete specific intronic regions in order to understand their role in the regulation of LCT expression.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 INTRONIC REGION&quot;" target="&quot;HUMAN LCT REGULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The deletion of a region in Mcm6 intron 13 is crucial for human LCT expression regulation, as shown by CRISPR-Cas9 experiments.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRISPR-CAS9 GENOME EDITING TECHNOLOGY&quot;" target="&quot;CRISPR-CAS9 OFF-TARGET ACTIVITY SURVEY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Used to confirm the specificity and accuracy of CRISPR-Cas9 deletions in genomic regions.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADULT INTESTINE VS INFANT INTESTINE REGULATION&quot;" target="&quot;LCT INTRONIC REGION 2 &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The intronic region influences LCT expression differently between adults and infants.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT–MCM6 EPIGENETIC INTERACTION&quot;" target="&quot;ENTEROCYTE SAMPLES&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The study of enterocytes provides crucial insights into how epigenetic interactions between MCM6 and LCT genes influence lactase persistence or non-persistence conditions in humans."</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENT ALLELE (T)&quot;" target="&quot;MILK CONSUMPTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals carrying the T allele of rs4988235 tend to consume more milk than those without it."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK CONSUMPTION&quot;" target="&quot;RENAL CELL CARCINOMA (RCC)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased consumption of milk is associated with an elevated risk of RCC, particularly in populations with high adherence to lactase persistence genotype."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;DESCRIPTIVE CHARACTERISTICS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The Hardy-Weinberg equilibrium is used to assess genetic consistency in populations, including descriptive characteristics such as allele frequencies in the context of lactase persistence."</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;ALLELE FREQUENCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Analysis of Hardy-Weinberg equilibrium helps in determining the allele frequencies and genetic variation in a population, crucial for SNP studies."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;PTPN2 GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genetic variations in the PTPN2 gene adhere to Hardy-Weinberg equilibrium principles within the studied population."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;RS231775&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Genotypes of rs231775 in control samples were generally consistent with Hardy-Weinberg equilibrium principles."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL11A GENE&quot;" target="&quot;RS4671393 SNP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The BCL11A gene also contains the rs4671393 SNP, showing similar correlations with baseline and MTD HbF levels."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL11A GENE&quot;" target="&quot;RS11886868 SNP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The BCL11A gene is also associated with rs11886868 SNP, influencing the delta HbF level in a less pronounced manner."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMIP-2 GENE&quot;" target="&quot;RS9399137 SNP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The HMIP-2 gene harbors the rs9399137 SNP that is correlated with higher baseline and MTD HbF levels but not delta HbF."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMIP-2 GENE&quot;" target="&quot;RS9402686 SNP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The HMIP-2 gene also includes the rs9402686 SNP, showing similar associations to rs9399137 for baseline and MTD HbF levels."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEMOGLOBIN F (HBF)&quot;" target="&quot;HYDROXYUREA TREATMENT (HU)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The use of hydroxyurea treatment correlates with increased hemoglobin F levels in patients, indicating its role in enhancing fetal hemoglobin production or stability."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEMOGLOBIN F (HBF)&quot;" target="&quot;MAXIMUM TOLERATED DOSE (MTD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Changes in MTD levels of hemoglobin F are observed and analyzed as part of the study on genetic variants and hydroxyurea treatment effects."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROXYUREA TREATMENT (HU)&quot;" target="&quot;NEUTROPHIL COUNT (ANC)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The assessment of HU's effects on hematological parameters includes monitoring neutrophil count to ensure safety during treatment."</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMIP-2 SNP&quot;" target="&quot;MTD HBF&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The association between the HMIP-2 SNP and MTD HbF was observed but lost significance after correcting for baseline hemoglobin F levels.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTD HBF&quot;" target="&quot;C-A HAPLOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"An analysis of haplotypes in the HMIP-2 region revealed that the C-A haplotype is associated with MTD HbF, though this association loses significance after correction for baseline hemoglobin F levels.")</data>
      <data key="d6">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T GENE&quot;" target="&quot;G.202332626_202341295DEL DELETION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The deletion in UBE2T gene is expected to be null, as it leads to loss of a majority of the gene including the start codon."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T GENE&quot;" target="&quot;G.202332626_202341295DUP DUPLICATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The duplication in UBE2T gene, resulting from recombination between two AluYa5 repeats, leads to a frameshift and premature stop codon."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.202332626_202341295DUP DUPLICATION&quot;" target="&quot;UBE2T TRANSCRIPT (C.-64_468DUP)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The transcript of the UBE2T gene with a duplication includes the noncoding region from exon 2, causing a frameshift and premature stop codon."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCD2 MONOUBIQUITINATION&quot;" target="&quot;FANCONI ANEMIA PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Monoubiquitination of FANCD2 is a key step in the activation of Fanconi anemia pathway for cellular response to DNA damage."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCD2 MONOUBIQUITINATION&quot;" target="&quot;WILD TYPE UBE2T EXPRESSION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Overexpression of wild type UBE2T protein restores FANCD2 monoubiquitination, which is crucial for the FA pathway's function in response to DNA damage."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHROMOSOMAL BREAKAGE&quot;" target="&quot;FANCONI ANEMIA PATHWAY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Elevated chromosomal breakage levels indicate deficiencies in DNA repair mechanisms associated with the FA pathway."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCONI ANEMIA PATHWAY&quot;" target="&quot;FANCONI ANEMIA (FA)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Deficiencies in genes involved in this pathway lead to Fanconi anemia, characterized by bone marrow failure and cellular hypersensitivity."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBROBLASTS (RA2627)&quot;" target="&quot;LYMPHOBLASTOID CELL LINE (RA2946)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The fibroblast cells and lymphoblastoid cell line from the same patient show differences in FA pathway activation, indicating somatic mosaicism."</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T&quot;" target="&quot;FANCONI ANEMIA-T (FA-T)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Deficiency or mutations in the UBE2T gene result in Fanconi anemia-T subtype, characterized by cellular hypersensitivity and defects in DNA repair pathways."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T EXPRESSION&quot;" target="&quot;FANCI MONOUBIQUITINATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Overexpression of wild type UBE2T protein also restores FANCI monoubiquitination, contributing further to the repair of interstrand DNA crosslinks."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T EXPRESSION&quot;" target="&quot;CROSSLINKING AGENTS (MMC, DEB, CISPLATIN)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Overexpression of wild type UBE2T protein rescues cells from the detrimental effects of crosslinking agents and restores cell survival and DNA repair efficiency."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T EXPRESSION&quot;" target="&quot;BJ CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression of wild type UBE2T in BJ cells serves as a control to compare with RA2627 fibroblasts to assess the rescue effect on cellular hypersensitivity and DNA repair."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROSSLINKING AGENTS (MMC, DEB, CISPLATIN)&quot;" target="&quot;G2 ARREST&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Treatment with crosslinking agents causes G2 arrest in RA2627 fibroblasts due to cellular hypersensitivity and defects in DNA repair pathways."</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPS19 GENE&quot;" target="&quot;MISSENSE MUTATION P.ARG101HIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The RPS19 gene carries a missense mutation at position Arg101His resulting in substitution from arginine to histidine, contributing to the pathogenesis of DBA.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPS19 GENE&quot;" target="&quot;FRAMESHIFT MUTATION C.58DELG&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The RPS19 gene has a frameshift mutation characterized by deletion of guanine at position 58 which leads to a premature stop codon and reduced protein function in DBA.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPS19 GENE&quot;" target="&quot;SPLICE SITE MUTATION C.1-1G&gt;A&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The RPS19 gene contains a splice site mutation at position -1G&gt;A affecting intron 1, leading to exon skipping and reduced protein function in DBA.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DERMAL FIBROBLASTS TRANSCRIPTOME&quot;" target="&quot;RPS19 GENE MUTATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The transcriptome of dermal fibroblasts from patients with RPS19 gene mutations shows differential expression patterns compared to healthy controls.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NMD (NONSENSE-MEDIATED DECAY)&quot;" target="&quot;SPLICE SITE MUTATION C.1-1G&gt;A IN RPS19 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The splice site mutation in the RPS19 gene leads to NMD targeting and degradation of mutant mRNA, affecting protein levels.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMINOACYL-TRNA BIOSYNTHESIS PATHWAY&quot;" target="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genes involved in aminoacyl-tRNA biosynthesis show differential expression patterns among DBA patients indicating potential functional alterations.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLYCINE, SERINE, AND THREONINE METABOLISM PATHWAY&quot;" target="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genes involved in the metabolism of glycine, serine, and threonine show differential expression patterns among DBA patients indicating potential functional alterations.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEATH RECEPTOR SIGNALING PATHWAY&quot;" target="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Enrichment of death receptor signaling pathway genes indicates activation or alteration in this pathway among DBA patients due to differential expression.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY&quot;" target="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genes involved in PKR-mediated interferon induction and antiviral response pathways show enrichment among DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAR ACTIVATION PATHWAY&quot;" target="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Enrichment of genes involved in RAR activation pathway among DBA patients indicates potential alterations in retinoic acid signaling.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RP GENES (RIBOSOMAL PROTEIN)&quot;" target="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ribosomal protein gene cluster shows differential expression patterns among DBA patients indicating involvement in the pathogenesis of DBA.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPID METABOLISM PATHWAY&quot;" target="&quot;DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genes involved in lipid metabolism show differential expression patterns among DBA patients indicating potential alterations in lipid-related processes.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPL14&quot;" target="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The RPL14 gene is involved in cellular functions such as molecular transport, contributing to the movement of molecules across cell membranes."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMPD3&quot;" target="&quot;DIAMOND-BLACKFAN ANEMIA (DBA)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Up-regulation of AMPD3 is noted in DBA patients relative to healthy subjects, as validated by RT-PCR analysis."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCND2&quot;" target="&quot;DIAMOND-BLACKFAN ANEMIA (DBA)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased CCND2 expression levels correlate with DBA patient status relative to controls."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOD2&quot;" target="&quot;DIAMOND-BLACKFAN ANEMIA (DBA)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Up-regulation of SOD2 is observed in DBA patients compared to healthy individuals, according to RT-PCR validation."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP3&quot;" target="&quot;DIAMOND-BLACKFAN ANEMIA (DBA)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Elevated TNFAIP3 expression levels are associated with the condition of Diamond-Blackfan Anemia in patients compared to controls."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RIBOSOMAL PROTEIN GENES (RP GENES)&quot;" target="&quot;CELLULAR DEVELOPMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"RP genes contribute to the process of cellular development and tissue growth within organisms."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOP BIO FUNCTIONS CATEGORY MOLECULAR AND CELLULAR FUNCTIONS&quot;" target="&quot;CANCER RELATED GENES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This category includes biological pathways that involve cancer-related genes contributing to disease development and progression."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAEMATOLOGICAL DISORDERS&quot;" target="&quot;RENAL DISORDERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic factors influencing the development of haematological disorders may also contribute to renal conditions, affecting overall health."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SKELETAL DISORDERS&quot;" target="&quot;DEVELOPMENT OF EMBRYONIC TISSUES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Processes involved in embryonic tissue formation can impact skeletal integrity and development, potentially leading to skeletal disorders."</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF GENE&quot;" target="&quot;RS6265 GENOMIC VARIANT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The BDNF gene contains the rs6265 polymorphism which has a significant association with migraine susceptibility."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF GENE&quot;" target="&quot;RS2049046 GENOMIC VARIANT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Another variant (A/T) within the BDNF gene, rs2049046, is also associated with migraine susceptibility."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS6265 GENOMIC VARIANT&quot;" target="&quot;MIGRAINE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of the G/A polymorphism in the rs6265 site is significantly associated with an increased risk or reduced resistance to developing migraines."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2049046 GENOMIC VARIANT&quot;" target="&quot;MIGRAINE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of the A/T polymorphism in the rs2049046 site has a significant association with susceptibility to migraines."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS SCORE&quot;" target="&quot;STUDY QUALITY ASSESSMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A high NOS score indicates that the quality of observational studies included in the meta-analysis is good, supporting robust analysis and conclusions."</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSORIASIS&quot;" target="&quot;CD15+ NEUTROPHILS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Neutrophils are highly abundant in the dermis of paradoxical skin reactions and play a significant role in the inflammatory response associated with psoriasis."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSORIASIS&quot;" target="&quot;EPIDERMAL HYPERPLASIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Epidermal hyperplasia is a common histological finding in psoriasis, indicating increased cell proliferation within the epidermis."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSORIASIS&quot;" target="&quot;PARAKERATOSIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Parakeratosis is often observed in psoriatic lesions and indicates incomplete keratinocyte differentiation."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSORIASIS&quot;" target="&quot;PAPILLARY VESSEL ECTASIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Enlargement of blood vessels in the papillary dermis layer can be a characteristic feature of psoriatic inflammation."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSORIASIS&quot;" target="&quot;PERIVASCULAR INFILTRATE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of perivascular infiltrates with immune cells is typical in inflammatory skin conditions like psoriasis."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIDRADENITIS SUPPURATIVA (HS)&quot;" target="&quot;SARTORIUS SCORE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Sartorius score is used to assess the severity of HS based on clinical findings such as nodules, sinuses, and fistulas."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;" target="&quot;ADALIMUMAB&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Treatment with adalimumab in patients with HS leads to paradoxical psoriasiform reactions, demonstrating that these drugs can cause unexpected immune responses."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;" target="&quot;BDCA2+ PDCS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Plasmacytoid dendritic cells significantly infiltrate the dermis during paradoxical psoriasiform reactions, contributing to an enhanced immune response in these conditions."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD15+ NEUTROPHILS&quot;" target="&quot;IL-36Γ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Neutrophils are a significant source of IL-36γ, contributing to the inflammatory response observed in paradoxical psoriasiform reactions."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-KIT/CD117+ MAST CELLS&quot;" target="&quot;INNATE IMMUNITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Mast cells expressing c-kit play important roles in innate immune responses and allergic inflammation."</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+&quot;" target="&quot;SKIN T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CD3+ skin T cells from HS patients are enriched in CD8+, reflecting a distinct inflammatory infiltrate pattern."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Β&quot;" target="&quot;KERATINOCYTES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Type I IFN-β expression is mainly observed in keratinocytes of paradoxical psoriasis skin lesions."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Κ&quot;" target="&quot;KERATINOCYTES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Interferon-kappa is expressed by keratinocytes and shows differential subcellular localization between psoriasiform and classical psoriasis lesions."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERAP1 GENE&quot;" target="&quot;SNP VARIANTS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Patients developing paradoxical psoriasis carry variants of the ERAP1 gene, indicating a genetic predisposition to such reactions."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCHCR1 GENE&quot;" target="&quot;SNP RS1576&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CCHCR1 gene contains SNP rs1576."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCHCR1 GENE&quot;" target="&quot;SNP RS130079&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CCHCR1 gene contains SNP rs130079."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCHCR1 GENE&quot;" target="&quot;SNP RS746647&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CCHCR1 gene contains SNP rs746647."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)&quot;" target="&quot;DIAGNOSTIC MARKER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Levels of IL-22 in PBMCs can serve as a diagnostic marker, showing reduction compared to psoriasiform lesions."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL23R GENE&quot;" target="&quot;SNP RS11209026&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Rs11209026 is a previously studied SNP in the IL23R gene linked to paradoxical reactions but not found in HS patients."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL23R GENE&quot;" target="&quot;SNP RS72676067&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Rs72676067 is a detected SNP in patient 2 located within the IL23R gene."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL23R GENE&quot;" target="&quot;SNP RS1004819&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Rs1004819 is a detected SNP in patient 1 located within the IL23R gene."</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SUSCEPTIBILITY&quot;" target="&quot;HLA-C REGION SNPS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Variants in the HLA-C region are found consistently among HS patients with paradoxical psoriasis, suggesting an association with disease susceptibility."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SUSCEPTIBILITY&quot;" target="&quot;HLA-B REGION SNPS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in the HLA-B region are associated with genetic predisposition to autoimmune diseases including psoriasis."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SUSCEPTIBILITY&quot;" target="&quot;NOMINAL SIGNIFICANCE IN GWAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"SNPs achieving nominal significance in the GWAS of general IgM suggest their potential roles in contributing to disease susceptibility."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDSN GENE &quot;" target="&quot;SKIN BARRIER FUNCTION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Polymorphisms in CDSN gene may affect skin barrier integrity and contribute to the pathogenesis of inflammatory skin conditions like psoriasis."</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCL GENE&quot;" target="&quot;DRWD DOMAIN (HUMAN)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The DRWD domain is part of the human protein encoded by the FANCL gene, playing a role in the Fanconi Anemia pathway."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCL GENE&quot;" target="&quot;HYDROPHOBIC CORE RESIDUES&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The hydrophobic core residues are conserved between DmFANCL and human FANCL, reflecting their role in protein-protein interactions critical for the Fanconi Anemia pathway."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRWD DOMAIN (HUMAN)&quot;" target="&quot;CYSTEINE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A cysteine residue is present in the β-element of the human DRWD domain, similar to the catalytic site of E2s but inactive for thioester formation."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;E2 UBC ENZYMES&quot;" target="&quot;URD (UBC-RWD DOMAIN)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The URD shares structural similarity with E2 enzymes, particularly with their C-terminal lobe."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD (UBC-RWD DOMAIN)&quot;" target="&quot;DMDRWD (PROTEIN)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The human FANCL domain (URD) is structurally different from the Drosophila version, particularly in its N-terminal lobe which lacks a helix."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYSTEINE&quot;" target="&quot;THIOESTER CHARGE ASSAY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The thioester charge assay was used to determine whether the cysteine residue forms a thioester bond with ubiquitin, which it does not."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;DMDRWD&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The Drosophila DRWD binds and interacts with human URD to form part of the larger FANCL complex."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;C-TERMINAL DOMAIN OF DMDRWD &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The C-terminal domain of DmDRWD interacts extensively with the human URD, forming part of the larger FANCL complex."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCI&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"FANCI binds to URD as indicated in the text by pulldown array experiments."&lt;SEP&gt;"FANCI binds to URD, and this interaction is reduced when specific mutants are present in the hydrophobic patches of URD."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"FANCD2 also binds to URD, similar to FANCI, but both show reduced binding with specific mutants of URD."&lt;SEP&gt;"FANCD2 also binds to URD, similarly affected by mutations in the C-terminal lobe hydrophobic patches but not in the N-terminal ones."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;L248A/F252A/L254A/I265A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"These mutations represent genomic variants that significantly reduce the binding affinity between URD and both FANCI and FANCD2."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;W212A/L214A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in this group do not affect the binding of URD to FANCI or FANCD2 as much, indicating less impact on the function compared to L248A/F252A/L254A/I265A."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;HYDROPHOBIC PATCH (C-TERMINAL)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The hydrophobic patches in the C-terminal lobe of URD are crucial for maintaining binding affinity with FANCI and FANCD2, whereas those in the N-terminal do not significantly impact binding."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;HYDROPHOBIC PATCH (N-TERMINAL)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in the hydrophobic patches of the N-terminal lobe of URD are less disruptive to substrate binding compared to mutations in the C-terminal lobe."</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RING DOMAIN (HUMAN)&quot;" target="&quot;FANCI&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The RING domain of FANCL interacts with FANCI and FANCD2 in the Fanconi Anemia pathway."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCI&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FANCI and FANCD2 form a complex that is critical for genome stability in the Fanconi Anemia pathway."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC PATCHES/GROOVES (URD)&quot;" target="&quot;FANCI/FANCD2 BINDING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Specific hydrophobic patches on the C-terminal lobe of URD are crucial for binding to FANCI and FANCD2."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC PATCHES/GROOVES (URD)&quot;" target="&quot;ELECTROSTATIC POTENTIAL DIFFERENCES (URD/DMDRWD)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The differences in electrostatic potential between human URD and Drosophila DRWD influence the interaction patterns of hydrophobic patches."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYDROPHOBIC GROOVES (URD)&quot;" target="&quot;UBE2T BINDING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Specific hydrophobic grooves on the C-terminal lobe of URD facilitate binding to Ube2T for E3 ligase activity."</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HPXXXP MOTIF&quot;" target="&quot;TRIPLE TURN YPXXXP MOTIF&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"While both motifs are found in RWD folds, only the human FANCL central domain (URD) contains an HPXXXP motif rather than YPXXXP."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CATALYTIC THIOESTER BOND FORMATION&quot;" target="&quot;Β-FLAP STRUCTURE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The β-flap structure in E2 enzymes facilitates thioester bond formation with ubiquitin, a process not observed in the URD due to lack of catalytic cysteine activity."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYSTEINE RESIDUE (URD)&quot;" target="&quot;THIOESTER LINKAGE STABILITY TEST&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The test was conducted to determine if the cysteine residue in the human FANCL domain could form thioester bonds with ubiquitin, which it cannot."</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS351855 (GLY388ARG)&quot;" target="&quot;CT DELAY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"In the GA/AA genotype group, colesevelam significantly delays CT by increasing AC t1/2 and decreasing GC24."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM TREATMENT EFFECTS&quot;" target="&quot;KLB RS4975017&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The KLB variant impacts the effect of colesevelam on CT, showing lower GC24 values in the CA/AA genotype group."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM TREATMENT EFFECTS&quot;" target="&quot;KLB RS17618244 (ARG728GLN)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This variant shows modest effects of colesevelam on AC t1/2 and GC24, but no significant effect in the GA/AA genotype group."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS4975017&quot;" target="&quot;KLB GENE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The KLB gene includes a variant associated with differential colesevelam treatment effects on CT."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROL PATIENTS&quot;" target="&quot;FGFR4 AND KLB GENES &quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic studies involving healthy control patients assess the impact of FGFR4 and KLB variants on drug responses."</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGF19&quot;" target="&quot;STOOL BA (BILE ACIDS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There were numerical differences in stool fat but no significant association with FGF19 levels across subgroups indicating the complexity of metabolic pathways involved."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BILE ACIDS (BA)&quot;" target="&quot;FGFR4 RS1966265, FGFR4 RS351855, FGFR4 RS376618&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variants within the FGFR4 gene are marginally associated with stool BA levels but not with serum C4."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BILE ACIDS (BA)&quot;" target="&quot;IBS-C (IRRITABLE BOWEL SYNDROME WITH CONSTIPATION)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Patients with IBS-C had lower levels of 48-hour stool BA compared to HV, indicating a differential impact on bile acid excretion patterns."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLECYSTECTOMY&quot;" target="&quot;IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Previous cholecystectomies were more prevalent in IBS-D patients but did not significantly affect their symptoms, indicating a complex relationship between gallbladder removal and IBS."&lt;SEP&gt;"Previous cholecystectomies were recorded in 23% of IBS-D patients, showing a potential relationship between gallbladder removal and the disease."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLECYSTECTOMY&quot;" target="&quot;IBS-C (IRRITABLE BOWEL SYNDROME WITH CONSTIPATION)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Previous cholecystectomies were recorded in approximately 4% of IBS-C patients, indicating a lower prevalence compared to IBS-D."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)&quot;" target="&quot;STOOL BA (BILE ACIDS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Patients with IBS-D had significantly higher 48-hour stool bile acid levels compared to IBS-C, indicating a differential impact on excretion."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL BA (BILE ACIDS)&quot;" target="&quot;SERUM C4&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There was an overall association of serum C4 with subgroup based on stool bile acid levels, suggesting a correlation between these biomarkers."</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;FANCA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The interaction between the N-terminal region of FAAP20 and FANCA is crucial for DNA repair processes."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;DNA DAMAGE SITES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The UBZ domain of FAAP20 interacts with ubiquitin to facilitate the protein's localization at sites of DNA damage, ensuring proper repair mechanisms are initiated."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCA&quot;" target="&quot;UBIQUITIN (UB)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The interaction between FANCA and ubiquitin may involve the UBZ domain of FAAP20 to modulate DNA repair pathways."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBZ DOMAIN (OF FAAP20)&quot;" target="&quot;K63-UB2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"FAAP20-UBZ specifically binds K63-linked Ub2, which suggests a role in cellular signaling and regulation of protein stability."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITIN (UB)&quot;" target="&quot;ASP164, TRP180 (FAAP20-UBZ)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Specific residues in the FAAP20-UBZ protein interact with ubiquitin via hydrogen bonds and hydrophobic interactions to stabilize the binding complex."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ (RESIDUES 143–180)&quot;" target="&quot;CENTRAL Α-HELIX (RESIDUES 160–173)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The central α-helix is a critical part of the FAAP20-UBZ structure that interacts specifically with ubiquitin in K63-linked Ub2 chains."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ (RESIDUES 143–180)&quot;" target="&quot;UBIQUITINATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The interaction between FAAP20-UBZ and ubiquitin chains is a part of the broader process of ubiquitination, involved in cellular signaling and regulation."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CENTRAL Α-HELIX (RESIDUES 160–173)&quot;" target="&quot;ILE44 PATCH&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The central α-helix interacts hydrophobically with the Ile44 patch of ubiquitin, contributing to the binding specificity of FAAP20-UBZ."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TWO LOOPS (RESIDUES 143–159 AND 174–180)&quot;" target="&quot;ZINC ION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The two loop regions of FAAP20-UBZ interact with the zinc ion to stabilize the protein structure."</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;LEU8, ILE44, VAL70, THR66, HIS68 (UB)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"These residues in ubiquitin form a hydrophobic patch that interacts with FAAP20-UBZ via specific molecular interactions to mediate binding affinity."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;ARG72, GLN49 (UB)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Residues in ubiquitin participate in molecular interactions with FAAP20-UBZ that are crucial for maintaining high affinity binding and subsequent cellular functions."</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;UB&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"FAAP20-UBZ binds Ub via hydrophobic residues on the α-helix and through specific charged residues crucial for interaction."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WRNIP1-UBZ&quot;" target="&quot;UB&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The WRNIP1-UBZ domain interacts with Ub through its β-loop structure, distinct from Polη-UBZ due to differences in specific binding residues."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ-UBZ&quot;" target="&quot;UB&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Polη-UBZ binds to Ub in a manner similar to FAAP20-UBZ, indicating conserved residues and structural features that facilitate interaction."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ-UBZ&quot;" target="&quot;NEMO-UBZ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both proteins interact differently with Ub compared to WRNIP1, indicating unique binding modes influenced by their distinct sequences."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ-UBZ&quot;" target="&quot;FAAP20-UBZ RESIDUES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The conservation or replacement of specific FAAP20-UBZ residues in Polη-UBZ (e.g., Asp652, Phe655, Ala656) indicates a similar mode of interaction with Ub."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO-UBZ&quot;" target="&quot;UB&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The interaction between NEMO-UBZ and Ub differs significantly compared to other UBZ domains, characterized by the replacement of Pro21-Val22 with charged residues disrupting normal hydrophobic interactions."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO-UBZ&quot;" target="&quot;CHARGED RESIDUES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In NEMO-UBZ, the presence of charged residues like Lys399 disrupts normal hydrophobic interactions with Ile44 of Ub."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQ8&quot;" target="&quot;CELIAC DISEASE (CD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"DQ8/DQX and other HLA-DQ8-related haplotypes are more frequent among CD patients compared to controls, indicating its association with increased risk of celiac disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2395182&quot;" target="&quot;CELIAC DISEASE (CD)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The minor allele 'G' in rs2395182 is more prevalent in healthy controls than CD patients, indicating a potential protective role against celiac disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7775228&quot;" target="&quot;CELIAC DISEASE (CD)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The minor allele 'C' in rs7775228 is more frequent in controls than CD patients, suggesting its potential protective role against celiac disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2187668&quot;" target="&quot;CELIAC DISEASE (CD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The minor allele 'T' in rs2187668 is significantly more prevalent among CD patients than healthy controls, indicating its role as a risk factor for celiac disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQ2.2&quot;" target="&quot;CELIAC DISEASE (CD)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The HLA-DQ2.2 haplotype frequency is higher in control groups compared to patient groups, suggesting a lower susceptibility to celiac disease in individuals with this haplotype."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELIAC DISEASE (CD)&quot;" target="&quot;HOMOZYGOUS DQ2.5 HAPLOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The homozygous form of the HLA-DQ2.5 haplotype significantly increases the likelihood of developing celiac disease compared to healthy controls."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELIAC DISEASE (CD)&quot;" target="&quot;DQ8/DQX HAPLOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Higher frequency of DQ8/DQX haplotype among CD patients than in controls indicates its role as a risk factor for celiac disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELIAC DISEASE (CD)&quot;" target="&quot;HOMOZYGOUS DQ2.2 HAPLOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher frequency of homozygous DQ2.2 haplotype in healthy controls compared to CD patients suggests a protective role against celiac disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELIAC DISEASE (CD)&quot;" target="&quot;HETEROZYGOUS DQ2.2 HAPLOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Similar frequency of heterozygous DQ2.2 haplotype in both patient and control groups indicates no significant risk or protective role against celiac disease."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELIAC DISEASE (CD)&quot;" target="&quot;EXTREMELY LOW RISK GROUP (DQX)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals lacking all high-risk HLA alleles are considered to be at extremely low risk for developing celiac disease, with similar incidence in both patient and control groups."</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 G&gt;A (RS1799793)&quot;" target="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ERCC2 variant rs1799793 is significantly correlated with PFI, suggesting its role in the effectiveness of platinum-based chemotherapy and patient prognosis.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 G&gt;A (RS1799793)&quot;" target="&quot;ERCC2 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ERCC2 gene harbors the variant rs1799793, which affects nucleotide excision repair and transcription regulation.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCC2 A&gt;G (RS12762549)&quot;" target="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ABCC2 variant rs12762549 is significantly associated with PFI in a fully-adjusted model, indicating its involvement in drug resistance or metabolism of platinum-based chemotherapy agents.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCC2 A&gt;G (RS12762549)&quot;" target="&quot;ABCC2 GENE (MRP2)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ABCC2 gene harbors the variant rs12762549, which affects drug resistance and transport activity of MRP2.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERPINB2 C&gt;G (RS6104)&quot;" target="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SERPINB2 variant rs6104 is significantly associated with PFI in a fully-adjusted model, suggesting its impact on patient survival and tumor progression after chemotherapy.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERPINB2 C&gt;G (RS6104)&quot;" target="&quot;SERPINB2 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SERPINB2 gene harbors the variant rs6104, influencing inflammation and tissue remodeling pathways.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;" target="&quot;ABCC2 GENE (MRP2)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in ABCC2 affect drug transport and resistance mechanisms, influencing PFI in patients undergoing chemotherapy.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;" target="&quot;SERPINB2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The influence of SERPINB2 variants on inflammation pathways may impact tumor progression and patient survival post-chemotherapy.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;" target="&quot;TUMOR GRADE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher tumor grade is associated with worse prognosis and can significantly affect PFI outcomes.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;" target="&quot;FIGO STAGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Earlier FIGO stages are generally associated with better outcomes and longer PFI in patients undergoing chemotherapy.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.302DELA (P.LYS101ARGFS*9)&quot;" target="&quot;UMPS PROTEIN TRUNCATION AND NMD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The variant c.302delA leads to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.385G&gt;T (P.GLY129*) &quot;" target="&quot;UMPS PROTEIN TRUNCATION AND NMD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The variant c.385G&gt;T leads to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.889G&gt;T (P.GLU297*) &quot;" target="&quot;UMPS PROTEIN TRUNCATION AND NMD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The variant c.889G&gt;T leads to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.224C&gt;A (P.PRO75HIS)&quot;" target="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Software programs predict the pathogenicity of missense alterations in UMPS gene including c.224C&gt;A."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.286A&gt;G (P.ARG96GLY) AND C.1285G&gt;C (P.GLY429ARG)&quot;" target="&quot;H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Missense alterations in UMPS gene affecting amino acids well-conserved from humans to fruit flies and roundworms."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.310G&gt;A (P.GLY104ARG)&quot;" target="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Software programs predict the pathogenicity of missense alterations in UMPS gene including c.310G&gt;A."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.689G&gt;A (P.ARG230HIS) AND C.688C&gt;T (P.ARG230CYS)&quot;" target="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Software programs predict the pathogenicity of missense alterations in UMPS gene including c.689G&gt;A and c.688C&gt;T."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.360A&gt;G (P.LEU120LEU)&quot;" target="&quot;H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Missense alteration in UMPS gene affecting amino acids well-conserved from humans to fruit flies and roundworms."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS&quot;" target="&quot;C.857T&gt;A (P.ILE286ASN)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Software programs predict the pathogenicity of missense alterations in UMPS gene including c.857T&gt;A."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS&quot;" target="&quot;C.451G&gt;A (P.VAL151MET)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Software programs predict the pathogenicity of missense alterations in UMPS gene including c.451G&gt;A."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION&quot;" target="&quot;EXAC BROWSER VARIANTS FREQUENCY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Conservation studies showing well-preserved amino acids across species linked to low frequency of variants in the Exac browser database."</data>
      <data key="d6">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 GENE (RS4073)&quot;" target="&quot;CRC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The IL-8 gene polymorphism at rs4073 was investigated for its association with CRC risk but no significant difference was observed between patients and controls."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 GENE (RS1800896)&quot;" target="&quot;CRC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The IL-10 gene polymorphism at rs1800896 showed a significantly lower frequency of the heterozygous genotype AG in CRC patients compared to controls, indicating an association with decreased risk."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENE (RS1179251)&quot;" target="&quot;CRC&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The IL-22 gene polymorphism at rs1179251 showed a significant decrease in the G allele frequency among CRC patients, indicating an association with decreased risk."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 GENE (RS2227485)&quot;" target="&quot;CRC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The IL-22 gene polymorphism at rs2227485 did not show a significant association with CRC risk in the investigated population, though trends were observed."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 GENE (RS17855750)&quot;" target="&quot;CRC&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The IL-27 gene polymorphism at rs17855750 showed a slight association with CRC risk, particularly in the homozygous GG genotype."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGFSS1 GENE (RS1800469)&quot;" target="&quot;CRC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TGF-β1 gene polymorphism at rs1800469 showed a significant decrease in the CT and TT genotypes among CRC patients, indicating an association with decreased risk."</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSLP GENE&quot;" target="&quot;ASTHMA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variants in the TSLP gene contribute to susceptibility for asthma development and progression."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1898671&quot;" target="&quot;EX-SMOKERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The risk of asthma associated with rs1898671 is higher among individuals who have previously smoked, indicating an interaction between smoking history and genetic susceptibility."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSLP PROTEIN&quot;" target="&quot;ASTHMA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The TSLP protein encoded by the TSLP gene plays a critical role in asthma pathogenesis through its involvement in immune responses."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;IGE (IMMUNOGLOBULIN E)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased levels of IgE are indicative of atopic conditions such as asthma."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;FEV1/FVC RATIO&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Reduced FEV1/FVC ratio is a hallmark sign of obstructive airway disease, such as asthma."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;FVC AND FEV1/FVC RATIO&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Sub-analyses excluding individuals with asthma showed persistent genetic associations, indicating disease independence."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRINCIPAL COMPONENT ANALYSIS (PCA)&quot;" target="&quot;POPULATION STRATIFICATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"PCA is used to identify and quantify population stratification in genetic association studies."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRUCTURE METHOD&quot;" target="&quot;POPULATION STRATIFICATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The STRUCTURE method complements PCA by estimating individual ancestry proportions, aiding in the adjustment for population stratification effects."</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FEV1/FVC RATIO&quot;" target="&quot;THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Genomic variants at this locus significantly impact the FEV1/FVC ratio in Hutterites."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POPULATION STRATIFICATION&quot;" target="&quot;GWAS RESULTS INTERPRETATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Negligible population stratification ensures accurate interpretation of GWAS results for genetic variants like rs35923643-G and rs735665-A."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 GENE&quot;" target="&quot;RS2476601&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The PTPN22 gene includes the SNP rs2476601, significant in other inflammatory autoimmune diseases but not directly related to Crohn's Disease."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;PTPN2 TRANSCRIPT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Presence of rs478582 influences the expression levels of PTPN2 transcript in CD subjects compared to healthy controls."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;PTPN2:RS478582 HAPLOTYPE C-G&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The heterozygous or minor/major haplotype is more frequent among CD patients compared to healthy controls."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;PTPN2:RS478582 HAPLOTYPE T-A&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"This haplotype combination shows a lower frequency in Crohn's Disease subjects relative to healthy controls."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS478582&quot;" target="&quot;PTPN2:RS478582 HAPLOTYPE C-A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This haplotype combination is more frequent among CD patients, suggesting a potential role in disease susceptibility."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2476601&quot;" target="&quot;PTPN22 TRANSCRIPT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The SNP rs2476601 does not significantly impact PTPN22 expression levels but is examined for its potential influence on other diseases."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 TRANSCRIPT&quot;" target="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Expression of the PTPN2 transcript is lower in Crohn's Disease subjects compared to healthy controls, indicating a role for this gene in disease pathology."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 TRANSCRIPT&quot;" target="&quot;CROHN'S DISEASE (CD)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Similarly, expression levels of the PTPN22 transcript are also lower in CD patients relative to healthy controls, suggesting an involvement in disease mechanisms."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 TRANSCRIPT&quot;" target="&quot;LYMPHOCYTE SUBSET&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The transcript levels of PTPN22 vary significantly among different lymphocyte subsets such as naïve, memory, and regulatory CD4+ T cells."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 TRANSCRIPT&quot;" target="&quot;MEMORY TCONV CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Memory CD4+ T cells have higher baseline expression of PTPN22 transcripts compared to naïve T cells at rest and respond differently upon activation."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Γ GENE EXPRESSION&quot;" target="&quot;PTPN2:RS478582&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of PTPN2:rs478582 genetic variant and MAPbacteremia increases the IFN-γ gene expression level in Crohn’s disease patients."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;GENE EXPRESSION LEVEL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Gene expression levels for PTPN2/PTPN22 are significantly lower in CD subjects compared to healthy controls, indicating the involvement of these genes in the disease pathology."</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;PTPN2:RS478582&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant rs478582 is associated with increased susceptibility to Crohn's Disease (CD), particularly impacting MAP infection rates."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;PTPN22:RS2476601&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genetic variations at rs2476601 are linked with altered gene expression patterns in CD subjects, influencing disease progression and outcomes."&lt;SEP&gt;"The genomic variant rs2476601 on the PTPN22 gene increases susceptibility to Crohn’s disease, particularly when combined with MAPbacteremia."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;IFN-Γ RELATIVE GENE EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased IFN-γ relative gene expression is observed in CD patients carrying the rs478582 variant at PTPN2, suggesting a role in disease pathogenesis."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;PTPN2/22 GENE EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression of PTPN2/22 genes is significantly lower in Crohn’s disease subjects compared to healthy controls, indicating a role for these variants in disease susceptibility."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CROHN'S DISEASE (CD)&quot;" target="&quot;PTPN22 GENE EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Decreased PTPN22 gene expression in CD subjects with MAPbacteremia and specific genotypes indicates a genetic contribution to disease susceptibility."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;IFN-Γ RELATIVE GENE EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant rs478582 at the PTPN2 gene locus influences IFN-γ relative gene expression, which is higher in CD subjects compared to those with normal alleles."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;MAP INFECTION SUSCEPTIBILITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant rs478582 at the PTPN2 gene locus increases susceptibility to MAP infection in CD subjects compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;HAPLOTYPE C-G&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The haplotype combination of rs478582 and rs2476601 (C-G) increases the risk of MAPbacteremia in Crohn’s disease patients."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2:RS478582&quot;" target="&quot;MAPBACTEREMIA PRESENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of MAP bacteria and the rs478582 variant increases the risk of Crohn’s disease and alters gene expression patterns."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22:RS2476601&quot;" target="&quot;PTPN22 GENE EXPRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant rs2476601 of the PTPN22 gene also affects its relative gene expression, which is lower in CD subjects compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22:RS2476601&quot;" target="&quot;T-CELL PROLIFERATION RESPONSE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genetic variations in the form of PTPN22:rs2476601 significantly impact T-cell proliferation response when MAPbacteremia is present."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN2 GENE EXPRESSION&quot;" target="&quot;PTPN2 PROTEIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression level of PTPN2 protein is correlated with the relative gene expression of PTPN2, which is lower in CD subjects compared to healthy controls."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 GENE EXPRESSION&quot;" target="&quot;PTPN22 PROTEIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variations at rs2476601 influence the expression level of PTPN22 protein and its gene, affecting disease outcomes in CD subjects."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Γ RELATIVE GENE EXPRESSION&quot;" target="&quot;MAP INFECTION SUSCEPTIBILITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher IFN-γ gene expression levels are associated with increased MAP infection susceptibility in CD subjects carrying specific genetic variants."</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPBACTEREMIA PRESENCE&quot;" target="&quot;IFN-Γ EXPRESSION LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased IFN-γ levels are associated with the presence of MAP bacteria combined with certain genetic variants in CD patients, indicating an inflammatory response."</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL PROLIFERATION RESPONSE&quot;" target="&quot;PHA TREATMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Treatment with PHA significantly increases T-cell proliferation response in both CD subjects and healthy controls, though differences are observed between groups."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPBACTEREMIA&quot;" target="&quot;T-CELLS FUNCTIONALITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The presence or absence of MAPbacteremia affects the overall functionality and proliferation rate of T-cells in CD subjects."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHA TREATMENT&quot;" target="&quot;HEALTHY CONTROL SUBJECTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Treatment with PHA shows a moderate increase in T-cell proliferation in healthy controls compared to the response seen in CD subjects."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAP PPD-LIKE TREATMENT&quot;" target="&quot;T-CELLS FUNCTIONALITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Treatment simulating MAP bacteria exposure affects the functionality of T-cells differently between CD subjects with or without MAPbacteremia."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAP PPD-LIKE TREATMENT&quot;" target="&quot;CD SUBJECTS WITHOUT MAPBACTEREMIA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The effect of MAP PPD-like treatment on T-cell proliferation is less pronounced in CD subjects who lack evidence of MAPbacteremia, suggesting a role for this environmental factor."</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22&quot;" target="&quot;LYMPHOCYTE SUBSET&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The expression levels of PTPN22 differ among various lymphocyte subsets at both rest and in response to activation."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYMPHOCYTE SUBSET&quot;" target="&quot;T1D NON-RISK ALLELE (LYP-620R)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of the non-risk allele LYP-620R in lymphocytes influences their functional characteristics and response to activation."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTIVATION STATE&quot;" target="&quot;TCR SIGNALING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Different activation states of T cells lead to varying degrees of TCR signaling activity due to differential expression of proteins like PTPN22."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTIVATION STATE&quot;" target="&quot;TCONV (NAÏVE CD4+ T CELLS)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Naive CD4+ T cells show changes in PTPN22 expression levels when transitioning from resting to activated states."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCR SIGNALING&quot;" target="&quot;MAPK/ERK PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MAPK/ERK pathway is a downstream signaling pathway initiated by TCR ligation and modulated differently depending on the variant (risk or non-risk) of PTPN22."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCR SIGNALING&quot;" target="&quot;RISK VARIANT LYP-620W&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The risk variant LYP-620W is less effective in regulating downstream signaling pathways initiated by TCR ligation compared to the non-risk variant."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCR SIGNALING&quot;" target="&quot;LYP-620W&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Overexpression of LYP-620W variant affects TCR signaling differently than the 620R variant, influencing downstream processes like cell proliferation and cytokine production.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALCIUM FLUX&quot;" target="&quot;ACTIVATION MARKERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Following calcium flux, T cells exhibit surface expression dynamics of various activation markers indicating changes in cellular activation state."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALCIUM FLUX&quot;" target="&quot;LAT SIGNALOSOME&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Following activation of the LAT signalosome, calcium flux increases significantly which can be modulated by PTPN22 variants."</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ICOS&quot;" target="&quot;TREGS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"ICOS expression is observed on regulatory T cells, indicating their activation state.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;T CELL ACTIVATION MARKERS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Overexpression of LYP-620R alters the expression kinetics of T cell activation markers, blunting their dynamic changes.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;TRESP PROLIFERATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The overexpression of LYP-620R significantly represses the proliferation of effector T cells (Tresp)."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620R&quot;" target="&quot;TREG SUPPRESSIVE CAPACITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Overexpression of LYP-620R in regulatory T cells does not significantly change their suppressive capacity compared to controls."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 RISK VARIANT&quot;" target="&quot;APC-MEDIATED PROLIFERATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The PTPN22 risk variant permits proliferation in conventional T cells but not regulatory T cells when activated by APCs.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22 RISK VARIANT&quot;" target="&quot;RS2476601 RISK VARIANT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The rs2476601 risk variant is synonymous with the PTPN22 risk variant, both associated with autoimmune disorders.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APC-MEDIATED PROLIFERATION&quot;" target="&quot;CELL TRACKING DYE DILUTION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Used to measure T cell proliferation in response to APC stimulation by assessing dye dilution over time.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PMA/IONOMYCIN-INDUCED PROLIFERATION&quot;" target="&quot;MICROBEAD ACTIVATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both microbead and PMA/ionomycin-induced activations do not alter the proliferation of transduced cells, suggesting differences in activation mechanisms.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-2 ACCUMULATION&quot;" target="&quot;T CELL CYTOKINE PRODUCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Net accumulation of IL-2 is influenced by LYP variant expression, affecting T cell cytokine production dynamics.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFNΓ SECRETION&quot;" target="&quot;LYP VARIANTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Neither LYP-620R nor LYP-620W variants significantly altered the secretion of IFNγ according to experimental data."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFNΓ SECRETION&quot;" target="&quot;PTPN22 KNOCKOUT MICE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Studies on Ptpn22 knockout mice indicate that overexpression of LYP variants does not affect IFNγ secretion."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620W&quot;" target="&quot;TREG SUPPRESSIVE CAPACITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Overexpressing LYP-620W in regulatory T cells slightly enhances their suppressive capacity over basal levels."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP-620W&quot;" target="&quot;TRESP ACTIVATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Overexpressing LYP-620W leads to reduced control over activation, proliferation, and effector mechanisms in conventional T cells (Tconv)."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREG-MEDIATED SUPPRESSION&quot;" target="&quot;PTPN22 GENE EXPRESSION LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression level of PTPN22 in regulatory T cells (Treg) is higher than that in conventional T cells (Tconv), influencing the suppressive capacity of Tregs."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE DISORDERS&quot;" target="&quot;PTPN22 RISK VARIANT (RS2476601)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The risk variant of PTPN22 is associated with an increased risk for autoimmune disorders due to its influence on Treg-mediated suppression."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH1 SIGNATURE&quot;" target="&quot;PTPN22 RISK VARIANT (RS2476601)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs2476601 variant is associated with a Th1 signature, indicating its role in autoimmune disorders."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOLOGOUS APCS&quot;" target="&quot;TREG SUPPRESSION ASSAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"APCs are used in the Treg suppression assay to assess the suppressive capacity of regulatory T cells when co-cultured with effector T cells."</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72&quot;" target="&quot;CC49 SCFV&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CC49 scFv specifically targets the TAG72 antigen expressed on cancer cells, facilitating recognition by CAR T cells."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN&quot;" target="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The 4-1BB domain is included in the CAR design to enhance activation and persistence of TAG72-BBζ CAR T cells."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD3Ζ CYTOLYTIC DOMAIN&quot;" target="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The CD3ζ domain contributes to the cytotoxic function of TAG72-BBζ CAR T cells against tumor targets expressing TAG72 antigen."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;SKOV3, OVCAR8, COV362.4, OVCAR3, OV90, LS174T&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These cancer cell lines express TAG72 and are used to evaluate the efficacy of TAG72-BBζ CAR T cells against tumors."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;TRUNCATED CD19 (CD19T)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The truncated CD19 protein serves as a marker for tracking and identifying TAG72-specific CAR T cells during their development."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;CO-CULTURE ASSAYS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Co-culture assays evaluate the ability of TAG72-specific CAR T cells to recognize and kill tumor targets expressing TAG72 antigen."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;I.P. DELIVERY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Regional intraperitoneal delivery of TAG72-BBζ CAR T cells exhibits potent anti-tumor activity, extending survival in ovarian ascites-bearing mice compared to systemic i.v. delivery."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;IFNΓ, IL-2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Upon interaction with TAG72-positive tumor cells, TAG72-BBζ CAR T cells produce cytokines like IFNγ and IL-2 as part of their anti-tumor activity."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;TAG72 EXPRESSION REDUCTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The therapy results in a decrease of TAG72 antigen on tumor cells over time, indicating a mechanism for tumor escape from targeted treatment."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72 EXPRESSION&quot;" target="&quot;OVARIAN CANCER CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Ovarian cancer cells express varying levels of TAG72, making them suitable targets for the TAG72-specific CAR T cell therapy."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER CELLS&quot;" target="&quot;ASCITES CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Cells isolated from ascites fluid represent a subset of ovarian cancer cells, often with elevated TAG72 expression, targeted by CAR T cell therapy."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS (DPBMC)&quot;" target="&quot;CD14+ AND CD25+&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Depletion of specific cell populations from dPBMCs is performed to enrich for the desired T cell population used in CAR generation."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS (DPBMC)&quot;" target="&quot;CAR TRANSDUCTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Peripheral blood mononuclear cells are transduced with the TAG72-BBζ CAR construct to generate functional CAR T cells."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CO-CULTURE ASSAYS&quot;" target="&quot;E:T RATIO&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The E:T ratio is a key parameter in co-culture assays, determining the proportion of effector CAR T cells to target tumor cells for assessing cytotoxic activity."</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OAS3, OAS4, OAS7&quot;" target="&quot;HUMAN OVARIAN CANCER ASCITES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Ascites samples from patients (OAS3, OAS4, OAS7) contain human ovarian cancer cells and are used in vitro to assess the efficacy of CAR T cell therapy."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVCAR3 CELLS&quot;" target="&quot;EGFP/FFLUC&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Transduction of OVCAR3 cells with eGFP and ffluc allows non-invasive tracking of tumor growth in mice."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NSG MICE&quot;" target="&quot;I.P. INJECTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Intraperitoneal injection of tumor cells into NSG mice is used to establish models for evaluating the therapeutic potential of TAG72-BBζ CAR T cells."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGIONAL I.P. DELIVERY&quot;" target="&quot;CAR T CELL THERAPY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The method of delivering CAR T cells directly into the peritoneal cavity enhances their anti-tumor effects compared with systemic administration."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REPEAT DOSING OF TAG72-BBΖ CAR T CELLS&quot;" target="&quot;OV90 MODEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Multiple doses of CAR T cells over a month demonstrated more durable anti-tumor responses compared with a single dose in aggressive OV90 ovarian cancer models."</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OV90 MODEL&quot;" target="&quot;CAR T CELLS EFFICACY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In the OV90 model, CAR T cells demonstrate reduced efficacy over time due to suppressive mechanisms within the tumor microenvironment."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUMOR ANTIGEN HETEROGENEITY&quot;" target="&quot;TAG72 EXPRESSION REDUCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The reduction in TAG72 expression observed post CAR T cell therapy correlates with the intrinsic tumor antigen heterogeneity characteristic of solid tumors."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUMOR ANTIGEN HETEROGENEITY&quot;" target="&quot;SOLID TUMORS AND ASCITES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Residual or recurrent cancer can persist and express varying antigen levels due to tumor heterogeneity in solid tumors and ascites sites."</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23&quot;" target="&quot;RS12441227&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The most significant SNP at this locus is rs12441227, explaining a portion of the residual variance in FEV1/FVC."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C10ORF11 GENE ON CHROMOSOME 10Q22.3&quot;" target="&quot;FEV1&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Downstream SNPs of C10orf11 are associated with FEV1, indicating a functional connection."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL23-CCL18 ON CHROMOSOME 17Q12&quot;" target="&quot;FVC AND FEV1/FVC&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This genomic variant is associated with both FVC and FEV1/FVC, indicating a role in lung function genetics."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PITPNC1 LOCUS ON CHROMOSOME 17Q24.2&quot;" target="&quot;FEV1/FVC&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The PITPNC1 locus shows evidence of association with FEV1/FVC in Hutterites, indicating genetic influence."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAF1B ON CHROMOSOME 21Q22.13&quot;" target="&quot;FEV1/FVC&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genomic variants near CHAF1B are associated with reduced FEV1/FVC, suggesting a role in lung function genetics."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL37 GENE ON CHROMOSOME 2Q13&quot;" target="&quot;FEV1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A SNP downstream of the IL37 gene is significantly associated with reduced FEV1 in Hutterites."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASXL3 ON CHROMOSOME 18Q12.1&quot;" target="&quot;FVC&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ASXL3 locus shows evidence for association with FVC, indicating genetic influence on lung function."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FEV1&quot;" target="&quot;FVC&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Both FEV1 and FVC are measures of lung function, with the FEV1/FVC ratio indicating respiratory health."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIATION&quot;" target="&quot;FEV1, FVC, FEV1/FVC RATIO&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic variation explains a significant portion of the variance in these physiological measures."</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW FEV1/FVC ALLELES&quot;" target="&quot;THSD4-UACA-TLE3 LOCUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The THSD4-UACA-TLE3 locus is associated with low FEV1/FVC alleles, suggesting a genetic predisposition towards reduced lung function."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β-DEFENSIN GENES&quot;" target="&quot;CHEMOKINE GENES (CCL18 AND CXCL12)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"β-defensins genes were found to be significantly connected with chemokine genes CCL18 and CXCL12 through the GRAIL analysis, suggesting a functional connection in lung immune responses."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β-DEFENSIN GENES&quot;" target="&quot;CCL23-CCL18 LOCUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNPs at the CCL23-CCL18 locus are significantly connected to β-defensin genes, indicating their involvement in lung immune responses and potentially influencing FEV1/FVC."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHEMOKINE GENES (CCL18 AND CXCL12)&quot;" target="&quot;TNFRSF13B GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TNFRSF13B gene was also found to be significantly connected with chemokine genes CCL18 and CXCL12, indicating its role in immune regulation related to lung function."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFRSF13B GENE&quot;" target="&quot;CCL23-CCL18 LOCUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The CCL23-CCL18 locus is also significantly connected to the TNFRSF13B gene, suggesting its role in immune regulation affecting lung function."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUTTERITES&quot;" target="&quot;RESIDUAL FEV1/FVC VARIANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The residual variance in FEV1/FVC for Hutterites was studied and analyzed in the context of genetic factors."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRAIL ALGORITHM&quot;" target="&quot;GENE ONTOLOGY DATABASE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The GRAIL algorithm was used to analyze the Gene Ontology database for functional connections between genes near predictive SNPs identified through GWAS."</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 GENE&quot;" target="&quot;RS231725&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Another significant polymorphism (rs231725) in the CTLA4 gene is associated with increased risk for primary biliary cholangitis."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 GENE&quot;" target="&quot;PBC SUSCEPTIBILITY&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The CTLA4 gene, and its various SNPs, influence an individual's susceptibility to primary biliary cholangitis."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINKAGE DISEQUILIBRIUM&quot;" target="&quot;RS231775, RS231725, RS3087243, AND RS5742909&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"There is no significant linkage disequilibrium observed between these four SNPs in the CTLA4 gene."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY ANALYSIS&quot;" target="&quot;RS231775, RS231725&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Results from sensitivity analyses suggest that associations of rs231775 and rs231725 with PBC susceptibility are robust to the exclusion of individual studies."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PUBLICATION BIAS &quot;" target="&quot;RS231775, RS231725, RS3087243, AND RS5742909&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No significant evidence of publication bias was found for these SNPs in the CTLA4 gene."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY ANALYSIS RESULTS&quot;" target="&quot;STABILITY OF FINDINGS FOR RS231775 AND RS231725&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The findings from sensitivity analysis indicate that results are stable and reliable for these two SNPs when excluding individual studies."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGGER'S TEST&quot;" target="&quot;PUBLICATION BIAS ASSESSMENT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A statistical test used to detect publication bias in meta-analysis, showing no significant evidence of bias for most SNP analyses."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BEGG'S FUNNEL PLOT&quot;" target="&quot;VISUAL REPRESENTATION OF PUBLICATION BIAS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A visual representation used to assess publication bias in meta-analysis, indicating the lack of significant bias for the majority of SNPs."</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3087243 (CT60A/G)&quot;" target="&quot;RS231806 (MH30C/G)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These two SNPs are in strong linkage disequilibrium, both influencing CTLA4 expression levels."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 PROTEIN &quot;" target="&quot;INHIBITORY IMMUNE CHECKPOINT GENE EXPRESSION LEVELS &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The protein product of the CTLA4 gene plays a crucial role in immune regulation and is influenced by the physiological process of gene expression."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4 PROTEIN &quot;" target="&quot;3’UTR OF CTLA4 &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variations within the 3' UTR of CTLA4 can influence mRNA stability, leading to differential protein levels."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1D &quot;" target="&quot;3’UTR OF CTLA4 &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variations in the 3' UTR region affect mRNA expression levels, which are linked to disease susceptibility in autoimmune conditions like T1D."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ T CELLS &quot;" target="&quot;CD8+ T CELLS &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression patterns and DNA methylation differences between CD4+ and CD8+ T cells indicate cell type-specific regulation of genes like CTLA4."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPG SITE (CG26091609)&quot;" target="&quot;CTLA4 GENE &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Methylation at this CpG site inversely correlates with CTLA4 mRNA expression levels in CD4+ and CD8+ T cells, affecting immune function."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG CODING RNA RP11−534L20.5 &quot;" target="&quot;IKBKE GENE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"RP11−534L20.5 is located downstream of the IKBKE gene and could potentially regulate its expression or function."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT6 &quot;" target="&quot;T CELL DIFFERENTIATION &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"STAT6 plays a critical role in T cell differentiation, with genetic variants influencing this process through eQTL effects."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANS-EQTL EFFECTS&quot;" target="&quot;T1D&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Transcriptional regulation influenced by distant genetic variants can impact the risk for Type 1 Diabetes (T1D)."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1131017&quot;" target="&quot;RPS26 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The trans-eQTL SNP rs1131017 is associated with broad-range effects on genes including RPS26 in CD4+ and CD8+ T cells, influencing disease susceptibility."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPS26 GENE&quot;" target="&quot;T1D&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The RPS26 gene is affected by a trans-eQTL SNP (rs1131017), influencing expression patterns that contribute to disease susceptibility including Type 1 Diabetes (T1D)."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1&quot;" target="&quot;SNP RS181206[G]&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The missense SNP in IL-27 leads to decreased expression levels of IRF1, suggesting it plays a causal role in regulating gene expression."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRF1&quot;" target="&quot;INTERFERON-INDUCED GENES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IRF1 itself is an interferon-stimulated gene whose expression can be induced by signaling through the STAT1/STAT3 pathway."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1D&quot;" target="&quot;IL-27 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IL-27 gene region harbors genetic variants that influence the expression of IRF1 and STAT1, contributing to reduced risk for Type 1 Diabetes (T1D)."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1D&quot;" target="&quot;IL27 MISSENSE VARIANT RS181206[G]&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This genetic variant influences the expression of IRF1 and STAT1, contributing to reduced risk for Type 1 Diabetes (T1D) in CD4+ T cells."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDK2 GENE&quot;" target="&quot;TRANSCRIPTIONAL REGULATION IN T CELLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The CDK2 gene within the regulatory locus at chr12q13.2 influences transcriptional regulation, affecting multiple genes' expression levels in T cells."</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERFERON-INDUCED GENES&quot;" target="&quot;STAT1/STAT3 PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The activation of this pathway leads to the expression and regulation of interferon-stimulated genes, such as IRF1."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT1/STAT3 PATHWAY&quot;" target="&quot;IL-27 SNP RS181206[G]&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The IL-27 missense SNP influences the activation of STAT1 and STAT3 pathways, affecting downstream gene expression."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 (PRO119)&quot;" target="&quot;PBMCS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The missense variant of IL-27 induces lower levels of STAT1 and IRF1 transcripts in PBMCs from healthy individuals compared to the wild-type variant."</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTRACELLULAR VESICLE TRANSPORT &quot;" target="&quot;STX2 (SYNTAXIN 7)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The gene STX2 encodes syntaxin 2, which is essential for the proper functioning of vesicle transport within cells, impacting various cellular processes including immune responses."</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 GENE&quot;" target="&quot;RS4073 GENOMIC VARIANT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs4073 polymorphism within the IL-8 gene influences asthma risk by altering genotype frequencies and associated allele effects."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4073 GENOMIC VARIANT&quot;" target="&quot;IL-8 MRNA EXPRESSION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The rs4073 polymorphism influences IL-8 mRNA expression levels, although no significant differences were observed between different genotypes within asthmatic individuals."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2227306 GENOMIC VARIANT&quot;" target="&quot;ASTHMA DISEASE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Certain genotypes of the rs2227306 polymorphism are associated with a higher risk for developing asthma, indicating genetic susceptibility to the disease."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 PROTEIN&quot;" target="&quot;ASTHMA DISEASE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Increased levels of IL-8 protein in serum are significantly higher among patients with asthma compared to controls, indicating a role for the protein in disease pathogenesis."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA DISEASE&quot;" target="&quot;IL-8 GENOTYPE DISTRIBUTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Specific genotypes of rs4073 and rs2227306 polymorphisms in the IL-8 gene are associated with increased risk for asthma development, particularly atopic asthma."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA DISEASE&quot;" target="&quot;HAPLOTYPE FREQUENCIES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Rare haplotypes of IL-8 gene polymorphisms were found to be significantly associated with reduced risk of childhood asthma in the population studied."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 MRNA LEVELS&quot;" target="&quot;PBMC COMPOSITION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant difference was observed between PBMC composition and IL-8 mRNA levels among cases and controls, suggesting that PBMC composition does not significantly affect IL-8 expression."</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ASAH1 gene is used in simulations to evaluate the power of kernel machine SNP-set tests against single SNP-based min tests."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;HAPMAP SNPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ASAH1 gene region is composed of 86 HapMap SNPs, which are used in SNP-set tests."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;" target="&quot;FGFR2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FGFR2 gene is used in simulations to show that in regions of high linkage disequilibrium, the kernel machine method outperforms min tests."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;" target="&quot;LD (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The performance of SNP-set tests can be influenced by linkage disequilibrium among SNPs within a gene region."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP-SET TEST (KERNEL MACHINE)&quot;" target="&quot;TYPE 1 ERROR RATE (Α = 0.05)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The type 1 error rate of kernel machine SNP-set tests was evaluated to ensure proper statistical significance."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST (SINGLE SNP-BASED)&quot;" target="&quot;NAT2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"For NAT2, certain SNPs show higher power with the min test compared to the kernel machine method when in high LD with typed SNPs and weak LD with others."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST (SINGLE SNP-BASED)&quot;" target="&quot;EMPIRICAL POWER&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both kernel machine and min test methods were assessed using empirical power simulations."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B GENE (HUMAN LEUKOCYTE ANTIGEN B)&quot;" target="&quot;MAF (MINOR ALLELE FREQUENCY)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HLA-B gene demonstrates how MAF affects SNP test power, with rarer alleles gaining more weight in the weighted IBS kernel."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILLUMINA HUMANHAP550 ARRAY&quot;" target="&quot;TYPED SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This array includes typed SNPs from the ASAH1 and NAT2 genes used in SNP-set tests."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINEAR KERNEL&quot;" target="&quot;IBS KERNEL AND WEIGHTED IBS KERNEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The linear kernel is compared with the IBS and weighted IBS kernels in terms of their effectiveness in SNP-set tests."</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE EFFECT&quot;" target="&quot;IBS KERNEL POWER&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Testing for the effect of the ASAH1 gene using IBS kernel has higher power compared to other kernels."</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RARE VARIANTS IMPORTANCE&quot;" target="&quot;WEIGHTED IBS KERNEL&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Incorporating rare variants importance into the weighted IBS kernel increases its effectiveness."</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1893217&quot;" target="&quot;ANTI-CTLA-4 TREATMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of the rs1893217 SNP significantly associates non-responsiveness to anti-CTLA-4 therapy in metastatic melanoma patients."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-CTLA-4 TREATMENT&quot;" target="&quot;COMBINATION THERAPY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Combination therapy involves anti-PD-1 treatment alongside or after anti-CTLA-4 treatment for metastatic melanoma patients, showing a higher response rate compared to single-agent therapies."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;ANTI-PD-1 TREATMENT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The presence of the rs17388568 SNP is associated with an increased response to anti-PD-1 therapy in metastatic melanoma patients."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17388568&quot;" target="&quot;IL2/ADAD1/IL21 LOCUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs17388568 SNP is located within the IL2, ADAD1 and IL21 genomic region that has been associated with several autoimmune conditions."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METASTATIC MELANOMA PATIENTS&quot;" target="&quot;ANTI-PD-1 TREATMENTS (NIVOLUMAB, PEMBROLIZUMAB)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"These patients are also treated with anti-PD-1 drugs which block the PD-1 receptor to enhance T cell activity against tumors."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METASTATIC MELANOMA PATIENTS&quot;" target="&quot;NYULH, UCLA, MGH&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Patients receive treatments at these institutions, indicating a geographic distribution of treatment sites for metastatic melanoma patients."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE DISTRIBUTION (62.85 YEARS MEDIAN AGE)&quot;" target="&quot;ICI EFFICACY TESTING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The efficacy testing of ICI treatments in metastatic melanoma patients considers the impact of different ages, including a median patient age of 62.85 years."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX DISTRIBUTION (67% MALE)&quot;" target="&quot;ICI EFFICACY TESTING&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Evaluations for treatment efficacy consider sex distribution in the study population with males accounting for 67 percent of patients."</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-CTLA-4, ANTI-PD-1 AND COMBINATION-THERAPY TREATED PATIENTS GROUPING&quot;" target="&quot;TREATMENT RESPONSE ASSOCIATION ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This grouping of patients was created to analyze the association between different treatments and patient responses across multiple therapies."</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREATMENT RESPONSE ASSOCIATION ANALYSIS&quot;" target="&quot;AGE, SEX AND TREATMENT DRUGS ADJUSTMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Adjustments were made to control environmental factors (age, sex, treatment drugs) in the pooled association analysis for more accurate results."</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TRAF3&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"EBNA2 preferentially binds to the risk allele for TRAF3 and decreases its expression relative to B cells, suggesting a role in immune evasion through altered gene regulation."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;CD40&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"EBNA2 alters CD40's allelic expression directionally compared to uninfected B cells, indicating a potential mechanism for immune evasion by modulating MS risk genes."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TNFAIP8&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"EBNA2 increases the expression of TNFAIP8, altering its role in host immune response and possibly contributing to enhanced viral survival strategies."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TNFRSF1A&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"EBNA2 binds to the protective allele for TNFRSF1A and decreases its expression compared to B cells, suggesting a mechanism through which EBV might evade host immune defenses."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRAF3/RCOR1 SNP (RS1258869)&quot;" target="&quot;EBNA2-TAT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The TRAF3/RCOR1 risk allele binding preference by EBNA2 influences the response to EBNA2-TAT treatment, altering MS-associated gene expression.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP8 LOCUS SNP (RS32658)&quot;" target="&quot;EBV DNA COPY NUMBER STABILITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The TNFAIP8 locus genotype influences EBV DNA copy number stability, which is affected upon inhibition of EBNA2 function by EBNA2-TAT treatment.")&lt;SEP&gt;"The genotype at TNFAIP8 locus affects EBV DNA copy number stability in untreated LCLs, which is altered upon treatment with EBNA2-TAT.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2-TAT&quot;" target="&quot;LMP1 GENE EXPRESSION REGULATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Inhibition of EBNA2 by EBNA2-TAT significantly reduces LMP1 expression, disrupting the EBV latency III growth program.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2-TAT&quot;" target="&quot;TRAF3, CD40, CLECL1, TNFAIP8, AND TNFRSF1A GENE EXPRESSION REGULATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Inhibition of EBNA2 transcriptional function by EBNA2-TAT alters the expression levels of MS risk genes in LCLs.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2-TAT&quot;" target="&quot;RBP-JΚ SITE BINDING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Inhibition of the EBNA2 interaction with RBP-Jκ is mediated by EBNA2-TAT, leading to altered transcriptional regulation.")</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRAF3&quot;" target="&quot;IMMUNE EVASION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Altered TRAF3 expression due to EBNA2 binding may contribute to immune evasion by affecting signaling pathways involved in host defense."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP8&quot;" target="&quot;VIRAL SURVIVAL STRATEGY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Increased TNFAIP8 expression due to EBNA2 interaction may serve as a viral survival strategy by altering host inflammatory responses."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFRSF1A&quot;" target="&quot;IMMUNE DEFENSE SUPPRESSION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Decreased TNFRSF1A expression from preferential EBNA2 binding may suppress immune defense mechanisms, aiding in the virus's evasion of detection."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBV LATENCY III PROGRAM&quot;" target="&quot;MS RISK GENES&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"EBNA2/risk gene interactions within the EBV latency III program are proposed to increase or decrease gene expression, influencing the virus's ability to evade host immunity."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBV LATENCY III PROGRAM&quot;" target="&quot;LMP1&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The interaction between LMP1 and MS risk genes within the EBV latency III program is crucial for viral survival strategies."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS RISK LOCI&quot;" target="&quot;EBNATBXTAT TREATMENT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The effect of EBNA2-TAT treatment on MS risk loci suggests that EBNA2's interaction with these genomic variants is crucial for regulating gene expression involved in immune evasion."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2-TAT TREATMENT&quot;" target="&quot;GENE EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Treatment with EBNA2-TAT modulates gene expression in a way that suggests it affects the interaction between EBNA2 and MS risk alleles."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LMP2&quot;" target="&quot;IMMUNE EVASION MECHANISM&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Proximal interactions of LMP2 with MS risk genes, regulated by EBNA2, suggest roles in immune evasion mechanisms."</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3842787&quot;" target="&quot;COX-1 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The COX-1 gene contains the genomic variant rs3842787, which was found to have no significant association with aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS20417&quot;" target="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs20417 genomic variant is significantly associated with increased risk of aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS20417&quot;" target="&quot;COX-2 GENE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A polymorphism in the COX-2 gene (rs20417) is associated with increased risk of aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS20417&quot;" target="&quot;CAD&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The genomic variant rs20417 is significantly related to differences in Coronary Artery Disease between patients and controls."</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643&quot;" target="&quot;AVERAGED PLATELET NUMBER&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The averaged platelet number contributes significantly to the heterogeneity explained by the genomic variant rs1126643."</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASPIRIN INSENSITIVITY&quot;" target="&quot;RS1126643-T ALLELE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The T allele of the rs1126643 variant is strongly associated with a higher risk of aspirin insensitivity, especially under dominant genetic models."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUCASIAN PATIENTS AND CONTROLS&quot;" target="&quot;CHINESE PATIENTS AND CONTROLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Differences in frequencies of certain polymorphisms between Caucasian and Chinese populations influence the prediction strength for aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ITGA2 GENE&quot;" target="&quot;RS1126643-T ALLELE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The ITGA2 gene contains a polymorphism, rs1126643, where the T allele is strongly associated with increased risk of aspirin insensitivity."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;META-REGRESSION MODEL&quot;" target="&quot;STUDY-LEVEL CONTINUOUS COVARIATES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The meta-regression model incorporates study-level continuous covariates to account for variability and enhance the analysis of genetic variants."</data>
      <data key="d6">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643-T ALLELE&quot;" target="&quot;RISK ESTIMATES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The risk estimates associated with the T allele of rs1126643 were notably high for aspirin insensitivity, especially under a dominant genetic model."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM DEVIATIONS&quot;" target="&quot;RS20118426 AND RS1126643&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Deviations from Hardy-Weinberg equilibrium were observed for the genomic variants rs20118426 and rs1126643 in some comparisons."</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B GENE&quot;" target="&quot;GROWTH HORMONE (GH)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"GH signaling involves STAT5B activation, which is impaired in individuals with mutations affecting this gene."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B GENE&quot;" target="&quot;IL-2 SIGNALING PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"STAT5B is essential for IL-2 signaling, which regulates T cell homeostasis and the induction of FOXP3 expression in regulatory T cells; deficiencies lead to impaired Treg function.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)&quot;" target="&quot;GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"rhIGF-1 is used to treat GHI, improving growth and immune function in patients with STAT5B mutations."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)&quot;" target="&quot;SERUM GH LEVELS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Despite clinical presentation indicative of GHI, serum GH levels are normal, suggesting a defect downstream from GH signaling."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)&quot;" target="&quot;IGF-1 LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Abnormally low IGF-1 levels in patients with STAT5B mutations suggest impaired growth hormone signaling."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)&quot;" target="&quot;IGF BINDING PROTEIN-3 (IGFBP3)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Abnormally low IGFBP3 levels contribute to the diagnosis of GHI, as it affects IGF bioavailability."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)&quot;" target="&quot;ACID LABILE SUBUNIT (ALS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Low ALS levels are indicative of impaired GH signaling pathways in individuals with GHI."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE THYROIDITIS&quot;" target="&quot;REACTIVE AIRWAY DISEASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both conditions often coexist and are part of a broader immune dysregulation observed in siblings with STAT5B mutations."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE THYROIDITIS&quot;" target="&quot;LEVOTHYROXINE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Levothyroxine is prescribed to treat autoimmune thyroiditis by providing the necessary thyroxine hormone."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE THYROIDITIS&quot;" target="&quot;ANTI-THYROGLOBULIN ANTIBODIES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of anti-thyroglobulin antibodies is a hallmark of autoimmune thyroiditis, which can develop in individuals with STAT5B deficiency.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHRONIC ECZEMA&quot;" target="&quot;ATOPY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Elevated IgE levels, often seen in patients with a LOF STAT5B variant, are associated with chronic eczema and reactive airway disease indicative of an atopic phenotype.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEVERE SHORT STATURE&quot;" target="&quot;INFECTIONS (SKIN, URINARY TRACT, PULMONARY)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Recurrent infections contribute to growth failure and the overall clinical presentation of GHI in affected individuals."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GASTROESOPHAGEAL REFLUX DISEASE&quot;" target="&quot;PHYSICAL COMFORT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This disease affects physical comfort, impacting quality of life in patients with STAT5B mutations."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNEUMONIA WITH SEPSIS&quot;" target="&quot;SUPPLEMENTAL OXYGEN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Patients with pneumonia and sepsis may require supplemental oxygen to manage respiratory distress."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DERMAL FIBROBLASTS&quot;" target="&quot;MUTATION CONFIRMATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Fibroblast cultures from affected individuals confirmed the homozygous mutation in STAT5B through sequencing."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SRC HOMOLOGY 2 (SH2) DOMAIN&quot;" target="&quot;STAT5B FUNCTIONALITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SH2 domain is crucial for STAT5B activation and function; mutations affecting it impair protein activity."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSACTIVATION DOMAIN (TAD)&quot;" target="&quot;GENE EXPRESSION REGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"TADs regulate gene expression by binding to DNA and promoting transcription, which is affected in the p.W631* variant."</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.W631* VARIANT STAT5B&quot;" target="&quot;T CELL LYMPHOPENIA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The p.W631* variant of the STAT5B gene is associated with reduced expression and subsequent impairment of T cell levels, leading to T cell lymphopenia in affected individuals.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.W631* VARIANT STAT5B&quot;" target="&quot;GH (GROWTH HORMONE)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"GH affects the expression and phosphorylation state of p.W631* variant STAT5B, impacting its function in immune cells.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELL LYMPHOPENIA&quot;" target="&quot;MEMORY CD8+ T CELLS DYSREGULATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"STAT5B deficiency results in a pronounced dysregulation of memory CD8+ T cells, with persistent reductions in naïve and increases in effector memory T cells leading to overall reduced T cell levels.")</data>
      <data key="d6">chunk-e323b0d4f82733a78f687e51f47b500a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ TEM CELLS&quot;" target="&quot;NORMAL RANGE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Proportion of CD4+ TEM cells remains within normal ranges despite the genomic variant, indicating no significant impact on this subset."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ TEM CELLS&quot;" target="&quot;NO ALTERATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Proportion of CD4+ TEM cells does not alter with age, indicating that the STAT5B variant has no significant impact on these T cell subsets."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ TEM CELLS&quot;" target="&quot;DYSREGULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increase in CD8+ TEM cell proportions with age is clinically significant and linked to dysregulation due to STAT5B deficiency."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ TEMRA CELLS&quot;" target="&quot;NORMALIZATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Elevations during infancy normalize around age 4, suggesting a developmental impact of the LOF variant on CD8+ TEMRA cell regulation."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DYSREGULATION OF CD8+ T CELLS&quot;" target="&quot;CD8+ MEMORY T CELLS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The dysregulation observed affects CD8+ memory T cells but does not significantly impact CD4+ memory T cell subsets."</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01&quot;" target="&quot;RS28383172, RS2395182, RS4713586, RS7775228&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SNPs are being investigated as potential predictors for the HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype carrier status."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS28383172, RS2395182, RS4713586, RS7775228&quot;" target="&quot;LINKAGE DISEQUILIBRIUM (LD)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNPs exhibit linkage disequilibrium in the studied populations."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS&quot;" target="&quot;CUSTOM TAQMAN SNP GENOTYPING ASSAY, KASPAR-ON-DEMAND PREVALIDATED ASSAYS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These genotyping techniques are used to determine the carrier status of this specific HLA haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS&quot;" target="&quot;EXON 2 OF HLA-DRB1 GENE, EXONS 2 AND 3 OF HLA-DQB1 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genetic variants in these exons are crucial for determining the carrier status of the specific haplotype associated with certain diseases."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS&quot;" target="&quot;RS28383172 AG OR GG GENOTYPES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The presence of these genotypes is associated with a high likelihood of being a carrier for the specific HLA haplotype."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS&quot;" target="&quot;RS2395182 TT OR TG AND RS4713586 TT AND RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These specific combinations of genotypes are strongly associated with the HLA haplotype carrier status."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CUSTOM TAQMAN SNP GENOTYPING ASSAY, KASPAR-ON-DEMAND PREVALIDATED ASSAYS&quot;" target="&quot;HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES, RS28383172, RS2395182, RS4713586, RS7775228&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These genotyping techniques are used to accurately determine the presence of specific SNPs and alleles within the HLA complex."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES&quot;" target="&quot;EXON 2 OF HLA-DRB1 GENE, EXONS 2 AND 3 OF HLA-DQB1 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These alleles within the specific exons are being investigated for their role in determining disease susceptibility."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The haplotype is a potential marker for screening E. coli ASP hypersensitivity, indicating its genetic contribution to the disease."</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;SNP-GENOTYPED SUBPOPULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SNP-genotyped subpopulation was used to evaluate the performance of the HLA haplotype and its surrogate markers."</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;" target="&quot;2-SNP TAGGING ALGORITHM V&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Algorithm V was used to identify surrogate markers for the haplotype, showing similar performance metrics but not perfect prediction."</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;E. COLI ASP HYPERSENSITIVITY&quot;" target="&quot;SNP-GENOTYPED SUBPOPULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The sensitivity and specificity of screening tests were evaluated in a subpopulation genotyped for SNPs related to E. coli ASP hypersensitivity."</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2-SNP TAGGING ALGORITHM V&quot;" target="&quot;ALGORITHM II&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Algorithm V showed better performance measures compared to Algorithm II, particularly in terms of specificity and positive predictive value."</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2-SNP TAGGING ALGORITHM V&quot;" target="&quot;ALGORITHM III&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The values of parameters for Algorithm V were generally higher than those of Algorithm III in various comparisons."</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2-SNP TAGGING ALGORITHM V&quot;" target="&quot;ALGORITHM IV&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Algorithm V outperformed Algorithm IV across different performance metrics, indicating superior tagging efficiency."</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS28383172 AG OR GG GENOTYPES&quot;" target="&quot;HLA-DRB1*07:01 ALLELE CARRIER STATUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The G allele of rs28383172 is in perfect concordance with the HLA-DRB1*07:01 allele carrier status."</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE &quot;" target="&quot;HIV DISEASE STAGE &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The prevalence of specific genotypes within the TLR7 gene is associated with different stages of HIV disease progression.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE &quot;" target="&quot;GENOMIC VARIANT (RS179008 AA)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The AA genotype of TLR7 rs179008 is distributed similarly among tobacco-consuming and non-consuming HIV-infected individuals.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE &quot;" target="&quot;GENOMIC VARIANT (RS179008 CC)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CC genotype of TLR7 rs179008 did not show significant differences in distribution among tobacco-using and non-consuming HIV-infected individuals.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE &quot;" target="&quot;GENOMIC VARIANT (RS179008 CT)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CT genotype of TLR7 rs179008 was present with similar frequency in both tobacco-using and non-consumers among HIV-infected individuals.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE &quot;" target="&quot;GENOMIC VARIANT (RS179009 AA)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The distribution of the AA genotype for TLR7 rs179009 was similar between alcohol-consuming and non-consuming HIV-infected individuals, indicating no significant environmental impact.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7 GENE &quot;" target="&quot;GENOMIC VARIANT (RS179009 AG)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Higher frequency of the AG genotype in tobacco consumers compared to non-users among HIV-infected individuals, although not statistically significant.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV DISEASE STAGE &quot;" target="&quot;GENOMIC VARIANT (RS179009 GG)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GG genotype for TLR7 rs179009 showed reduced frequency in advanced stages of HIV disease compared to healthy controls, suggesting potential association with progression.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS (TOBACCO &amp; ALCOHOL)&quot;" target="&quot;GENOMIC VARIANT (RS179008)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The distribution of TLR7 rs179008 polymorphism did not differ significantly between HIV-infected individuals with and without tobacco or alcohol use.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS (TOBACCO &amp; ALCOHOL)&quot;" target="&quot;GENOMIC VARIANT (RS179009)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The distribution of TLR7 rs179009 polymorphism did not differ significantly between HIV-infected individuals with and without tobacco or alcohol use.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TLR7&quot;" target="&quot;RS179009&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Similarly, another genetic variant within the TLR7 gene is rs179009, also investigated concerning HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOBACCO USAGE&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Tobacco usage may affect the rate and severity of HIV disease progression, acting as a modifiable environmental risk factor."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL USAGE&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Like tobacco, alcohol consumption is considered for its potential impact on accelerating or mitigating HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE CD4 COUNTS&quot;" target="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CD4 counts at the time of initial diagnosis are a key indicator used to predict and monitor HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE CD4 COUNTS&quot;" target="&quot;MULTIVARIATE LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CD4 counts are a key variable analyzed using multivariate logistic regression in studies of HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TABLE NOT SHOWN&quot;" target="&quot;RISK FACTOR ASSESSMENT RESULTS FOR HIV DISEASE PROGRESSION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The table not shown contains results of risk factor assessment concerning factors like TLR7 polymorphisms and CD4 counts."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT (RS179008)&quot;" target="&quot;HEALTHY CONTROL &quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The distribution of rs179008 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROL &quot;" target="&quot;GENOMIC VARIANT (RS179009)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The distribution of rs179009 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK FACTOR FOR HIV DISEASE PROGRESSION&quot;" target="&quot;TLR7 POLYMORPHISMS (RS179008, RS179009)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Polymorphisms within the TLR7 gene were examined but not found to be significant independent risk factors for HIV disease progression."</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;PROTECT SOFTWARE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ProTECT software is used to predict and validate neoepitopes arising from the ALK R1275Q mutation."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q&quot;" target="&quot;MAQDIYRASY (NEOEPITOPE)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The MAQDIYRASY neoepitope is derived from the ALK R1275Q mutation and may be a target for immune responses."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NRAS Q61K&quot;" target="&quot;NBL (NEUROBLASTOMA)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Activating mutations like NRAS Q61K are also observed in neuroblastoma, suggesting roles in tumorigenesis."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NRAS Q61K&quot;" target="&quot;ILDTAGKEEY (NEOEPITOPE)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The ILDTAGKEEY neoepitope arises from the NRAS Q61K mutation and binds HLA-A*01:01."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NBL (NEUROBLASTOMA)&quot;" target="&quot;ZNF717 Q716 MUTATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The ZNF717 Q716 mutation is observed in neuroblastoma samples, indicating its potential role in tumorigenesis."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;AQDIYRASYY (NEOEPITOPE)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The AQDIYRASYY neoepitope binds strongly to HLA-B*15:01, indicating potential immunological relevance."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;NONAMER PEPTIDE AQDIYRASY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The nonamer peptide adopts a canonical extended conformation when bound to HLA-B*15:01, with N-terminal and C-terminal anchors deeply embedded within the binding groove."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;DECAMER PEPTIDE AQDIYRASYY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The decamer peptide adopts a short 310 helical backbone conformation when bound to HLA-B*15:01, with Tyr10 replacing Tyr9 as the C-terminal anchor residue."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;ALK R1275Q NEOEPITOPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ALK R1275Q neoepitope forms a stable complex with HLA-B*15:01, indicating strong binding affinity and immunogenic potential.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;SELF-PEPTIDE ARDIYRASY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The self-peptide ARDIYRASY shows poor binding to HLA-B*15:01 due to steric hindrance, reflecting immune tolerance mechanisms.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;SARS CORONAVIRUS-DERIVED EPITOPE VQQESSFVM &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Used as a positive control in experiments to validate T cell recognition of known epitopes."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AQDIYRASYY (NEOEPITOPE)&quot;" target="&quot;SEC (SIZE EXCLUSION CHROMATOGRAPHY)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SEC was used to purify and confirm the formation of stable complexes between AQDIYRASYY neoepitopes and HLA-B*15:01."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GMAQDIYRA (NEOEPITOPE)&quot;" target="&quot;HLA-A*02:01&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The GMAQDIYRA neoepitope has a predicted binding affinity for HLA-A*02:01, suggesting potential immune responses."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILDTAGKEEY (NEOEPITOPE)&quot;" target="&quot;HLA-A*01:01&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The ILDTAGKEEY neoepitope binds effectively to HLA-A*01:01, suggesting it may elicit specific T cell responses."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-A*01:01&quot;" target="&quot;DECAMER PEPTIDE AQDIYRASYY &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Formed stable p/MHC complexes with the decamer peptide for structural and functional characterization."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LC–MS (LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY)&quot;" target="&quot;AQDIYRASY (NEOEPITOPE)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"LC-MS confirmed the presence of AQDIYRASYY in HLA-B*15:01 complexes, validating its binding affinity."</data>
      <data key="d6">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;DECAMER PEPTIDE AQDIYRASYY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The decamer peptide forms a more compact 310 helical structure compared to the extended backbone of the nonamer peptide, suggesting distinct binding modes."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;HLA-B*15:01 BINDING MOTIF&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The nonamer peptide fits established HLA-B*15:01-binding motifs with preferred anchor residues at positions 2 and 9."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;EPSTEIN–BARR VIRUS EPITOPE LEKARGSTY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both epitopes from Epstein–Barr virus and the nonamer peptide display similar binding conformations within HLA-B*15:01."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both epitopes from human ubiquitin-conjugating enzyme-E2 and the nonamer peptide display similar binding conformations within HLA-B*15:01."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;SARS CORONAVIRUS EPITOPE VQQESSFVM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both epitopes from SARS coronavirus and the nonamer peptide display similar binding conformations within HLA-B*15:01."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;EPSTEIN–BARR VIRUS EPITOPE LEKARGSTY BINDING MODE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both epitopes exhibit similar extended conformation when bound to HLA-B*15:01, indicating a conserved binding mode."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY BINDING MODE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both epitopes exhibit similar extended conformation when bound to HLA-B*15:01, indicating a conserved binding mode."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY&quot;" target="&quot;SARS CORONAVIRUS EPITOPE VQQESSFVM BINDING MODE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both epitopes exhibit similar extended conformation when bound to HLA-B*15:01, indicating a conserved binding mode."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECAMER PEPTIDE AQDIYRASYY&quot;" target="&quot;HLA-B*15:01 BINDING MOTIF&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The decamer peptide fits established HLA-B*15:01-binding motifs but forms a more compact helix, burying residues further into the groove."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECAMER PEPTIDE AQDIYRASYY&quot;" target="&quot;NONAMER PEPTIDE AQDIYRASY BINDING MODE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The decamer peptide forms a more compact helical structure compared to the extended backbone of the nonamer peptide, indicating distinct binding modes within HLA-B*15:01."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEOEPITOPES&quot;" target="&quot;T-CELL RECEPTORS (TCRS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Neoepitopes can be recognized by TCRs when bound to HLA molecules in a manner that depends on their conformation and surface features."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL RECOGNITION&quot;" target="&quot;NONAMER PEPTIDE AQDIYRASY BINDING MODE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"TCRs recognize nonamer peptides bound to HLA-B*15:01 in an extended conformation, leading to immune responses."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL RECOGNITION&quot;" target="&quot;DECAMER PEPTIDE AQDIYRASYY BINDING MODE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"TCRs may recognize decamer peptides bound to HLA-B*15:01 differently due to the distinct surface features of their binding modes."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q NEOEPITOPE&quot;" target="&quot;TERTIARY STRUCTURE COMPACTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ALK R1275Q neoepitope binds to HLA-B*15:01 through a compacted tertiary structure, enhancing stability and interaction strength.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-PEPTIDE ARDIYRASY&quot;" target="&quot;TERTIARY STRUCTURE COMPACTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The self-peptide ARDIYRASY does not undergo similar compaction or stabilization mechanisms as the neoepitope when interacting with HLA-B*15:01.")</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCRS&quot;" target="&quot;PEPTIDE DOCKING APPROACH&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The docking approach predicts how peptides will interact with HLA molecules, which is essential for understanding TCR recognition of neoepitopes."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01 STRUCTURE&quot;" target="&quot;NONAMER/HLA-B*15:01 STRUCTURES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The structure of HLA-B*15:01 serves as a template for modeling peptide conformations in other HLA alleles."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXTENDED AND 310 HELICAL CONFORMATIONS&quot;" target="&quot;HLA-A*01:01 BINDING POCKET RESIDUES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The pocket residues of HLA-A*01:01 play a critical role in stabilizing the extended and helical conformations of ALK-derived peptides."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15 ALLELES&quot;" target="&quot;POLAR CONTACTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Specific polar contacts within the binding pockets of HLA-B*15 alleles are crucial for peptide binding, influencing immune response specificity."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-A ALLELES&quot;" target="&quot;NONAMER PEPTIDE &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Several HLA-A alleles exhibit lower binding energies than the initial HLA-B*15:01 template for the nonamer peptide."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B ALLELES&quot;" target="&quot;DECAMER PEPTIDE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Some specific HLA-B alleles show low binding energies for the decamer peptide, indicating a broad potential repertoire of HLAs displaying this epitope."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-C ALLELES&quot;" target="&quot;NONAMER/DECAMER PEPTIDES &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"HLA-C alleles also exhibit lower binding energies than initial templates for both nonamer and decamer peptides, contributing to the broader HLA display of ALK-derived neoepitopes."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOCK POLYALA HLA &quot;" target="&quot;NONAMER/DECAMER PEPTIDES &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A mock polyAlanine model demonstrates high binding energy compared to actual good binders, indicating its utility as a negative control in peptide-HLA binding studies."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KULLBACK–LEIBLER SEQUENCE LOGO &quot;" target="&quot;HLA-B*15:84 AND HLA-B*15:107 &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The sequence logo reveals key residues that allow peptides to be accommodated in the MHC groove, including those specific for high-affinity binders like HLA-B*15:84 and B*15:107."</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MHC COMPLEX FORMATION &quot;" target="&quot;CD8+ T CELL RECOGNITION &quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The formation of p/MHC complexes is essential for the presentation and recognition by CD8+ T cells."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β2-MICROGLOBULIN (Β2M)&quot;" target="&quot;HLA-A*01:01, HLA-B*15:01 &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Binds to HLA proteins as part of the MHC class I complex for peptide presentation."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TETRAMER STAINING ASSAY &quot;" target="&quot;CD8+ T CELL RECOGNITION &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Used to identify CD8+ T cells reactive to specific p/MHC complexes."</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER PEPTIDE AQDIYRASY BINDING MODE&quot;" target="&quot;HLA-B*15:01 BINDING GROOVE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The binding groove accommodates the extended conformation of nonamer peptides, with specific anchor residues deeply embedded in pockets."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01 BINDING GROOVE&quot;" target="&quot;DECAMER PEPTIDE AQDIYRASYY BINDING MODE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The binding groove adapts to accommodate the compact 310 helical conformation of decamer peptides, with a more buried and amphipathic structure."</data>
      <data key="d6">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643-G&quot;" target="&quot;CLL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The rs35923643-G SNP has been identified as a risk allele for CLL based on meta-analysis results."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRAMD1B GENE&quot;" target="&quot;IGM ANTI-PC LEVELS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Variants in the GRAMD1B gene are associated with IgM anti-PC levels through linkage disequilibrium."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665-A&quot;" target="&quot;GENERAL IGM LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs735665-A SNP is a key genetic variant specific for general IgM, as identified in GWAS analyses."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC LEVELS&quot;" target="&quot;POLYGENIC RISK SCORE (PRS)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A PRS based on alleles increasing IgM anti-PC levels was found to be associated with higher risk of CLL."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC LEVELS&quot;" target="&quot;IGM ANTI-PC DISCOVERY GWAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The discovery phase identified significant SNPs influencing IgM anti-PC levels, providing insights into genetic susceptibility to these levels."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC LEVELS&quot;" target="&quot;11Q24.1 SNPS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The significant SNPs in the 11q24.1 region are strongly associated with IgM anti-PC levels, highlighting their importance in the physiological process."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;1P31.3 SNPS&quot;" target="&quot;VALIDATION COHORT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNPs in the 1p31.3 region were not replicated, indicating a lack of consistent association across different cohorts."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLL GWAS META-ANALYSIS&quot;" target="&quot;RS735665-A RISK ALLELE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The meta-analysis of CLL GWASs identified the risk allele rs735665-A, contributing to understanding genetic predisposition to CLL."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENERAL IGM LEVELS GWAS&quot;" target="&quot;RS735665-A SPECIFICITY FOR GENERAL IGM&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The GWAS results indicate that rs735665-A is specific for general IgM levels, distinguishing it from other immunoglobulin types."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS ANALYSIS OF IGM ANTI-PC&quot;" target="&quot;CLL RISK PREDICTION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"PRS analysis based on IgM anti-PC increasing alleles predicts higher risk of CLL, linking physiological processes to disease susceptibility."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NAGELKERKE R^2 &quot;" target="&quot;VARIANCE EXPLAINED BY PRSS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The Nagelkerke r^2 statistic measures how well PRSs explain variance in CLL risk, indicating the cumulative impact of genetic variants."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTONE MARK H3K4ME1 AND DNASEI HYPERSENSITIVITY&quot;" target="&quot;REGULATORY FUNCTION PREDICTION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"These marks predict potential regulatory functions of genetic variants within the 11q24.1 locus, aiding in understanding their roles in physiological processes."</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;H3K4ME1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs35923643 is located at a peak of monomethylated histone H3 lysine 4, suggesting potential regulatory function."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;DNASEI HYPERSENSITIVITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Peaks of DNaseI hypersensitivity were found at the genomic position of rs35923643 in GM12878 and other cell lines, indicating regulatory activity."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;IGM ANTI-PC AND CLL ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The association between IgM anti-PC levels and CLL cases may be influenced by the genomic variant rs35923643, as it is located in a regulatory region."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;REGULOMEDB DATABASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The RegulomeDB database supports evidence that SNP rs35923643 affects binding of transcription factors, implicating it in regulatory function."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPTION FACTORS (TFS)&quot;" target="&quot;RUNX3 BINDING MOTIF&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Binding sites for 10 different transcription factors within the ~700bp region around rs35923643, including RUNX3 binding motifs that include SNP rs35923643."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPTION FACTORS (TFS)&quot;" target="&quot;CHROMATIN IMMUNOPRECIPITATION-SEQUENCING (CHIP-SEQ)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The ChIP-seq technique was used to identify binding sites for 22 different transcription factors within the genomic region around rs35923643."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPTION FACTORS (TFS)&quot;" target="&quot;ENCYCLOPEDIA OF DNA ELEMENTS (ENCODE)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"ENCODE data provided evidence for TF binding in the ~700bp region around rs35923643, involving various transcription factors including RUNX3 and SPI1."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPTION FACTORS (TFS)&quot;" target="&quot;FIND INDIVIDUAL MOTIF OCCURRENCES (FIMO)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FIMO tool was used to identify the strongest binding motifs for transcription factors like RUNX3 and SPI1 within the region around rs35923643."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RUNX3 BINDING MOTIF&quot;" target="&quot;SPI1 (PU.1)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both RUNX3 and SPI1 transcription factors show strong binding signals in the region around rs35923643, suggesting potential regulatory roles."</data>
      <data key="d6">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
      <data key="d7">1</data>
    </edge>
  </graph>
</graphml>
